Sentence,class,file
"Retrieved December 23, 2010, from http://www.zinpro.com/lameness/swine/ lesion-identiﬁcation.",Non-OADS,/arxiv_data1/oa_pdf/5e/c1/S1751731113000232a.PMC3666190.pdf
"Retrieved November 2, 2012, from http://www.nsif.com/Conferences/2006/pdf/FactorsInﬂuencingSowCulling.pdf.",Non-OADS,/arxiv_data1/oa_pdf/5e/c1/S1751731113000232a.PMC3666190.pdf
"Retrieved January 10, 2012, from http://www.fao.org/ﬁleadmin/user_upload/animalwelfare/TheeconomicandwelfareimpactoﬂamenessinsowsinEngland.pdf.Economic impact of lameness in group-housed sows 1181",Non-OADS,/arxiv_data1/oa_pdf/5e/c1/S1751731113000232a.PMC3666190.pdf
Available at: http://dailymed.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/50/3d/10.1177_0269881113482532.PMC3666194.pdf
Available at: http://www.SfN.,Non-OADS,/arxiv_data1/oa_pdf/50/3d/10.1177_0269881113482532.PMC3666194.pdf
Avail - able at: http://clinicaltrials.gov/ct2/show/NCT00247572 (accessed   August 2012).,Non-OADS,/arxiv_data1/oa_pdf/50/3d/10.1177_0269881113482532.PMC3666194.pdf
Available at:  http://clinicaltrials.gov/show/NCT00248092 (accessed  August 2012).,Non-OADS,/arxiv_data1/oa_pdf/50/3d/10.1177_0269881113482532.PMC3666194.pdf
Available  at: http://www.SfN.org (accessed August 2012).,Non-OADS,/arxiv_data1/oa_pdf/50/3d/10.1177_0269881113482532.PMC3666194.pdf
Available at: http://dailymed.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/50/3d/10.1177_0269881113482532.PMC3666194.pdf
The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike licence <http://creativecommons.org/licenses/ by-nc-sa/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/b2/c5/S0021932012000466a.PMC3666211.pdf
"By 2008, the results were reported to be ‘staggering’ and elimination of the disease was anticipated to be a real possibility by 2020 (‘End in sight’ for elephantiasis, BBC,8th October 2008, http://news.bbc.co.uk/1/hi/health/7659222.stm).",Non-OADS,/arxiv_data1/oa_pdf/b2/c5/S0021932012000466a.PMC3666211.pdf
"is reﬂected in statements such as those by the WHO Department of Control of Neglected Tropical Diseases in 2011, suggesting the campaign is ‘halfway towards eliminatinglymphatic ﬁlariasis’ (http://www.who.int/neglected_diseases/integrated_media/integrated_ media_urogenital_lf_2011/en/index.html), and by those associated with the January 2012 joint London Declaration on Neglected Tropical Diseases (NTDs), in which partnerspledged new levels of collaboration and announced a co-ordinated push to accelerateprogress toward the eradication of lymphatic ﬁlariasis and the control or eliminationof a range of other NTDs (http://www.dﬁd.gov.uk/Documents/publications1/NTD%20Event%20-%20Table%20of%20Commitments.pdf).",Non-OADS,/arxiv_data1/oa_pdf/b2/c5/S0021932012000466a.PMC3666211.pdf
URL: http://www.dailynews.co.tz/feature/?search=Rowdy+mob+Morogoro& searchtext=Search.M.,Non-OADS,/arxiv_data1/oa_pdf/b2/c5/S0021932012000466a.PMC3666211.pdf
URL: http://www.irinnews.org/printreport.aspx?,Non-OADS,/arxiv_data1/oa_pdf/b2/c5/S0021932012000466a.PMC3666211.pdf
URL: http://www.ntd.rti.org/publications/ index.cfm?fuseaction=throwpub&id=294 (accessed 27th March 2012).M.,OADS,/arxiv_data1/oa_pdf/b2/c5/S0021932012000466a.PMC3666211.pdf
URL: http://www.who.int/ lymphatic_ﬁlariasis/disease/en/ (accessed 27th March 2012).,Non-OADS,/arxiv_data1/oa_pdf/b2/c5/S0021932012000466a.PMC3666211.pdf
2009); (3) its persistent activation elicits the opening of a membrane pore permeable to The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike licence <http://creativecommons.org/licenses/by-nc-sa/2.5/ >.,Non-OADS,/arxiv_data1/oa_pdf/53/72/S1461145711001933a.PMC3666310.pdf
"Microarray proﬁling on amygdalasamples was performed in the Agilent MicroarrayCore Facility (Semmelweis University, Budapest;http://www.dgci.sote.hu/microarray).",OADS,/arxiv_data1/oa_pdf/53/72/S1461145711001933a.PMC3666310.pdf
2002) through GEO series accession number GSE21218 (http://www.ncbi.nlm.nih.gov/g eo/query/acc.cgi?token= rzwxlikqskwayfk&acc=GSE21218).,Non-OADS,/arxiv_data1/oa_pdf/53/72/S1461145711001933a.PMC3666310.pdf
Note Supplementary material accompanies this paper on the Journal’s website (http://journals.cambridge.org/pnp).,Non-OADS,/arxiv_data1/oa_pdf/53/72/S1461145711001933a.PMC3666310.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/",Non-OADS,/arxiv_data1/oa_pdf/37/bc/mt201331a.PMC3666629.pdf
http://www.ashg.org/pdf/policy/ ASHG_PS_March2000_v2.pdf .,Non-OADS,/arxiv_data1/oa_pdf/3f/60/12687_2012_Article_132.PMC3666841.pdf
 http://dx.doi.org/10.4082/kjfm.2013.34.3.159 Korean J Fam Med.,Non-OADS,/arxiv_data1/oa_pdf/0e/b2/kjfm-34-159.PMC3667222.pdf
 http://dx.doi.org/10.4082/kjfm.2013.34.3.160 Korean J Fam Med.,Non-OADS,/arxiv_data1/oa_pdf/90/c0/kjfm-34-160.PMC3667223.pdf
"Keywords:  Cardiovascular Diseases; Health Surveys; Korean; Risk Factors; Smoking Cessation Received: August 28, 2012,  Accepted: May 7, 2013 *Corresponding Author: Yun-Mi Song T el: +82-2-3410-2442, Fax: +82-2-3410-0388E-mail: yunmisong@skku.edu Korean Journal of Family Medicine Copyright © 2013 The Korean Academy of Family Medicine  This is an open-access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/lice nses/by-nc/3.0) which permits  unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Cardiovascular disease (CVD) including stroke and coronary  heart disease is one of the major causes of death worldwide.1)  In 2010, CVD was the second leading cause of death in Korean people, accounting for one-fourth of entire deaths.",Non-OADS,/arxiv_data1/oa_pdf/90/c0/kjfm-34-160.PMC3667223.pdf
Available from: http://kostat.go.kr.,Non-OADS,/arxiv_data1/oa_pdf/90/c0/kjfm-34-160.PMC3667223.pdf
 http://dx.doi.org/10.4082/kjfm.2013.34.3.169 Korean J Fam Med.,Non-OADS,/arxiv_data1/oa_pdf/dd/0b/kjfm-34-169.PMC3667224.pdf
"Keywords:  Adaptation, Psychological; Adolescent Behavior; Family Relations; Korea; Questionnaires Received: July 13, 2012,  Accepted: May 2, 2013 *Corresponding Author: Y eon Pyo Kim T el: +82-61-379-7290, Fax: +82-61-379-8096E-mail: ypkim@jnu.ac.kr Korean Journal of Family Medicine Copyright © 2013 The Korean Academy of Family Medicine  This is an open-access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/lice nses/by-nc/3.0) which permits  unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.during adolescence.1) In many previous studies, researchers  have reported that adolescent problem behaviors are associated with family function.",Non-OADS,/arxiv_data1/oa_pdf/dd/0b/kjfm-34-169.PMC3667224.pdf
http://dx.doi.org/10.1111/appy.12028.,Non-OADS,/arxiv_data1/oa_pdf/dd/0b/kjfm-34-169.PMC3667224.pdf
http://dx.doi.org/10.1177/1010539512446958.,Non-OADS,/arxiv_data1/oa_pdf/dd/0b/kjfm-34-169.PMC3667224.pdf
 http://dx.doi.org/10.4082/kjfm.2013.34.3.178 Korean J Fam Med.,Non-OADS,/arxiv_data1/oa_pdf/12/92/kjfm-34-178.PMC3667225.pdf
"Keywords:  Smoking; Suicidal Ideation; Attempted Suicide Received: August 31, 2012,  Accepted: March 5, 2013 *Corresponding Author: Hwan-Sik Hwang T el: +82-2-2290-8741, Fax: +82-2-2281-7279E-mail: fmhwang@hanyang.ac.kr Korean Journal of Family Medicine Copyright © 2013 The Korean Academy of Family Medicine  This is an open-access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/lice nses/by-nc/3.0) which permits  unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION The mortality rate of Korean adults over the age of 20 is  31.2 per 100,000 according to Statistics Korea, 2010.1) This  is double the mortality rate in Organization for Economic Cooperation and Development nations and 2.4 times the figure ten years previously.",Non-OADS,/arxiv_data1/oa_pdf/12/92/kjfm-34-178.PMC3667225.pdf
Available from: http://dx.doi.org/10.1787/health_glance-2011-en.,Non-OADS,/arxiv_data1/oa_pdf/12/92/kjfm-34-178.PMC3667225.pdf
Available from: http://www.wpro.who.int/mediacentre/factsheets/fs_20050420a/en/index.html.,Non-OADS,/arxiv_data1/oa_pdf/12/92/kjfm-34-178.PMC3667225.pdf
Available from: http://www.euroqol.org.,Non-OADS,/arxiv_data1/oa_pdf/12/92/kjfm-34-178.PMC3667225.pdf
 http://dx.doi.org/10.4082/kjfm.2013.34.3.190 Korean J Fam Med.,Non-OADS,/arxiv_data1/oa_pdf/82/4e/kjfm-34-190.PMC3667226.pdf
"Keywords:  Smoking Cessation; Education; Carbon Monoxide; Motivation Received: August 22, 2012,  Accepted: May 2, 2013 *Corresponding Author: Cheol-Hwan Kim T el: +82-2-2270-0946, Fax: +82-2-2270-0988E-mail: fmmother@naver.com Korean Journal of Family Medicine Copyright © 2013 The Korean Academy of Family Medicine  This is an open-access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/lice nses/by-nc/3.0) which permits  unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Smoking is one of the preventable causes of death.1) According  to a report on the global tobacco epidemic in 2011 by the World Health Organization, smoking has caused 6 million deaths and economic loss of over a hundred billion won each year worldwide.",Non-OADS,/arxiv_data1/oa_pdf/82/4e/kjfm-34-190.PMC3667226.pdf
 http://dx.doi.org/10.4082/kjfm.2013.34.3.199 Korean J Fam Med.,Non-OADS,/arxiv_data1/oa_pdf/4f/10/kjfm-34-199.PMC3667227.pdf
"Keywords:  Non-alcoholic Fatty Liver Disease; Chronic Renal Insufficiency; Ultrasonography; Glomerular Filtration Rate;  Proteinuria Received: August 26, 2011,  Accepted: May 7, 2013 *Corresponding Author: Jae-Kyung Choi T el: +82-2-2030-7683, Fax: +82-2-2030-7748E-mail: cjk@kuh.ac.kr Korean Journal of Family Medicine Copyright © 2013 The Korean Academy of Family Medicine  This is an open-access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/lice nses/by-nc/3.0) which permits  unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Non-alcoholic fatty liver disease (NAFLD) is defined as fat  accumulation in the liver exceeding 5% to 10% by weight and refers to a spectrum of diseases ranging from simple steatosis to steatohepatitis and cirrhosis.",Non-OADS,/arxiv_data1/oa_pdf/4f/10/kjfm-34-199.PMC3667227.pdf
 http://dx.doi.org/10.4082/kjfm.2013.34.3.206 Korean J Fam Med.,Non-OADS,/arxiv_data1/oa_pdf/e2/ec/kjfm-34-206.PMC3667228.pdf
"Keywords:  Child; Family Meals; Family Function; Depression Received: August 31, 2011,  Accepted: March 12, 2013 *Corresponding Author: Dae-Hyun Kim T el: +82-53-250-7548, Fax: +82-53-250-7071E-mail: dhkim@dsmc.or.kr Korean Journal of Family Medicine Copyright © 2013 The Korean Academy of Family Medicine  This is an open-access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/lice nses/by-nc/3.0) which permits  unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.2009, the proportion of children having more than 4 family meals  per week was 86.3% for breakfast, 2.1% for lunch, and 96.2% for dinner.",Non-OADS,/arxiv_data1/oa_pdf/e2/ec/kjfm-34-206.PMC3667228.pdf
 http://dx.doi.org/10.4082/kjfm.2013.34.3.213 Korean J Fam Med.,Non-OADS,/arxiv_data1/oa_pdf/65/12/kjfm-34-213.PMC3667229.pdf
"Keywords:  Aorta; Calcification; Atherosclerosis; Life Style Received: August 31, 2011,  Accepted: February 28, 2013 *Corresponding Author: Jong Sung Kim T el: +82-42-280-8172, Fax: +82-42-280-7879E-mail: jskim@cnuh.co.kr Korean Journal of Family Medicine Copyright © 2013 The Korean Academy of Family Medicine  This is an open-access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/lice nses/by-nc/3.0) which permits  unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Once atherosclerosis develops, atheromatous plaque or  fibrous fatty plaque forms, narrowing the blood vessel lumen and weakening the media.",Non-OADS,/arxiv_data1/oa_pdf/65/12/kjfm-34-213.PMC3667229.pdf
Available from: http://cancercontrol.cancer.gov/tcrb/monographs/1/index.html.,Non-OADS,/arxiv_data1/oa_pdf/65/12/kjfm-34-213.PMC3667229.pdf
 http://dx.doi.org/10.4082/kjfm.2013.34.3.221 Korean J Fam Med.,Non-OADS,/arxiv_data1/oa_pdf/e6/96/kjfm-34-221.PMC3667230.pdf
"Keywords:  Tonsillolith; Referred Otalgia; Glossopharyngeal Nerve Received: December 20, 2012,  Accepted: May 2, 2013 *Corresponding Author: Kyung Soo Kim T el: +82-2-6299-1765, Fax: +82-2-825-1765E-mail: entkks@naver.com Korean Journal of Family Medicine Copyright © 2013 The Korean Academy of Family Medicine  This is an open-access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/lice nses/by-nc/3.0) which permits  unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.be excluded.",Non-OADS,/arxiv_data1/oa_pdf/e6/96/kjfm-34-221.PMC3667230.pdf
 http://dx.doi.org/10.4082/kjfm.2013.34.3.224 Korean J Fam Med.,Non-OADS,/arxiv_data1/oa_pdf/4e/42/kjfm-34-224.PMC3667231.pdf
Available from: http://www.ich.org/products/guidelines/efficacy/article/efficacy-guidelines.html.,Non-OADS,/arxiv_data1/oa_pdf/4e/42/kjfm-34-224.PMC3667231.pdf
 http://dx.doi.org/10.4082/kjfm.2013.34.3.226 Korean J Fam Med.,Non-OADS,/arxiv_data1/oa_pdf/a5/17/kjfm-34-226.PMC3667232.pdf
"*Corresponding Author: Kieran Walsh T el: +44-20-7383-6550, Fax: +44-20-7383-6242E-mail: kmwalsh@bmjgroup.com Korean Journal of Family Medicine Copyright © 2013 The Korean Academy of Family Medicine  This is an open-access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/lice nses/by-nc/3.0) which permits  unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a5/17/kjfm-34-226.PMC3667232.pdf
References 1.http://www.idf.org/media-events/press-releases/2011/diabetes-atlas- 5th-edition .,Non-OADS,/arxiv_data1/oa_pdf/63/d6/12011_2013_Article_9688.PMC3667367.pdf
Accessed 14 August 2012 2.http://ki.se/content/1/c6/04/90/19/AnimeshBiswas.pdf .,Non-OADS,/arxiv_data1/oa_pdf/63/d6/12011_2013_Article_9688.PMC3667367.pdf
Accessed 14 August 2012 3.http://www.nice.org.uk/nicemedia /live/13472/54345/54345.pdf .,Non-OADS,/arxiv_data1/oa_pdf/63/d6/12011_2013_Article_9688.PMC3667367.pdf
Accessed 14 August 2012 4.http://diabetes.niddk.nih.gov/ dm/pubs/amIatrisktype2AI/ amerindrisk.pdf .,Non-OADS,/arxiv_data1/oa_pdf/63/d6/12011_2013_Article_9688.PMC3667367.pdf
Available from: http://www.ipindia.nic.in/iponew/TK_Guidelines_08November2012.pdf.,Non-OADS,/arxiv_data1/oa_pdf/54/be/JAIM-4-1.PMC3667426.pdf
International bureau of WIPO  available at http://www.wipo.int/arab/en/meetings/2002/muscat_forum_ip/iptk_mct02_i3.htm.,Non-OADS,/arxiv_data1/oa_pdf/54/be/JAIM-4-1.PMC3667426.pdf
Available from: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm070491.pdf.,Non-OADS,/arxiv_data1/oa_pdf/56/e7/JAIM-4-4.PMC3667432.pdf
Available from: http://www.pharmabiz.com/NewsDetails.aspx?aid=65573 and sid=1 [Last accessed on 2012 Jul 7].,OADS,/arxiv_data1/oa_pdf/56/e7/JAIM-4-4.PMC3667432.pdf
Available from http://www.deafnessresearch.org.uk/content/your-hearing/main-types-of-hearing-loss/age-related-hearing-loss 4.,Non-OADS,/arxiv_data1/oa_pdf/e9/a9/JAIM-4-48.PMC3667435.pdf
"ACKNOWLEDGMENT The author sincerely thanks Madan Thangavelu, Cambridge, UK,  of  the Research Council for Complimentary Medicine (http://www.rccm.org.uk/node/4) for his constructive feedback and suggestions.",Non-OADS,/arxiv_data1/oa_pdf/9b/cc/JAIM-4-52.PMC3667436.pdf
Available from: http://www.indianmedic  ine.nic.in/writereaddata/linkimages/3157884330-Medical% 20Education ﬁ nall%20 ﬁ nal.pdf.,Non-OADS,/arxiv_data1/oa_pdf/9b/cc/JAIM-4-52.PMC3667436.pdf
"Available from: http://www.quandl.com/society/saudi‑  arabia‑all‑society‑indicators [Last accessed on February 8, 2013].",Non-OADS,/arxiv_data1/oa_pdf/9e/60/ATM-8-105.PMC3667438.pdf
"Available from: http://www.unicef.org/infobycountry/saudiarabia_statistics.html [Last accessed on January 19, 2013].",Non-OADS,/arxiv_data1/oa_pdf/9e/60/ATM-8-105.PMC3667438.pdf
Available from: http://www.gallup.com/consulting/126806/q12-meta-analysis.aspx.,Non-OADS,/arxiv_data1/oa_pdf/bc/1f/AJNS-8-2.PMC3667456.pdf
Available from: http://www.bis.gov.uk/policies/employment-matters/strategies/employee-engagement.,Non-OADS,/arxiv_data1/oa_pdf/bc/1f/AJNS-8-2.PMC3667456.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/e3/0b/srep01924.PMC3667465.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ How to cite this article: Arau´jo, R. et al.",Non-OADS,/arxiv_data1/oa_pdf/e3/0b/srep01924.PMC3667465.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 1906 | DOI: 10.1038/srep01906 6,Non-OADS,/arxiv_data1/oa_pdf/61/85/srep01906.PMC3667486.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/How to cite this article: Mu¨ller, K. et al.",Non-OADS,/arxiv_data1/oa_pdf/61/85/srep01906.PMC3667486.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/4c/ff/srep01896.PMC3667487.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Capozza, R., Barel, I.",Non-OADS,/arxiv_data1/oa_pdf/4c/ff/srep01896.PMC3667487.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/bd/01/srep01923.PMC3667488.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Thakur, G., Prashanthi, K. & Thundat, T. Directed self-assembly of proteins into discrete radial patterns.",Non-OADS,/arxiv_data1/oa_pdf/bd/01/srep01923.PMC3667488.pdf
"at ,http://www.bis.org/statistics/ derstats.htm .accessed April 29, 2013.",Non-OADS,/arxiv_data1/oa_pdf/56/1d/srep01898.PMC3667490.pdf
"at ,http://www.fhfa.gov ., accessed April 29, 2013.",Non-OADS,/arxiv_data1/oa_pdf/56/1d/srep01898.PMC3667490.pdf
"at ,http://www.risk.net/risk- magazine/feature/1594823/the-price-wrong ., accessed April 29, 2013.",Non-OADS,/arxiv_data1/oa_pdf/56/1d/srep01898.PMC3667490.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/56/1d/srep01898.PMC3667490.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Quax, R., Kandhai, D. & Sloot, P.M.A.",Non-OADS,/arxiv_data1/oa_pdf/56/1d/srep01898.PMC3667490.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/5c/2d/srep01920.PMC3667491.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Zheng, H. et al.",Non-OADS,/arxiv_data1/oa_pdf/5c/2d/srep01920.PMC3667491.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/7f/1b/srep01796.PMC3667492.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Abeyrathne, C.D., Halgamuge, M.N., Farrell, P.M. & Skafidas, E. An ab-initio Computational Method to Determine Dielectric Properties of Biological Materials.",Non-OADS,/arxiv_data1/oa_pdf/7f/1b/srep01796.PMC3667492.pdf
"To analyze the genome data, we first download the list of all E. coli sequences from UniProt database (http://www.uniprot.org/), which contains 4,279 non-redundant entries.",OADS,/arxiv_data1/oa_pdf/29/74/srep01895.PMC3667494.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/29/74/srep01895.PMC3667494.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Xu, D. & Zhang, Y. Ab Initio structure prediction for Escherichia coli: towards genome-wide protein structure modeling and fold assignment.",Non-OADS,/arxiv_data1/oa_pdf/29/74/srep01895.PMC3667494.pdf
"2–17 The inability to visualize hard tissue structures has prevented conventional MRI techniques from depicting the highly mineralized components of the tooth like dentine (which comprises up to 70% mineral hydroxyl-apatite, about 20% organic material and only 10% water)*Correspondence to: Professor Volker Rasche, Department of Internal Medicine II, University Hospital of Ulm, Albert-Einstein-Allee 23, 89081 Ulm, Germany.E-mail: volker.rasche@uni-ulm.de Received 13 September 2012; revised 14 November 2012; accepted 16November 2012Dentomaxillofacial Radiology (2013) 42, 20120321 ª2013 The Authors http://dmfr.birjournals.org",Non-OADS,/arxiv_data1/oa_pdf/35/40/dmfr-42-6-D12321.PMC3667523.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Wu, G.H., Takahashi, M., Arai, K., Inaba, H. & Minoshima, K. Extremely high-accuracy correction of air refractive index using two-colour opticalfrequency combs.",Non-OADS,/arxiv_data1/oa_pdf/2c/5e/srep01894.PMC3667570.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/17/c7/srep01921.PMC3667571.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Choi, Y.J.",Non-OADS,/arxiv_data1/oa_pdf/17/c7/srep01921.PMC3667571.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Lanin, A.A., Fedotov, I.V., Fedotov, A.B., Sidorov-Biryukov, D.A.",Non-OADS,/arxiv_data1/oa_pdf/95/31/srep01842.PMC3667572.pdf
"B. J. Gemke6, Tanja G. M. Vrijkotte1, Eco J. de Geus3,4 1Department of Public Health, Academic Medical Center - University of Amsterdam 2Department of Epidemiology, Documentation and Health Promotion, Public Health Service of Amsterdam (GGD) 3Department of Biological Psychology, VU University 4EMGO+ Institute, VU University Medical Center 5Institute of Health Sciences, VU University 6Department of Pediatrics, VU University Medical Center *These authors contributed equally Correspondence to: Aimée E. van Dijk at a.e.vandijk@amc.nl URL: http://www.jove.com/video/50073 DOI: doi:10.3791/50073 Keywords: Medicine, Issue 74, Neurobiology, Neuroscience, Anatomy, Physiology, Pediatrics, Cardiology, Heart, Central Nervous System, stress (psychological effects, human), effects of stress (psychological, human), sympathetic nervous system, parasympathetic nervous system, autonomic nervous system, ANS, childhood, ambulatory monitoring system, electrocardiogram, ECG, clinical techniques Date Published: 4/29/2013 Citation: van Dijk, A.E., van Lien, R., van Eijsden, M., Gemke, R.J.B.J., Vrijkotte, T.G.M., de Geus, E.J.",Non-OADS,/arxiv_data1/oa_pdf/5d/aa/jove-74-50073.PMC3667644.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/50073/ Protocol 1.,Non-OADS,/arxiv_data1/oa_pdf/5d/aa/jove-74-50073.PMC3667644.pdf
"http://informahealthcare.com/bmk ISSN: 1354-750X (print), 1366-5804 (electronic) Biomarkers, 2013; 18(3): 183–195 !2013 Informa UK Ltd. DOI: 10.3109/1354750X.2013.777116 REVIEW ARTICLE Lung cancer biomarkers for the assessment of modified risk tobacco products: an oxidative stress perspective Frazer J. Lowe1, Karsta Luettich1*, and Evan O. Gregg2 1British American Tobacco, Southampton, UK and2ENI Limited, Towcester, UK Abstract Manufacturers have developed prototype cigarettes yielding reduced levels of some tobacco smoke toxicants, when tested using laboratory machine smoking under standardisedconditions.",Non-OADS,/arxiv_data1/oa_pdf/b4/6f/BMK-18-183.PMC3667677.pdf
Available from: http://www.path.,Non-OADS,/arxiv_data1/oa_pdf/58/75/EDD-10-761.PMC3667678.pdf
http://www.masterpharm  .com.,Non-OADS,/arxiv_data1/oa_pdf/af/03/10.1177_1090820X13478971.PMC3667690.pdf
http://www.nature.com/nrmicro/journal/v7/n2/abs/nrmicro207.,OADS,/arxiv_data1/oa_pdf/af/03/10.1177_1090820X13478971.PMC3667690.pdf
Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/bd/7f/ncomms2748.PMC3667715.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/How to cite this article: Hilton, J.",Non-OADS,/arxiv_data1/oa_pdf/bd/7f/ncomms2748.PMC3667715.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms2748 ARTICLE NATURE COMMUNICATIONS | 4:1767 | DOI: 10.1038/ncomms2748 | www.nature.com/naturecommunications 7 &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/bd/7f/ncomms2748.PMC3667715.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/4f/7a/1615.PMC3667716.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/83/36/1619.PMC3667717.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/da/5a/1638.PMC3667718.pdf
Available at: http://seer.cancer.gov/csr/1975_2009_pops09/index.html  (accessed 2012) Hui AB  et al.,Non-OADS,/arxiv_data1/oa_pdf/da/5a/1638.PMC3667718.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/e3/7e/1649.PMC3667719.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/91/c2/1661.PMC3667720.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/c0/a9/1676.PMC3667721.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/6f/86/1688.PMC3667722.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/e1/06/1700.PMC3667723.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/3e/81/1713.PMC3667724.pdf
Two months after publi - cation it is available to the public under an Attribution–Noncommercial–Share  Alike 3.0 Unported Creative Commons License (http://creativecommons.org/ licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/0b/98/1725.PMC3667725.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/d7/db/1735.PMC3667726.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/04/f0/1749.PMC3667727.pdf
aGenotype for each P-element insertion obtained from FlyBase (http://flybase.org/).,OADS,/arxiv_data1/oa_pdf/04/f0/1749.PMC3667727.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported Cre - ative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/8b/5f/1765.PMC3667728.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/d7/24/1776.PMC3667729.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/8c/65/1791.PMC3667730.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/23/1c/1801.PMC3667731.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/42/d7/1812.PMC3667732.pdf
"www.landesbioscience.com  Channels  109Channels 7:2, 109–114; March/April 2013; © 2013 Landes Bioscience RESEARCH PAPER RESEARCH PAPER *Correspondence to: Paul P.M. Schnetkamp; Email: pschnetk@ucalgary.ca Submitted: 01/30/13; Revised: 02/05/13; Accepted: 02/05/13http://dx.doi.org/10.4161/chan.23898Introduction Members of the SLC8  and SLC24  gene families encode   Na+/Ca2+ (NCX) and Na+/Ca2+-K+ exchangers (NCKX), respec - tively.",Non-OADS,/arxiv_data1/oa_pdf/30/2b/chan-7-109.PMC3667879.pdf
Biochem J  2007; 406:365-82; PMID:17716241; http://dx.doi.org/10.1042/BJ20070619.,OADS,/arxiv_data1/oa_pdf/30/2b/chan-7-109.PMC3667879.pdf
Mol Aspects Med 2013; 34:455-64: http://dx.doi.org/10.1016/j.mam.2012.07.008 4.,OADS,/arxiv_data1/oa_pdf/30/2b/chan-7-109.PMC3667879.pdf
Biochemistry 2003; 42:9438-45; PMID:12899631; http://dx.doi.org/10.1021/bi0342261.,Non-OADS,/arxiv_data1/oa_pdf/30/2b/chan-7-109.PMC3667879.pdf
Biochem Biophys Res Commun 1995; 212:968-74; PMID:7626138; http://dx.doi.org/10.1006/bbrc.1995.2064.,Non-OADS,/arxiv_data1/oa_pdf/30/2b/chan-7-109.PMC3667879.pdf
J Biol Chem 1999; 274:910- 7; PMID:9873031; http://dx.doi.org/10.1074/jbc.274.2.910.,OADS,/arxiv_data1/oa_pdf/30/2b/chan-7-109.PMC3667879.pdf
FEBS Lett 1999; 446:264-8; PMID:10100855; http://dx.doi.org/10.1016/S0014-5793(99)00218-5.,OADS,/arxiv_data1/oa_pdf/30/2b/chan-7-109.PMC3667879.pdf
J Biol Chem 2002; 277:48923-30; PMID:12377762; http://dx.doi.org/10.1074/jbc.M208818200.9.,OADS,/arxiv_data1/oa_pdf/30/2b/chan-7-109.PMC3667879.pdf
Biochemistry 2003; 42:2485-91; PMID:12600216; http://dx.doi.org/10.1021/bi0270788.,Non-OADS,/arxiv_data1/oa_pdf/30/2b/chan-7-109.PMC3667879.pdf
Science 2012; 335:686-90; PMID:22323814; http://dx.doi.org/10.1126/sci - ence.1215759.,OADS,/arxiv_data1/oa_pdf/30/2b/chan-7-109.PMC3667879.pdf
J Biol Chem  1996; 271:13385-91; PMID:8662775; http://dx.doi.org/10.1074/jbc.271.23.13385.,OADS,/arxiv_data1/oa_pdf/30/2b/chan-7-109.PMC3667879.pdf
J Biol Chem 2005; 280:1061-9; PMID:15519995; http://dx.doi.org/10.1074/jbc.M411899200.,OADS,/arxiv_data1/oa_pdf/30/2b/chan-7-109.PMC3667879.pdf
J Biol Chem 2010; 285:15245-55; PMID:20231282; http://dx.doi.org/10.1074/jbc.M109.090738.,OADS,/arxiv_data1/oa_pdf/30/2b/chan-7-109.PMC3667879.pdf
Biochemistry 2003; 42:543-52; PMID:12525183; http://dx.doi.org/10.1021/bi026982x.,Non-OADS,/arxiv_data1/oa_pdf/30/2b/chan-7-109.PMC3667879.pdf
J Biol  Chem 2005; 280:6823-33; PMID:15583008; http://dx.doi.org/10.1074/jbc.M407933200.16.,OADS,/arxiv_data1/oa_pdf/30/2b/chan-7-109.PMC3667879.pdf
J Biol Chem 2005; 280:6834- 9; PMID:15611132; http://dx.doi.org/10.1074/jbc.M412933200.,OADS,/arxiv_data1/oa_pdf/30/2b/chan-7-109.PMC3667879.pdf
Biochemistry 2001; 40:13288-301; PMID:11683639; http://dx.doi.org/10.1021/bi0107647.,Non-OADS,/arxiv_data1/oa_pdf/30/2b/chan-7-109.PMC3667879.pdf
Biochemistry 2004; 43:7940-7; PMID:15196038; http://dx.doi.org/10.1021/bi049538y.,Non-OADS,/arxiv_data1/oa_pdf/30/2b/chan-7-109.PMC3667879.pdf
J Mol Cell Cardiol 2013; 57C:68-71; PMID:23376057; http://dx.doi.org/10.1016/j.yjmcc.2013.01.010.,OADS,/arxiv_data1/oa_pdf/30/2b/chan-7-109.PMC3667879.pdf
Cytometry 1987; 8:413-20; PMID:3113897; http://dx.doi.org/10.1002/cyto.990080411.,Non-OADS,/arxiv_data1/oa_pdf/30/2b/chan-7-109.PMC3667879.pdf
"Channels 2012; 6:426-37;   PMID:22990911; http://dx.doi.org/10.4161/chan.22016 Jonathan Satin; Department of Physiology; The University of Kentucky College of Medicine; Lexington, KY USA Email: jsatin1@uky.edu; http://dx.doi.org/10.4161/chan.24147 The CaV1.2 pore-forming Ca2+-channel pro - tein is encoded by up to ~50 exons, though  there is substantial heterogeneity of CaV1.2  exon usage.",Non-OADS,/arxiv_data1/oa_pdf/01/3c/chan-7-57.PMC3667883.pdf
Proc Natl Acad Sci U S A  2002; 99:17185-90; PMID:12486220; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/01/3c/chan-7-57.PMC3667883.pdf
Br J Pharmacol 2010; 160:1631-40;  PMID:20649567; http://dx.doi.org/10.1111/j.1476- 5381.2010.00798.x 3.,Non-OADS,/arxiv_data1/oa_pdf/01/3c/chan-7-57.PMC3667883.pdf
Hypertension 2010; 56:422-9;  PMID:20696985; http://dx.doi.org/10.1161/ HYPERTENSIONAHA.109.149344 4.,Non-OADS,/arxiv_data1/oa_pdf/01/3c/chan-7-57.PMC3667883.pdf
Channels (Austin) 2012; 6:426-37;  PMID:22990911; http://dx.doi.org/10.4161/ chan.22016 5.,Non-OADS,/arxiv_data1/oa_pdf/01/3c/chan-7-57.PMC3667883.pdf
Nature 2008; 451:830-4;  PMID:18235447; http://dx.doi.org/10.1038/ nature06529 6.,Non-OADS,/arxiv_data1/oa_pdf/01/3c/chan-7-57.PMC3667883.pdf
Am J Physiol Heart Circ Physiol  2012; PMID:23203963; http://dx.doi.org/ 10.1152/ ajpheart.00396.2012 7.,Non-OADS,/arxiv_data1/oa_pdf/01/3c/chan-7-57.PMC3667883.pdf
"Channels (Austin) 2010; 4:192- 202; PMID:20458179; http://dx.doi.org/10.4161/ chan.4.3.11867 Pannexins after stroke: Knocking-out membrane channels   to improve neurological function Comment on: Bargiotas P , et al.",Non-OADS,/arxiv_data1/oa_pdf/01/3c/chan-7-57.PMC3667883.pdf
"Channels 2012; 6:453-6;   PMID:23111424; http://dx.doi.org/10.4161/chan.22315;  Anna Rosell; Neurovascular Research Laboratory; Vall d’Hebron Research Institute; Universitat Autònoma de Barcelona; Barcelona, Spain Email:anna.rosell@vhir.org; http://dx.doi.org/10.4161/chan.24143 New therapeutic approaches are urgently  needed to treat stroke patients.",Non-OADS,/arxiv_data1/oa_pdf/01/3c/chan-7-57.PMC3667883.pdf
Stroke 2011; 42(Suppl):S16-9;  PMID:21164113; http://dx.doi.org/10.1161/ STROKEAHA.110.598763 2.,Non-OADS,/arxiv_data1/oa_pdf/01/3c/chan-7-57.PMC3667883.pdf
Proc Natl Acad Sci U S A 2011;  108:20772-7; PMID:22147915; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/01/3c/chan-7-57.PMC3667883.pdf
Channels (Austin) 2012; 6:453- 6; PMID:23111424; http://dx.doi.org/10.4161/ chan.22315 4.,Non-OADS,/arxiv_data1/oa_pdf/01/3c/chan-7-57.PMC3667883.pdf
Channels (Austin) 2011; 5:193- 7; PMID:21532340; http://dx.doi.org/10.4161/ chan.5.3.15765 5.,Non-OADS,/arxiv_data1/oa_pdf/01/3c/chan-7-57.PMC3667883.pdf
Proc Natl Acad Sci U S A 2003;  100:13644-9; PMID:14597722; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/01/3c/chan-7-57.PMC3667883.pdf
J Vasc Res 2012; 49:101- 10; PMID:22301733; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/01/3c/chan-7-57.PMC3667883.pdf
J Neurosci 2009; 29:7092-7;  PMID:19474335; http://dx.doi.org/10.1523/ JNEUROSCI.6062-08.2009 8.,Non-OADS,/arxiv_data1/oa_pdf/01/3c/chan-7-57.PMC3667883.pdf
Trends Neurosci 2010; 33:93- 102; PMID:20022389; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/01/3c/chan-7-57.PMC3667883.pdf
"Channels 2012; 6:426-37;   PMID:22990911; http://dx.doi.org/10.4161/chan.22016 Jonathan Satin; Department of Physiology; The University of Kentucky College of Medicine; Lexington, KY USA Email: jsatin1@uky.edu; http://dx.doi.org/10.4161/chan.24147 The CaV1.2 pore-forming Ca2+-channel pro - tein is encoded by up to ~50 exons, though  there is substantial heterogeneity of CaV1.2  exon usage.",Non-OADS,/arxiv_data1/oa_pdf/66/11/chan-7-59.PMC3667884.pdf
Proc Natl Acad Sci U S A  2002; 99:17185-90; PMID:12486220; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/66/11/chan-7-59.PMC3667884.pdf
Br J Pharmacol 2010; 160:1631-40;  PMID:20649567; http://dx.doi.org/10.1111/j.1476- 5381.2010.00798.x 3.,Non-OADS,/arxiv_data1/oa_pdf/66/11/chan-7-59.PMC3667884.pdf
Hypertension 2010; 56:422-9;  PMID:20696985; http://dx.doi.org/10.1161/ HYPERTENSIONAHA.109.149344 4.,Non-OADS,/arxiv_data1/oa_pdf/66/11/chan-7-59.PMC3667884.pdf
Channels (Austin) 2012; 6:426-37;  PMID:22990911; http://dx.doi.org/10.4161/ chan.22016 5.,Non-OADS,/arxiv_data1/oa_pdf/66/11/chan-7-59.PMC3667884.pdf
Nature 2008; 451:830-4;  PMID:18235447; http://dx.doi.org/10.1038/ nature06529 6.,Non-OADS,/arxiv_data1/oa_pdf/66/11/chan-7-59.PMC3667884.pdf
Am J Physiol Heart Circ Physiol  2012; PMID:23203963; http://dx.doi.org/ 10.1152/ ajpheart.00396.2012 7.,Non-OADS,/arxiv_data1/oa_pdf/66/11/chan-7-59.PMC3667884.pdf
"Channels (Austin) 2010; 4:192- 202; PMID:20458179; http://dx.doi.org/10.4161/ chan.4.3.11867 Pannexins after stroke: Knocking-out membrane channels   to improve neurological function Comment on: Bargiotas P , et al.",Non-OADS,/arxiv_data1/oa_pdf/66/11/chan-7-59.PMC3667884.pdf
"Channels 2012; 6:453-6;   PMID:23111424; http://dx.doi.org/10.4161/chan.22315;  Anna Rosell; Neurovascular Research Laboratory; Vall d’Hebron Research Institute; Universitat Autònoma de Barcelona; Barcelona, Spain Email:anna.rosell@vhir.org; http://dx.doi.org/10.4161/chan.24143 New therapeutic approaches are urgently  needed to treat stroke patients.",Non-OADS,/arxiv_data1/oa_pdf/66/11/chan-7-59.PMC3667884.pdf
Stroke 2011; 42(Suppl):S16-9;  PMID:21164113; http://dx.doi.org/10.1161/ STROKEAHA.110.598763 2.,Non-OADS,/arxiv_data1/oa_pdf/66/11/chan-7-59.PMC3667884.pdf
Proc Natl Acad Sci U S A 2011;  108:20772-7; PMID:22147915; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/66/11/chan-7-59.PMC3667884.pdf
Channels (Austin) 2012; 6:453- 6; PMID:23111424; http://dx.doi.org/10.4161/ chan.22315 4.,Non-OADS,/arxiv_data1/oa_pdf/66/11/chan-7-59.PMC3667884.pdf
Channels (Austin) 2011; 5:193- 7; PMID:21532340; http://dx.doi.org/10.4161/ chan.5.3.15765 5.,Non-OADS,/arxiv_data1/oa_pdf/66/11/chan-7-59.PMC3667884.pdf
Proc Natl Acad Sci U S A 2003;  100:13644-9; PMID:14597722; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/66/11/chan-7-59.PMC3667884.pdf
J Vasc Res 2012; 49:101- 10; PMID:22301733; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/66/11/chan-7-59.PMC3667884.pdf
J Neurosci 2009; 29:7092-7;  PMID:19474335; http://dx.doi.org/10.1523/ JNEUROSCI.6062-08.2009 8.,Non-OADS,/arxiv_data1/oa_pdf/66/11/chan-7-59.PMC3667884.pdf
Trends Neurosci 2010; 33:93- 102; PMID:20022389; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/66/11/chan-7-59.PMC3667884.pdf
Science 2012;  338:1308–13; PMID:23180775; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/87/a8/chan-7-71.PMC3667887.pdf
"org/10.1126/science.1228757Keywords:  CRAC channel, X-ray crys - tallography, stoichiometry, selectivity  filter, pore structure Submitted: 02/07/13 Accepted: 02/07/13 http://dx.doi.org/10.4161/chan.24163 Correspondence to: Andrew P .",Non-OADS,/arxiv_data1/oa_pdf/87/a8/chan-7-71.PMC3667887.pdf
J Cell Biol 2005; 169:435- 45; PMID:15866891; http://dx.doi.org/10.1083/ jcb.200502019 2.,OADS,/arxiv_data1/oa_pdf/87/a8/chan-7-71.PMC3667887.pdf
Nature 2008; 456:116-20; PMID:18820677;  http://dx.doi.org/10.1038/nature07338 4.,Non-OADS,/arxiv_data1/oa_pdf/87/a8/chan-7-71.PMC3667887.pdf
J Physiol 2008; 586:419-25;  PMID:18006576; http://dx.doi.org/10.1113/jphysi - ol.2007.147249 5.,Non-OADS,/arxiv_data1/oa_pdf/87/a8/chan-7-71.PMC3667887.pdf
Proc Natl Acad Sci U S A  2011; 108:17832-7; PMID:21987805; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/87/a8/chan-7-71.PMC3667887.pdf
Nature 2009; 458:597-602; PMID:19340074;  http://dx.doi.org/10.1038/nature07869,Non-OADS,/arxiv_data1/oa_pdf/87/a8/chan-7-71.PMC3667887.pdf
"Channels 7:2, 74–84; March/April 2013; © 2013 Landes Bioscience RESEARCH PAPER 74 Channels  Volume 7 Issue 2*Correspondence to: Linda M. Boland; Email: lboland@richmond.edu Submitted: 08/17/12; Revised: 12/17/12; Accepted: 12/31/12http://dx.doi.org/10.4161/chan.23453Introduction Polyunsaturated fatty acids (PUFAs) contain two or more double  bonds in cis positions and are major constituents of plasma mem - brane phospholipids in nervous tissue1 and cardiac muscle.2 Free PUFAs such as arachidonic acid (AA; 20:4) and doco - sahexaenoic acid (DHA; C22:6) are enzymatically released dur - ing certain cell signaling events.",Non-OADS,/arxiv_data1/oa_pdf/04/47/chan-7-74.PMC3667888.pdf
Mol Neurobiol 2005; 31:219- 30; PMID:15953823; http://dx.doi.org/10.1385/MN:31:1-3:219 2.,Non-OADS,/arxiv_data1/oa_pdf/04/47/chan-7-74.PMC3667888.pdf
J Membr Biol 2005; 206:141-54; PMID:16456724; http://dx.doi.org/10.1007/s00232-005-0786-z 3.,Non-OADS,/arxiv_data1/oa_pdf/04/47/chan-7-74.PMC3667888.pdf
EMBO J 2001; 20:5715-24; PMID:11598014; http://dx.doi.org/10.1093/emboj/20.20.5715 7.,Non-OADS,/arxiv_data1/oa_pdf/04/47/chan-7-74.PMC3667888.pdf
J Comput Neurosci 1999; 7:5-15; PMID:10481998; http://dx.doi.org/10.1023/A:1008906225285 9.,Non-OADS,/arxiv_data1/oa_pdf/04/47/chan-7-74.PMC3667888.pdf
J Neurosci 2006; 26:12143-51; PMID:17122039; http://dx.doi.org/10.1523/JNEUROSCI.2667-06.200610.,Non-OADS,/arxiv_data1/oa_pdf/04/47/chan-7-74.PMC3667888.pdf
J Biol Chem 2002; 277:43881-7; PMID:12235140; http://dx.doi.org/10.1074/jbc.M205872200 11.,OADS,/arxiv_data1/oa_pdf/04/47/chan-7-74.PMC3667888.pdf
FEBS Lett 1995; 377:358-62; PMID:8549755; http://dx.doi.org/10.1016/0014-5793(95)01371-7 12.,Non-OADS,/arxiv_data1/oa_pdf/04/47/chan-7-74.PMC3667888.pdf
Br J Pharmacol 2001; 132:1417-22; PMID:11264234; http://dx.doi.org/10.1038/sj.bjp.0703970 14.,Non-OADS,/arxiv_data1/oa_pdf/04/47/chan-7-74.PMC3667888.pdf
Neuron 2006; 50:89-100; PMID:16600858; http://dx.doi.org/10.1016/j.neuron.2006.03.010 15.,OADS,/arxiv_data1/oa_pdf/04/47/chan-7-74.PMC3667888.pdf
Circ Res 2005; 97:1342-50; PMID:16293790; http://dx.doi.org/10.1161/01.RES.0000196559.63223.aa 16.,OADS,/arxiv_data1/oa_pdf/04/47/chan-7-74.PMC3667888.pdf
Am J Physiol Cell Physiol 2009; 296:C1003-14; PMID:19261906; http://dx.doi.org/10.1152/ajpcell.00474.2008 17.,Non-OADS,/arxiv_data1/oa_pdf/04/47/chan-7-74.PMC3667888.pdf
J Physiol 2010; 588:3179-85; PMID:20519312; http://dx.doi.org/10.1113/jphysi - ol.2010.19215319.,Non-OADS,/arxiv_data1/oa_pdf/04/47/chan-7-74.PMC3667888.pdf
J Gen Physiol 1994; 104:645-73; PMID:7530766; http://dx.doi.org/10.1085/jgp.104.4.645 21.,Non-OADS,/arxiv_data1/oa_pdf/04/47/chan-7-74.PMC3667888.pdf
Nat Rev Mol Cell Biol 2006; 7:109-19; PMID:16493417; http://dx.doi.org/10.1038/nrm1833 22.,OADS,/arxiv_data1/oa_pdf/04/47/chan-7-74.PMC3667888.pdf
Cell Biochem Biophys 2008; 52:59-84; PMID:18830821; http://dx.doi.org/10.1007/s12013-008-9027-2 24.,Non-OADS,/arxiv_data1/oa_pdf/04/47/chan-7-74.PMC3667888.pdf
Nat Struct Biol 1998; 5:827-35; PMID:9731778; http://dx.doi.org/10.1038/1869 25.,Non-OADS,/arxiv_data1/oa_pdf/04/47/chan-7-74.PMC3667888.pdf
J Mol Biol 2001; 314:955-60; PMID:11743713; http://dx.doi.org/10.1006/jmbi.2000.5208 26.,OADS,/arxiv_data1/oa_pdf/04/47/chan-7-74.PMC3667888.pdf
J Biol Chem 1997; 272:7140-50; PMID:9054409; http://dx.doi.org/10.1074/jbc.272.11.7140,OADS,/arxiv_data1/oa_pdf/04/47/chan-7-74.PMC3667888.pdf
J Gen Physiol 1999; 113:641-60; PMID:10228180; http://dx.doi.org/10.1085/jgp.113.5.641 54.,Non-OADS,/arxiv_data1/oa_pdf/04/47/chan-7-74.PMC3667888.pdf
J Mol Biol 1993; 234:779-815; PMID:8254673; http://dx.doi.org/10.1006/jmbi.1993.1626 55.,Non-OADS,/arxiv_data1/oa_pdf/04/47/chan-7-74.PMC3667888.pdf
Bioinformatics 2007; 23:2947-8; PMID:17846036; http://dx.doi.org/10.1093/bioinfor - matics/btm404 56.,OADS,/arxiv_data1/oa_pdf/04/47/chan-7-74.PMC3667888.pdf
Science 2005; 309:897-903;  PMID:16002581; http://dx.doi.org/10.1126/sci - ence.1116269 57.,OADS,/arxiv_data1/oa_pdf/04/47/chan-7-74.PMC3667888.pdf
Nature 2007; 450:376-82; PMID:18004376; http://dx.doi.org/10.1038/nature06265 58.,Non-OADS,/arxiv_data1/oa_pdf/04/47/chan-7-74.PMC3667888.pdf
Structure 2007; 15:955-62; PMID:17698000; http://dx.doi.org/10.1016/j.str.2007.06.012 59.,OADS,/arxiv_data1/oa_pdf/04/47/chan-7-74.PMC3667888.pdf
Proteins 2003; 50:437-50; PMID:12557186; http://dx.doi.org/10.1002/prot.10286.,OADS,/arxiv_data1/oa_pdf/04/47/chan-7-74.PMC3667888.pdf
Acta Crystallogr D Biol Crystallogr 2010; 66:213-21; PMID:20124702; http://dx.doi.org/10.1107/S0907444909052925 61.,OADS,/arxiv_data1/oa_pdf/04/47/chan-7-74.PMC3667888.pdf
J Mol Biol 2008; 382:24-33; PMID:18638484; http://dx.doi.org/10.1016/j.jmb.2008.06.08541.,OADS,/arxiv_data1/oa_pdf/04/47/chan-7-74.PMC3667888.pdf
J Comput Chem 2009; 30:1251-60; PMID:18991303; http://dx.doi.org/10.1002/jcc.21141 42.,OADS,/arxiv_data1/oa_pdf/04/47/chan-7-74.PMC3667888.pdf
Protein Sci 1994; 3:1883-8; PMID:7849603; http://dx.doi.org/10.1002/pro.5560031027 43.,OADS,/arxiv_data1/oa_pdf/04/47/chan-7-74.PMC3667888.pdf
Nat Chem Biol 2006; 2:564-7; PMID:17051226; http://dx.doi.org/10.1038/nchem - bio1106-564 45.,OADS,/arxiv_data1/oa_pdf/04/47/chan-7-74.PMC3667888.pdf
Chem Phys Lipids 2008; 153:76-80; PMID:18358239; http://dx.doi.org/10.1016/j.chemphyslip.2008.02.013 46.,OADS,/arxiv_data1/oa_pdf/04/47/chan-7-74.PMC3667888.pdf
Nat Struct Biol 2003; 10:694-700; PMID:12881720; http://dx.doi.org/10.1038/nsb960 47.,OADS,/arxiv_data1/oa_pdf/04/47/chan-7-74.PMC3667888.pdf
Nat Neurosci 2009; 12:988-95; PMID:19561601; http://dx.doi.org/10.1038/nn.2358 48.,Non-OADS,/arxiv_data1/oa_pdf/04/47/chan-7-74.PMC3667888.pdf
Science 2004; 304:265-70; PMID:15031437; http://dx.doi.org/10.1126/science.1094113 49.,OADS,/arxiv_data1/oa_pdf/04/47/chan-7-74.PMC3667888.pdf
EMBO J 2010; 29:2101-13; PMID:20461057; http://dx.doi.org/10.1038/emboj.2010.88 50.,OADS,/arxiv_data1/oa_pdf/04/47/chan-7-74.PMC3667888.pdf
Nat Commun 2011; 2:436; PMID:21847110; http://dx.doi.org/10.1038/ncomms1446 51.,OADS,/arxiv_data1/oa_pdf/04/47/chan-7-74.PMC3667888.pdf
J Physiol 2001; 535:65-81; PMID:11507158; http://dx.doi.org/10.1111/j.1469-7793.2001.00065.x 52.,Non-OADS,/arxiv_data1/oa_pdf/04/47/chan-7-74.PMC3667888.pdf
J Physiol 2011; 589:461-79; PMID:21098008; http://dx.doi.org/10.1113/jphysiol.2010.19196529.,Non-OADS,/arxiv_data1/oa_pdf/04/47/chan-7-74.PMC3667888.pdf
Biochemistry 1994; 33:3649-59; PMID:8142363; http://dx.doi.org/10.1021/bi00178a023 30.,Non-OADS,/arxiv_data1/oa_pdf/04/47/chan-7-74.PMC3667888.pdf
Neuron  1994; 12:301-15; PMID:8110460; http://dx.doi.org/10.1016/0896-6273(94)90273-9 31.,OADS,/arxiv_data1/oa_pdf/04/47/chan-7-74.PMC3667888.pdf
J Gen Physiol 1997; 109:767- 78; PMID:9222902; http://dx.doi.org/10.1085/jgp.109.6.767 32.,Non-OADS,/arxiv_data1/oa_pdf/04/47/chan-7-74.PMC3667888.pdf
J Gen Physiol 2008; 132:667-80; PMID:19029374; http://dx.doi.org/10.1085/jgp.200810048 33.,Non-OADS,/arxiv_data1/oa_pdf/04/47/chan-7-74.PMC3667888.pdf
J Physiol  1999; 514:667-75; PMID:9882738; http://dx.doi.org/10.1111/j.1469-7793.1999.667ad.x 34.,Non-OADS,/arxiv_data1/oa_pdf/04/47/chan-7-74.PMC3667888.pdf
J Gen Physiol 2009; 133:205-24; PMID:19171772; http://dx.doi.org/10.1085/jgp.200810073 35.,Non-OADS,/arxiv_data1/oa_pdf/04/47/chan-7-74.PMC3667888.pdf
J Biol Chem 2000; 275:4928-36; PMID:10671530; http://dx.doi.org/10.1074/jbc.275.7.4928 37.,OADS,/arxiv_data1/oa_pdf/04/47/chan-7-74.PMC3667888.pdf
Biochemistry 2003; 42:11243-52; PMID:14503874; http://dx.doi.org/10.1021/bi034738f 38.,Non-OADS,/arxiv_data1/oa_pdf/04/47/chan-7-74.PMC3667888.pdf
Br  J Pharmacol 2010; 159:1475-85; PMID:20136839; http://dx.doi.org/10.1111/j.1476-5381.2010.00642.x 39.,Non-OADS,/arxiv_data1/oa_pdf/04/47/chan-7-74.PMC3667888.pdf
J Am Chem Soc 2000; 122:4750-5; http://dx.doi.org/10.1021/ja993600a 40.,OADS,/arxiv_data1/oa_pdf/04/47/chan-7-74.PMC3667888.pdf
J Phys Chem A 2001; 105:4963-8; http://dx.doi.org/10.1021/jp003888m,Non-OADS,/arxiv_data1/oa_pdf/04/47/chan-7-74.PMC3667888.pdf
OncoImmunology 2013; 2:e23850; http://dx.doi.org/10.4161/onci.23850and pathophysiological involvement of  RANKL in hematopoietic malignancies like chronic lymphoid leukemia (CLL) and Multiple Myeloma (MM).,Non-OADS,/arxiv_data1/oa_pdf/a0/2a/onci-2-e23850.PMC3667891.pdf
Nat Rev Drug Discov  2012; 11:401-19; PMID:22543469; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a0/2a/onci-2-e23850.PMC3667891.pdf
Nature  1997; 390:175-9; PMID:9367155; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a0/2a/onci-2-e23850.PMC3667891.pdf
J Exp Med  1997; 186:2075-80; PMID:9396779; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a0/2a/onci-2-e23850.PMC3667891.pdf
Nat Immunol 2007; 8:601-9;  PMID:17496895; http://dx.doi.org/10.1038/ni1471 10.,Non-OADS,/arxiv_data1/oa_pdf/a0/2a/onci-2-e23850.PMC3667891.pdf
Cancer Res  2013; 73:683-94; PMID:23139212; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a0/2a/onci-2-e23850.PMC3667891.pdf
J Immunol 2013; 190:821-31;  PMID:23241893; http://dx.doi.org/10.4049/jimmu- nol.1201792 8.,Non-OADS,/arxiv_data1/oa_pdf/a0/2a/onci-2-e23850.PMC3667891.pdf
Nature 2011; 470:548- 53; PMID:21326202; http://dx.doi.org/10.1038/ nature09707 5.,Non-OADS,/arxiv_data1/oa_pdf/a0/2a/onci-2-e23850.PMC3667891.pdf
J Cell Physiol 2006; 207:158-64; PMID:16270354;  http://dx.doi.org/10.1002/jcp.20547 6.,OADS,/arxiv_data1/oa_pdf/a0/2a/onci-2-e23850.PMC3667891.pdf
"OncoImmunology 2013; 2:e23851; http://dx.doi.org/10.4161/onci.23851In order to identify potential inflam - matory DCs in humans, we analyzed  myeloid cell populations in two differ - ent inflammatory microenvironments: the synovial fluid of rheumatoid arthritis patients and inflammatory tumor ascites from breast and ovarian cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/20/c8/onci-2-e23851.PMC3667892.pdf
Immunity 2007; 26:519-31;  PMID:17412618; http://dx.doi.org/10.1016/j.immu- ni.2007.01.017 2.,OADS,/arxiv_data1/oa_pdf/20/c8/onci-2-e23851.PMC3667892.pdf
Immunity 2013; 38:336-48; PMID:23352235; http://dx.doi.org/10.1016/j.immuni.2012.10.018 4.,OADS,/arxiv_data1/oa_pdf/20/c8/onci-2-e23851.PMC3667892.pdf
J Exp Med 2012; 209:1135-52; PMID:22615127; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/20/c8/onci-2-e23851.PMC3667892.pdf
J Exp Med  2010; 207:1283-92; PMID:20479118; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/20/c8/onci-2-e23851.PMC3667892.pdf
Ann N Y Acad Sci 2011; 1217:60-76;  PMID:21155836; http://dx.doi.org/10.1111/j.1749- 6632.2010.05825.x 7.,OADS,/arxiv_data1/oa_pdf/20/c8/onci-2-e23851.PMC3667892.pdf
Cell 2010; 140:883-99;  PMID:20303878; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/20/c8/onci-2-e23851.PMC3667892.pdf
OncoImmunology 2013; 2:e23852; http://dx.doi.org/10.4161/onci.23852high densities of intratumoral Tregs can  correlate with better clinical outcomes in patients affected by CC and several other cancers.,Non-OADS,/arxiv_data1/oa_pdf/97/9d/onci-2-e23852.PMC3667893.pdf
Science  2006; 313:1960-4; PMID:17008531; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/97/9d/onci-2-e23852.PMC3667893.pdf
Curr Opin Oncol 2009; 21:524-30; PMID:19770763;  http://dx.doi.org/10.1097/CCO.0b013e328331a78e 3.,Non-OADS,/arxiv_data1/oa_pdf/97/9d/onci-2-e23852.PMC3667893.pdf
Carcinogenesis 2011; 32:643-9; PMID:21304053;  http://dx.doi.org/10.1093/carcin/bgr019 4.,Non-OADS,/arxiv_data1/oa_pdf/97/9d/onci-2-e23852.PMC3667893.pdf
Cancer Metastasis Rev 2011; 30:45-60; PMID:21287360; http://dx.doi.org/10.1007/s10555- 011-9286-z5.,Non-OADS,/arxiv_data1/oa_pdf/97/9d/onci-2-e23852.PMC3667893.pdf
Cancer Res 2009; 69:5490-7; PMID:19570783; http://dx.doi.org/10.1158/0008-5472.CAN-09-0304 6.,Non-OADS,/arxiv_data1/oa_pdf/97/9d/onci-2-e23852.PMC3667893.pdf
Proc Natl Acad Sci U S A 2010; 107:6430- 5; PMID:20308560; http://dx.doi.org/10.1073/ pnas.0913683107 7.,OADS,/arxiv_data1/oa_pdf/97/9d/onci-2-e23852.PMC3667893.pdf
Sci T ransl Med 2012; 4:ra159;  PMID:23241743; http://dx.doi.org/10.1126/scitrans- lmed.30045668.,OADS,/arxiv_data1/oa_pdf/97/9d/onci-2-e23852.PMC3667893.pdf
Cancer Res 2011; 71:1263-71; PMID:21303976;  http://dx.doi.org/10.1158/0008-5472.CAN-10-2907 9.,Non-OADS,/arxiv_data1/oa_pdf/97/9d/onci-2-e23852.PMC3667893.pdf
Sci T ransl Med  2012; 4:64fs44; PMID:23241741; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/97/9d/onci-2-e23852.PMC3667893.pdf
"OncoImmunology 2013; 2:e23887; http://dx.doi.org/10.4161/onci.23887tumor-infiltrating regulatory T cells,2,4  indicating that this cell subset plays a key  role in tumor-elicited immunosuppression (and hence in disease progression).",Non-OADS,/arxiv_data1/oa_pdf/7b/5f/onci-2-e23887.PMC3667894.pdf
Int J Cancer 2008; 122:91- 9; PMID:17893878; http://dx.doi.org/10.1002/ ijc.23083 10.,Non-OADS,/arxiv_data1/oa_pdf/7b/5f/onci-2-e23887.PMC3667894.pdf
Cancer Res 2010; 70:9581-90; PMID:21098714;  http://dx.doi.org/10.1158/0008-5472.CAN-10-1379 6.,Non-OADS,/arxiv_data1/oa_pdf/7b/5f/onci-2-e23887.PMC3667894.pdf
Nat Med  2001; 7:1339-46; PMID:11726975; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7b/5f/onci-2-e23887.PMC3667894.pdf
Clin Cancer Res 2004; 10:7466-74; PMID:15569976;  http://dx.doi.org/10.1158/1078-0432.CCR-04-0684 8.,Non-OADS,/arxiv_data1/oa_pdf/7b/5f/onci-2-e23887.PMC3667894.pdf
J Exp Med 2007; 204:105-15; PMID:17200410; http://dx.doi.org/10.1084/ jem.20061660References 1.,Non-OADS,/arxiv_data1/oa_pdf/7b/5f/onci-2-e23887.PMC3667894.pdf
Cancer  Res 2012; 72:5240-9; PMID:22850422; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7b/5f/onci-2-e23887.PMC3667894.pdf
Cancer Res 2012; 72:6130-41; PMID:23026134; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7b/5f/onci-2-e23887.PMC3667894.pdf
"OncoImmunology 2013; 2:e23901; http://dx.doi.org/10.4161/onci.23901cytotoxic T cells and may sustain tumori - genic inflammation.3 However, the tumor  cell-derived signals that deregulate the  functions of tumor-infiltrating myeloid cells, and ultimately of T cells, remain to be fully elucidated.",Non-OADS,/arxiv_data1/oa_pdf/6a/57/onci-2-e23901.PMC3667895.pdf
Immunol  Rev 2011; 239:27-44; PMID:21198663; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/6a/57/onci-2-e23901.PMC3667895.pdf
J Immunol  2011; 187:4403-9; PMID:22013206; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/6a/57/onci-2-e23901.PMC3667895.pdf
Sci T ransl Med 2012; 4:ra159;  PMID:23241743; http://dx.doi.org/10.1126/scitrans- lmed.3004566,Non-OADS,/arxiv_data1/oa_pdf/6a/57/onci-2-e23901.PMC3667895.pdf
PLoS One 2012; 7:e51845;  PMID:23272178; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/6a/57/onci-2-e23901.PMC3667895.pdf
Science 2012; 337:1678- 84; PMID:23019653; http://dx.doi.org/10.1126/sci- ence.1224922 8.,OADS,/arxiv_data1/oa_pdf/6a/57/onci-2-e23901.PMC3667895.pdf
Proc Natl Acad Sci U S A  2011; 108:6561-6; PMID:21464300; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/6a/57/onci-2-e23901.PMC3667895.pdf
Science  2011; 334:1081-6; PMID:22116877; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/6a/57/onci-2-e23901.PMC3667895.pdf
J Biol Chem 2011; 286:41862- 70; PMID:22002058; http://dx.doi.org/10.1074/jbc.M111.304956,OADS,/arxiv_data1/oa_pdf/6a/57/onci-2-e23901.PMC3667895.pdf
OncoImmunology 2013; 2:e23974; http://dx.doi.org/10.4161/onci.23974both CMV-infected and leukemic cells.,Non-OADS,/arxiv_data1/oa_pdf/eb/f7/onci-2-e23974.PMC3667896.pdf
Blood 2011; 118:1402-12; PMID:21540462; http://dx.doi.org/10.1182/blood- 2010-08-3041212.,Non-OADS,/arxiv_data1/oa_pdf/eb/f7/onci-2-e23974.PMC3667896.pdf
Leukemia 2013; In press; PMID:23277330;  http://dx.doi.org/10.1038/leu.2012.3743.,Non-OADS,/arxiv_data1/oa_pdf/eb/f7/onci-2-e23974.PMC3667896.pdf
Nat Rev Immunol 2010; 10:467-78; PMID:20539306; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/eb/f7/onci-2-e23974.PMC3667896.pdf
Expert Opin Biol Ther 2009;  9:579-91; PMID:19368527; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/eb/f7/onci-2-e23974.PMC3667896.pdf
Blood 2011; 118:50- 9; PMID:21566093; http://dx.doi.org/10.1182/blood-2010-12-3259934.,Non-OADS,/arxiv_data1/oa_pdf/eb/f7/onci-2-e23974.PMC3667896.pdf
J Exp Med  2005; 201:1567-78; PMID:15897274; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/eb/f7/onci-2-e23974.PMC3667896.pdf
Blood 2012; 120:5153-62; PMID:23018643; http://dx.doi.org/10.1182/blood-2012-05-432427,Non-OADS,/arxiv_data1/oa_pdf/eb/f7/onci-2-e23974.PMC3667896.pdf
OncoImmunology 2013; 2:e24010;; http://dx.doi.org/10.4161/onci.24010these stromal cells.,Non-OADS,/arxiv_data1/oa_pdf/75/76/onci-2-e24010.PMC3667897.pdf
Cancer Cell 2012; 21:309-22; PMID:22439926;  http://dx.doi.org/10.1016/j.ccr.2012.02.022 2.,Non-OADS,/arxiv_data1/oa_pdf/75/76/onci-2-e24010.PMC3667897.pdf
Cell 2010; 140:883-99;  PMID:20303878; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/75/76/onci-2-e24010.PMC3667897.pdf
PLoS  One 2012; 7:e49047; PMID:23145063; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/75/76/onci-2-e24010.PMC3667897.pdf
Immunobiology  2009; 214:835-42; PMID:19628296; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/75/76/onci-2-e24010.PMC3667897.pdf
PLoS One 2009; 4:e7965; PMID:19956757;  http://dx.doi.org/10.1371/journal.pone.00079658.,Non-OADS,/arxiv_data1/oa_pdf/75/76/onci-2-e24010.PMC3667897.pdf
Breast  Cancer Res T reat 2009; 116:39-52; PMID:19241156;  http://dx.doi.org/10.1007/s10549-009-0351-z 9.,Non-OADS,/arxiv_data1/oa_pdf/75/76/onci-2-e24010.PMC3667897.pdf
PLoS One 2012; 7:e52796; PMID:23300781; http://dx.doi.org/10.1371/journal.pone.0052796,Non-OADS,/arxiv_data1/oa_pdf/75/76/onci-2-e24010.PMC3667897.pdf
OncoImmunology 2013; 2:e24036; http://dx.doi.org/10.4161/onci.24036infiltration.,Non-OADS,/arxiv_data1/oa_pdf/d3/e2/onci-2-e24036.PMC3667898.pdf
J Clin Oncol 2009; 27:5944- 51; PMID:19858404; http://dx.doi.org/10.1200/ JCO.2008.19.6147 2.,Non-OADS,/arxiv_data1/oa_pdf/d3/e2/onci-2-e24036.PMC3667898.pdf
Clin Cancer Res 2008; 14:5220-7;  PMID:18698040; http://dx.doi.org/10.1158/1078- 0432.CCR-08-0133 3.,Non-OADS,/arxiv_data1/oa_pdf/d3/e2/onci-2-e24036.PMC3667898.pdf
J Clin Oncol 2007; 25:2586-93; PMID:17577038; http://dx.doi.org/10.1200/ JCO.2006.09.4565 4.,Non-OADS,/arxiv_data1/oa_pdf/d3/e2/onci-2-e24036.PMC3667898.pdf
J Clin Oncol 2013; 31:490- 8; PMID:23269987; http://dx.doi.org/10.1200/ JCO.2012.45.20525.,Non-OADS,/arxiv_data1/oa_pdf/d3/e2/onci-2-e24036.PMC3667898.pdf
Clin Cancer Res 2011; 17:5247-56;  PMID:21659461; http://dx.doi.org/10.1158/1078- 0432.CCR-10-2805 6.,Non-OADS,/arxiv_data1/oa_pdf/d3/e2/onci-2-e24036.PMC3667898.pdf
Blood  2005; 106:3846-53; PMID:16081683; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d3/e2/onci-2-e24036.PMC3667898.pdf
PLoS One 2009; 4:e6119;  PMID:19582164; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/d3/e2/onci-2-e24036.PMC3667898.pdf
Blood  2012; 119:4133-41; PMID:22354001; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d3/e2/onci-2-e24036.PMC3667898.pdf
Nat Rev Immunol 2009; 9:480-90; PMID:19543225;  http://dx.doi.org/10.1038/nri2580 10.,Non-OADS,/arxiv_data1/oa_pdf/d3/e2/onci-2-e24036.PMC3667898.pdf
OncoImmunology 2013; 2:e24052; http://dx.doi.org/10.4161/onci.24052Oncogenic mutations in the gene cod - ing for the GTPase v-Ki-ras2  Kirsten rat  sarcoma viral oncogene homolog ( KRAS )  have been unravelled as the most preva - lent factors underpinning the resistance  of mCRC patients to EGFR-targeting antibodies.,Non-OADS,/arxiv_data1/oa_pdf/7c/4a/onci-2-e24052.PMC3667899.pdf
MAbs 2009; 1:590- 9; PMID:20068398; http://dx.doi.org/10.4161/ mabs.1.6.10051 2.,Non-OADS,/arxiv_data1/oa_pdf/7c/4a/onci-2-e24052.PMC3667899.pdf
Lancet Oncol 2012; 13:33-42; PMID:22056021;  http://dx.doi.org/10.1016/S1470-2045(11)70318-7 3.,Non-OADS,/arxiv_data1/oa_pdf/7c/4a/onci-2-e24052.PMC3667899.pdf
Eur J Cancer  2012; PMID:23265711; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/7c/4a/onci-2-e24052.PMC3667899.pdf
J Immunol  2012; 189:5230-9; PMID:23100515; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7c/4a/onci-2-e24052.PMC3667899.pdf
MAbs 2011; 3:584- 95; PMID:22123060; http://dx.doi.org/10.4161/ mabs.3.6.17955 9.,Non-OADS,/arxiv_data1/oa_pdf/7c/4a/onci-2-e24052.PMC3667899.pdf
Cancer Sci 2011; 102:1761-8;  PMID:21718386; http://dx.doi.org/10.1111/j.1349- 7006.2011.02019.x 10.,Non-OADS,/arxiv_data1/oa_pdf/7c/4a/onci-2-e24052.PMC3667899.pdf
Cancer Biol Ther  2009; 8:2147-52; PMID:19783899; http://dx.doi.org/10.4161/cbt.8.22.9765,Non-OADS,/arxiv_data1/oa_pdf/7c/4a/onci-2-e24052.PMC3667899.pdf
OncoImmunology 2013; 2:e24064; http://dx.doi.org/10.4161/onci.24064from mice bearing bone metastases under - went osteoclast differentiation in vitro in  the presence of receptor activator of nuclear factor- κB ligand (RANKL) and macro - phage colony-stimulating factor (M-CSF).,Non-OADS,/arxiv_data1/oa_pdf/e0/a7/onci-2-e24064.PMC3667900.pdf
Nat Rev Immunol 2012; 12:253-68; PMID:22437938;  http://dx.doi.org/10.1038/nri3175 2.,Non-OADS,/arxiv_data1/oa_pdf/e0/a7/onci-2-e24064.PMC3667900.pdf
Cancer Res 2013; 73:672-82;  PMID:23243021; http://dx.doi.org/10.1158/0008-5472.CAN-12-2202 4.,Non-OADS,/arxiv_data1/oa_pdf/e0/a7/onci-2-e24064.PMC3667900.pdf
Oncoimmunology 2012; 1:1484-94; PMID:23264895; http://dx.doi.org/10.4161/onci.219905.,Non-OADS,/arxiv_data1/oa_pdf/e0/a7/onci-2-e24064.PMC3667900.pdf
PLoS One 2012; 7:e48871;  PMID:23173040; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/e0/a7/onci-2-e24064.PMC3667900.pdf
J Clin Invest 2012; 122:4592-605; PMID:23114597;  http://dx.doi.org/10.1172/JCI60920 7.,Non-OADS,/arxiv_data1/oa_pdf/e0/a7/onci-2-e24064.PMC3667900.pdf
J Biol Chem 2011; 286:9612- 22; PMID:21169638; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/e0/a7/onci-2-e24064.PMC3667900.pdf
Clin Cancer Res 2011; 17:1278-86; PMID:21411443;  http://dx.doi.org/10.1158/1078-0432.CCR-10-18049.,Non-OADS,/arxiv_data1/oa_pdf/e0/a7/onci-2-e24064.PMC3667900.pdf
J Immunol  2012; 189:4258-65; PMID:23018462; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e0/a7/onci-2-e24064.PMC3667900.pdf
Cancer Cell 2009; 16:309- 23; PMID:19800576; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/e0/a7/onci-2-e24064.PMC3667900.pdf
"OncoImmunology 2013; 2:e24065;  http://dx.doi.org/10.4161/onci.24065to eliminate tumor cells in the absence  of therapeutic interventions.4 To evaluate  the relevance of the PD-1/PD-L1 pathway in HPV-HNSCC, we compared PD-1 expression by TILs and peripheral blood mononuclear cells (PBMCs) in patients with HPV-HNSCCs and from patients with a nonmalignant tonsil process.",Non-OADS,/arxiv_data1/oa_pdf/ea/d1/onci-2-e24065.PMC3667901.pdf
J Natl Cancer Inst  2000; 92:709-20; PMID:10793107; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ea/d1/onci-2-e24065.PMC3667901.pdf
J Clin Oncol 2011; 29:4294- 301; PMID:21969503; http://dx.doi.org/10.1200/ JCO.2011.36.4596 3.,Non-OADS,/arxiv_data1/oa_pdf/ea/d1/onci-2-e24065.PMC3667901.pdf
Head Neck  Pathol 2009; 3:78-81; PMID:20596995; http://dx.doi.org/10.1007/s12105-009-0100-y 4.,Non-OADS,/arxiv_data1/oa_pdf/ea/d1/onci-2-e24065.PMC3667901.pdf
Blood 2011; 118:965- 74; PMID:21652684; http://dx.doi.org/10.1182/ blood-2010-12-328070 7.,Non-OADS,/arxiv_data1/oa_pdf/ea/d1/onci-2-e24065.PMC3667901.pdf
N Engl J Med 2010; 363:711-23; PMID:20525992;  http://dx.doi.org/10.1056/NEJMoa1003466 8.,OADS,/arxiv_data1/oa_pdf/ea/d1/onci-2-e24065.PMC3667901.pdf
N Engl J Med 2012; 366:2443-54; PMID:22658127;  http://dx.doi.org/10.1056/NEJMoa1200690 10.,OADS,/arxiv_data1/oa_pdf/ea/d1/onci-2-e24065.PMC3667901.pdf
N  Engl J Med 2012; 366:2455-65; PMID:22658128;  http://dx.doi.org/10.1056/NEJMoa1200694,OADS,/arxiv_data1/oa_pdf/ea/d1/onci-2-e24065.PMC3667901.pdf
"OncoImmunology 2013; 2:e24077; http://dx.doi.org/10.4161/onci.24077combination with other immunotherapeu - tic strategies to overcome immunological  tolerance, promote tumor regression and prevent metastatic disease.",Non-OADS,/arxiv_data1/oa_pdf/c1/50/onci-2-e24077.PMC3667902.pdf
Science 2011; 331:1565-70;  PMID:21436444; http://dx.doi.org/10.1126/sci- ence.12034862.,OADS,/arxiv_data1/oa_pdf/c1/50/onci-2-e24077.PMC3667902.pdf
Cell Immunol  2011; 266:143-53; PMID:21055733; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c1/50/onci-2-e24077.PMC3667902.pdf
Carcinogenesis  2007; 28:1067-73; PMID:17183065; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c1/50/onci-2-e24077.PMC3667902.pdf
Cancer Res 2013; 73:1107-17; PMID:23204230;  http://dx.doi.org/10.1158/0008-5472.CAN-12-2418 10.,Non-OADS,/arxiv_data1/oa_pdf/c1/50/onci-2-e24077.PMC3667902.pdf
J Immunol 2010; 184:2476-86;  PMID:20130215; http://dx.doi.org/10.4049/jimmu- nol.09028767.,Non-OADS,/arxiv_data1/oa_pdf/c1/50/onci-2-e24077.PMC3667902.pdf
Immunity 2012; 36:322-35; PMID:22444630;  http://dx.doi.org/10.1016/j.immuni.2012.03.004 8.,OADS,/arxiv_data1/oa_pdf/c1/50/onci-2-e24077.PMC3667902.pdf
J Exp Med 2012; 209:1985-2000; PMID:23027923;  http://dx.doi.org/10.1084/jem.201116654.,Non-OADS,/arxiv_data1/oa_pdf/c1/50/onci-2-e24077.PMC3667902.pdf
Arch Med  Sci 2010; 6:545-51; PMID:22371798; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c1/50/onci-2-e24077.PMC3667902.pdf
Cold Spring Harb Perspect  Biol 2011; 3:3; PMID:21123394; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c1/50/onci-2-e24077.PMC3667902.pdf
Cell Immunol  2011; 266:116-22; PMID:20970781; http://dx.doi.org/10.1016/j.cellimm.2010.09.005,OADS,/arxiv_data1/oa_pdf/c1/50/onci-2-e24077.PMC3667902.pdf
"OncoImmunology 2013; 2:e24169;  http://dx.doi.org/10.4161/onci.24169angiogenesis and metastasis, the precise  role of TAMs on the functions of CSCs remains largely unknown.",Non-OADS,/arxiv_data1/oa_pdf/b1/3e/onci-2-e24169.PMC3667903.pdf
Cancer Res 2006; 66:4553-7;  PMID:16651403; http://dx.doi.org/10.1158/0008- 5472.CAN-05-3986 2.,Non-OADS,/arxiv_data1/oa_pdf/b1/3e/onci-2-e24169.PMC3667903.pdf
Cell 2010; 141:39- 51; PMID:20371344; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b1/3e/onci-2-e24169.PMC3667903.pdf
T rends  Cell Biol 2006; 16:79-87; PMID:16406521; http://dx.doi.org/10.1016/j.tcb.2005.12.005 5.,OADS,/arxiv_data1/oa_pdf/b1/3e/onci-2-e24169.PMC3667903.pdf
Front Biosci 2008; 13:4361-72; PMID:18508515; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b1/3e/onci-2-e24169.PMC3667903.pdf
J Cell Mol Med  2010; 14:2037-44; PMID:20597997; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b1/3e/onci-2-e24169.PMC3667903.pdf
Oncogene  2005; 24:489-501; PMID:15516973; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b1/3e/onci-2-e24169.PMC3667903.pdf
Immunology 2011; 132:39-48;  PMID:20722758; http://dx.doi.org/10.1111/j.1365- 2567.2010.03335.x10.,Non-OADS,/arxiv_data1/oa_pdf/b1/3e/onci-2-e24169.PMC3667903.pdf
Surgery  2006; 140:132-40; PMID:16904962; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/3e/onci-2-e24169.PMC3667903.pdf
OncoImmunology 2013; 2:e24170; http://dx.doi.org/10.4161/onci.24170expression is limited to some populations  of immune cells.,Non-OADS,/arxiv_data1/oa_pdf/8c/e4/onci-2-e24170.PMC3667904.pdf
Cell 2008; 134:215- 30; PMID:18662538; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/8c/e4/onci-2-e24170.PMC3667904.pdf
Curr Opin Immunol 2008; 20:234-40; PMID:18486463; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8c/e4/onci-2-e24170.PMC3667904.pdf
T rends Immunol  2010; 31:220-7; PMID:20538542; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8c/e4/onci-2-e24170.PMC3667904.pdf
Proc Natl Acad Sci U S A 2009; 106:12067- 72; PMID:19574455; http://dx.doi.org/10.1073/ pnas.0900971106 7.,OADS,/arxiv_data1/oa_pdf/8c/e4/onci-2-e24170.PMC3667904.pdf
Immunol Rev  2009; 227:54-65; PMID:19120475; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8c/e4/onci-2-e24170.PMC3667904.pdf
Cancer Res  2013; In press; PMID:23338611; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8c/e4/onci-2-e24170.PMC3667904.pdf
"OncoImmunology 2013; 2:e24183;  http://dx.doi.org/10.4161/onci.24183system more profoundly, by remotely  instigating the amplification of cells that promote tumor progression once recruited to the tumor microenviron - ment.",Non-OADS,/arxiv_data1/oa_pdf/d6/d9/onci-2-e24183.PMC3667905.pdf
Cell 2010; 141:39- 51; PMID:20371344; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d6/d9/onci-2-e24183.PMC3667905.pdf
Cancer Res 2010; 70:5728-39; PMID:20570887;  http://dx.doi.org/10.1158/0008-5472.CAN-09-4672 3.,Non-OADS,/arxiv_data1/oa_pdf/d6/d9/onci-2-e24183.PMC3667905.pdf
Science 2009; 325:612-6;  PMID:19644120; http://dx.doi.org/10.1126/sci-ence.11752025.,OADS,/arxiv_data1/oa_pdf/d6/d9/onci-2-e24183.PMC3667905.pdf
Cell Rep 2012; 2:628-39; PMID:22959433; http://dx.doi.org/10.1016/j.celrep.2012.08.006 6.,OADS,/arxiv_data1/oa_pdf/d6/d9/onci-2-e24183.PMC3667905.pdf
Immunity 2013; 38:296-308; PMID:23333075;  http://dx.doi.org/10.1016/j.immuni.2012.10.015 7.,OADS,/arxiv_data1/oa_pdf/d6/d9/onci-2-e24183.PMC3667905.pdf
Lancet Oncol 2011; 12:65-82;  PMID:21123111; http://dx.doi.org/10.1016/S1470- 2045(10)70260-69.,Non-OADS,/arxiv_data1/oa_pdf/d6/d9/onci-2-e24183.PMC3667905.pdf
Am J Cardiol 2011; 107:1028-33; PMID:21256465; http://dx.doi.org/10.1016/j.amjcard.2010.11.026 10.,Non-OADS,/arxiv_data1/oa_pdf/d6/d9/onci-2-e24183.PMC3667905.pdf
Hypertension 1979; 1:287-91; PMID:399240;  http://dx.doi.org/10.1161/01.HYP .1.3.287,Non-OADS,/arxiv_data1/oa_pdf/d6/d9/onci-2-e24183.PMC3667905.pdf
"OncoImmunology 2013; 2:e24184; http://dx.doi.org/10.4161/onci.24184products (RAGE, also known as AGER)  is a pattern-recognition receptor that rec - ognizes several DAMPs including high-mobility group box 1 (HMGB1) and S100A8/A9.",Non-OADS,/arxiv_data1/oa_pdf/be/64/onci-2-e24184.PMC3667906.pdf
Cancer Res 2007; 67:9518-27; PMID:17909062;  http://dx.doi.org/10.1158/0008-5472.CAN-07-0175 2.,Non-OADS,/arxiv_data1/oa_pdf/be/64/onci-2-e24184.PMC3667906.pdf
Mol Cancer Res 2011; 9:133-48;  PMID:21228116; http://dx.doi.org/10.1158/1541- 7786.MCR-10-0394 3.,Non-OADS,/arxiv_data1/oa_pdf/be/64/onci-2-e24184.PMC3667906.pdf
Immunol  Rev 2007; 220:60-81; PMID:17979840; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/be/64/onci-2-e24184.PMC3667906.pdf
Proceedings of the National Academy of Sciences 2012; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/be/64/onci-2-e24184.PMC3667906.pdf
Cancer Res  2012; 72:3735-43; PMID:22593190; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/be/64/onci-2-e24184.PMC3667906.pdf
Cell Death Differ 2010; 17:666-76; PMID:19834494; http://dx.doi.org/10.1038/cdd.2009.149 7.,Non-OADS,/arxiv_data1/oa_pdf/be/64/onci-2-e24184.PMC3667906.pdf
J Immunol 2013; 190:794-804; PMID:23248262;  http://dx.doi.org/10.4049/jimmunol.12020888.,Non-OADS,/arxiv_data1/oa_pdf/be/64/onci-2-e24184.PMC3667906.pdf
Cancer Cell 2003; 4:437-50; PMID:14706336;  http://dx.doi.org/10.1016/S1535-6108(03)00309-X 9.,Non-OADS,/arxiv_data1/oa_pdf/be/64/onci-2-e24184.PMC3667906.pdf
J Immunol 2013; 190:1372-9;  PMID:23269246; http://dx.doi.org/10.4049/jimmu- nol.1201151 10.,Non-OADS,/arxiv_data1/oa_pdf/be/64/onci-2-e24184.PMC3667906.pdf
Science 2011; 331:1612-6; PMID:21436454; http://dx.doi.org/10.1126/sci- ence.1198443,OADS,/arxiv_data1/oa_pdf/be/64/onci-2-e24184.PMC3667906.pdf
"OncoImmunology 2013; 2:e24211; http://dx.doi.org/10.4161/onci.24211are in place.2 Why in some, but not all,  tumor models Tregs seem to play a critical  role in suppressing anticancer immunity?",Non-OADS,/arxiv_data1/oa_pdf/0a/56/onci-2-e24211.PMC3667907.pdf
Nat  Rev Immunol 2008; 8:59-73; PMID:18097448;  http://dx.doi.org/10.1038/nri2216 2.,Non-OADS,/arxiv_data1/oa_pdf/0a/56/onci-2-e24211.PMC3667907.pdf
Oncoimmunology 2012; 1:326-33; PMID:22737608; http://dx.doi.org/10.4161/onci.18852 3.,Non-OADS,/arxiv_data1/oa_pdf/0a/56/onci-2-e24211.PMC3667907.pdf
Cancer Res 2013; 73:1514-23; PMID:23319803;  http://dx.doi.org/10.1158/0008-5472.CAN-12-2567 4.,Non-OADS,/arxiv_data1/oa_pdf/0a/56/onci-2-e24211.PMC3667907.pdf
Adv Cancer Res 2008; 101:277-348;  PMID:19055947; http://dx.doi.org/10.1016/S0065- 230X(08)00408-95.,Non-OADS,/arxiv_data1/oa_pdf/0a/56/onci-2-e24211.PMC3667907.pdf
J Exp Med 2001; 193:233- 8; PMID:11208863; http://dx.doi.org/10.1084/ jem.193.2.233 7.,OADS,/arxiv_data1/oa_pdf/0a/56/onci-2-e24211.PMC3667907.pdf
Clin Cancer Res 2012; 18:6446-59; PMID:23147997;  http://dx.doi.org/10.1158/1078-0432.CCR-12-07048.,Non-OADS,/arxiv_data1/oa_pdf/0a/56/onci-2-e24211.PMC3667907.pdf
Immunol Cell Biol 2013; 91:105- 14; PMID:23090488; http://dx.doi.org/10.1038/ icb.2012.58 9.,Non-OADS,/arxiv_data1/oa_pdf/0a/56/onci-2-e24211.PMC3667907.pdf
Clin Immunol 2011; 140:160-6; PMID:21233022;  http://dx.doi.org/10.1016/j.clim.2010.12.010 10.,OADS,/arxiv_data1/oa_pdf/0a/56/onci-2-e24211.PMC3667907.pdf
Clin Immunol 2009; 132:321- 33; PMID:19564135; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/0a/56/onci-2-e24211.PMC3667907.pdf
OncoImmunology 2013; 2:e24212; http://dx.doi.org/10.4161/onci.24212The antitumor activity of MV attenu - ated strains is due to their ability to pref - erentially infect and kill tumor cells.,Non-OADS,/arxiv_data1/oa_pdf/c9/1a/onci-2-e24212.PMC3667908.pdf
Nat Biotechnol 2012; 30:658-70; PMID:22781695;  http://dx.doi.org/10.1038/nbt.2287 2.,Non-OADS,/arxiv_data1/oa_pdf/c9/1a/onci-2-e24212.PMC3667908.pdf
Biology 2013; 2:587-602; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c9/1a/onci-2-e24212.PMC3667908.pdf
Cancer Res  2004; 64:4919-26; PMID:15256464; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c9/1a/onci-2-e24212.PMC3667908.pdf
Mol Immunol 2003; 40:109-23;  PMID:12914817; http://dx.doi.org/10.1016/S0161- 5890(03)00112-35.,Non-OADS,/arxiv_data1/oa_pdf/c9/1a/onci-2-e24212.PMC3667908.pdf
Cancer Res  2008; 68:4882-92; PMID:18559536; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c9/1a/onci-2-e24212.PMC3667908.pdf
Gene  Ther 2013; 20:7-15; PMID:22170342; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c9/1a/onci-2-e24212.PMC3667908.pdf
Clin Cancer Res 2013; 19:1147-58; PMID:23339127;  http://dx.doi.org/10.1158/1078-0432.CCR-12-27338.,Non-OADS,/arxiv_data1/oa_pdf/c9/1a/onci-2-e24212.PMC3667908.pdf
Nat Rev Immunol 2008; 8:594-606; PMID:18641647; http://dx.doi.org/10.1038/nri2358 9.,Non-OADS,/arxiv_data1/oa_pdf/c9/1a/onci-2-e24212.PMC3667908.pdf
Cancer Immunol Immunother 2012; 61:1279-88; PMID:22294456;  http://dx.doi.org/10.1007/s00262-012-1210-z 10.,Non-OADS,/arxiv_data1/oa_pdf/c9/1a/onci-2-e24212.PMC3667908.pdf
J Interferon Cytokine Res  2012; 32:235-47; PMID:22490303; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c9/1a/onci-2-e24212.PMC3667908.pdf
OncoImmunology 2013; 2:e24238; http://dx.doi.org/10.4161/onci.24238Adoptive cell transfer (ACT) represents a prominent form  of immunotherapy against malignant diseases.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
Nat  Rev Clin Oncol 2011; 8:577-85; PMID:21808266;  http://dx.doi.org/10.1038/nrclinonc.2011.116 2.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
Sci T ransl Med 2012;  4:ps8; PMID:22461638; http://dx.doi.org/10.1126/ scitranslmed.3003634 3.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
J Clin Oncol 2011; 29:4828- 36; PMID:22042955; http://dx.doi.org/10.1200/ JCO.2011.38.0899 4.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
Nat Rev Cancer  2008; 8:299-308; PMID:18354418; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
Nat Rev Immunol 2012; 12:269-81;  PMID:22437939; http://dx.doi.org/10.1038/nri3191 6.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
Oncoimmunology  2012; 1:1197-9; PMID:23170278; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
Oncoimmunology 2012; 1:1223-5; PMID:23243584; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
Oncoimmunology 2012; 1:1181-2; PMID:23170272; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
OncoImmunology 2013;  2:e22789; http://dx.doi.org/10.4161/onci.22789 10.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
Oncoimmunology 2012;  1:28-37; PMID:22720209; http://dx.doi.org/10.4161/ onci.1.1.17938 11.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
Oncoimmunology 2012; 1:493-506;  PMID:22754768; http://dx.doi.org/10.4161/onci.20459 12.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
Oncoimmunology 2012; 1:1111-34; PMID:23170259;  http://dx.doi.org/10.4161/onci.21494 13.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
Oncoimmunology  2012; 1:1557-76; PMID:23264902; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
Oncoimmunology  2012; 1:306-15; PMID:22737606; http://dx.doi.org/10.4161/onci.19549 16.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
Semin Immunol 2011; 23:21-7; PMID:21277223; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
Nat Biotechnol 2010; 28:813-5; PMID:20697407; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
Nat Rev Cancer  2010; 10:213-21; PMID:20168320; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
Biol Res 2012; 45:307-16;  PMID:23283440; http://dx.doi.org/10.4067/S0716- 97602012000300012 21.,OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
Cancer Immunol Immunother  2009; 58:553-66; PMID:18751701; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
Semin Cancer Biol 2012; 22:14-22; PMID:22210183;  http://dx.doi.org/10.1016/j.semcancer.2011.12.006 24.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
J Immunother 2010; 33:672- 83; PMID:20664359; http://dx.doi.org/10.1097/ CJI.0b013e3181e475cd 27.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
Blood  2011; 117:808-14; PMID:20971955; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
Oncoimmunology 2012; 1:986-8; PMID:23162781;  http://dx.doi.org/10.4161/onci.20213 29.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
Nat Rev Immunol 2005; 5:928-40;  PMID:16322746; http://dx.doi.org/10.1038/nri1729 30.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
Oncoimmunology  2012; 1:1577-83; PMID:23264903; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
T rends Biotechnol  2011; 29:550-7; PMID:21663987; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
N Engl J Med 1988; 319:1676- 80; PMID:3264384; http://dx.doi.org/10.1056/ NEJM198812223192527 33.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
J Immunother 2012; 35:107-15; PMID:22306898;  http://dx.doi.org/10.1097/CJI.0b013e318242169f 37.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
Cancer J 2010; 16:348- 53; PMID:20693846; http://dx.doi.org/10.1097/ PPO.0b013e3181eb3358 38.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
Immunol Rev 2011; 241:63-76;  PMID:21488890; http://dx.doi.org/10.1111/j.1600- 065X.2011.01004.x 39.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
Immunol Rev 2011; 241:260-8; PMID:21488902; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
J Immunol  2012; 189:5147-54; PMID:23100512; http://dx.doi.org/10.4049/jimmunol.1200274 42.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
Oncoimmunology 2012; 1:326-33; PMID:22737608;  http://dx.doi.org/10.4161/onci.18852 43.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
J Exp Med 2005; 202:907-12; PMID:16203864;  http://dx.doi.org/10.1084/jem.20050732 44.,OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
T rends Immunol 2005; 26:111- 7; PMID:15668127; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
J  Immunother 2010; 33:1-7; PMID:19952961; http://dx.doi.org/10.1097/CJI.0b013e3181b88ffc 46.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
Int J Cancer 1995; 63:205- 12; PMID:7591205; http://dx.doi.org/10.1002/ ijc.2910630210 47.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
Biomed Pharmacother  1992; 46:473-84; PMID:1306361; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
Blood 2006; 107:2409-14;  PMID:16304057; http://dx.doi.org/10.1182/blood- 2005-06-2399 49.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
N Engl J Med  2011; 365:2055-66; PMID:22129252; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
Cancer  Lett 1994; 85:39-46; PMID:7923100; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
Cancer Immunol Immunother 2010; 59:1325-34; PMID:20532883; http://dx.doi.org/10.1007/s00262- 010-0860-y 55.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
Clin Cancer Res  2011; 17:3134-45; PMID:21252159; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
Cancer Res 2010; 70:6171-80;  PMID:20631075; http://dx.doi.org/10.1158/0008- 5472.CAN-10-0153 57.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
Oncoimmunology 2012; 1:699-716; PMID:22934262; http://dx.doi.org/10.4161/ onci.20696 58.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
Clin Cancer Res 2007; 13:5280-9;  PMID:17875756; http://dx.doi.org/10.1158/1078- 0432.CCR-07-1378 59.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
Oncoimmunology 2012; 1:894-907; PMID:23162757;  http://dx.doi.org/10.4161/onci.20931 60.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
Nat Rev Drug Discov 2012; 11:215-33;  PMID:22301798; http://dx.doi.org/10.1038/nrd3626 62.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
Science 2011; 334:1573- 7; PMID:22174255; http://dx.doi.org/10.1126/sci- ence.1208347 63.,OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
Science 2012; 337:1678- 84; PMID:23019653; http://dx.doi.org/10.1126/sci-ence.1224922 64.,OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
N Engl J Med 2008; 358:2698-703; PMID:18565862;  http://dx.doi.org/10.1056/NEJMoa0800251,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
Clin Cancer Res  2011; 17:4987-95; PMID:21690573; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
Cancer Cell 2005; 7:411- 23; PMID:15894262; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
Proc Natl Acad Sci U S A  2011; 108:10662-7; PMID:21670304; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
Clin Cancer Res  2011; 17:6287-97; PMID:21844012; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
Science 2002; 295:2097-100;  PMID:11896281; http://dx.doi.org/10.1126/sci- ence.1068440 72.,OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
Curr Opin Immunol  2009; 21:525-30; PMID:19717293; http://dx.doi.org/10.1016/j.coi.2009.07.015 73.,OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
Clin Cancer Res 2010; 16:2646-55;  PMID:20406835; http://dx.doi.org/10.1158/1078- 0432.CCR-10-0041 74.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
Clin Cancer Res  2010; 16:6122-31; PMID:20668005; http://dx.doi.org/10.1158/1078-0432.CCR-10-1297 76.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
OncoImmunology 2013; 2:e23082; http://dx.doi.org/10.4161/onci.23082 77.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
Oncoimmunology 2012; 1:179-88; PMID:22720239;  http://dx.doi.org/10.4161/onci.1.2.19026 78.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
OncoImmunology 2013; 2:e23510; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
Oncoimmunology 2012; 1:1323- 43; PMID:23243596; http://dx.doi.org/10.4161/ onci.22009 80.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
Blood 2012; 119:2956-9; PMID:22289893;  http://dx.doi.org/10.1182/blood-2011-09-378398 81.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
Hum Gene Ther  2012; 23:444-50; PMID:22107246; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
Blood  2012; 119:2709-20; PMID:22160384; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
Haematologica 2012; 97:1205-8; PMID:22511490; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
Blood 2012; 119:3940-50;  PMID:22308288; http://dx.doi.org/10.1182/blood- 2011-10-387969 85.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
Bone Marrow T ransplant 2012; 47:957- 66; PMID:21986635; http://dx.doi.org/10.1038/bmt.2011.202 86.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
Clin Cancer Res 2012; 18:6732-41;  PMID:23092876; http://dx.doi.org/10.1158/1078- 0432.CCR-12-1432 87.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
J T ransl Med 2012; 10:157; PMID:22863016;  http://dx.doi.org/10.1186/1479-5876-10-157 89.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
Cancer Res 2012; 72:1116-25; PMID:22282657;  http://dx.doi.org/10.1158/0008-5472.CAN-11-3399 90.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
J Cancer 2011; 2:363-8; PMID:21716717; http://dx.doi.org/10.7150/ jca.2.36391.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
Clin Cancer Res 2011; 17:4550-7; PMID:21498393;  http://dx.doi.org/10.1158/1078-0432.CCR-11-0116 92.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
Sci T ransl Med 2012; 4:32ra53;  PMID:22553251; http://dx.doi.org/10.1126/scitrans- lmed.3003761 93.,OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
Nature 2010; 467:318- 22; PMID:20844535; http://dx.doi.org/10.1038/ nature09328 94.,OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
J Clin Invest 2008; 118:3132- 42; PMID:18688285; http://dx.doi.org/10.1172/ JCI35700 95.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
Cancer Immunol  Immunother 2012; 61:1221-31; PMID:22237888;  http://dx.doi.org/10.1007/s00262-011-1199-8 96.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
J Immunol 2012; 189:3299-310; PMID:22925929;  http://dx.doi.org/10.4049/jimmunol.1102495 98.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
J Invest  Dermatol 2013; 133:545-52; PMID:23014345; http://dx.doi.org/10.1038/jid.2012.336 99.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
J T ransl  Med 2013; 11:37; PMID:23402380; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
PLoS One 2012; 7:e45401;  PMID:23028986; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
Blood 2012; 120:4334-42; PMID:22898597;  http://dx.doi.org/10.1182/blood-2012-02-412973 102.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
J Immunol 2012; 189:1812-25;  PMID:22798667; http://dx.doi.org/10.4049/jimmu-nol.1200552 104.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
Hum Gene Ther 2013; 24:27- 37; PMID:22998346; http://dx.doi.org/10.1089/ hum.2012.130 105.,OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
J Immunol 2012; 189:1627-38;  PMID:22798675; http://dx.doi.org/10.4049/jimmu- nol.1103271 107.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
Clin Cancer Res 2012; 18:1672-83; PMID:22291136; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
Cancer Res 2012; 72:1239-47;  PMID:22232735; http://dx.doi.org/10.1158/0008- 5472.CAN-11-3375 109.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
Nat Immunol 2003; 4:815;  PMID:12942076; http://dx.doi.org/10.1038/ni0903- 815 110.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
Oncoimmunology  2012; 1:1658-60; PMID:23264928; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
Blood 2012; 119:5164-72;  PMID:22498742; http://dx.doi.org/10.1182/blood-2011-11-389924 112.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
Nat Biotechnol 2013;  31:71-5; PMID:23242161; http://dx.doi.org/10.1038/ nbt.2459 113.,OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
Cancer J 2010; 16:336-41;  PMID:20693844; http://dx.doi.org/10.1097/ PPO.0b013e3181eb3879 115.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
J Immunother 2012; 35:276-82; PMID:22421945;  http://dx.doi.org/10.1097/CJI.0b013e31824e7f43116.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
J Immunother 2012; 35:460-72; PMID:22735804;  http://dx.doi.org/10.1097/CJI.0b013e31826092db 117.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
Int J Cancer 2012; 130:2618- 28; PMID:21792901; http://dx.doi.org/10.1002/ ijc.26316 118.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
Cancer Res  2012; 72:5209-18; PMID:22915761; http://dx.doi.org/10.1158/0008-5472.CAN-12-1187 119.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
Cancer Res 2012; 72:3928-37;  PMID:22693252; http://dx.doi.org/10.1158/0008- 5472.CAN-11-2837 120.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
Clin Cancer Res  2013; 19:393-403; PMID:23204132; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
PLoS  One 2012; 7:e32211; PMID:22359671; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
Int J Cancer 2012; 131:1601- 10; PMID:21607945; http://dx.doi.org/10.1002/ijc.26191 124.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
J Immunol 2012; 188:3829-38; PMID:22422886;  http://dx.doi.org/10.4049/jimmunol.1103329 125.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
Clin Cancer Res 2013; 19:106-17; PMID:23149818; http://dx.doi.org/10.1158/1078- 0432.CCR-12-2143 127.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
Cancer Sci  2012; 103:1414-9; PMID:22621620; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
Cell Mol Immunol 2012; 9:34-44; PMID:21666706;  http://dx.doi.org/10.1038/cmi.2011.16 131.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
Oncoimmunology 2012; 1:237- 9; PMID:22720255; http://dx.doi.org/10.4161/ onci.1.2.18231 132.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
Oncoimmunology 2012; 1:1435-7; PMID:23243620;  http://dx.doi.org/10.4161/onci.21206 135.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
Blood 2013; 121:573-84; PMID:23160470;  http://dx.doi.org/10.1182/blood-2012-05-431718 136.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
Nat Med 2011; 17:1290-7;  PMID:21926977; http://dx.doi.org/10.1038/nm.2446 138.,OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
Cell Stem Cell  2013; 12:114-26; PMID:23290140; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
Oncoimmunology 2012; 1:735-8; PMID:22934265;  http://dx.doi.org/10.4161/onci.20823 140.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
Cell Stem Cell 2013; 12:31-6; PMID:23290135; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
Nat Rev Cancer 2005; 5:615-25; PMID:16034368;  http://dx.doi.org/10.1038/nrc1669 142.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
Oncoimmunology  2012; 1:1476-83; PMID:23264894; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
Oncoimmunology 2012;  1:997-9; PMID:23189245; http://dx.doi.org/10.4161/ onci.19865,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
Oncoimmunology 2012; 1:544-6; PMID:22754781;  http://dx.doi.org/10.4161/onci.19442 146.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
Mol Ther  2011; 19:2258-68; PMID:21915103; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
Nat Rev Cancer  2009; 9:463-75; PMID:19536107; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
Cancer Lett 2012; 316:1- 5; PMID:22099879; http://dx.doi.org/10.1016/j.can- let.2011.10.027 149.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
Oncoimmunology  2012; 1:458-66; PMID:22754764; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
N Engl J Med  2011; 365:1673-83; PMID:22047558; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a5/23/onci-2-e24238.PMC3667909.pdf
OncoImmunology 2013; 2:e24270; http://dx.doi.org/10.4161/onci.24270Ovarian cancer is one of the neoplasms affecting the reproductive tract associated with high mortality rate because of  limited therapeutic options and an elevated incidence of chemoresistance and recurrence.,Non-OADS,/arxiv_data1/oa_pdf/00/0a/onci-2-e24270.PMC3667910.pdf
CA Cancer J Clin 2012; 62:10-29;  PMID:22237781; http://dx.doi.org/10.3322/ caac.20138 2.,Non-OADS,/arxiv_data1/oa_pdf/00/0a/onci-2-e24270.PMC3667910.pdf
Oncoimmunology 2012; 1:1194- 6; PMID:23170277; http://dx.doi.org/10.4161/ onci.20686 3.,Non-OADS,/arxiv_data1/oa_pdf/00/0a/onci-2-e24270.PMC3667910.pdf
Clin Cancer  Res 2007; 13:1421-8; PMID:17332284; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/00/0a/onci-2-e24270.PMC3667910.pdf
Cancer Res 2008; 68:8240-8;  PMID:18922895; http://dx.doi.org/10.1158/0008- 5472.CAN-08-1708 5.,Non-OADS,/arxiv_data1/oa_pdf/00/0a/onci-2-e24270.PMC3667910.pdf
Cancer Epidemiol Biomarkers  Prev 2009; 18:630-9; PMID:19190149; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/00/0a/onci-2-e24270.PMC3667910.pdf
Cancer 2009; 115:2671- 83; PMID:19326449; http://dx.doi.org/10.1002/ cncr.242937.,Non-OADS,/arxiv_data1/oa_pdf/00/0a/onci-2-e24270.PMC3667910.pdf
J Clin Endocrinol Metab  2009; 94:4613-8; PMID:19820019; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/00/0a/onci-2-e24270.PMC3667910.pdf
Leuk  Res 2010; 34:858-63; PMID:20138665; http://dx.doi.org/10.1016/j.leukres.2010.01.017 9.,OADS,/arxiv_data1/oa_pdf/00/0a/onci-2-e24270.PMC3667910.pdf
Am J Pathol 2011; 178:1009- 20; PMID:21356354; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/00/0a/onci-2-e24270.PMC3667910.pdf
PLoS One 2010; 5:e10471;  PMID:20485677; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/00/0a/onci-2-e24270.PMC3667910.pdf
Clin  Dev Immunol 2010; 2010:1505-15; PMID:20885926;  http://dx.doi.org/10.1155/2010/891505 16.,Non-OADS,/arxiv_data1/oa_pdf/00/0a/onci-2-e24270.PMC3667910.pdf
Br J Haematol  2008; 140:465-68; http://dx.doi.org/10.1111/j.1365- 2141.2007.06940.x 17.,Non-OADS,/arxiv_data1/oa_pdf/00/0a/onci-2-e24270.PMC3667910.pdf
Prostate  2012; 72:12-23; PMID:21520158; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/00/0a/onci-2-e24270.PMC3667910.pdf
"Obstetrics,  Gynaecol Reprod Med 2012; 22:33-7; http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/00/0a/onci-2-e24270.PMC3667910.pdf
Curr Opin  Oncol 2009; 21:71-6; PMID:19125021; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/00/0a/onci-2-e24270.PMC3667910.pdf
Nat Med 2011; 17:916-8; PMID:21818078; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/00/0a/onci-2-e24270.PMC3667910.pdf
Clin Cancer Res 2006; 12:398-404; PMID:16428478;  http://dx.doi.org/10.1158/1078-0432.CCR-05-1902 23.,Non-OADS,/arxiv_data1/oa_pdf/00/0a/onci-2-e24270.PMC3667910.pdf
Proc Natl Acad Sci U S A 2005; 102:18538- 43; PMID:16344461; http://dx.doi.org/10.1073/ pnas.050918210224.,OADS,/arxiv_data1/oa_pdf/00/0a/onci-2-e24270.PMC3667910.pdf
Clin Cancer Res  2009; 15:4467-74; PMID:19531622; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/00/0a/onci-2-e24270.PMC3667910.pdf
Clin Cancer Res 2008; 14:2740-8; PMID:18451240; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/00/0a/onci-2-e24270.PMC3667910.pdf
Hum Mol Genet  2006; 15:201-11; PMID:16377660; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/00/0a/onci-2-e24270.PMC3667910.pdf
Gynecol Oncol 2005; 99:183- 8; PMID:16005946; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/00/0a/onci-2-e24270.PMC3667910.pdf
OncoImmunology 2013; 2:e24271; http://dx.doi.org/10.4161/onci.24271The identification of growth and differentiation pathways that are responsible for the proliferation and survival of  cancer stem cells ( csc s) has opened avenues for the discovery of novel therapeutic targets.,Non-OADS,/arxiv_data1/oa_pdf/d0/2c/onci-2-e24271.PMC3667911.pdf
Supplemental Material Supplemental materials may be found here:http://www.landesbioscience.com/journals/oncoimmunology/article/24271/ References 1.,Non-OADS,/arxiv_data1/oa_pdf/d0/2c/onci-2-e24271.PMC3667911.pdf
Cell Immunol 2012; 278:21- 6; PMID:23121972; http://dx.doi.org/10.1016/j.cel- limm.2012.06.014 2.,OADS,/arxiv_data1/oa_pdf/d0/2c/onci-2-e24271.PMC3667911.pdf
Immunotherapy 2011; 3:539- 56; PMID:21463194; http://dx.doi.org/10.2217/ imt.11.20 3.,Non-OADS,/arxiv_data1/oa_pdf/d0/2c/onci-2-e24271.PMC3667911.pdf
J T ransl  Med 2012; 10:1; PMID:22214470; http://dx.doi.org/10.1186/1479-5876-10-1 4.,Non-OADS,/arxiv_data1/oa_pdf/d0/2c/onci-2-e24271.PMC3667911.pdf
Gynecol Oncol  2008; 108:421-7; PMID:18036640; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d0/2c/onci-2-e24271.PMC3667911.pdf
Cancer Immunol Immunother  2004; 53:176-86; PMID:14685782; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d0/2c/onci-2-e24271.PMC3667911.pdf
Nature 2011; 474:212- 5; PMID:21572395; http://dx.doi.org/10.1038/ nature10135 8.,Non-OADS,/arxiv_data1/oa_pdf/d0/2c/onci-2-e24271.PMC3667911.pdf
Cancer Immunol Immunother 2001; 50:3- 15; PMID:11315507; http://dx.doi.org/10.1007/ s002620000169 9.,Non-OADS,/arxiv_data1/oa_pdf/d0/2c/onci-2-e24271.PMC3667911.pdf
Blood 2007; 110:201-10; PMID:17371945;  http://dx.doi.org/10.1182/blood-2006-11-056168 10.,Non-OADS,/arxiv_data1/oa_pdf/d0/2c/onci-2-e24271.PMC3667911.pdf
Nat Rev  Immunol 2002; 2:735-47; PMID:12360212; http://dx.doi.org/10.1038/nri911 13.,Non-OADS,/arxiv_data1/oa_pdf/d0/2c/onci-2-e24271.PMC3667911.pdf
J Leukoc Biol 2004; 75:163- 89; PMID:14525967; http://dx.doi.org/10.1189/ jlb.0603252 15.,Non-OADS,/arxiv_data1/oa_pdf/d0/2c/onci-2-e24271.PMC3667911.pdf
Proc Natl Acad Sci U S A  2003; 100:3983-8; PMID:12629218; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d0/2c/onci-2-e24271.PMC3667911.pdf
Nat Med 1997; 3:730-7;  PMID:9212098; http://dx.doi.org/10.1038/nm0797- 730 17.,Non-OADS,/arxiv_data1/oa_pdf/d0/2c/onci-2-e24271.PMC3667911.pdf
Cancer Res 2005; 65:10946-51;  PMID:16322242; http://dx.doi.org/10.1158/0008- 5472.CAN-05-2018 18.,Non-OADS,/arxiv_data1/oa_pdf/d0/2c/onci-2-e24271.PMC3667911.pdf
Proc Natl Acad Sci U S A 2007; 104:10158-63; PMID:17548814; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d0/2c/onci-2-e24271.PMC3667911.pdf
Cell Stem Cell 2011; 9:357-65;  PMID:21982235; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d0/2c/onci-2-e24271.PMC3667911.pdf
Cancer Res  2005; 65:9328-37; PMID:16230395; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d0/2c/onci-2-e24271.PMC3667911.pdf
Cell Stem Cell 2007; 1:313- 23; PMID:18371365; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d0/2c/onci-2-e24271.PMC3667911.pdf
Nature 2008; 456:593-8; PMID:19052619; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d0/2c/onci-2-e24271.PMC3667911.pdf
J Vis Exp 2010; PMID:20972397; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d0/2c/onci-2-e24271.PMC3667911.pdf
Cancer Res 2008; 68:4311-20;  PMID:18519691; http://dx.doi.org/10.1158/0008- 5472.CAN-08-0364 27.,Non-OADS,/arxiv_data1/oa_pdf/d0/2c/onci-2-e24271.PMC3667911.pdf
Stem Cells 2007; 25:1675-80;  PMID:17379765; http://dx.doi.org/10.1634/stem- cells.2006-0611 30.,Non-OADS,/arxiv_data1/oa_pdf/d0/2c/onci-2-e24271.PMC3667911.pdf
Am J Surg Pathol 2004; 28:935-40; PMID:15223965; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d0/2c/onci-2-e24271.PMC3667911.pdf
Curr Opin Immunol 2010; 22:245-50; PMID:20144857; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d0/2c/onci-2-e24271.PMC3667911.pdf
Adv Immunol 2012; 114:151-76;  PMID:22449781; http://dx.doi.org/10.1016/B978-0- 12-396548-6.00006-8 36.,Non-OADS,/arxiv_data1/oa_pdf/d0/2c/onci-2-e24271.PMC3667911.pdf
J Exp Med  1994; 179:1005-9; PMID:8113668; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d0/2c/onci-2-e24271.PMC3667911.pdf
Immunol Lett  1994; 40:171-8; PMID:8088874; http://dx.doi.org/10.1016/0165-2478(94)90189-9 38.,Non-OADS,/arxiv_data1/oa_pdf/d0/2c/onci-2-e24271.PMC3667911.pdf
Crit Rev Immunol  2001; 21:263-73; PMID:11642608; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d0/2c/onci-2-e24271.PMC3667911.pdf
Crit Rev Oncol Hematol 2008; 66:118-34; PMID:18262431;  http://dx.doi.org/10.1016/j.critrevonc.2007.12.007 43.,Non-OADS,/arxiv_data1/oa_pdf/d0/2c/onci-2-e24271.PMC3667911.pdf
Cancer Res 2009; 69:2927-34; PMID:19318559;  http://dx.doi.org/10.1158/0008-5472.CAN-08-3920 44.,Non-OADS,/arxiv_data1/oa_pdf/d0/2c/onci-2-e24271.PMC3667911.pdf
Mol Ther 2012; 20:1063-74; PMID:22371843; http://dx.doi.org/10.1038/mt.2012.1146.,Non-OADS,/arxiv_data1/oa_pdf/d0/2c/onci-2-e24271.PMC3667911.pdf
Cancer Res  2011; 71:5423-34; PMID:21697280; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d0/2c/onci-2-e24271.PMC3667911.pdf
Gynecol Oncol  2010; 117:366-72; PMID:20144842; http://dx.doi.org/10.1016/j.ygyno.2010.01.019 51.,Non-OADS,/arxiv_data1/oa_pdf/d0/2c/onci-2-e24271.PMC3667911.pdf
Cancer Res 2007; 67:8900-5; PMID:17875732;  http://dx.doi.org/10.1158/0008-5472.CAN-07-1866 52.,Non-OADS,/arxiv_data1/oa_pdf/d0/2c/onci-2-e24271.PMC3667911.pdf
Nat Med 2004; 10:942- 9; PMID:15322536; http://dx.doi.org/10.1038/ nm1093 53.,OADS,/arxiv_data1/oa_pdf/d0/2c/onci-2-e24271.PMC3667911.pdf
J Exp Med  2007; 204:831-40; PMID:17389240; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d0/2c/onci-2-e24271.PMC3667911.pdf
J Huazhong Univ Sci  Technolog Med Sci 2007; 27:675-7; PMID:18231740; http://dx.doi.org/10.1007/s11596-007-0614-z58.,OADS,/arxiv_data1/oa_pdf/d0/2c/onci-2-e24271.PMC3667911.pdf
J Biol Chem 2012; 287:32800-24; PMID:22847005; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/d0/2c/onci-2-e24271.PMC3667911.pdf
Genes Dev 2010; 24:916-32; PMID:20382729;  http://dx.doi.org/10.1101/gad.1899710 61.,OADS,/arxiv_data1/oa_pdf/d0/2c/onci-2-e24271.PMC3667911.pdf
J Pathol  2011; 223:672-82; PMID:21341266; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d0/2c/onci-2-e24271.PMC3667911.pdf
Histopathology 2011; 59:763-75; PMID:22014056;  http://dx.doi.org/10.1111/j.1365-2559.2011.03993.x 63.,Non-OADS,/arxiv_data1/oa_pdf/d0/2c/onci-2-e24271.PMC3667911.pdf
J Oral Pathol Med 2011; 40:621-8;  PMID:21342274; http://dx.doi.org/10.1111/j.1600- 0714.2011.01015.x 65.,Non-OADS,/arxiv_data1/oa_pdf/d0/2c/onci-2-e24271.PMC3667911.pdf
Br J Cancer 2010; 102:1276- 83; PMID:20354527; http://dx.doi.org/10.1038/sj.bjc.6605626 66.,Non-OADS,/arxiv_data1/oa_pdf/d0/2c/onci-2-e24271.PMC3667911.pdf
Oncogene 2010; 29:2672-80; PMID:20190812; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d0/2c/onci-2-e24271.PMC3667911.pdf
Oncoimmunology 2012; 1:1507-16; PMID:23264897; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d0/2c/onci-2-e24271.PMC3667911.pdf
"OncoImmunology 2013; 2:e24272; http://dx.doi.org/10.4161/onci.24272might produce LT αβ or other important  HEV-inducing factors.5 Alternatively, the  development of HEV may be dictated  by the nature of developing tumor.",Non-OADS,/arxiv_data1/oa_pdf/e3/7d/onci-2-e24272.PMC3667912.pdf
J Exp Med  2007; 204:735-45; PMID:17371928; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e3/7d/onci-2-e24272.PMC3667912.pdf
Cancer Res 2011; 71:5678-87;  PMID:21846823; http://dx.doi.org/10.1158/0008- 5472.CAN-11-0431 5.,Non-OADS,/arxiv_data1/oa_pdf/e3/7d/onci-2-e24272.PMC3667912.pdf
Nature 2011; 479:542-6; PMID:22080953;  http://dx.doi.org/10.1038/nature10540References 1.,Non-OADS,/arxiv_data1/oa_pdf/e3/7d/onci-2-e24272.PMC3667912.pdf
Annu Rev Immunol 2011; 29:235-71;  PMID:21219185; http://dx.doi.org/10.1146/annurev- immunol-031210-101324 2.,Non-OADS,/arxiv_data1/oa_pdf/e3/7d/onci-2-e24272.PMC3667912.pdf
Cancer Res  2012; 72:5473-82; PMID:22962270; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e3/7d/onci-2-e24272.PMC3667912.pdf
Nat Immunol 2006; 7:344-53;  PMID:16550197; http://dx.doi.org/10.1038/ni1330,Non-OADS,/arxiv_data1/oa_pdf/e3/7d/onci-2-e24272.PMC3667912.pdf
OncoImmunology 2013; 2:e34320; http://dx.doi.org/10.4161/onci.24320Intense efforts are currently being  dedicated at the identification of strate - gies that may prolong clinical responses  to vemurafenib.,Non-OADS,/arxiv_data1/oa_pdf/d5/9f/onci-2-e24320.PMC3667913.pdf
N Engl J Med 2011;  364:2507-16; PMID:21639808; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d5/9f/onci-2-e24320.PMC3667913.pdf
N Engl J Med 2010; 363:711-23; PMID:20525992;  http://dx.doi.org/10.1056/NEJMoa1003466 4.,OADS,/arxiv_data1/oa_pdf/d5/9f/onci-2-e24320.PMC3667913.pdf
N Engl J Med 2012; 366:2443-54; PMID:22658127; http://dx.doi.org/10.1056/NEJMoa1200690 5.,OADS,/arxiv_data1/oa_pdf/d5/9f/onci-2-e24320.PMC3667913.pdf
Cancer Res  2010; 70:5213-9; PMID:20551059; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d5/9f/onci-2-e24320.PMC3667913.pdf
Clin Cancer Res 2012; 18:1386-94;  PMID:22156613; http://dx.doi.org/10.1158/1078- 0432.CCR-11-2479 8.,Non-OADS,/arxiv_data1/oa_pdf/d5/9f/onci-2-e24320.PMC3667913.pdf
Clin Cancer Res  2013; 19:1225-31; PMID:23307859; http://dx.doi.org/10.1158/1078-0432.CCR-12-16309.,Non-OADS,/arxiv_data1/oa_pdf/d5/9f/onci-2-e24320.PMC3667913.pdf
Clin  Cancer Res 2012; 18:5329-40; PMID:22850568;  http://dx.doi.org/10.1158/1078-0432.CCR-12-1632 10.,Non-OADS,/arxiv_data1/oa_pdf/d5/9f/onci-2-e24320.PMC3667913.pdf
Clin Cancer Res  2013; 19:393-403; PMID:23204132; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d5/9f/onci-2-e24320.PMC3667913.pdf
"OncoImmunology 2013;  2:e24383; http://dx.doi.org/10.4161/onci.24383Introduction Tumor-specific CD4+ T cells have repeatedly been shown to play  a central role in antitumor immune responses.1–6 CD4+ T cells  provide help to tumor-specific CD8+ T cells and B cells, and can  promote the cytotoxic function of innate immune cells includ - ing macrophages.",Non-OADS,/arxiv_data1/oa_pdf/8d/76/onci-2-e24383.PMC3667914.pdf
J Exp Med  1994; 179:1215-24; PMID:7908321; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8d/76/onci-2-e24383.PMC3667914.pdf
J Exp Med  1998; 188:2357-68; PMID:9858522; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8d/76/onci-2-e24383.PMC3667914.pdf
Immunity 2005; 22:371-83; PMID:15780993; http://dx.doi.org/10.1016/j.immuni.2005.02.003 7.,OADS,/arxiv_data1/oa_pdf/8d/76/onci-2-e24383.PMC3667914.pdf
Nat Rev Cancer 2012; 12:298-306;  PMID:22419253; http://dx.doi.org/10.1038/nrc3245 10.,Non-OADS,/arxiv_data1/oa_pdf/8d/76/onci-2-e24383.PMC3667914.pdf
N Engl J Med 2010; 363:711-23; PMID:20525992;  http://dx.doi.org/10.1056/NEJMoa1003466 11.,OADS,/arxiv_data1/oa_pdf/8d/76/onci-2-e24383.PMC3667914.pdf
N Engl J Med 2012; 366:2443-54; PMID:22658127;  http://dx.doi.org/10.1056/NEJMoa120069012.,OADS,/arxiv_data1/oa_pdf/8d/76/onci-2-e24383.PMC3667914.pdf
Eur J Immunol 1992;  22:703-9; PMID:1547816; http://dx.doi.org/10.1002/ eji.1830220313 14.,Non-OADS,/arxiv_data1/oa_pdf/8d/76/onci-2-e24383.PMC3667914.pdf
Proc Natl Acad Sci U S  A 1994; 91:5700-4; PMID:7911244; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8d/76/onci-2-e24383.PMC3667914.pdf
Eur J Immunol 1995; 25:3079-86; PMID:7489746;  http://dx.doi.org/10.1002/eji.1830251114 16.,Non-OADS,/arxiv_data1/oa_pdf/8d/76/onci-2-e24383.PMC3667914.pdf
Cell Immunol 1993; 148:177-88; PMID:8098665; http://dx.doi.org/10.1006/ cimm.1993.1100 17.,Non-OADS,/arxiv_data1/oa_pdf/8d/76/onci-2-e24383.PMC3667914.pdf
Cancer Res 2009; 69:5901-7;  PMID:19567679; http://dx.doi.org/10.1158/0008- 5472.CAN-08-4816 18.,Non-OADS,/arxiv_data1/oa_pdf/8d/76/onci-2-e24383.PMC3667914.pdf
Blood  2012; 119:2176-7; PMID:22383793; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8d/76/onci-2-e24383.PMC3667914.pdf
Nat Commun 2011; 2:240; PMID:21407206;  http://dx.doi.org/10.1038/ncomms1239 21.,OADS,/arxiv_data1/oa_pdf/8d/76/onci-2-e24383.PMC3667914.pdf
Oncoimmunology  2012; 1:1146-55; PMID:23170261; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8d/76/onci-2-e24383.PMC3667914.pdf
Blood 2008; 112:1557-69; PMID:18725574;  http://dx.doi.org/10.1182/blood-2008-05-07815423.,Non-OADS,/arxiv_data1/oa_pdf/8d/76/onci-2-e24383.PMC3667914.pdf
Science 2002; 296:1634-5; PMID:12040173;  http://dx.doi.org/10.1126/science.1071924 24.,OADS,/arxiv_data1/oa_pdf/8d/76/onci-2-e24383.PMC3667914.pdf
Immunity 2008; 28:468-76;  PMID:18400189; http://dx.doi.org/10.1016/j.immu-ni.2008.03.003 25.,OADS,/arxiv_data1/oa_pdf/8d/76/onci-2-e24383.PMC3667914.pdf
J Exp Med 1981; 154:1455-74; PMID:6975347; http://dx.doi.org/10.1084/jem.154.5.1455 26.,Non-OADS,/arxiv_data1/oa_pdf/8d/76/onci-2-e24383.PMC3667914.pdf
Immunity  2009; 30:155-67; PMID:19144320; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8d/76/onci-2-e24383.PMC3667914.pdf
Nat Immunol 2008; 9:1091-4; PMID:18800157; http://dx.doi.org/10.1038/ni1008-1091 29.,Non-OADS,/arxiv_data1/oa_pdf/8d/76/onci-2-e24383.PMC3667914.pdf
Annu Rev Immunol 2001; 19:23-45; PMID:11244029; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8d/76/onci-2-e24383.PMC3667914.pdf
Annu Rev Immunol 2009; 27:591-619; PMID:19132916; http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/8d/76/onci-2-e24383.PMC3667914.pdf
Immunity 2004; 20:455-65;  PMID:15084274; http://dx.doi.org/10.1016/S1074- 7613(04)00077-9 32.,OADS,/arxiv_data1/oa_pdf/8d/76/onci-2-e24383.PMC3667914.pdf
Immunity 2010; 32:104- 15; PMID:20079666; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/8d/76/onci-2-e24383.PMC3667914.pdf
Scand J Immunol 2003; 58:306-11;  PMID:12950676; http://dx.doi.org/10.1046/j.1365- 3083.2003.01303.x 60.,Non-OADS,/arxiv_data1/oa_pdf/8d/76/onci-2-e24383.PMC3667914.pdf
Eur J Immunol 1997; 27:1469- 78; PMID:9209500; http://dx.doi.org/10.1002/ eji.1830270625 62.,Non-OADS,/arxiv_data1/oa_pdf/8d/76/onci-2-e24383.PMC3667914.pdf
Cytometry 1997;  27:71-6; PMID:9000587; http://dx.doi.org/10.1002/(SICI)1097-0320(19970101)27:1<71::AID- CYTO9>3.0.CO;2-O 63.,Non-OADS,/arxiv_data1/oa_pdf/8d/76/onci-2-e24383.PMC3667914.pdf
Scand J  Immunol 2009; 70:326-36; PMID:19751267; http://dx.doi.org/10.1111/j.1365-3083.2009.02308.x 64.,Non-OADS,/arxiv_data1/oa_pdf/8d/76/onci-2-e24383.PMC3667914.pdf
Cancer  Res 2013; 73:128-38; PMID:23135914; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8d/76/onci-2-e24383.PMC3667914.pdf
Biochemistry 1968; 7:4126-34; PMID:4177521;  http://dx.doi.org/10.1021/bi00851a048 66.,Non-OADS,/arxiv_data1/oa_pdf/8d/76/onci-2-e24383.PMC3667914.pdf
Stat Appl Genet Mol Biol 2004; 3:e3;  PMID:16646809; http://dx.doi.org/10.2202/1544- 6115.1027 67.,OADS,/arxiv_data1/oa_pdf/8d/76/onci-2-e24383.PMC3667914.pdf
Nat Protoc 2009; 4:44- 57; PMID:19131956; http://dx.doi.org/10.1038/ nprot.2008.211 68.,Non-OADS,/arxiv_data1/oa_pdf/8d/76/onci-2-e24383.PMC3667914.pdf
Nucleic Acids  Res 2009; 37:1-13; PMID:19033363; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8d/76/onci-2-e24383.PMC3667914.pdf
EMBO  J 2007; 26:3191-202; PMID:17568779; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8d/76/onci-2-e24383.PMC3667914.pdf
Science 2005; 310:1159- 63; PMID:16293754; http://dx.doi.org/10.1126/sci- ence.1117893 50.,OADS,/arxiv_data1/oa_pdf/8d/76/onci-2-e24383.PMC3667914.pdf
Nature  1999; 401:708-12; PMID:10537110; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8d/76/onci-2-e24383.PMC3667914.pdf
Immunity  1994; 1:405-13; PMID:7882171; http://dx.doi.org/10.1016/1074-7613(94)90071-X 53.,OADS,/arxiv_data1/oa_pdf/8d/76/onci-2-e24383.PMC3667914.pdf
Crit Rev Oncol Hematol  2008; 66:52-64; PMID:18289867; http://dx.doi.org/10.1016/j.critrevonc.2008.01.002 54.,Non-OADS,/arxiv_data1/oa_pdf/8d/76/onci-2-e24383.PMC3667914.pdf
Crit Rev Immunol 2006; 26:213-30; PMID:16928187; http://dx.doi.org/10.1615/ CritRevImmunol.v26.i3.20 55.,Non-OADS,/arxiv_data1/oa_pdf/8d/76/onci-2-e24383.PMC3667914.pdf
Curr Opin Immunol 2007; 19:309-14; PMID:17433872; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8d/76/onci-2-e24383.PMC3667914.pdf
Curr Opin Immunol  2010; 22:326-32; PMID:20116985; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8d/76/onci-2-e24383.PMC3667914.pdf
Immunity 2001; 15:801-12; PMID:11728341; http://dx.doi.org/10.1016/S1074-7613(01)00236-9 37.,OADS,/arxiv_data1/oa_pdf/8d/76/onci-2-e24383.PMC3667914.pdf
Annu Rev Immunol 2005; 23:515-48; PMID:15771580; http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/8d/76/onci-2-e24383.PMC3667914.pdf
Nat Rev Immunol 2007; 7:238-43;  PMID:17290299; http://dx.doi.org/10.1038/nri2020 40.,Non-OADS,/arxiv_data1/oa_pdf/8d/76/onci-2-e24383.PMC3667914.pdf
Eur J Immunol 1998; 28:865-73;  PMID:9541581; http://dx.doi.org/10.1002/ (SICI)1521-4141(199803)28:03<865::AID- IMMU865>3.0.CO;2-T 41.,Non-OADS,/arxiv_data1/oa_pdf/8d/76/onci-2-e24383.PMC3667914.pdf
Curr Opin Immunol 2001; 13:114-9;  PMID:11154927; http://dx.doi.org/10.1016/S0952- 7915(00)00191-6 43.,Non-OADS,/arxiv_data1/oa_pdf/8d/76/onci-2-e24383.PMC3667914.pdf
Proc Natl Acad Sci U S A 2010; 107:19461-6; PMID:20978210; http://dx.doi.org/10.1073/ pnas.1011748107 45.,OADS,/arxiv_data1/oa_pdf/8d/76/onci-2-e24383.PMC3667914.pdf
"OncoImmunology 2013; 2:e24436; http://dx.doi.org/10.4161/onci.24436Introduction Melanoma is the fifth and sixth most common malignancy in  men and women, respectively, in the United States.1 Although  patients with early stage disease can be cured with resection, the prognosis of individuals affected by metastatic melanoma is dis - mal.",Non-OADS,/arxiv_data1/oa_pdf/04/83/onci-2-e24436.PMC3667915.pdf
Supplemental Material Supplemental materials may be found here: http://www.landesbioscience.com/journals/oncoimmunology/article/24436/part of a restaging visit that included imaging.,Non-OADS,/arxiv_data1/oa_pdf/04/83/onci-2-e24436.PMC3667915.pdf
CA Cancer J Clin 2012; 62:10-29;  PMID:22237781; http://dx.doi.org/10.3322/ caac.20138 2.,Non-OADS,/arxiv_data1/oa_pdf/04/83/onci-2-e24436.PMC3667915.pdf
Future Oncol  2009; 5:543-57; PMID:19450181; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/04/83/onci-2-e24436.PMC3667915.pdf
Mayo Clin Proc 2007; 82:490-513;  PMID:17418079; http://dx.doi.org/10.4065/82.4.490 4.,Non-OADS,/arxiv_data1/oa_pdf/04/83/onci-2-e24436.PMC3667915.pdf
N Engl J Med 2010; 363:711-23; PMID:20525992; http://dx.doi.org/10.1056/NEJMoa1003466 6.,OADS,/arxiv_data1/oa_pdf/04/83/onci-2-e24436.PMC3667915.pdf
N Engl J Med 2011; 364:2507-16; PMID:21639808; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/04/83/onci-2-e24436.PMC3667915.pdf
Lancet 2008; 372:117-26;  PMID:18620949; http://dx.doi.org/10.1016/S0140- 6736(08)61033-8 8.,Non-OADS,/arxiv_data1/oa_pdf/04/83/onci-2-e24436.PMC3667915.pdf
Cancer  2006; 106:375-82; PMID:16342250; http://dx.doi.org/10.1002/cncr.21611 9.,Non-OADS,/arxiv_data1/oa_pdf/04/83/onci-2-e24436.PMC3667915.pdf
Cancer 2011; 117:1704- 10; PMID:21472717; http://dx.doi.org/10.1002/ cncr.25659 10.,Non-OADS,/arxiv_data1/oa_pdf/04/83/onci-2-e24436.PMC3667915.pdf
N Engl J Med 2004; 350:2335- 42; PMID:15175435; http://dx.doi.org/10.1056/ NEJMoa032691 12.,OADS,/arxiv_data1/oa_pdf/04/83/onci-2-e24436.PMC3667915.pdf
N  Engl J Med 2003; 349:427-34; PMID:12890841;  http://dx.doi.org/10.1056/NEJMoa021491 14.,Non-OADS,/arxiv_data1/oa_pdf/04/83/onci-2-e24436.PMC3667915.pdf
Clin Cancer Res  2009; 15:1931-9; PMID:19240164; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/04/83/onci-2-e24436.PMC3667915.pdf
Cancer Immunol Immunother  2007; 56:761-70; PMID:17086423; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/04/83/onci-2-e24436.PMC3667915.pdf
Clin Cancer Res 2012; 18:1386-94;  PMID:22156613; http://dx.doi.org/10.1158/1078- 0432.CCR-11-2479 19.,Non-OADS,/arxiv_data1/oa_pdf/04/83/onci-2-e24436.PMC3667915.pdf
Br J Cancer 2011; 105:93-103;  PMID:21629244; http://dx.doi.org/10.1038/ bjc.2011.189 20.,Non-OADS,/arxiv_data1/oa_pdf/04/83/onci-2-e24436.PMC3667915.pdf
J Clin Oncol 2008; 26:2292- 8; PMID:18467720; http://dx.doi.org/10.1200/ JCO.2007.13.316521.,Non-OADS,/arxiv_data1/oa_pdf/04/83/onci-2-e24436.PMC3667915.pdf
Clin Cancer Res 2009; 15:2148-57;  PMID:19276286; http://dx.doi.org/10.1158/1078- 0432.CCR-08-1332 22.,Non-OADS,/arxiv_data1/oa_pdf/04/83/onci-2-e24436.PMC3667915.pdf
J Immunother 2010; 33:991-8; PMID:20948437;  http://dx.doi.org/10.1097/CJI.0b013e3181f4c208 23.,Non-OADS,/arxiv_data1/oa_pdf/04/83/onci-2-e24436.PMC3667915.pdf
Cancer Res  2013; 73:539-49; PMID:23108136; http://dx.doi.org/10.1158/0008-5472.CAN-12-2325 24.,Non-OADS,/arxiv_data1/oa_pdf/04/83/onci-2-e24436.PMC3667915.pdf
Melanoma Res  2005; 15:199-204; PMID:15917702; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/04/83/onci-2-e24436.PMC3667915.pdf
Cytokines Cell Mol Ther  2002; 7:151-6; PMID:14660055; http://dx.doi.org/10.1080/13684730210002328 27.,Non-OADS,/arxiv_data1/oa_pdf/04/83/onci-2-e24436.PMC3667915.pdf
Clin Cancer  Res 2007; 13:2422-8; PMID:17438101; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/04/83/onci-2-e24436.PMC3667915.pdf
Cancer Immunol Immunother 2012; 61:145-55;  PMID:21853302; http://dx.doi.org/10.1007/s00262- 011-1084-5,Non-OADS,/arxiv_data1/oa_pdf/04/83/onci-2-e24436.PMC3667915.pdf
OncoImmunology 2013; 2:e24437;  http://dx.doi.org/10.4161/onci.24437*Correspondence to: Shigeo Koido;  Email: shigeo_koido@jikei.ac.jpVarious strategies have been developed  to deliver tumor-associated antigens  (TAAs) to dendritic cells (DCs).,Non-OADS,/arxiv_data1/oa_pdf/78/66/onci-2-e24437.PMC3667916.pdf
Annu Rev Immunol 1991; 9:271- 96; PMID:1910679; http://dx.doi.org/10.1146/ annurev.iy.09.040191.001415 2.,Non-OADS,/arxiv_data1/oa_pdf/78/66/onci-2-e24437.PMC3667916.pdf
J Exp Med 1996; 183:283-7; PMID:8551233;  http://dx.doi.org/10.1084/jem.183.1.283 4.,Non-OADS,/arxiv_data1/oa_pdf/78/66/onci-2-e24437.PMC3667916.pdf
Nat Med  2003; 9:1215-9; PMID:12925849; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/78/66/onci-2-e24437.PMC3667916.pdf
J Exp Med 1996; 183:317-22; PMID:8551239; http://dx.doi.org/10.1084/ jem.183.1.317 6.,Non-OADS,/arxiv_data1/oa_pdf/78/66/onci-2-e24437.PMC3667916.pdf
Nat Med 1997; 3:558- 61; PMID:9142127; http://dx.doi.org/10.1038/ nm0597-558 8.,Non-OADS,/arxiv_data1/oa_pdf/78/66/onci-2-e24437.PMC3667916.pdf
Expert  Rev Vaccines 2008; 7:1055-68; PMID:18767954;  http://dx.doi.org/10.1586/14760584.7.7.1055 9.,Non-OADS,/arxiv_data1/oa_pdf/78/66/onci-2-e24437.PMC3667916.pdf
Clin Immunol 2004; 113:261- 9; PMID:15507391; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/78/66/onci-2-e24437.PMC3667916.pdf
Clin  Cancer Res 2005; 11:7891-900; PMID:16278414;  http://dx.doi.org/10.1158/1078-0432.CCR-05-133013.,Non-OADS,/arxiv_data1/oa_pdf/78/66/onci-2-e24437.PMC3667916.pdf
Clin Dev Immunol  2010; 2010:516768; PMID:21048993; http://dx.doi.org/10.1155/2010/516768 14.,Non-OADS,/arxiv_data1/oa_pdf/78/66/onci-2-e24437.PMC3667916.pdf
PLoS ONE  2013; 8:e59280; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/78/66/onci-2-e24437.PMC3667916.pdf
"OncoImmunology 2013; 2:e24520; http://dx.doi.org/10.4161/onci.24520Introduction Prostate cancer has a dramatic social impact, being the most fre - quently diagnosed cancer and the second cause of cancer-related  mortality among men in economically more developed countries.1  Despite significant progress in the fields of surgery, radiotherapy and chemotherapy, therapeutic options for locally advanced or metastatic prostate cancer remain limited.",Non-OADS,/arxiv_data1/oa_pdf/30/27/onci-2-e24520.PMC3667917.pdf
"Supplemental Material Supplemental materials may be found here: http://www.landesbioscience.com/journals/oncoimmunology/article/24520ACC TCA ACC TG, REV: CCC ATC ACA ACG TCA TCT TG, annealing temperature 58°C), PAP (FWD: TCT GGA GAA GTT TGC GGA CGT ACT GGA, REV: TCA GTT CTG CTA CCC AGC GCG TTC TAA C, annealing tempera - ture 54°C).",Non-OADS,/arxiv_data1/oa_pdf/30/27/onci-2-e24520.PMC3667917.pdf
Nat Immunol 2000; 1:119-26;  PMID:11248803; http://dx.doi.org/10.1038/77793 30.,Non-OADS,/arxiv_data1/oa_pdf/30/27/onci-2-e24520.PMC3667917.pdf
Cancer Res 2005; 65:6640-50;  PMID:16061644; http://dx.doi.org/10.1158/0008- 5472.CAN-04-2548 31.,Non-OADS,/arxiv_data1/oa_pdf/30/27/onci-2-e24520.PMC3667917.pdf
Prostate  2009; 69:755-60; PMID:19170049; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/30/27/onci-2-e24520.PMC3667917.pdf
Eur J Immunol 2005; 35:66- 75; PMID:15597325; http://dx.doi.org/10.1002/ eji.200425531 33.,Non-OADS,/arxiv_data1/oa_pdf/30/27/onci-2-e24520.PMC3667917.pdf
Cancer Res  2010; 70:3505-14; PMID:20388780; http://dx.doi.org/10.1158/0008-5472.CAN-09-4253 35.,Non-OADS,/arxiv_data1/oa_pdf/30/27/onci-2-e24520.PMC3667917.pdf
J Immunother 2008; 31:458-65; PMID:18463539;  http://dx.doi.org/10.1097/CJI.0b013e318174a512 36.,Non-OADS,/arxiv_data1/oa_pdf/30/27/onci-2-e24520.PMC3667917.pdf
Annu Rev Immunol 2011; 29:235-71;  PMID:21219185; http://dx.doi.org/10.1146/annurev- immunol-031210-101324 37.,Non-OADS,/arxiv_data1/oa_pdf/30/27/onci-2-e24520.PMC3667917.pdf
Cancer Res  2008; 68:292-300; PMID:18172322; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/30/27/onci-2-e24520.PMC3667917.pdf
Cancer Res 2007; 67:1344-51; PMID:17283172; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/30/27/onci-2-e24520.PMC3667917.pdf
Stem Cells 2010; 28:2129-40;  PMID:20936707; http://dx.doi.org/10.1002/stem.538 41.,Non-OADS,/arxiv_data1/oa_pdf/30/27/onci-2-e24520.PMC3667917.pdf
Cancer Res 2007; 67:5683-90;  PMID:17553900; http://dx.doi.org/10.1158/0008- 5472.CAN-07-076815.,Non-OADS,/arxiv_data1/oa_pdf/30/27/onci-2-e24520.PMC3667917.pdf
Cancer Res 2005; 65:10946-51;  PMID:16322242; http://dx.doi.org/10.1158/0008- 5472.CAN-05-2018 16.,Non-OADS,/arxiv_data1/oa_pdf/30/27/onci-2-e24520.PMC3667917.pdf
Oncogene 2011; 30:1261- 71; PMID:21119602; http://dx.doi.org/10.1038/ onc.2010.530 19.,Non-OADS,/arxiv_data1/oa_pdf/30/27/onci-2-e24520.PMC3667917.pdf
Methods Enzymol 2006; 419:3-23;  PMID:17141049; http://dx.doi.org/10.1016/S0076- 6879(06)19001-1 20.,OADS,/arxiv_data1/oa_pdf/30/27/onci-2-e24520.PMC3667917.pdf
Cancer Res 2004; 64:7011-21; PMID:15466194; http://dx.doi.org/10.1158/0008- 5472.CAN-04-1364 21.,Non-OADS,/arxiv_data1/oa_pdf/30/27/onci-2-e24520.PMC3667917.pdf
Proc Natl Acad Sci U S  A 1995; 92:3439-43; PMID:7724580; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/30/27/onci-2-e24520.PMC3667917.pdf
Am J Pathol 2008; 172:236- 46; PMID:18156212; http://dx.doi.org/10.2353/ ajpath.2008.070602 26.,Non-OADS,/arxiv_data1/oa_pdf/30/27/onci-2-e24520.PMC3667917.pdf
Neoplasia 2007; 9:938-50; PMID:18030362; http://dx.doi.org/10.1593/neo.07562 27.,Non-OADS,/arxiv_data1/oa_pdf/30/27/onci-2-e24520.PMC3667917.pdf
Cancer Res 2009; 69:8555-62;  PMID:19887604; http://dx.doi.org/10.1158/0008- 5472.CAN-08-4673 28.,Non-OADS,/arxiv_data1/oa_pdf/30/27/onci-2-e24520.PMC3667917.pdf
Cancer Res 2006; 66:9339-44;  PMID:16990346; http://dx.doi.org/10.1158/0008- 5472.CAN-06-3126References 1.,Non-OADS,/arxiv_data1/oa_pdf/30/27/onci-2-e24520.PMC3667917.pdf
CA Cancer J Clin 2012; 62:10-29;  PMID:22237781; http://dx.doi.org/10.3322/ caac.20138 2.,Non-OADS,/arxiv_data1/oa_pdf/30/27/onci-2-e24520.PMC3667917.pdf
Cancer 2002; 95:1864-8; PMID:12404279;  http://dx.doi.org/10.1002/cncr.10844 3.,Non-OADS,/arxiv_data1/oa_pdf/30/27/onci-2-e24520.PMC3667917.pdf
N Engl J Med 2004;  351:1502-12; PMID:15470213; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/30/27/onci-2-e24520.PMC3667917.pdf
N Engl J Med  2004; 351:1513-20; PMID:15470214; http://dx.doi.org/10.1056/NEJMoa041318 5.,OADS,/arxiv_data1/oa_pdf/30/27/onci-2-e24520.PMC3667917.pdf
N Engl J Med  2011; 364:2055-8; PMID:21612475; http://dx.doi.org/10.1056/NEJMe1102758 6.,Non-OADS,/arxiv_data1/oa_pdf/30/27/onci-2-e24520.PMC3667917.pdf
Nat Rev Cancer 2008; 8:755-68;  PMID:18784658; http://dx.doi.org/10.1038/nrc2499 7.,Non-OADS,/arxiv_data1/oa_pdf/30/27/onci-2-e24520.PMC3667917.pdf
N Engl J Med 2010; 363:411-22;  PMID:20818862; http://dx.doi.org/10.1056/ NEJMoa1001294 8.,OADS,/arxiv_data1/oa_pdf/30/27/onci-2-e24520.PMC3667917.pdf
Clin Cancer Res 2010; 16:800-13;  PMID:20103663; http://dx.doi.org/10.1158/1078- 0432.CCR-09-2730 9.,Non-OADS,/arxiv_data1/oa_pdf/30/27/onci-2-e24520.PMC3667917.pdf
Cancer Res 2009; 69:8886-93; PMID:19903840;  http://dx.doi.org/10.1158/0008-5472.CAN-09-2687 10.,Non-OADS,/arxiv_data1/oa_pdf/30/27/onci-2-e24520.PMC3667917.pdf
Int  Immunol 2009; 21:793-801; PMID:19491215; http://dx.doi.org/10.1093/intimm/dxp047 11.,Non-OADS,/arxiv_data1/oa_pdf/30/27/onci-2-e24520.PMC3667917.pdf
J Immunol 2009; 182:7287-96;  PMID:19454726; http://dx.doi.org/10.4049/jimmu- nol.0804288 12.,Non-OADS,/arxiv_data1/oa_pdf/30/27/onci-2-e24520.PMC3667917.pdf
Cancer Res 2006; 66:10247-52;  PMID:17079441; http://dx.doi.org/10.1158/0008- 5472.CAN-06-2048 13.,Non-OADS,/arxiv_data1/oa_pdf/30/27/onci-2-e24520.PMC3667917.pdf
Stem Cells 2009; 27:1734-40; PMID:19536809;  http://dx.doi.org/10.1002/stem.102 14.,Non-OADS,/arxiv_data1/oa_pdf/30/27/onci-2-e24520.PMC3667917.pdf
Cancer Res  2012; 72:1853-64; PMID:22473314; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/30/27/onci-2-e24520.PMC3667917.pdf
J Exp Med 1985;  162:1745-59; PMID:3877776; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/30/27/onci-2-e24520.PMC3667917.pdf
J Exp Med 2004; 200:287-95; PMID:15289500;  http://dx.doi.org/10.1084/jem.2004037048.,OADS,/arxiv_data1/oa_pdf/30/27/onci-2-e24520.PMC3667917.pdf
Nat Rev Immunol 2008; 8:726- 36; PMID:19172693; http://dx.doi.org/10.1038/ nri2395 49.,Non-OADS,/arxiv_data1/oa_pdf/30/27/onci-2-e24520.PMC3667917.pdf
Cancer Res  2010; 70:697-708; PMID:20068175; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/30/27/onci-2-e24520.PMC3667917.pdf
Cancer Immunol Immunother 2006; 55:1515-23;  PMID:16622681; http://dx.doi.org/10.1007/s00262- 006-0165-3 51.,Non-OADS,/arxiv_data1/oa_pdf/30/27/onci-2-e24520.PMC3667917.pdf
Nat Rev Immunol 2012; 12:269-81;  PMID:22437939; http://dx.doi.org/10.1038/nri319142.,Non-OADS,/arxiv_data1/oa_pdf/30/27/onci-2-e24520.PMC3667917.pdf
Cancer Immunol Immunother  2012; 61:453-68; PMID:22331081; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/30/27/onci-2-e24520.PMC3667917.pdf
Vaccine  2009; 27(Suppl 6):G52-9; PMID:20006141; http://dx.doi.org/10.1016/j.vaccine.2009.09.106,Non-OADS,/arxiv_data1/oa_pdf/30/27/onci-2-e24520.PMC3667917.pdf
OncoImmunology 2013; 2:e24523;  http://dx.doi.org/10.4161/onci.24523Prostate cancer is a common malignancy among elderly men  and is essentially incurable once it becomes metastatic.,Non-OADS,/arxiv_data1/oa_pdf/9a/8e/onci-2-e24523.PMC3667918.pdf
CA Cancer J Clin 2012; 62:10-29;  PMID:22237781; http://dx.doi.org/10.3322/ caac.20138 2.,Non-OADS,/arxiv_data1/oa_pdf/9a/8e/onci-2-e24523.PMC3667918.pdf
Eur J Cancer 2010; 46:765-81; PMID:20116997;  http://dx.doi.org/10.1016/j.ejca.2009.12.014 3.,Non-OADS,/arxiv_data1/oa_pdf/9a/8e/onci-2-e24523.PMC3667918.pdf
Int J Clin Pract 2011; 65:1180-92;  PMID:21995694; http://dx.doi.org/10.1111/j.1742- 1241.2011.02799.x 4.,OADS,/arxiv_data1/oa_pdf/9a/8e/onci-2-e24523.PMC3667918.pdf
Urology 2009; 73:1104-9; PMID:19394511; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9a/8e/onci-2-e24523.PMC3667918.pdf
J Clin Oncol 2005; 23:2918- 25; PMID:15860850; http://dx.doi.org/10.1200/ JCO.2005.01.529 6.,Non-OADS,/arxiv_data1/oa_pdf/9a/8e/onci-2-e24523.PMC3667918.pdf
Eur Urol 2011; 60:279-90; PMID:21592649; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9a/8e/onci-2-e24523.PMC3667918.pdf
Eur Urol 2008; 53:694- 708; PMID:18061335; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/9a/8e/onci-2-e24523.PMC3667918.pdf
Cancer 2009; 115:3670- 9; PMID:19536890; http://dx.doi.org/10.1002/ cncr.24429 12.,Non-OADS,/arxiv_data1/oa_pdf/9a/8e/onci-2-e24523.PMC3667918.pdf
N Engl J Med 2010; 363:411-22;  PMID:20818862; http://dx.doi.org/10.1056/ NEJMoa1001294 13.,OADS,/arxiv_data1/oa_pdf/9a/8e/onci-2-e24523.PMC3667918.pdf
Eur Urol 2012; 61:639- 47; PMID:22036643; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/9a/8e/onci-2-e24523.PMC3667918.pdf
Nat Rev Immunol 2010; 10:580-93;  PMID:20651745; http://dx.doi.org/10.1038/nri281715.,Non-OADS,/arxiv_data1/oa_pdf/9a/8e/onci-2-e24523.PMC3667918.pdf
Nat Rev Urol 2013; 10:149-60;  PMID:23399727; http://dx.doi.org/10.1038/nru- rol.2013.8 16.,Non-OADS,/arxiv_data1/oa_pdf/9a/8e/onci-2-e24523.PMC3667918.pdf
J  Natl Cancer Inst 2012; 104:273-9; PMID:22232132;  http://dx.doi.org/10.1093/jnci/djr514 17.,Non-OADS,/arxiv_data1/oa_pdf/9a/8e/onci-2-e24523.PMC3667918.pdf
"J Natl Cancer Inst 2012; 104:1422, author reply 1422-3; PMID:22911668; http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/9a/8e/onci-2-e24523.PMC3667918.pdf
"J Natl  Cancer Inst 2012; 104:1106, author reply 1109-12;  PMID:22825555; http://dx.doi.org/10.1093/jnci/ djs280 19.",Non-OADS,/arxiv_data1/oa_pdf/9a/8e/onci-2-e24523.PMC3667918.pdf
J Urol  2007; 178:1515-20; PMID:17707059; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9a/8e/onci-2-e24523.PMC3667918.pdf
J T ransl Med 2006; 4:1;  PMID:16390546; http://dx.doi.org/10.1186/1479- 5876-4-1,Non-OADS,/arxiv_data1/oa_pdf/9a/8e/onci-2-e24523.PMC3667918.pdf
J Clin Oncol 2003; 21:1232- 7; PMID:12663709; http://dx.doi.org/10.1200/ JCO.2003.06.100 47.,Non-OADS,/arxiv_data1/oa_pdf/9a/8e/onci-2-e24523.PMC3667918.pdf
Curr Oncol 2011; 18:e150-7; PMID:21655153;  http://dx.doi.org/10.3747/co.v18i3.783 48.,Non-OADS,/arxiv_data1/oa_pdf/9a/8e/onci-2-e24523.PMC3667918.pdf
Proc Natl Acad Sci U S A 2008; 105:14987- 92; PMID:18818309; http://dx.doi.org/10.1073/ pnas.0806075105 50.,OADS,/arxiv_data1/oa_pdf/9a/8e/onci-2-e24523.PMC3667918.pdf
Lancet Oncol 2012; 13:501-8;  PMID:22326924; http://dx.doi.org/10.1016/S1470- 2045(12)70006-2 51.,Non-OADS,/arxiv_data1/oa_pdf/9a/8e/onci-2-e24523.PMC3667918.pdf
J Clin Oncol  2005; 23:741-50; PMID:15613700; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9a/8e/onci-2-e24523.PMC3667918.pdf
Proc Natl Acad Sci U S A  2003; 100:8372-7; PMID:12826605; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9a/8e/onci-2-e24523.PMC3667918.pdf
J Clin Oncol 2005; 23:6043-53; PMID:16087944; http://dx.doi.org/10.1200/JCO.2005.06.205 54.,Non-OADS,/arxiv_data1/oa_pdf/9a/8e/onci-2-e24523.PMC3667918.pdf
J Clin Oncol  2010; 28:3167-75; PMID:20516446; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9a/8e/onci-2-e24523.PMC3667918.pdf
J Biomed Biotechnol  2010; 2010:237623; PMID:20617155; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9a/8e/onci-2-e24523.PMC3667918.pdf
Cancer Biother Radiopharm 2012; 27:2- 5; PMID:22251077; http://dx.doi.org/10.1089/ cbr.2012.1200 57.,Non-OADS,/arxiv_data1/oa_pdf/9a/8e/onci-2-e24523.PMC3667918.pdf
Expert Rev Vaccines  2007; 6:255-66; PMID:17408374; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9a/8e/onci-2-e24523.PMC3667918.pdf
Hum Gene Ther 2001; 12:1955-67; PMID:11686937;  http://dx.doi.org/10.1089/104303401753204535 34.,OADS,/arxiv_data1/oa_pdf/9a/8e/onci-2-e24523.PMC3667918.pdf
"Cancer J 2010; 16:304-10;  PMID:20693840; http://dx.doi.org/10.1097/ PPO.0b013e3181eb33d7 37. van den Eertwegh AJ, Versluis J, van den Berg HP , Santegoets SJ, van Moorselaar RJ, van der Sluis TM, et  al.",OADS,/arxiv_data1/oa_pdf/9a/8e/onci-2-e24523.PMC3667918.pdf
"Lancet Oncol 2012; 13:509-17;  PMID:22326922; http://dx.doi.org/10.1016/S1470- 2045(12)70007-4 38. van Elsas A, Hurwitz AA, Allison JP .",OADS,/arxiv_data1/oa_pdf/9a/8e/onci-2-e24523.PMC3667918.pdf
J Exp Med  1999; 190:355-66; PMID:10430624; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9a/8e/onci-2-e24523.PMC3667918.pdf
N Engl J Med 2010; 363:711-23; PMID:20525992;  http://dx.doi.org/10.1056/NEJMoa1003466 41.,OADS,/arxiv_data1/oa_pdf/9a/8e/onci-2-e24523.PMC3667918.pdf
J Clin Oncol 2009; 27:4035-7;  PMID:19635998; http://dx.doi.org/10.1200/ JCO.2009.22.2299 44.,Non-OADS,/arxiv_data1/oa_pdf/9a/8e/onci-2-e24523.PMC3667918.pdf
Prostate 2002; 53:109-17; PMID:12242725;  http://dx.doi.org/10.1002/pros.1013021.,Non-OADS,/arxiv_data1/oa_pdf/9a/8e/onci-2-e24523.PMC3667918.pdf
J Clin Oncol  2010; 28:1099-105; PMID:20100959; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9a/8e/onci-2-e24523.PMC3667918.pdf
Cancer Immunol Immunother 2010; 59:663-74; PMID:19890632; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9a/8e/onci-2-e24523.PMC3667918.pdf
Clin Cancer Res 2006; 12:1260-9; PMID:16489082;  http://dx.doi.org/10.1158/1078-0432.CCR-05-2059 25.,Non-OADS,/arxiv_data1/oa_pdf/9a/8e/onci-2-e24523.PMC3667918.pdf
Clin  Cancer Res 2009; 15:7375-80; PMID:19920098; http://dx.doi.org/10.1158/1078-0432.CCR-09-1910 26.,Non-OADS,/arxiv_data1/oa_pdf/9a/8e/onci-2-e24523.PMC3667918.pdf
Clin Cancer Res 2007; 13:3883-91; PMID:17606721;  http://dx.doi.org/10.1158/1078-0432.CCR-06-2937 27.,Non-OADS,/arxiv_data1/oa_pdf/9a/8e/onci-2-e24523.PMC3667918.pdf
Cancer 2008; 113:975- 84; PMID:18646045; http://dx.doi.org/10.1002/ cncr.23669 28.,Non-OADS,/arxiv_data1/oa_pdf/9a/8e/onci-2-e24523.PMC3667918.pdf
Lancet Oncol 2012; 13:509-17;  PMID:22326922; http://dx.doi.org/10.1016/S1470- 2045(12)70007-4 30.,Non-OADS,/arxiv_data1/oa_pdf/9a/8e/onci-2-e24523.PMC3667918.pdf
J Clin Oncol  2009; 27:4047-54; PMID:19636017; http://dx.doi.org/10.1200/JCO.2008.19.9968 31.,Non-OADS,/arxiv_data1/oa_pdf/9a/8e/onci-2-e24523.PMC3667918.pdf
Hum Gene Ther 1999;  10:1239-49; PMID:10340555; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9a/8e/onci-2-e24523.PMC3667918.pdf
J Cell Biochem 2011; 112:1969- 77; PMID:21465529; http://dx.doi.org/10.1002/ jcb.23126 72.,OADS,/arxiv_data1/oa_pdf/9a/8e/onci-2-e24523.PMC3667918.pdf
Int J Radiat Oncol Biol Phys  2004; 58:1520-9; PMID:15050332; http://dx.doi.org/10.1016/j.ijrobp.2003.09.083 73.,OADS,/arxiv_data1/oa_pdf/9a/8e/onci-2-e24523.PMC3667918.pdf
OncoImmunology 2013; 2:e23803; http://dx.doi.org/10.4161/onci.23803 74.,Non-OADS,/arxiv_data1/oa_pdf/9a/8e/onci-2-e24523.PMC3667918.pdf
Int J Radiat  Oncol Biol Phys 2001; 51:605-13; PMID:11597799;  http://dx.doi.org/10.1016/S0360-3016(01)01692-366.,OADS,/arxiv_data1/oa_pdf/9a/8e/onci-2-e24523.PMC3667918.pdf
Prostate  2005; 62:217-23; PMID:15389792; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9a/8e/onci-2-e24523.PMC3667918.pdf
Mol Ther 2006; 13:320-7; PMID:16185933;  http://dx.doi.org/10.1016/j.ymthe.2005.08.005 68.,OADS,/arxiv_data1/oa_pdf/9a/8e/onci-2-e24523.PMC3667918.pdf
Hum Gene Ther 1996; 7:515-23; PMID:8800746; http://dx.doi.org/10.1089/ hum.1996.7.4-515 70.,OADS,/arxiv_data1/oa_pdf/9a/8e/onci-2-e24523.PMC3667918.pdf
Hum Gene  Ther 2006; 17:220-9; PMID:16454655; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9a/8e/onci-2-e24523.PMC3667918.pdf
Expert Rev Vaccines 2012; 11:857-68;  PMID:22913261; http://dx.doi.org/10.1586/erv.12.54 63.,Non-OADS,/arxiv_data1/oa_pdf/9a/8e/onci-2-e24523.PMC3667918.pdf
Genet Vaccines  Ther 2012; 10:9; PMID:23046944; http://dx.doi.org/10.1186/1479-0556-10-9 65.,Non-OADS,/arxiv_data1/oa_pdf/9a/8e/onci-2-e24523.PMC3667918.pdf
J Immunother  2010; 33:639-47; PMID:20551832; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9a/8e/onci-2-e24523.PMC3667918.pdf
"The company focuses on developing advanced therapeutic vaccines that are active against cancers with a high Letter from the Editor ronald Ellis1,* and Eva M. r iedmann2 1senior Vice President r &d and c hief t echnology o fficer; n asVax, Ltd.; n ess Ziona, Israel; 2acquisitions Editor; Landes Bioscience; Vienna, a ustria *Correspondence to: Ronald Ellis; Email: rellis@landesbioscience.com Submitted: 12/22/12; Accepted: 12/22/12http://dx.doi.org/10.4161/hv.23606",Non-OADS,/arxiv_data1/oa_pdf/ae/16/hvi-9-1.PMC3667919.pdf
"Human Vaccines & Immunotherapeutics 9:1, 136–143; January 2013; © 2013 Landes Bioscience ReseaR cH papeR 136 Human Vaccines & Immunotherapeutics Volume 9 Issue 1*Correspondence to: David W. Scheifele; Email: dscheifele@cfri.ca Submitted: 09/12/12; Revised: 10/16/12; Accepted: 10/22/12http://dx.doi.org/10.4161/hv.22619Introduction During the A/H1N1 2009 global pandemic,1 adjuvanted  influenza vaccines were widely used for the first time.",Non-OADS,/arxiv_data1/oa_pdf/fc/06/hvi-9-136.PMC3667929.pdf
Clin Infect Dis 2003; 36:705-13;  PMID:12627354; http://dx.doi.org/10.1086/367667.,Non-OADS,/arxiv_data1/oa_pdf/fc/06/hvi-9-136.PMC3667929.pdf
Vaccine 2005; 23:3726-32; PMID:15882534;  http://dx.doi.org/10.1016/j.vaccine.2005.01.154.,Non-OADS,/arxiv_data1/oa_pdf/fc/06/hvi-9-136.PMC3667929.pdf
Pharmacoepidemiol Drug Saf 2002; 11:189- 202; PMID:12051118; http://dx.doi.org/10.1002/ pds.712.,Non-OADS,/arxiv_data1/oa_pdf/fc/06/hvi-9-136.PMC3667929.pdf
Clin Vaccine Immunol 2011; 18:1401- 5; PMID:21795459; http://dx.doi.org/10.1128/ CVI.05046-11.,Non-OADS,/arxiv_data1/oa_pdf/fc/06/hvi-9-136.PMC3667929.pdf
J Infect Dis 1981;  144:376; PMID:7288216; http://dx.doi.org/10.1093/ infdis/144.4.376.,Non-OADS,/arxiv_data1/oa_pdf/fc/06/hvi-9-136.PMC3667929.pdf
Clin T rials  2011; 8:699-704; PMID:21900340; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fc/06/hvi-9-136.PMC3667929.pdf
Clin Infect Dis 2003; 36:850-7;  PMID:12652385; http://dx.doi.org/10.1086/368189.,Non-OADS,/arxiv_data1/oa_pdf/fc/06/hvi-9-136.PMC3667929.pdf
BMC Infect Dis 2010; 10:71;  PMID:20236548; http://dx.doi.org/10.1186/1471- 2334-10-71.,Non-OADS,/arxiv_data1/oa_pdf/fc/06/hvi-9-136.PMC3667929.pdf
Clin Infect Dis 2012; 54:661-9; PMID:22267719; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/fc/06/hvi-9-136.PMC3667929.pdf
Vaccine 2011; 30:35- 41; PMID:22063386; http://dx.doi.org/10.1016/j.vac- cine.2011.10.062.,Non-OADS,/arxiv_data1/oa_pdf/fc/06/hvi-9-136.PMC3667929.pdf
Vaccine 2012; 23:3389-94;  http://dx.doi.org/10.1016/j.vaccine.2012.03.046.References 1.,Non-OADS,/arxiv_data1/oa_pdf/fc/06/hvi-9-136.PMC3667929.pdf
J Infect Dis 2012; 205:733-44;  PMID:22315336; http://dx.doi.org/10.1093/infdis/ jir641.,OADS,/arxiv_data1/oa_pdf/fc/06/hvi-9-136.PMC3667929.pdf
Vaccine 2010; 28:1740-5; PMID:20034605; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/fc/06/hvi-9-136.PMC3667929.pdf
CMAJ 2011; 183:E1033-7; PMID:21788422;  http://dx.doi.org/10.1503/cmaj.110196.,OADS,/arxiv_data1/oa_pdf/fc/06/hvi-9-136.PMC3667929.pdf
Vaccine  2011; 29:5785-92; PMID:21624411; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/fc/06/hvi-9-136.PMC3667929.pdf
Pediatr Infect Dis  J 2009; 28:985-9; PMID:19755930; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fc/06/hvi-9-136.PMC3667929.pdf
Infect Immun  2005; 73:8130-5; PMID:16299307; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/fc/06/hvi-9-136.PMC3667929.pdf
"Human Vaccines & Immunotherapeutics 9:1, 144–152; January 2013; © 2013 Landes Bioscience ReseaR cH papeR 144 Human Vaccines & Immunotherapeutics Volume 9 Issue 1*Correspondence to: Roberto Gasparini; Email: gasparini@unige.it Submitted: 07/31/12; Revised: 09/07/12; Accepted: 09/14/12http://dx.doi.org/10.4161/hv.22231Introduction Influenza is an acute respiratory illness that manifests itself in  the form of a typical seasonal epidemic during winter and can be characterized by a pandemic when an antigenically distinct virus is introduced and spreads in the human population.",Non-OADS,/arxiv_data1/oa_pdf/5b/9d/hvi-9-144.PMC3667930.pdf
Vaccine 2011; 29:7554-8; PMID:21820477; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5b/9d/hvi-9-144.PMC3667930.pdf
Vaccine 2007; 25:5086- 96; PMID:17544181; http://dx.doi.org/10.1016/j.vac- cine.2007.03.046.,Non-OADS,/arxiv_data1/oa_pdf/5b/9d/hvi-9-144.PMC3667930.pdf
J Infect Dis 2001; 184:665-70;  PMID:11517426; http://dx.doi.org/10.1086/323085.,OADS,/arxiv_data1/oa_pdf/5b/9d/hvi-9-144.PMC3667930.pdf
N Engl J Med 2007; 357:1373-81; PMID:17914038; http://dx.doi.org/10.1056/ NEJMoa070844.,OADS,/arxiv_data1/oa_pdf/5b/9d/hvi-9-144.PMC3667930.pdf
http://www.who.int/influenza/vaccines/use/en/ 9.,Non-OADS,/arxiv_data1/oa_pdf/5b/9d/hvi-9-144.PMC3667930.pdf
BMC Public  Health 2011; 11:207; PMID:21457562; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5b/9d/hvi-9-144.PMC3667930.pdf
Vaccine 2012; 30:195-200; PMID:22100636;  http://dx.doi.org/10.1016/j.vaccine.2011.11.024.,Non-OADS,/arxiv_data1/oa_pdf/5b/9d/hvi-9-144.PMC3667930.pdf
Vaccine 2001; 19:2673-80; PMID:11257408;  http://dx.doi.org/10.1016/S0264-410X(00)00499-0.,Non-OADS,/arxiv_data1/oa_pdf/5b/9d/hvi-9-144.PMC3667930.pdf
Yakugaku Zasshi 2011; 131:1733- 41; PMID:22129867; http://dx.doi.org/10.1248/ yakushi.131.1733.,OADS,/arxiv_data1/oa_pdf/5b/9d/hvi-9-144.PMC3667930.pdf
PLoS  One 2011; 6:e27622; PMID:22110695; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5b/9d/hvi-9-144.PMC3667930.pdf
PLoS  One 2011; 6:e27420; PMID:22110645; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5b/9d/hvi-9-144.PMC3667930.pdf
Vaccine 2004; 23:283-9;  PMID:15530669; http://dx.doi.org/10.1016/j.vac- cine.2004.07.017.,Non-OADS,/arxiv_data1/oa_pdf/5b/9d/hvi-9-144.PMC3667930.pdf
Vaccine 2010; 28:2903-7;  PMID:20153351; http://dx.doi.org/10.1016/j.vac- cine.2010.01.054.,Non-OADS,/arxiv_data1/oa_pdf/5b/9d/hvi-9-144.PMC3667930.pdf
Vaccine  2007; 25:3066-9; PMID:17275144; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5b/9d/hvi-9-144.PMC3667930.pdf
J Epidemiol Community Health 1997; 51:526- 30; PMID:9425463; http://dx.doi.org/10.1136/ jech.51.5.526.,Non-OADS,/arxiv_data1/oa_pdf/5b/9d/hvi-9-144.PMC3667930.pdf
Vaccine 2007; 25:154-60; PMID:17064823;  http://dx.doi.org/10.1016/j.vaccine.2006.05.129.,Non-OADS,/arxiv_data1/oa_pdf/5b/9d/hvi-9-144.PMC3667930.pdf
JAMA 1993; 270:1956;  PMID:8182809; http://dx.doi.org/10.1001/ jama.1993.03510160074032.,OADS,/arxiv_data1/oa_pdf/5b/9d/hvi-9-144.PMC3667930.pdf
Epidemiol Infect 1997; 118:27-33; PMID:9042032; http://dx.doi.org/10.1017/S0950268896007121.,Non-OADS,/arxiv_data1/oa_pdf/5b/9d/hvi-9-144.PMC3667930.pdf
Int J Epidemiol 1995; 24:1240-8; PMID:8824869; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5b/9d/hvi-9-144.PMC3667930.pdf
J Infect Dis 2003;  187:1000-9; PMID:12660947; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5b/9d/hvi-9-144.PMC3667930.pdf
Available at http://demo.istat.it/pop2010/index.html 47.,Non-OADS,/arxiv_data1/oa_pdf/5b/9d/hvi-9-144.PMC3667930.pdf
Available at http://www.influciri.it 41.,Non-OADS,/arxiv_data1/oa_pdf/5b/9d/hvi-9-144.PMC3667930.pdf
N Engl J Med 2009; 361:1945-52; PMID:19745214; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5b/9d/hvi-9-144.PMC3667930.pdf
Clin Infect  Dis 2010; 51:668-77; PMID:20687838; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5b/9d/hvi-9-144.PMC3667930.pdf
Int J Clin Pract 2010; 64:432-8; PMID:20039974;  http://dx.doi.org/10.1111/j.1742-1241.2009.02309.x.,OADS,/arxiv_data1/oa_pdf/5b/9d/hvi-9-144.PMC3667930.pdf
J Infect  Dis 2011; 203:500-8; PMID:21220776; http://dx.doi.org/10.1093/infdis/jiq076.,OADS,/arxiv_data1/oa_pdf/5b/9d/hvi-9-144.PMC3667930.pdf
Vaccine  2002; 20:1831-6; PMID:11906772; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5b/9d/hvi-9-144.PMC3667930.pdf
Lancet 2005; 366:1165-74; PMID:16198765;  http://dx.doi.org/10.1016/S0140-6736(05)67339-4.,Non-OADS,/arxiv_data1/oa_pdf/5b/9d/hvi-9-144.PMC3667930.pdf
"arya* and n irmala a garwal sant Parmanand Hospital; d elhi, India Keywords:  Polio, fatality rate, viral, neurovirulence, genetic factors, risk assessment *Correspondence to: Subhash C. Arya; Email: subhashbhaji@gmail.com Submitted: 09/29/12; Accepted: 10/09/12http://dx.doi.org/10.4161/hv.22489testing for poliovirus isolates showed that their genetic components  were not significantly different from the Angolan parent virus and from related cases from neighboring countries.",Non-OADS,/arxiv_data1/oa_pdf/b5/fa/hvi-9-195.PMC3667937.pdf
Clin  Infect Dis 2012; PMID:22911644; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b5/fa/hvi-9-195.PMC3667937.pdf
J Neurol Neurosurg Psychiatry  1964; 27:10-24; PMID:14123918; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b5/fa/hvi-9-195.PMC3667937.pdf
Clin Infect Dis 2012; PMID:22911642; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b5/fa/hvi-9-195.PMC3667937.pdf
J Infect Dis 1983; 147:422- 6; PMID:6833791; http://dx.doi.org/10.1093/ infdis/147.3.422.,OADS,/arxiv_data1/oa_pdf/b5/fa/hvi-9-195.PMC3667937.pdf
"Resea Rch  pape R 198 h uman Vaccines & Immunotherapeutics  V olume 9 Issue 1h uman Vaccines & Immunotherapeutics 9:1, 198–209; January 2013; © 2013 Landes Bioscience *Correspondence to: Petr G. Lokhov; Email: lokhovpg@rambler.ru Submitted: 07/11/12; Revised: 10/29/12; Accepted: 11/08/12http://dx.doi.org/10.4161/hv.22828Introduction Despite tremendous progress in basic research, effective treat - ments for most types of cancers are still lacking.",Non-OADS,/arxiv_data1/oa_pdf/2f/d9/hvi-9-198.PMC3667939.pdf
Nat Rev Cancer 2006; 6:204-16;  PMID:16498443; http://dx.doi.org/10.1038/nrc1815.,Non-OADS,/arxiv_data1/oa_pdf/2f/d9/hvi-9-198.PMC3667939.pdf
Nat Rev Drug Discov 2008; 7:966-7; PMID:19043443; http://dx.doi.org/10.1038/nrd2766.,Non-OADS,/arxiv_data1/oa_pdf/2f/d9/hvi-9-198.PMC3667939.pdf
Nature 1997; 390:404-7; PMID:9389480; http://dx.doi.org/10.1038/37126.,Non-OADS,/arxiv_data1/oa_pdf/2f/d9/hvi-9-198.PMC3667939.pdf
N Engl J Med 1971; 285:1182-6; PMID:4938153; http://dx.doi.org/10.1056/NEJM197111182852108.,OADS,/arxiv_data1/oa_pdf/2f/d9/hvi-9-198.PMC3667939.pdf
J Natl Cancer Inst 1990; 82:4-6; PMID:1688381; http://dx.doi.org/10.1093/jnci/82.1.4.,Non-OADS,/arxiv_data1/oa_pdf/2f/d9/hvi-9-198.PMC3667939.pdf
Nature 2000; 407:249-57; PMID:11001068; http://dx.doi.org/10.1038/35025220.,OADS,/arxiv_data1/oa_pdf/2f/d9/hvi-9-198.PMC3667939.pdf
Int Rev Immunol 2006; 25:297-319; PMID:17169778; http://dx.doi.org/10.1080/08830180600992472.,Non-OADS,/arxiv_data1/oa_pdf/2f/d9/hvi-9-198.PMC3667939.pdf
Nat Med 2000; 6:1160-6; PMID:11017149; http://dx.doi.org/10.1038/80506.,Non-OADS,/arxiv_data1/oa_pdf/2f/d9/hvi-9-198.PMC3667939.pdf
Cancer Immunol Immunother 2004; 53:955-62; PMID:15449042; http://dx.doi.org/10.1007/s00262-004-0529-5.,Non-OADS,/arxiv_data1/oa_pdf/2f/d9/hvi-9-198.PMC3667939.pdf
Cancer Sci 2004; 95:85-90; PMID:14720332; http://dx.doi.org/10.1111/j.1349-7006.2004.tb03175.x.,Non-OADS,/arxiv_data1/oa_pdf/2f/d9/hvi-9-198.PMC3667939.pdf
Clin Cancer Res 2006; 12:5834-40; PMID:17020991; http://dx.doi.org/10.1158/1078-0432.CCR-06-1105.,Non-OADS,/arxiv_data1/oa_pdf/2f/d9/hvi-9-198.PMC3667939.pdf
Eur J Surg Oncol 2006; 32:363-70; PMID:16520018; http://dx.doi.org/10.1016/j.ejso.2006.01.016.,OADS,/arxiv_data1/oa_pdf/2f/d9/hvi-9-198.PMC3667939.pdf
Circ Res 2007; 100:158-73; PMID:17272818; http://dx.doi.org/10.1161/01.RES.0000255691.76142.4a.,OADS,/arxiv_data1/oa_pdf/2f/d9/hvi-9-198.PMC3667939.pdf
Circ Res 2007; 100:174-90; PMID:17272819; http://dx.doi.org/10.1161/01.RES.0000255690.03436.ae.18.,OADS,/arxiv_data1/oa_pdf/2f/d9/hvi-9-198.PMC3667939.pdf
Science 2000; 289:1197-202; PMID:10947988; http://dx.doi.org/10.1126/sci-ence.289.5482.1197.,OADS,/arxiv_data1/oa_pdf/2f/d9/hvi-9-198.PMC3667939.pdf
J Cell Sci 2003; 116:1013-22; PMID:12584245; http://dx.doi.org/10.1242/jcs.00281.,OADS,/arxiv_data1/oa_pdf/2f/d9/hvi-9-198.PMC3667939.pdf
Am J Pathol 2008; 172:1381-90; PMID:18403594; http://dx.doi.org/10.2353/ajpath.2008.070988.,Non-OADS,/arxiv_data1/oa_pdf/2f/d9/hvi-9-198.PMC3667939.pdf
Cancer Res 2006; 66:10770-7; PMID:17108113; http://dx.doi.org/10.1158/0008-5472.CAN-06-1609.,Non-OADS,/arxiv_data1/oa_pdf/2f/d9/hvi-9-198.PMC3667939.pdf
Mol Cancer Ther 2006; 5:467-75; PMID:16505122; http://dx.doi.org/10.1158/1535-7163.MCT-05-0417.,Non-OADS,/arxiv_data1/oa_pdf/2f/d9/hvi-9-198.PMC3667939.pdf
Cancer Res 2007; 67:4138-48; PMID:17483324; http://dx.doi.org/10.1158/0008-5472.CAN-06-3032.,Non-OADS,/arxiv_data1/oa_pdf/2f/d9/hvi-9-198.PMC3667939.pdf
In Vitro Cell Dev Biol Anim 2002; 38:273-81; PMID:12418924; http://dx.doi.org/10.1290/1071-2690(2002)038<0273:IAMCOB>2.0.CO;2.,OADS,/arxiv_data1/oa_pdf/2f/d9/hvi-9-198.PMC3667939.pdf
J Clin Invest 1983; 71:1822-9; PMID:6306056; http://dx.doi.org/10.1172/JCI110937.,Non-OADS,/arxiv_data1/oa_pdf/2f/d9/hvi-9-198.PMC3667939.pdf
Differentiation 1987; 36:57-70; PMID:2451631; http://dx.doi.org/10.1111/j.1432-0436.1987.tb00181.x.,OADS,/arxiv_data1/oa_pdf/2f/d9/hvi-9-198.PMC3667939.pdf
Eur J Cell Biol 2003; 82:163-73; PMID:12751902; http://dx.doi.org/10.1078/0171-9335-00306.,OADS,/arxiv_data1/oa_pdf/2f/d9/hvi-9-198.PMC3667939.pdf
J Cell Physiol 1991; 146:8-17; PMID:1990021; http://dx.doi.org/10.1002/jcp.1041460103.,Non-OADS,/arxiv_data1/oa_pdf/2f/d9/hvi-9-198.PMC3667939.pdf
Int J Biochem Cell Biol 2001; 33:325-35; PMID:11312103; http://dx.doi.org/10.1016/S1357-2725(01)00020-6.32.,OADS,/arxiv_data1/oa_pdf/2f/d9/hvi-9-198.PMC3667939.pdf
J Invest Dermatol 1992; 98:79-85; PMID:1370233; http://dx.doi.org/10.1111/1523-1747.ep12495643.,Non-OADS,/arxiv_data1/oa_pdf/2f/d9/hvi-9-198.PMC3667939.pdf
In Vitro Cell Dev Biol Anim 1993; 29A:325-31; PMID:7686548; http://dx.doi.org/10.1007/BF02633961.,Non-OADS,/arxiv_data1/oa_pdf/2f/d9/hvi-9-198.PMC3667939.pdf
Gastroenterology 1996; 111:1230-40; PMID:8898637; http://dx.doi.org/10.1053/gast.1996.v111.pm8898637.,Non-OADS,/arxiv_data1/oa_pdf/2f/d9/hvi-9-198.PMC3667939.pdf
In Vitro Cell Dev Biol 1994; 30:145-7; http://dx.doi.org/10.1007/BF02631436.,Non-OADS,/arxiv_data1/oa_pdf/2f/d9/hvi-9-198.PMC3667939.pdf
Methods Mol Biol 2012; 843:147-54; PMID:22222529; http://dx.doi.org/10.1007/978-1-61779-523-7_14.,Non-OADS,/arxiv_data1/oa_pdf/2f/d9/hvi-9-198.PMC3667939.pdf
J Cancer 2010; 1:230-41; PMID:21151581; http://dx.doi.org/10.7150/jca.1.230.,Non-OADS,/arxiv_data1/oa_pdf/2f/d9/hvi-9-198.PMC3667939.pdf
Cancer Immunol Immunother 2008; 57:1569-77; PMID:18523771; http://dx.doi.org/10.1007/s00262-008-0536-z.,Non-OADS,/arxiv_data1/oa_pdf/2f/d9/hvi-9-198.PMC3667939.pdf
Semin Immunol 2010; 22:132-43; PMID:20356763; http://dx.doi.org/10.1016/j.smim.2010.02.004.,Non-OADS,/arxiv_data1/oa_pdf/2f/d9/hvi-9-198.PMC3667939.pdf
Clin Cancer Res 2009; 15:5323-37; PMID:19723653; http://dx.doi.org/10.1158/1078-0432.CCR-09-0737.,Non-OADS,/arxiv_data1/oa_pdf/2f/d9/hvi-9-198.PMC3667939.pdf
Expert Rev Vaccines 2009; 8:1657-61; PMID:19943761; http://dx.doi.org/10.1586/erv.09.134.,Non-OADS,/arxiv_data1/oa_pdf/2f/d9/hvi-9-198.PMC3667939.pdf
Semin Immunol 2010; 22:105-12; PMID:20226686; http://dx.doi.org/10.1016/j.smim.2010.02.001.,OADS,/arxiv_data1/oa_pdf/2f/d9/hvi-9-198.PMC3667939.pdf
J Exp Med 1994; 180:83-93; PMID:8006603; http://dx.doi.org/10.1084/jem.180.1.83.,Non-OADS,/arxiv_data1/oa_pdf/2f/d9/hvi-9-198.PMC3667939.pdf
J Immunol Methods 2005; 299:37-46; PMID:15890354; http://dx.doi.org/10.1016/j.jim.2004.12.014.,Non-OADS,/arxiv_data1/oa_pdf/2f/d9/hvi-9-198.PMC3667939.pdf
Neoplasia 2000; 2:449-59; PMID:11191112; http://dx.doi.org/10.1038/sj.neo.7900108.56.,Non-OADS,/arxiv_data1/oa_pdf/2f/d9/hvi-9-198.PMC3667939.pdf
Ann Surg Oncol 2005; 12:1005-16; PMID:16283570; http://dx.doi.org/10.1245/ASO.2005.03.536.,OADS,/arxiv_data1/oa_pdf/2f/d9/hvi-9-198.PMC3667939.pdf
J Clin Oncol 2005; 23:6043-53; PMID:16087944; http://dx.doi.org/10.1200/JCO.2005.06.205.,Non-OADS,/arxiv_data1/oa_pdf/2f/d9/hvi-9-198.PMC3667939.pdf
Nat Rev Immunol 2003; 3:630-41; PMID:12974478; http://dx.doi.org/10.1038/nri1150.,Non-OADS,/arxiv_data1/oa_pdf/2f/d9/hvi-9-198.PMC3667939.pdf
J Immunother 2005; 28:148-57; PMID:15725959; http://dx.doi.org/10.1097/01.cji.0000154247.97254.ef.,Non-OADS,/arxiv_data1/oa_pdf/2f/d9/hvi-9-198.PMC3667939.pdf
J Immunother Emphasis T umor Immunol 1995; 18:86-94; PMID:8574470; http://dx.doi.org/10.1097/00002371-199508000-00002.,Non-OADS,/arxiv_data1/oa_pdf/2f/d9/hvi-9-198.PMC3667939.pdf
2010; 2:126-31; http://dx.doi.org/10.4172/1948-5956.1000037.,Non-OADS,/arxiv_data1/oa_pdf/2f/d9/hvi-9-198.PMC3667939.pdf
2010; 1:1-3; http://dx.doi.org/10.4172/2157-2518.1000103.,Non-OADS,/arxiv_data1/oa_pdf/2f/d9/hvi-9-198.PMC3667939.pdf
"Mol Cell Proteomics 2012; 11:M111, 014480; PMID:22074704; http://dx.doi.org/10.1074/mcp.M111.014480.",OADS,/arxiv_data1/oa_pdf/2f/d9/hvi-9-198.PMC3667939.pdf
Rapid Commun Mass Spectrom 2009; 23:680-2; PMID:19184978; http://dx.doi.org/10.1002/rcm.3928.,OADS,/arxiv_data1/oa_pdf/2f/d9/hvi-9-198.PMC3667939.pdf
Neoplasia 2000; 2:449-59; PMID:11191112; http://dx.doi.org/10.1038/sj.neo.7900108.,Non-OADS,/arxiv_data1/oa_pdf/2f/d9/hvi-9-198.PMC3667939.pdf
J Exp Med 2000; 191:795-804; PMID:10704461; http://dx.doi.org/10.1084/jem.191.5.795.,Non-OADS,/arxiv_data1/oa_pdf/2f/d9/hvi-9-198.PMC3667939.pdf
Science 2002; 298:850-4; PMID:12242449; http://dx.doi.org/10.1126/sci-ence.1076514.,OADS,/arxiv_data1/oa_pdf/2f/d9/hvi-9-198.PMC3667939.pdf
"Do not distribute.Human Vaccines & Immunotherapeutics 9:2, 210–212; February 2013; © 2013 Landes Bioscience Commentary 210 Human Vaccines & Immunotherapeutics  V olume 9 Issue 2Keywords:  peptide vaccine, glypican-3,  clinical trial, hepatocellular carcinoma,  cytotoxic T lymphocyte Abbreviations:  HCC, hepatocellular car - cinoma; GPC3, glypican-3; CTLs, cyto - toxic T lymphocytes; IFA, incomplete  Freund’s adjuvant; PR, partial response; SD, stable disease; IFN- γ, interferon- γ;  ELISPOT, enzyme-linked immunospot; PBMCs, peripheral blood  mononuclear cells Submitted: 09/23/12Accepted: 10/06/12http://dx.doi.org/10.4161/hv.22473 *Correspondence to: Tetsuya Nakatsura;   Email: tnakatsu@east.ncc.go.jpImmunotherapy is a potentially attrac - tive treatment option for patients with  hepatocellular carcinoma (HCC).",Non-OADS,/arxiv_data1/oa_pdf/17/ba/hvi-9-210.PMC3667940.pdf
Cancer Sci 2009; 100:1403-7; PMID:19496787; http://dx.doi.org/10.1111/j.1349-7006.2009.01206.x.,Non-OADS,/arxiv_data1/oa_pdf/17/ba/hvi-9-210.PMC3667940.pdf
Clin Cancer Res 2006; 12:2689-97; PMID:16675560; http://dx.doi.org/10.1158/1078-0432.CCR-05-2267.,Non-OADS,/arxiv_data1/oa_pdf/17/ba/hvi-9-210.PMC3667940.pdf
Cancer Sci 2011; 102:918-25; PMID:21281401; http://dx.doi.org/10.1111/j.1349-7006.2011.01896.x.,Non-OADS,/arxiv_data1/oa_pdf/17/ba/hvi-9-210.PMC3667940.pdf
Cancer Sci 2011; 102:1622-9; PMID:21668581; http://dx.doi.org/10.1111/j.1349-7006.2011.02003.x.,Non-OADS,/arxiv_data1/oa_pdf/17/ba/hvi-9-210.PMC3667940.pdf
Curr Opin Immunol 2009; 21:233-40; PMID:19304471; http://dx.doi.org/10.1016/j.coi.2009.03.002.References 1.,OADS,/arxiv_data1/oa_pdf/17/ba/hvi-9-210.PMC3667940.pdf
CA Cancer J Clin 2005; 55:74-108; PMID:15761078; http://dx.doi.org/10.3322/canjclin.55.2.74.,OADS,/arxiv_data1/oa_pdf/17/ba/hvi-9-210.PMC3667940.pdf
N Engl J Med 2008; 359:378-90; PMID:18650514; http://dx.doi.org/10.1056/NEJMoa0708857.,Non-OADS,/arxiv_data1/oa_pdf/17/ba/hvi-9-210.PMC3667940.pdf
Lancet Oncol 2009; 10:25-34; PMID:19095497; http://dx.doi.org/10.1016/S1470-2045(08)70285-7.,Non-OADS,/arxiv_data1/oa_pdf/17/ba/hvi-9-210.PMC3667940.pdf
BMC Cancer 2010; 10:209; PMID:20478057; http://dx.doi.org/10.1186/1471-2407-10-209.,Non-OADS,/arxiv_data1/oa_pdf/17/ba/hvi-9-210.PMC3667940.pdf
Hematol Oncol 2009; 27:130-9; PMID:19294626; http://dx.doi.org/10.1002/hon.886.,Non-OADS,/arxiv_data1/oa_pdf/17/ba/hvi-9-210.PMC3667940.pdf
Clin Cancer Res 2012; 18:3686-96; PMID:22577059; http://dx.doi.org/10.1158/1078-0432.CCR-11-3044.,Non-OADS,/arxiv_data1/oa_pdf/17/ba/hvi-9-210.PMC3667940.pdf
Glycoconj J 2002; 19:319-23; PMID:12975611; http://dx.doi.org/10.1023/A:1025312819804.,Non-OADS,/arxiv_data1/oa_pdf/17/ba/hvi-9-210.PMC3667940.pdf
Biochem Biophys Res Commun 2003; 306:16-25; PMID:12788060; http://dx.doi.org/10.1016/S0006-291X(03)00908-2.,OADS,/arxiv_data1/oa_pdf/17/ba/hvi-9-210.PMC3667940.pdf
Clin Cancer Res 2004; 10:8630-40; PMID :15623647; http://dx.doi.org/10.1158/1078-0432.CCR-04-1177.randomized clinical trial to determine  the efficacy of the GPC3-derived pep - tide vaccine and to advance future drug development.,Non-OADS,/arxiv_data1/oa_pdf/17/ba/hvi-9-210.PMC3667940.pdf
"Human Vaccines & Immunotherapeutics 9:1, 50–62; January 2013; © 2013 Landes Bioscience ReseaR cH papeR 50 Human Vaccines & Immunotherapeutics Volume 9 Issue 1*Correspondence to: Helen McShane; Email: helen.mcshane@ndm.ox.ac.uk Submitted: 07/21/12; Revised: 09/27/12; Accepted: 10/05/12http://dx.doi.org/10.4161/hv.22464Introduction There were 8.8 million new cases and almost 1.5 million deaths  from tuberculosis (TB) in 2010.1 While global TB incidence, death  rates and prevalence are falling, new strategies are required if the Stop TB partnership targets are to be achieved.",Non-OADS,/arxiv_data1/oa_pdf/e3/14/hvi-9-50.PMC3667946.pdf
Lancet 2006; 367:1173-80;  PMID:16616560; http://dx.doi.org/10.1016/S0140- 6736(06)68507-3.,OADS,/arxiv_data1/oa_pdf/e3/14/hvi-9-50.PMC3667946.pdf
JAMA 1994; 271:698- 702; PMID:8309034; http://dx.doi.org/10.1001/jama.1994.03510330076038.,OADS,/arxiv_data1/oa_pdf/e3/14/hvi-9-50.PMC3667946.pdf
T uberculosis (Edinb)  2004; 84:93-101; PMID:14670350; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e3/14/hvi-9-50.PMC3667946.pdf
Am J Respir Crit Care Med 2012; 185:769-78;  PMID:22281831; http://dx.doi.org/10.1164/rccm.201108-1548OC.8.,Non-OADS,/arxiv_data1/oa_pdf/e3/14/hvi-9-50.PMC3667946.pdf
BMJ Open  2011; 1:e000223; PMID:22102640; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e3/14/hvi-9-50.PMC3667946.pdf
Sci T ransl Med 2011; 3:88ra56;  PMID:21697532; http://dx.doi.org/10.1126/scitrans- lmed.3002461.,OADS,/arxiv_data1/oa_pdf/e3/14/hvi-9-50.PMC3667946.pdf
J Infect Dis 2011; 203:1832-43; PMID:21606542; http://dx.doi.org/10.1093/infdis/ jir195.,OADS,/arxiv_data1/oa_pdf/e3/14/hvi-9-50.PMC3667946.pdf
Am J Respir Crit Care Med 2009; 179:724-33; PMID:19151191; http://dx.doi.org/10.1164/ rccm.200809-1486OC.,Non-OADS,/arxiv_data1/oa_pdf/e3/14/hvi-9-50.PMC3667946.pdf
PLoS One 2008; 3:e2921; PMID:18698342; http://dx.doi.org/10.1371/journal.pone.0002921.,Non-OADS,/arxiv_data1/oa_pdf/e3/14/hvi-9-50.PMC3667946.pdf
J Infect Dis 2008; 198:544-52;  PMID:18582195; http://dx.doi.org/10.1086/590185.14.,Non-OADS,/arxiv_data1/oa_pdf/e3/14/hvi-9-50.PMC3667946.pdf
Eur J Immunol  2007; 37:3089-100; PMID:17948267; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e3/14/hvi-9-50.PMC3667946.pdf
PLoS One 2007; 2:e1052; PMID:17957238;  http://dx.doi.org/10.1371/journal.pone.0001052.,OADS,/arxiv_data1/oa_pdf/e3/14/hvi-9-50.PMC3667946.pdf
Nat Med 2004; 10:1240-4;  PMID:15502839; http://dx.doi.org/10.1038/nm1128.,OADS,/arxiv_data1/oa_pdf/e3/14/hvi-9-50.PMC3667946.pdf
Infect Immun  2005; 73:3814-6; PMID:15908420; http://dx.doi.org/10.1128/IAI.73.6.3814-3816.2005.,Non-OADS,/arxiv_data1/oa_pdf/e3/14/hvi-9-50.PMC3667946.pdf
Vaccine 2006; 24:3026-34; PMID:16488059; http://dx.doi.org/10.1016/j.vac- cine.2005.10.058.,Non-OADS,/arxiv_data1/oa_pdf/e3/14/hvi-9-50.PMC3667946.pdf
PLoS Pathog  2007; 3:1511-29; PMID:17937498; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e3/14/hvi-9-50.PMC3667946.pdf
Hum Immunol 2006; 67:512- 20; PMID:16829305; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e3/14/hvi-9-50.PMC3667946.pdf
Proc Natl Acad Sci U S A 2003; 100:217- 22; PMID:12518065; http://dx.doi.org/10.1073/ pnas.262668999.27.,OADS,/arxiv_data1/oa_pdf/e3/14/hvi-9-50.PMC3667946.pdf
J Gen Virol  2004; 85:305-22; PMID:14769888; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e3/14/hvi-9-50.PMC3667946.pdf
Vaccine 1994; 12:569-73; PMID:8036832;  http://dx.doi.org/10.1016/0264-410X(94)90319-0.,Non-OADS,/arxiv_data1/oa_pdf/e3/14/hvi-9-50.PMC3667946.pdf
Infect Immun 2002; 70:1623-6; PMID:11854254;  http://dx.doi.org/10.1128/IAI.70.3.1623-1626.2002.,Non-OADS,/arxiv_data1/oa_pdf/e3/14/hvi-9-50.PMC3667946.pdf
Vaccine 2010; 28:7306- 12; PMID:20816902; http://dx.doi.org/10.1016/j.vac- cine.2010.08.077.,Non-OADS,/arxiv_data1/oa_pdf/e3/14/hvi-9-50.PMC3667946.pdf
J Proteome  Res 2008; 7:2703-11; PMID:18507432; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e3/14/hvi-9-50.PMC3667946.pdf
T rials in Vaccinology 2012; 1:27-35;  http://dx.doi.org/10.1016/j.trivac.2012.07.001.,OADS,/arxiv_data1/oa_pdf/e3/14/hvi-9-50.PMC3667946.pdf
Vaccine 2011; 29:1948-58; PMID:21216311; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e3/14/hvi-9-50.PMC3667946.pdf
PLoS One 2010; 5:e13983; PMID:21085591;  http://dx.doi.org/10.1371/journal.pone.0013983.,Non-OADS,/arxiv_data1/oa_pdf/e3/14/hvi-9-50.PMC3667946.pdf
J Virol  2004; 78:5820-34; PMID:15140980; http://dx.doi.org/10.1128/JVI.78.11.5820-5834.2004.,Non-OADS,/arxiv_data1/oa_pdf/e3/14/hvi-9-50.PMC3667946.pdf
"It is a short acting, and easily controllable hypnotic  Copyright ⓒ the Korean Society of Anesthesiologists, 2013 www.ekja.orgKorean J Anesthesiol 2013 May 64(5): 399-401  http://dx.doi.org/10.4097/kjae.2013.64.5.399 Editorial",Non-OADS,/arxiv_data1/oa_pdf/cf/0c/kjae-64-399.PMC3668099.pdf
"Tel: 82-2-6299-2571, Fax: 82-2-6299-2585, E-mail: roman00@naver.com     This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.CC Copyright ⓒ the Korean Society of Anesthesiologists, 2013 www.ekja.orgKorean J Anesthesiol 2013 May 64(5): 402-406  http://dx.doi.org/10.4097/kjae.2013.64.5.402  Missing data (or missing values) is defined as the data value  that is not stored for a variable in the observation of interest.",Non-OADS,/arxiv_data1/oa_pdf/54/7c/kjae-64-402.PMC3668100.pdf
"Tel: 82-31-219-5572, Fax: 82-31-219-5574, E-mail: anesmin@nate.com     This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.CC Copyright ⓒ the Korean Society of Anesthesiologists, 2013 www.ekja.orgKorean J Anesthesiol 2013 May 64(5): 407-413  http://dx.doi.org/10.4097/kjae.2013.64.5.407",Non-OADS,/arxiv_data1/oa_pdf/0d/bb/kjae-64-407.PMC3668101.pdf
"Tel: 82-31-780-5431, Fax: 82-31-780-5566, E-mail: anesthpark@cha.ac.kr     This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.CC Copyright ⓒ the Korean Society of Anesthesiologists, 2013 www.ekja.orgKorean J Anesthesiol 2013 May 64(5): 414-419  http://dx.doi.org/10.4097/kjae.2013.64.5.414",Non-OADS,/arxiv_data1/oa_pdf/50/96/kjae-64-414.PMC3668102.pdf
"Tel: 82-2-2228-2429, Fax: 82-2-312-7185, E-mail: csho99@yuhs.ac     This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.CC Copyright ⓒ the Korean Society of Anesthesiologists, 2013 www.ekja.orgKorean J Anesthesiol 2013 May 64(5): 420-425  http://dx.doi.org/10.4097/kjae.2013.64.5.420",Non-OADS,/arxiv_data1/oa_pdf/52/f9/kjae-64-420.PMC3668103.pdf
"Tel: 82-55-360-2129, Fax: 82-55-360-2149, E-mail: anebsh@pusan.ac.kr     This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.CC Copyright ⓒ the Korean Society of Anesthesiologists, 2013 www.ekja.orgKorean J Anesthesiol 2013 May 64(5): 426-431  http://dx.doi.org/10.4097/kjae.2013.64.5.426",Non-OADS,/arxiv_data1/oa_pdf/8c/2d/kjae-64-426.PMC3668104.pdf
"Tel:  00302413502952, Fax: 00302413501017, E-mail: gvretzakis@yahoo.com     This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.CC Copyright ⓒ the Korean Society of Anesthesiologists, 2013 www.ekja.orgKorean J Anesthesiol 2013 May 64(5): 432-438  http://dx.doi.org/10.4097/kjae.2013.64.5.432",Non-OADS,/arxiv_data1/oa_pdf/9d/18/kjae-64-432.PMC3668105.pdf
"Tel: 82-41-570-2823, Fax: 82-41-573-3559, E-mail:  wolftom@hanmail.net     This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.CC Copyright ⓒ the Korean Society of Anesthesiologists, 2013 www.ekja.orgKorean J Anesthesiol 2013 May 64(5): 439-442  http://dx.doi.org/10.4097/kjae.2013.64.5.439",Non-OADS,/arxiv_data1/oa_pdf/3c/f9/kjae-64-439.PMC3668106.pdf
"Tel: 82-2-2650-5558, Fax: 82-2-2655-2924, E-mail: kdyeon@ewha.ac.kr     This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.CC Copyright ⓒ the Korean Society of Anesthesiologists, 2013 www.ekja.orgKorean J Anesthesiol 2013 May 64(5): 443-447  http://dx.doi.org/10.4097/kjae.2013.64.5.443",Non-OADS,/arxiv_data1/oa_pdf/4e/81/kjae-64-443.PMC3668107.pdf
"She had undergone  a plication of the diaphragm for diaphragmatic eventration  caused by phrenic nerve palsy through the same approach,  Copyright ⓒ the Korean Society of Anesthesiologists, 2013 www.ekja.orgKorean J Anesthesiol 2013 May 64(5): 448-450  http://dx.doi.org/10.4097/kjae.2013.64.5.448 Case Report",Non-OADS,/arxiv_data1/oa_pdf/2c/90/kjae-64-448.PMC3668108.pdf
"Copyright ⓒ the Korean Society of Anesthesiologists, 2013 www.ekja.orgKorean J Anesthesiol 2013 May 64(5): 451-455  http://dx.doi.org/10.4097/kjae.2013.64.5.451 Case Report",Non-OADS,/arxiv_data1/oa_pdf/02/86/kjae-64-451.PMC3668109.pdf
"Copyright ⓒ the Korean Society of Anesthesiologists, 2013 www.ekja.orgKorean J Anesthesiol 2013 May 64(5): 456-459  http://dx.doi.org/10.4097/kjae.2013.64.5.456 Case Report",Non-OADS,/arxiv_data1/oa_pdf/d6/48/kjae-64-456.PMC3668110.pdf
"After the surgery,  Copyright ⓒ the Korean Society of Anesthesiologists, 2013 www.ekja.orgKorean J Anesthesiol 2013 May 64(5): 460-463  http://dx.doi.org/10.4097/kjae.2013.64.5.460 Case Report",Non-OADS,/arxiv_data1/oa_pdf/f5/76/kjae-64-460.PMC3668111.pdf
"Although physical examinations test for motion palpation  Copyright ⓒ the Korean Society of Anesthesiologists, 2013 www.ekja.orgKorean J Anesthesiol 2013 May 64(5): 464-468  http://dx.doi.org/10.4097/kjae.2013.64.5.464 Case Report",Non-OADS,/arxiv_data1/oa_pdf/6b/e0/kjae-64-464.PMC3668112.pdf
"The guidewire was removed and then another needle  puncture was attempted in which subsequent placement of a  new guidewire was achieved uneventfully with ultrasonographic  Copyright ⓒ the Korean Society of Anesthesiologists, 2013 www.ekja.orgKorean J Anesthesiol 2013 May 64(5): 469-471  http://dx.doi.org/10.4097/kjae.2013.64.5.469 Letter to the Editor",Non-OADS,/arxiv_data1/oa_pdf/df/7e/kjae-64-469.PMC3668113.pdf
"Therefore, gabapentin, pregabalin, and a non-steroidal anti- inflammatory agent were administered, which were not  Copyright ⓒ the Korean Society of Anesthesiologists, 2013 www.ekja.orgKorean J Anesthesiol 2013 May 64(5): 472-473  http://dx.doi.org/10.4097/kjae.2013.64.5.472 Letter to the Editor",Non-OADS,/arxiv_data1/oa_pdf/02/b7/kjae-64-472.PMC3668114.pdf
"Ingested food and saliva are retained in the  Copyright ⓒ the Korean Society of Anesthesiologists, 2013 www.ekja.orgKorean J Anesthesiol 2013 May 64(5): 474-475  http://dx.doi.org/10.4097/kjae.2013.64.5.474 Letter to the Editor",Non-OADS,/arxiv_data1/oa_pdf/7a/d8/kjae-64-474.PMC3668115.pdf
"It is believed that  the use of the tourniquet was unable to block the graft artery  flow but collapsed the venous flow, which resulted in the  Copyright ⓒ the Korean Society of Anesthesiologists, 2013 www.ekja.orgKorean J Anesthesiol 2013 May 64(5): 476-477  http://dx.doi.org/10.4097/kjae.2013.64.5.476 Letter to the Editor",Non-OADS,/arxiv_data1/oa_pdf/14/2f/kjae-64-476.PMC3668116.pdf
"In addition, this study conducted an evaluation  of the items on their understanding of the anesthesia drug,  monitoring and anesthesia equipment, their confidence to  approach the anesthesia patient after simulation practice, and  the appropriateness and necessity of simulation practice, and  the utility of debriefing after simulation based on a 5-point  Copyright ⓒ the Korean Society of Anesthesiologists, 2013 www.ekja.orgKorean J Anesthesiol 2013 May 64(5): 478-479  http://dx.doi.org/10.4097/kjae.2013.64.5.478 Letter to the Editor",Non-OADS,/arxiv_data1/oa_pdf/3c/f2/kjae-64-478.PMC3668117.pdf
Sequence com - parison of the 16S rRNA gene was carried out using the  BLAST program ( http://www.ncbi.nlm.nih.gov/blast ) and  the global alignment algorithm of the EzTaxon server ( htt p://www.eztaxon.org/ ; Chun et al.,OADS,/arxiv_data1/oa_pdf/ca/98/203_2013_Article_895.PMC3668118.pdf
"191 http://dx.doi.org/10.3345/kjp.2013.56.5.191Phenotypes and endotypes of severe asthma in  children Young Yoo, MD, PhD Department of Pediatrics, Allergy Immunology Center, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea Severe childhood asthma is a complicated and heterogeneous disorder with distinct phenotypes.",Non-OADS,/arxiv_data1/oa_pdf/f4/8c/kjped-56-191.PMC3668198.pdf
"Key words: Severe asthma, Child, Phenotype, EndotypeCorresponding author: Young Yoo, MD, PhD Department of Pediatrics, Korea University Anam Hospital, 73 Inchon-ro, Seongbuk-gu, Seoul 136-705, KoreaTel: +82-2-920-5090, Fax: +82-2-922-7476, E-mail: yoolina@korea.ac.kr   Received: 24 August, 2012 Accepted: 28 December, 2012 Copyright © 2013 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Review article Korean J Pediatr 2013;56(5):191-195 http://dx.doi.org/10.3345/kjp.2013.56.5.191 pISSN 1738-1061•eISSN 2092-7258 Korean J Pediatr Introduction Children with severe asthma account for about 5% to 10% of all patients with asthma1).",Non-OADS,/arxiv_data1/oa_pdf/f4/8c/kjped-56-191.PMC3668198.pdf
"http://dx.doi.org/10.3345/kjp.2013.56.5.191Young Yoo  • Phenotypes and endotypes of severe asthma in children 192of severe asthma5,6).",Non-OADS,/arxiv_data1/oa_pdf/f4/8c/kjped-56-191.PMC3668198.pdf
"193 http://dx.doi.org/10.3345/kjp.2013.56.5.191Korean J Pediatr 2013;56(5):191-195 CXCL1), regulated on activation, normal T cell expressed and  secreted (RANTES; CCL5), interleukin (IL)-12, and IL-10 can  be used to characterize severe asthma in children.",Non-OADS,/arxiv_data1/oa_pdf/f4/8c/kjped-56-191.PMC3668198.pdf
http://dx.doi.org/10.3345/kjp.2013.56.5.191Young Yoo  • Phenotypes and endotypes of severe asthma in children 1942.,Non-OADS,/arxiv_data1/oa_pdf/f4/8c/kjped-56-191.PMC3668198.pdf
195 http://dx.doi.org/10.3345/kjp.2013.56.5.191Korean J Pediatr 2013;56(5):191-195 References  1.,Non-OADS,/arxiv_data1/oa_pdf/f4/8c/kjped-56-191.PMC3668198.pdf
"196 http://dx.doi.org/10.3345/kjp.2013.56.5.196Systemic use of fluoroquinolone in children Soo-Han Choi, MD1, Eun Young Kim, Pharm D2, Yae-Jean Kim, MD, PhD3 1Department of Pediatrics, KEPCO Medical Foundation KEPCO Medical Center, Seoul,  2Department of Clinical Pharmacy, College of Pharmacy, Chung-Ang University, Seoul,  3Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea Fluoroquinolones are an important class of antibiotics that are widely used in adult patients because  of their broad spectrum of activity, good tissue penetration, and oral bioavailability.",Non-OADS,/arxiv_data1/oa_pdf/59/d5/kjped-56-196.PMC3668199.pdf
"Key words: Fluoroquinolones, Adverse effects, Joint diseases, ChildCorresponding author: Yae-Jean Kim, MD, PhD Department of Pediatrics, Samsung Medical Cen-ter, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 135-710, KoreaTel: +82-2-3410-3539, Fax: +82-2-3410-0043E-mail: yaejeankim@skku.edu Received: 18 December, 2012 Accepted: 13 March, 2013 Copyright © 2013 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Review article Korean J Pediatr 2013;56(5):196-201 http://dx.doi.org/10.3345/kjp.2013.56.5.196 pISSN 1738-1061•eISSN 2092-7258 Korean J Pediatr Introduction Fluoroquinolones (FQs) are important antibiotics that are widely utilized in adult  patients because of their excellent spectrum of activity, good tissue penetration, and oral  bioavailability.",Non-OADS,/arxiv_data1/oa_pdf/59/d5/kjped-56-196.PMC3668199.pdf
197 http://dx.doi.org/10.3345/kjp.2013.56.5.196Korean J Pediatr 2013;56(5):196-201 chloroquine4).,Non-OADS,/arxiv_data1/oa_pdf/59/d5/kjped-56-196.PMC3668199.pdf
"http://dx.doi.org/10.3345/kjp.2013.56.5.196SH Choi, et al.",OADS,/arxiv_data1/oa_pdf/59/d5/kjped-56-196.PMC3668199.pdf
"199 http://dx.doi.org/10.3345/kjp.2013.56.5.196Korean J Pediatr 2013;56(5):196-201 and 12-month follow-ups (3.4% vs. 1.8%, P=0.03).",OADS,/arxiv_data1/oa_pdf/59/d5/kjped-56-196.PMC3668199.pdf
"http://dx.doi.org/10.3345/kjp.2013.56.5.196SH Choi, et al.",OADS,/arxiv_data1/oa_pdf/59/d5/kjped-56-196.PMC3668199.pdf
201 http://dx.doi.org/10.3345/kjp.2013.56.5.196Korean J Pediatr 2013;56(5):196-201 American Academy of Pediatrics.,Non-OADS,/arxiv_data1/oa_pdf/59/d5/kjped-56-196.PMC3668199.pdf
Available from: http://www.accessdata.fda.gov/drugsatfda_docs/ nda/2004/019537s49_19847s27_19857s31_20780s13TOC.cfm.,Non-OADS,/arxiv_data1/oa_pdf/59/d5/kjped-56-196.PMC3668199.pdf
Available from: http://clinicaltrials.gov/ct2/show/NCT01069900.,Non-OADS,/arxiv_data1/oa_pdf/59/d5/kjped-56-196.PMC3668199.pdf
Available from: http://clinicaltrials.gov/ct2/show/ NCT01049022.,Non-OADS,/arxiv_data1/oa_pdf/59/d5/kjped-56-196.PMC3668199.pdf
Available  from: http://ec.europa.eu/health/files/paediatrics/2012-09_ pediatric_report-annex1-2_en.pdf.,Non-OADS,/arxiv_data1/oa_pdf/59/d5/kjped-56-196.PMC3668199.pdf
Available from: http://www.emea.europa.eu/ema/index.,Non-OADS,/arxiv_data1/oa_pdf/59/d5/kjped-56-196.PMC3668199.pdf
Available from: http://www.who.int/ maternal_child_adolescent/documents/9241546700/en/.,Non-OADS,/arxiv_data1/oa_pdf/59/d5/kjped-56-196.PMC3668199.pdf
Available from: http://apps.who.int/iris/bitstream/10665/44771/1/WHO_TRS_965_eng.pdf.,OADS,/arxiv_data1/oa_pdf/59/d5/kjped-56-196.PMC3668199.pdf
Available from: http://apps.who.int/iris/bitstre am/10665/44597/1/9789241501583_eng.pdf.,OADS,/arxiv_data1/oa_pdf/59/d5/kjped-56-196.PMC3668199.pdf
"202 http://dx.doi.org/10.3345/kjp.2013.56.5.202Comparison of the serum vitamin D level  between breastfed and formula-fed infants:   several factors which can affect serum vitamin D  concentration Yong Joo Kim, MD, PhD Department of Pediatrics, Hanyang University Seoul Hospital, Seoul, Korea Corresponding author: Yong Joo Kim, MD, PhD Department of Pediatrics, Hanyang University Seoul Hospital, 222 Wangsimni-ro, Seongdong-gu, Seoul 133-791, KoreaTel: +82-2-2290-8390, Tel: +82-2-2297-2380E-mail: kyjoo@hanyang.ac.kr Received: 11 April, 2013 Accepted: 25 April, 2013 Copyright © 2013 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Editorial Korean J Pediatr 2013;56(5):202-204 http://dx.doi.org/10.3345/kjp.2013.56.5.202 pISSN 1738-1061•eISSN 2092-7258 Korean J Pediatr It is common knowledge among pediatricians that exclusively breastfed infants should  be supplemented with vitamin D (400 IU/day) because human breast milk contains an  inadequate amount of vitamin D. Accordingly, Choi et al.1) reported a vitamin deficiency  in early infants in a comparative study between breastfed and formula-fed infants in this issue.",Non-OADS,/arxiv_data1/oa_pdf/57/40/kjped-56-202.PMC3668200.pdf
"203 http://dx.doi.org/10.3345/kjp.2013.56.5.202Korean J Pediatr 2013;56(5):202-204 certain fish oils, animal liver, aquatic mammal fat and egg yolks  of vitamin D-fed chickens.",Non-OADS,/arxiv_data1/oa_pdf/57/40/kjped-56-202.PMC3668200.pdf
http://dx.doi.org/10.3345/kjp.2013.56.5.202YJ Kim  • Several factors which can affect serum vitamin D concentration?,Non-OADS,/arxiv_data1/oa_pdf/57/40/kjped-56-202.PMC3668200.pdf
"205 http://dx.doi.org/10.3345/kjp.2013.56.5.205Vitamin D deficiency in infants aged 1 to 6 months  You Jin Choi, MD, Moon Kyu Kim, MD, Su Jin Jeong, MD Department of Pediatrics, CHA Bundang Medical Center, CHA University, Seongnam, Korea See accompanying editorial on page 202.",Non-OADS,/arxiv_data1/oa_pdf/f9/b5/kjped-56-205.PMC3668201.pdf
"Key words: Breastfeeding , Female infant, Healthy infant, Risk factor, Vitamin DCorresponding author: Su Jin Jeong, MD Department of Pediatrics, CHA Bundang Medical Center, CHA University, 59 Yatap-ro, Bundang-gu, Seongnam 463-712, KoreaTel: +82-31-780-5230Fax: +82-31-780-5239E-mail: jinped@cha.ac.kr  Received: 11 August 2012 Revised: 7 December 2012Accepted: 25 January 2013 Copyright © 2013 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Original article Korean J Pediatr 2013;56(5):205-210 http://dx.doi.org/10.3345/kjp.2013.56.4.205 pISSN 1738-1061•eISSN 2092-7258 Korean J Pediatr Introduction Vitamin D is a fat-soluble vitamin that performs a key role in calcium homeostasis and  bone metabolism1).",Non-OADS,/arxiv_data1/oa_pdf/f9/b5/kjped-56-205.PMC3668201.pdf
"http://dx.doi.org/10.3345/kjp.2013.56.5.205YJ Choi, et al.",OADS,/arxiv_data1/oa_pdf/f9/b5/kjped-56-205.PMC3668201.pdf
"207 http://dx.doi.org/10.3345/kjp.2013.56.5.205Korean J Pediatr 2013;56(5):205-210 body weight at sampling, season at birth and sampling, the  presence of siblings, and mother's occupation during pregnancy  affected the vitamin D deficiency, except maternal age.",Non-OADS,/arxiv_data1/oa_pdf/f9/b5/kjped-56-205.PMC3668201.pdf
"http://dx.doi.org/10.3345/kjp.2013.56.5.205YJ Choi, et al.",OADS,/arxiv_data1/oa_pdf/f9/b5/kjped-56-205.PMC3668201.pdf
209 http://dx.doi.org/10.3345/kjp.2013.56.5.205Korean J Pediatr 2013;56(5):205-210 statistical data of vitamin D at infancy exist13).,Non-OADS,/arxiv_data1/oa_pdf/f9/b5/kjped-56-205.PMC3668201.pdf
"http://dx.doi.org/10.3345/kjp.2013.56.5.205YJ Choi, et al.",OADS,/arxiv_data1/oa_pdf/f9/b5/kjped-56-205.PMC3668201.pdf
"211 http://dx.doi.org/10.3345/kjp.2013.56.5.211Depression and marital intimacy level in parents  of infants with sleep onset association disorder: a preliminary study on the effect of sleep education Sihyoung Lee, MD, Seonkyeong Rhie, MD, Kyu Young Chae, MD Department of Pediatrics, CHA Bundang Medical Center, CHA University, Seongnam, Korea Purpose: Sleep onset association disorder (SOAD) is a form of behavioral insomnia observed in  children that is caused by inappropriate sleep training.",Non-OADS,/arxiv_data1/oa_pdf/03/75/kjped-56-211.PMC3668202.pdf
"Key words: Sleep onset association, Infant, Sleep practice, Depression, Marital intimacyCorresponding author: Kyu Young Chae, MD Department of Pediatric Neurology, Sleep Center, CHA Bundang Medical Center, CHA University, 59 Yatap-ro, Bundang-gu, Seongnam 463-712, Korea Tel: +82-31-780-5230, 5264Fax: +82-31-780-5239E-mail: danielchae21@gmail.com Received: 10 September, 2012 Revised: 17 September, 2012Accepted: 15 October, 2012 Copyright © 2013 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Original article Korean J Pediatr 2013;56(5):211-217 http://dx.doi.org/10.3345/kjp.2013.56.5.211 pISSN 1738-1061•eISSN 2092-7258 Korean J Pediatr Introduction  Sleep onset association disorder (SOAD) is a typical behavioral insomnia in children  caused by inappropriate sleep training, which requires special conditioning such as  feeding, rocking or swinging while falling asleep.",Non-OADS,/arxiv_data1/oa_pdf/03/75/kjped-56-211.PMC3668202.pdf
"http://dx.doi.org/10.3345/kjp.2013.56.5.211S Lee, et al.",OADS,/arxiv_data1/oa_pdf/03/75/kjped-56-211.PMC3668202.pdf
213 http://dx.doi.org/10.3345/kjp.2013.56.5.211Korean J Pediatr 2013;56(5):211-217 participated.,OADS,/arxiv_data1/oa_pdf/03/75/kjped-56-211.PMC3668202.pdf
"http://dx.doi.org/10.3345/kjp.2013.56.5.211S Lee, et al.",OADS,/arxiv_data1/oa_pdf/03/75/kjped-56-211.PMC3668202.pdf
215 http://dx.doi.org/10.3345/kjp.2013.56.5.211Korean J Pediatr 2013;56(5):211-217 the increased sensory contact and proximity between the  mother and infant induces potentially beneficial behavioral and  physiological changes in the infants15).,Non-OADS,/arxiv_data1/oa_pdf/03/75/kjped-56-211.PMC3668202.pdf
"http://dx.doi.org/10.3345/kjp.2013.56.5.211S Lee, et al.",OADS,/arxiv_data1/oa_pdf/03/75/kjped-56-211.PMC3668202.pdf
217 http://dx.doi.org/10.3345/kjp.2013.56.5.211Korean J Pediatr 2013;56(5):211-217 References   1.,Non-OADS,/arxiv_data1/oa_pdf/03/75/kjped-56-211.PMC3668202.pdf
"218 http://dx.doi.org/10.3345/kjp.2013.56.5.218Serum levels of interleukin-6 and interleukin-8  as diagnostic markers of acute pyelonephritis in children Abolfazl Mahyar, MD, Parviz Ayazi, MD,  Mohammad Reza Maleki, MD, Mohammad Mahdi Daneshi-Kohan, LD,  Hamid Reza  Sarokhani, LD,  Hassan Jahani Hashemi, PhD, Mousa Talebi-Bakhshayesh, MSc Department of Pediatrics, Qazvin University of Medical Sciences, Qazvin, Iran Purpose:  Early diagnosis and treatment of acute pyelonephritis in children is of special importance in  order to prevent serious complications.",Non-OADS,/arxiv_data1/oa_pdf/9d/81/kjped-56-218.PMC3668203.pdf
"Key words: Interleukin-6, Interleukin-8, Acute pyelonephritisCorresponding author: Abolfazl Mahyar, MD Department of Pediatrics, Qazvin Children Hospi - tal, Qazvin University of Medical Sciences, Valiasr Square, Qazvin, IranTel: +98-2813334807-9Fax: +98-2813344088E-mail: Abolfazl473@yahoo.com  Received: 5 September, 2012 Revised: 17 December, 2012Accepted:  11 March, 2013 Copyright © 2013 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Original article Korean J Pediatr 2013;56(5):218-223 http://dx.doi.org/10.3345/kjp.2013.56.5.218 pISSN 1738-1061•eISSN 2092-7258 Korean J Pediatr Introduction Urinary tract infection (UTI) is caused by invasion of pathogenic microorganisms into  the urinary tract system.",Non-OADS,/arxiv_data1/oa_pdf/9d/81/kjped-56-218.PMC3668203.pdf
"219 http://dx.doi.org/10.3345/kjp.2013.56.5.218Korean J Pediatr 2013;56(5):218-223 location of UTI, these symptoms are not always reliable7).",Non-OADS,/arxiv_data1/oa_pdf/9d/81/kjped-56-218.PMC3668203.pdf
http://dx.doi.org/10.3345/kjp.2013.56.5.218A.,OADS,/arxiv_data1/oa_pdf/9d/81/kjped-56-218.PMC3668203.pdf
"221 http://dx.doi.org/10.3345/kjp.2013.56.5.218Korean J Pediatr 2013;56(5):218-223 of VUR (Tables 7, 8).",OADS,/arxiv_data1/oa_pdf/9d/81/kjped-56-218.PMC3668203.pdf
http://dx.doi.org/10.3345/kjp.2013.56.5.218A.,OADS,/arxiv_data1/oa_pdf/9d/81/kjped-56-218.PMC3668203.pdf
223 http://dx.doi.org/10.3345/kjp.2013.56.5.218Korean J Pediatr 2013;56(5):218-223  5.,Non-OADS,/arxiv_data1/oa_pdf/9d/81/kjped-56-218.PMC3668203.pdf
"224 http://dx.doi.org/10.3345/kjp.2013.56.5.224Liver transplantation in a child with acute liver  failure resulting from drug rash with eosinophilia  and systemic symptoms syndrome Seung Min Song, MD1, Min Sung Cho, MD1, Seak Hee Oh, MD1, Kyung Mo Kim, MD1, Young Seo Park, MD1, Dae Yeon Kim, MD2,  Sung Gyu Lee, MD3   Departments of 1Pediatrics and 2Pediatric Surgery, Asan Medical Center Children's Hospital, University of Ulsan College of Medicine, Seoul 3Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome is characterized by a severe  idiosyncratic reaction including rash and fever, often with associated hepatitis, arthralgias, lymph node  enlargement, or hematologic abnormalities.",Non-OADS,/arxiv_data1/oa_pdf/7f/0f/kjped-56-224.PMC3668204.pdf
"Key words: DRESS syndrome, Vancomycin, Acute liver failure, Liver transplantationCorresponding author: Kyung Mo Kim, MD Department of Pediatrics, Asan Medical Center  Children’s Hospital, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 138-736, KoreaTel: +82-2-3010-3380Fax: +82-2-473-3725E-mail: kmkim@amc.seoul.kr Received: 21 July 2012 Revised: 28 September 2012Accepted: 29 November 2012 Copyright © 2013 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Case report Korean J Pediatr 2012;56(5):224-226 http://dx.doi.org/10.3345/kjp.2013.56.5.224 pISSN 1738-1061•eISSN 2092-7258 Korean J Pediatr Introduction The hypersensitivity syndrome, described as drug rash with eosinophilia and systemic  symptoms (DRESS) syndrome is a severe, acute, drug reaction, defined by the presence  of fever, cutaneous eruption, and systemic findings including enlarged lymph nodes,  hepatitis, or hematologic abnormalities with eosinophilia and atypical lymphocytes1,2).",Non-OADS,/arxiv_data1/oa_pdf/7f/0f/kjped-56-224.PMC3668204.pdf
225 http://dx.doi.org/10.3345/kjp.2013.56.5.224Korean J Pediatr 2013;56(4):224-226 craniectomy.,Non-OADS,/arxiv_data1/oa_pdf/7f/0f/kjped-56-224.PMC3668204.pdf
"http://dx.doi.org/10.3345/kjp.2013.56.5.224SM Song, et al.",OADS,/arxiv_data1/oa_pdf/7f/0f/kjped-56-224.PMC3668204.pdf
"227 http://dx.doi.org/10.3345/kjp.2013.56.5.227Two cases of chronic pancreatitis associated with  anomalous pancreaticobiliary ductal union and  SPINK1 mutation Eun Sam Rho, MD1, Earl Kim, MD1, Hong Koh, MD1, Han-Wook Yoo, MD2,3, Beom Hee Lee, MD2,3, Gu-Hwan Kim, MD3 1Department of Pediatrics, Severance Children’s Hospital, Yonsei University College of Medicine, Seoul 2Department of Pediatrics, 3Medical Genetics Center, Asan Medical Center Children’s Hospital, University of Ulsan College of Medicine, Seoul, Korea Chronic pancreatitis is a progressive inflammatory disease resulting from repeated episodes of acute  pancreatitis that impair exocrine function and eventually produce endocrine insufficiency.",Non-OADS,/arxiv_data1/oa_pdf/30/3f/kjped-56-227.PMC3668205.pdf
"Key words: Chronic pancreatitis, Anomalous pancreaticobiliary ductal union, Serine protease inhibitor,  Kazal type 1Corresponding author: Hong Koh, MD Department of Pediatrics, Severance Children’s Hospital, Yonsei University College of Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul 120-752, KoreaTel: +82-2-2228-2050Fax: +82-2-393-9118E-mail: khong@yuhs.ac Received: 8 December, 2011 Revised: 17 April, 2012Accepted: 2 August, 2012 Copyright © 2013 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Case report Korean J Pediatr 2013;56(5):227-230 http://dx.doi.org/10.3345/kjp.2013.56.5.227 pISSN 1738-1061•eISSN 2092-7258 Korean J Pediatr Introduction Chronic pancreatitis (CP) is a progressive inflammatory disease, initiated by repeated  episodes of acute pancreatitis, that results in impairment of exocrine and eventually  endocrine insufficiency1,2).",Non-OADS,/arxiv_data1/oa_pdf/30/3f/kjped-56-227.PMC3668205.pdf
"http://dx.doi.org/10.3345/kjp.2013.56.5.227ES Rho, et al.",OADS,/arxiv_data1/oa_pdf/30/3f/kjped-56-227.PMC3668205.pdf
229 http://dx.doi.org/10.3345/kjp.2013.56.5.227Korean J Pediatr 2013;56(5):227 ­230 demonstrated incomplete pancreas divisum and APBDU.,OADS,/arxiv_data1/oa_pdf/30/3f/kjped-56-227.PMC3668205.pdf
"http://dx.doi.org/10.3345/kjp.2013.56.5.227ES Rho, et al.",OADS,/arxiv_data1/oa_pdf/30/3f/kjped-56-227.PMC3668205.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.License: This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License.,Non-OADS,/arxiv_data1/oa_pdf/f7/1a/srep01926.PMC3668317.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Maselli, V. & Trincardi, F. Man made deltas.",Non-OADS,/arxiv_data1/oa_pdf/f7/1a/srep01926.PMC3668317.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/ee/df/srep01925.PMC3668318.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Choi, J.-H. et al.",Non-OADS,/arxiv_data1/oa_pdf/ee/df/srep01925.PMC3668318.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/f8/3a/srep01929.PMC3668319.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Some, S. et al.",Non-OADS,/arxiv_data1/oa_pdf/f8/3a/srep01929.PMC3668319.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/e5/3b/srep01930.PMC3668320.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Iwasawa, H. et al.",Non-OADS,/arxiv_data1/oa_pdf/e5/3b/srep01930.PMC3668320.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Kikushima, K., Kita, S. & Higuchi, H. A non-invasive imaging for thein vivo tracking of high-speed vesicle transport in mouse neutrophils.",Non-OADS,/arxiv_data1/oa_pdf/84/b6/srep01913.PMC3668321.pdf
"Article, supplemental material, and publi- cation date are at http://www.genome .org/cgi/doi/10.1101/gr.154070.112.",OADS,/arxiv_data1/oa_pdf/a4/90/1008.PMC3668355.pdf
"Article, supplemental material, and pub-lication date are at http://www.genome.org/cgi/doi/10.1101/gr.153031.112.",Non-OADS,/arxiv_data1/oa_pdf/52/0f/1028.PMC3668357.pdf
"Article, supplemental material, and pub- lication date are at http://www.genome.org/cgi/doi/10.1101/gr.146233.112.",OADS,/arxiv_data1/oa_pdf/c6/80/1039.PMC3668358.pdf
Analysis of heat shock response in eight species We ran Arboretum on expression data measuring the heat shockresponse of eight species using orthology mappings from the Syn-ergy algorithm (http://www.broadinstitute.org/regev/orthogroups/) (Wapinski et al.,OADS,/arxiv_data1/oa_pdf/c6/80/1039.PMC3668358.pdf
Source code availability Source code and usage instructions can be downloaded from http://www.broadinstitute.org/ ;sroy/arboretum or http://pages.,OADS,/arxiv_data1/oa_pdf/c6/80/1039.PMC3668358.pdf
"Article, supplemental material, and pub- lication date are at http://www.genome.org/cgi/doi/10.1101/gr.150078.112.",OADS,/arxiv_data1/oa_pdf/dd/37/907.PMC3668359.pdf
Data access Gene expression and sequencing data have been deposited in theNCBI Gene Expression Omnibus (GEO) (http://www.ncbi.nlm.nih.,OADS,/arxiv_data1/oa_pdf/dd/37/907.PMC3668359.pdf
"Article, supplemental material, and publi- cation date are at http://www.genome .org/cgi/doi/10.1101/gr.149674.112.",OADS,/arxiv_data1/oa_pdf/7e/5d/917.PMC3668360.pdf
Data access All sequencing data were deposited in the NCBI Gene ExpressionOmnibus (GEO) (http://www.ncbi.nlm.nih.gov/geo/) under ac- cession number GSE41166.,OADS,/arxiv_data1/oa_pdf/7e/5d/917.PMC3668360.pdf
The data are also available through the Cardiovascular Development Consortium at https://b2b.hci.utah.edu/gnomex/.,OADS,/arxiv_data1/oa_pdf/7e/5d/917.PMC3668360.pdf
"Article, supplemental material, and pub- lication date are at http://www.genome.org/cgi/doi/10.1101/gr.151472.112.",OADS,/arxiv_data1/oa_pdf/5d/95/928.PMC3668361.pdf
Predicted genome binding profiles for these Drosophila factors have been constructed within Genome Surveyor (http://veda.cs.uiuc.edu/gs) where combinations of these motifs can be coupled with evolutionary comparisons across 12 Drosophila species for the discovery of cis-regulatory modules (Noyes et al.,OADS,/arxiv_data1/oa_pdf/5d/95/928.PMC3668361.pdf
Methods Discovery and clustering of Cys 2-His 2ZFPs for analysis ZFPs were identified based on the motif annotations within the SMART database (http://smart.embl.de/) (Letunic et al.,OADS,/arxiv_data1/oa_pdf/5d/95/928.PMC3668361.pdf
Data access The sequencing data from this study have been submitted to theNCBI Gene Expression Omnibus (GEO) (http://www.ncbi.nlm.nih.,OADS,/arxiv_data1/oa_pdf/5d/95/928.PMC3668361.pdf
"Article, supplemental material, and pub- lication date are at http://www.genome.org/cgi/doi/10.1101/gr.152876.112.",Non-OADS,/arxiv_data1/oa_pdf/68/ef/941.PMC3668362.pdf
We have created a website through which users can perform a candidate regulator screen for any expression profiling experiment of interest (http://celegansrwas.stanford.edu).,Non-OADS,/arxiv_data1/oa_pdf/68/ef/941.PMC3668362.pdf
Methods ChIP-seq data sets and analysis Ninety-eight ChIP-seq data sets for 57 transcription factors were obtained from the modENCODE Consortium as of 4/30/12 (http://submit.modencode.org/submit/public/list or http://data.modencode.org/).,OADS,/arxiv_data1/oa_pdf/68/ef/941.PMC3668362.pdf
Binding data were mapped to WS220 coordi-nates using scripts available from WormBase (ftp://ftp.sanger.ac.,OADS,/arxiv_data1/oa_pdf/68/ef/941.PMC3668362.pdf
"Article, supplemental material, and pub- lication date are at http://www.genome.org/cgi/doi/10.1101/gr.150466.112.",OADS,/arxiv_data1/oa_pdf/59/57/954.PMC3668363.pdf
"We thank the National BioResource Project (http://www.shigen.nig.ac.jp/c.elegans/index.jsp) for insulin mutant strains, and Keith Black- well for the Pgst-4::GFP transgenic strain.",Non-OADS,/arxiv_data1/oa_pdf/59/57/954.PMC3668363.pdf
http://www.wormbook.org.,Non-OADS,/arxiv_data1/oa_pdf/59/57/954.PMC3668363.pdf
http://www.wormbook.org.,Non-OADS,/arxiv_data1/oa_pdf/59/57/954.PMC3668363.pdf
"Article, supplemental material, and pub- lication date are at http://www.genome.org/cgi/doi/10.1101/gr.149096.112.",Non-OADS,/arxiv_data1/oa_pdf/89/fa/966.PMC3668364.pdf
"Article, supplemental material, and pub- lication date are at http://www.genome.org/cgi/doi/10.1101/gr.150342.112.",OADS,/arxiv_data1/oa_pdf/5c/db/977.PMC3668365.pdf
"Data access The TL-seq and TATL-seq data, as well as processed TL-lengths,and links to UCSC and SGD Genome Browser-formatted data from these experiments have been submitted to the NCBI Gene Expression Omnibus (GEO) (http://www.ncbi.nlm.nih.gov/geo/)under series accession no.",OADS,/arxiv_data1/oa_pdf/5c/db/977.PMC3668365.pdf
The data are also viewable under ‘‘Select Tracks’’ in GBrowse at SGD (http://yeastgenome.org).,OADS,/arxiv_data1/oa_pdf/5c/db/977.PMC3668365.pdf
"Article, supplemental material, and publi- cation date are at http://www.genome .org/cgi/doi/10.1101/gr.146654.112.",OADS,/arxiv_data1/oa_pdf/eb/75/988.PMC3668366.pdf
"Data access Protein binding microarray and sequencing data used in this study have been deposited with the NCBI Gene Expression Omnibus (GEO) (http://www.ncbi.nlm.nih.gov/geo) under accession num-bers GSE44338 and GSE44942, respectively.",OADS,/arxiv_data1/oa_pdf/eb/75/988.PMC3668366.pdf
"Article, supplemental material, and pub-lication date are at http://www.genome.org/cgi/doi/10.1101/gr.147546.112.",OADS,/arxiv_data1/oa_pdf/26/13/998.PMC3668367.pdf
"In summary, we provide an important resource, which aids theanalysis of potential causative genes involved in T1D susceptibility.Database URLs: http://www.sanger.ac.uk/resources/mouse/nod/; http://vega-previous.sanger.ac.uk/info/data/mouse_regions.",OADS,/arxiv_data1/oa_pdf/ae/67/bat032.PMC3668384.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ae/67/bat032.PMC3668384.pdf
National Institutes of Health (2013) http://www.nih.gov/.18.,Non-OADS,/arxiv_data1/oa_pdf/ae/67/bat032.PMC3668384.pdf
NOD mouse ftp site (2013) ftp://ftp.sanger.ac.uk/pub/NODmouse/ NOD_resource_paper_data/.,OADS,/arxiv_data1/oa_pdf/ae/67/bat032.PMC3668384.pdf
European Nucleotide Archive (2013) http://www.ebi.ac.uk/ena/.,OADS,/arxiv_data1/oa_pdf/ae/67/bat032.PMC3668384.pdf
NOD mouse webpage (2013) http://www.sanger.ac.uk/resources/ mouse/nod/.,Non-OADS,/arxiv_data1/oa_pdf/ae/67/bat032.PMC3668384.pdf
NOD mouse sequences (2013) http://www.sanger.ac.uk/cgi-bin/ Projects/M_musculus/mouse_NOD_clones_TPF.,Non-OADS,/arxiv_data1/oa_pdf/ae/67/bat032.PMC3668384.pdf
Genome Reference Consortium (GRC) (2013) http://www.ncbi.nlm.,OADS,/arxiv_data1/oa_pdf/ae/67/bat032.PMC3668384.pdf
Vega Iddregions (2012) http://vega.sanger.ac.uk/info/data/mouse_ regions.html.,Non-OADS,/arxiv_data1/oa_pdf/ae/67/bat032.PMC3668384.pdf
Mouse-Genomes (2012) http://www.sanger.ac.uk/resources/mouse/ genomes/.,OADS,/arxiv_data1/oa_pdf/ae/67/bat032.PMC3668384.pdf
European Bioinformatics Institute (2013) http://www.ebi.ac.uk/ embl.,Non-OADS,/arxiv_data1/oa_pdf/ae/67/bat032.PMC3668384.pdf
HAVANA-software-manual (2013) http://www.sanger.ac.uk/re search/projects/vertebrategenome/havana/assets/otterlace_user_manual.pdf.,OADS,/arxiv_data1/oa_pdf/ae/67/bat032.PMC3668384.pdf
HAVANA annotation guidelines (2013) http://www.sanger.ac.uk/re- search/projects/vertebrategenome/havana/assets/guidelines.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ae/67/bat032.PMC3668384.pdf
UniProt (2013) http://www.uniprot.org/.,Non-OADS,/arxiv_data1/oa_pdf/ae/67/bat032.PMC3668384.pdf
Vega biotypes (2013) http://vega.sanger.ac.uk/info/about/gene_ and_transcript_types.html.,OADS,/arxiv_data1/oa_pdf/ae/67/bat032.PMC3668384.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/19/28/bat040.PMC3668385.pdf
To view these files please visitthe journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003067).,Non-OADS,/arxiv_data1/oa_pdf/8b/24/bmjopen-2013-003067.PMC3668416.pdf
To view these filesplease visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-002656).,OADS,/arxiv_data1/oa_pdf/4a/79/bmjopen-2013-002656.PMC3668417.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-002739).,Non-OADS,/arxiv_data1/oa_pdf/23/6a/bmjopen-2013-002739.PMC3668418.pdf
"Dendrograms classifying samples with centroid linkage methods using the Pearson correlation as a distance metric were obtained on the basis of the expression profile of quantitative RT–PCR with dchip 2010.01 (Li and Wong, 2001; http://biosun1.harvard.edu/ complab/dchip/).",OADS,/arxiv_data1/oa_pdf/0c/e2/bjc2013132a.PMC3668460.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Colospheres as a relevant preclinical model BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2013.132 1731,Non-OADS,/arxiv_data1/oa_pdf/0c/e2/bjc2013132a.PMC3668460.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Epigenetic regulation of VANGL2 in colon cancer 1756 www.bjcancer.com | DOI:10.1038/bjc.2013.142,Non-OADS,/arxiv_data1/oa_pdf/c4/53/bjc2013142a.PMC3668461.pdf
"Currently, 2042 human mature miRNAs are registered at miRBase release 19.0 (http://microrna.sanger.ac.uk/).",Non-OADS,/arxiv_data1/oa_pdf/02/3e/bjc2013122a.PMC3668462.pdf
"Complexes were visualised with an Immun-Star WesternC Chemiluminescence Kit (Bio-Rad), and the expression levels of these genes were evaluated by ImageJ software (ver.1.44; http://rsbweb.nih.gov/ij/).",OADS,/arxiv_data1/oa_pdf/02/3e/bjc2013122a.PMC3668462.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Tumour-suppressive miR-874 targets HDAC1 in HNSCC 1658 www.bjcancer.com | DOI:10.1038/bjc.2013.122,Non-OADS,/arxiv_data1/oa_pdf/02/3e/bjc2013122a.PMC3668462.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER miR-205 in prostate cancer 1676 www.bjcancer.com | DOI:10.1038/bjc.2013.131,Non-OADS,/arxiv_data1/oa_pdf/4f/0e/bjc2013131a.PMC3668465.pdf
"A National Cancer Institute of Canada funded phase II study (NCT01396408) investigating the efficacy of sunitinib in patients with advanced rare tumours, including recurrent OCCC, is currently ongoing (http://clinicaltrials.gov/ct2/show /NCT01396408).",Non-OADS,/arxiv_data1/oa_pdf/b8/dd/bjc2013126a.PMC3668466.pdf
http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-06- 14_QuickReference_8.5 /C211.pdf (accessed August 2011).,OADS,/arxiv_data1/oa_pdf/f7/f4/bjc2013151a.PMC3668467.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER KRAS- mutation and colorectal cancer survival 1764 www.bjcancer.com | DOI:10.1038/bjc.2013.118,Non-OADS,/arxiv_data1/oa_pdf/af/52/bjc2013118a.PMC3668469.pdf
These findings opened the path to the ongoing clinical studies combining TLR9 agonists with EGFR inhibitors in cancer patients (http://clinicaltrials.gov/ct2/show/ NCT01040832).,Non-OADS,/arxiv_data1/oa_pdf/3d/5a/bjc2013153a.PMC3668470.pdf
"According to Sanger Institute catalogue of somatic mutations in cancer (*COSMIC database, Catalogue of Somatic Mutations In Cancer, http://www.sanger.ac.uk/) and to previous studies (Ashida et al, 2002; Shinojima et al, 2007), ACHN cells are wild type, whereas the other cell lines are mutant for the VHL gene.",OADS,/arxiv_data1/oa_pdf/3d/5a/bjc2013153a.PMC3668470.pdf
"DISCUSSION Based on the efficacy of treatment with antiangiogenic agents inpatients with RCC, several clinical studies are now evaluating the antitumour activity of different combinations of these agents(http://clinicaltrials.gov/ct2/show/NCT01122615; http://clinicaltrials.",Non-OADS,/arxiv_data1/oa_pdf/3d/5a/bjc2013153a.PMC3668470.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)TLR9 agonist and everolimus in renal cancer BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2013.153 1623,Non-OADS,/arxiv_data1/oa_pdf/3d/5a/bjc2013153a.PMC3668470.pdf
"Cancer in the UK Retrieved 01 June 2010, from http://info.cancerresearchuk.org/prod_consump/groups/cr_common/@nre/@sta/documents/generalcontent/018070.pdf.",Non-OADS,/arxiv_data1/oa_pdf/92/47/bjc2013139a.PMC3668471.pdf
"Cancer incidence by age- UK statistics Retrieved 22 July, 2011, from http://info.cancerresearchuk.org/cancerstats/incidence/age/#Adults.",Non-OADS,/arxiv_data1/oa_pdf/92/47/bjc2013139a.PMC3668471.pdf
"National Cancer Action Team (2011) Improving Patient Information Retrieved 23 August, 2011, from http://www.ncat.nhs.uk/our-work/improvement/improving-patient-information.",Non-OADS,/arxiv_data1/oa_pdf/92/47/bjc2013139a.PMC3668471.pdf
"One recent study has shown that vemurafenib is promising not only in patients with metastatic melanoma but also in patients with non- small-cell lung cancer carrying a BRAF mutation (Gautschi et al, 2012), and selumetinib and BYL-719, which target KRAS and PIK3CA mutations, are currently being evaluated in several clinical trials (http://ctmagnifier.org/).",Non-OADS,/arxiv_data1/oa_pdf/d1/ef/bjc2013130a.PMC3668472.pdf
"Hybridisations were performed on slides of four arrays, each containing 180 880 in situ synthesised 60-mer oligonucleotides (4 /C2180 K, Agilent Technologies, Palo Alto, CA, USA) representing 169 793 unique chromosomal locations evenly distributed across the genome (spaceB17 kb), and 4548 additional unique oligonucleotides, located at 238 of the Cancer Census genes (http://www.sanger.",OADS,/arxiv_data1/oa_pdf/4d/f1/bjc2013141a.PMC3668473.pdf
"The aCGH data have been deposited in NCBI’s Gene Expression Omnibus (Edgar et al, 2002) and are accessible through GEO accession number GSE41253 (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc= GSE41253).",OADS,/arxiv_data1/oa_pdf/4d/f1/bjc2013141a.PMC3668473.pdf
"Data normalisation, segmen- tation and calling were performed in R (v.2.8.2 and 2.13;http://www.r-project.org), using median normalisation and Wave Smoothing and CGH-call packages (van de Wiel and Zhang, 2007).",OADS,/arxiv_data1/oa_pdf/4d/f1/bjc2013141a.PMC3668473.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Extensive genomic loss in BRCA1/2 ovarian tumours 1742 www.bjcancer.com | DOI:10.1038/bjc.2013.141,Non-OADS,/arxiv_data1/oa_pdf/4d/f1/bjc2013141a.PMC3668473.pdf
"All analyses were carried out with the SAS software (SAS Institute, Cary, NC, USA) and the R (http://cran.r-project.org/) software with the Harrell’s Design and Hmisc libraries.",OADS,/arxiv_data1/oa_pdf/7d/de/bjc2013147a.PMC3668474.pdf
http://clinicaltrials.gov/ct2/show/ NCT00053898?term=B-35&rank=1.,Non-OADS,/arxiv_data1/oa_pdf/7d/de/bjc2013147a.PMC3668474.pdf
"Real-time PCRreactions were performed using the SYBR Green PCR Master Mix (Applied Biosystems, Foster City, CA, USA) and sequence-specific primer sets designed from PrimerBank (http://pga.mgh.harvard.",OADS,/arxiv_data1/oa_pdf/49/f8/bjc2013115a.PMC3668475.pdf
"These data allowed the activation of a phase I clinical trial that is still open using the 20D7 antibody (recently called flanvotumab, IMC-20D7S; http://clinicaltrials.gov/ ct2/show/NCT01137006).",Non-OADS,/arxiv_data1/oa_pdf/49/f8/bjc2013115a.PMC3668475.pdf
"MicroRNAs are well-known examples of non-coding RNAs (Ying et al, 2008) and identified human miRs currently number1424 according to miRBase (http://www.mirbase.org/).",Non-OADS,/arxiv_data1/oa_pdf/51/56/bjc2013125a.PMC3668476.pdf
We used the Human Protein Atlas (http://www.proteinatlas.org/) as a reference for immunohistochemistry assessment.,OADS,/arxiv_data1/oa_pdf/51/56/bjc2013125a.PMC3668476.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Oncogenic microRNA-183 in prostate cancer BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2013.125 1667,Non-OADS,/arxiv_data1/oa_pdf/51/56/bjc2013125a.PMC3668476.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER CYFRA 21-1 in advanced pancreatic cancer 1694 www.bjcancer.com | DOI:10.1038/bjc.2013.158,Non-OADS,/arxiv_data1/oa_pdf/9b/45/bjc2013158a.PMC3668481.pdf
"National Institute for Health and Clinical Excellence: London, Retrievedfrom http://www.nice.org.ukon 21 June 2012.Oostenbrink JB, Koopmanschap MA, Rutten FFH (2000) Handleiding voor kostenonderzoek, methoden en richtlijnen voor economische evaluaties in degezondheidszorg .",Non-OADS,/arxiv_data1/oa_pdf/aa/04/bjc2013149a.PMC3668482.pdf
The HS-181 line is included in the EU hESC registry (http://www.hescreg.eu/) and cultured as described by Hovatta et al.,Non-OADS,/arxiv_data1/oa_pdf/3a/e7/cddis201388a.PMC3668624.pdf
"The data presented in this publication havebeen deposited in NCBI’s GEO 37and are accessible through GEO Series accession number GSE29072 (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE29072).In addition, data were subjected to Gene Ontology analysis and IPA software todetermine the possible biological functions and pathways.",OADS,/arxiv_data1/oa_pdf/3a/e7/cddis201388a.PMC3668624.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Mesodermal differentiation by zebularine A Horrillo et al 14 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/3a/e7/cddis201388a.PMC3668624.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Menin mediates histone H3 K9 methylation Y-J Yang et al 10 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/02/ef/cddis201398a.PMC3668625.pdf
"To view a copy of this license,visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Proapoptotic role of PTPL1 and PKC d C Castilla et al 10 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/eb/4d/cddis201390a.PMC3668626.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Iron alters ovarian cell survival via Ras/MAPK KA Bauckman et al 19 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/0c/e5/cddis201387a.PMC3668627.pdf
Primers were designed using Primer3 software (http://frodo.wi.mit.edu) and veriﬁed by BLAST (http://blas-t.ncbi.nlm.nih.gov/Blast.cgi).,OADS,/arxiv_data1/oa_pdf/31/a7/cddis2013136a.PMC3668628.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Bmf in seizure-induced cell death C Moran et al 11 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/31/a7/cddis2013136a.PMC3668628.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Grafting of stem cells causes gliosis Y Sato et al 9 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/b6/6d/cddis201392a.PMC3668629.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)GSK-3 binhibition and autophagy activation in tumor cells E Gavila ´net al 11 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/f2/8a/cddis201395a.PMC3668630.pdf
"Finally, the functional properties of the identiﬁed proteins were analyzed by the Swiss-Prot (http://www.expasy.org/sprot) andHuman Protein Reference Databases (http://www.hprd.org).",OADS,/arxiv_data1/oa_pdf/1d/55/cddis201393a.PMC3668631.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Plasticity of AF-MSCs D Zagoura et al 12 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/1d/55/cddis201393a.PMC3668631.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/3.0/12/15-LO inhibition induces PPAR b/dto treat EAE JX u et al 12 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/51/e9/cddis201386a.PMC3668632.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Ack1 in neurotrophin signaling A La Torre et al 14 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/a1/ab/cddis201399a.PMC3668633.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Trolox protects from cigarette smoke injury EM Messier et al 11 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/72/5e/cddis201396a.PMC3668634.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)miR-199a-5p suppresses sustained hepatic ER stress B-H Dai et al 11 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/7f/46/cddis2013134a.PMC3668635.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Hox-C9 and spontaneous regression in neuroblastoma H Kocak et al 11 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/24/a2/cddis201384a.PMC3668636.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Phospholipid scrambling and Cl/C0currents by Ano6 A Kmit et al 8 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/8a/0b/cddis2013135a.PMC3668637.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on Heredity website (http://www.nature.com/hdy)Linkage vs pleiotropy in LD analysis ID a v i d et al 238 Heredity",Non-OADS,/arxiv_data1/oa_pdf/b7/31/hdy201270a.PMC3668649.pdf
Rattner; Email: barbara@landesbioscience.com Submitted: 02/25/13; Accepted: 02/25/13http://dx.doi.org/10.4161/epi.24122DNA binding protein MeCP2.,OADS,/arxiv_data1/oa_pdf/5d/84/epi-8-229.PMC3669114.pdf
"www.landesbioscience.com Epigenetics 231Epigenetics 8:3, 231–236; March 2013; © 2013 Landes BiosciencePoint-of-ViE w  Point-of-ViE w Point-of-ViE w Keywords:  metabolism and cancer,   epigenetics, redox regulation, reactive  oxygen species, non-essential amino acids, proline metabolism Abbreviations:  PRODH, proline dehy - drogenase; P5C, pyrroline-5-carboxylate;  P5CS, pyrroline-5-carboxylate synthase; PYCR, pyrroline-5-carboxylate reductase; NEAA, non-essential amino acids Submitted: 01/15/13Accepted: 02/18/13http://dx.doi.org/10.4161/epi.24042 *Correspondence to: James M. Phang;   Email: phangj@mail.nih.govRecent research suggests that chro - matin-modifying enzymes are meta - bolic sensors regulating gene expression.",Non-OADS,/arxiv_data1/oa_pdf/ed/a9/epi-8-231.PMC3669115.pdf
Science 2009;  324:1029-33; PMID:19460998; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ed/a9/epi-8-231.PMC3669115.pdf
Cell Metab  2011; 14:443-51; PMID:21982705; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ed/a9/epi-8-231.PMC3669115.pdf
Clin Chem 2004; 50:1511-25; PMID:15265818; http://dx.doi.org/10.1373/ clinchem.2004.032482.,OADS,/arxiv_data1/oa_pdf/ed/a9/epi-8-231.PMC3669115.pdf
J Nucl Med 2008; 49(Suppl 2):24S- 42S; PMID:18523064; http://dx.doi.org/10.2967/ jnumed.107.047258.,OADS,/arxiv_data1/oa_pdf/ed/a9/epi-8-231.PMC3669115.pdf
Front Oncol 2012;  2:60; PMID:22737668; http://dx.doi.org/10.3389/ fonc.2012.00060.,OADS,/arxiv_data1/oa_pdf/ed/a9/epi-8-231.PMC3669115.pdf
Eukaryot Cell 2006; 5:272-6; PMID:16467468; http://dx.doi.org/10.1128/EC.5.2.272-276.2006.,Non-OADS,/arxiv_data1/oa_pdf/ed/a9/epi-8-231.PMC3669115.pdf
Nature 2011; 476:346-50; PMID:21760589;  http://dx.doi.org/10.1038/nature10350.,Non-OADS,/arxiv_data1/oa_pdf/ed/a9/epi-8-231.PMC3669115.pdf
Cell Metab 2012; 15:110-21; PMID:22225880;  http://dx.doi.org/10.1016/j.cmet.2011.12.009.,OADS,/arxiv_data1/oa_pdf/ed/a9/epi-8-231.PMC3669115.pdf
Amino Acids 2008; 35:681- 90; PMID:18401543; http://dx.doi.org/10.1007/ s00726-008-0063-4.,Non-OADS,/arxiv_data1/oa_pdf/ed/a9/epi-8-231.PMC3669115.pdf
Front Biosci 2012; 17:1835-45; PMID:22201839;  http://dx.doi.org/10.2741/4022.,Non-OADS,/arxiv_data1/oa_pdf/ed/a9/epi-8-231.PMC3669115.pdf
Annu Rev Biochem 1980; 49:1005- 61; PMID:6250440; http://dx.doi.org/10.1146/ annurev.bi.49.070180.005041.,Non-OADS,/arxiv_data1/oa_pdf/ed/a9/epi-8-231.PMC3669115.pdf
Nature  1997; 389:300-5; PMID:9305847; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ed/a9/epi-8-231.PMC3669115.pdf
Proc Natl Acad Sci U S  A 1971; 68:820-3; PMID:5279523; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ed/a9/epi-8-231.PMC3669115.pdf
Trends Genet 1993; 9:138-41;  PMID:8516849; http://dx.doi.org/10.1016/0168- 9525(93)90209-Z.,OADS,/arxiv_data1/oa_pdf/ed/a9/epi-8-231.PMC3669115.pdf
Nat Med 2004; 10:789- 99; PMID:15286780; http://dx.doi.org/10.1038/ nm1087.,OADS,/arxiv_data1/oa_pdf/ed/a9/epi-8-231.PMC3669115.pdf
N Engl J Med  2008; 358:1148-59; PMID:18337604; http://dx.doi.org/10.1056/NEJMra072067.,Non-OADS,/arxiv_data1/oa_pdf/ed/a9/epi-8-231.PMC3669115.pdf
Nat Rev Cancer 2011; 11:726-34; PMID:21941284;  http://dx.doi.org/10.1038/nrc3130.,Non-OADS,/arxiv_data1/oa_pdf/ed/a9/epi-8-231.PMC3669115.pdf
Cell 2012; 150:12- 27; PMID:22770212; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ed/a9/epi-8-231.PMC3669115.pdf
Nat Rev Genet 2005; 6:597-610; PMID:16136652;  http://dx.doi.org/10.1038/nrg1655.,OADS,/arxiv_data1/oa_pdf/ed/a9/epi-8-231.PMC3669115.pdf
Nature 2009; 459:108- 12; PMID:19295514; http://dx.doi.org/10.1038/ nature07829.,Non-OADS,/arxiv_data1/oa_pdf/ed/a9/epi-8-231.PMC3669115.pdf
Front Oncol 2012; 2:163; PMID:23162793;  http://dx.doi.org/10.3389/fonc.2012.00163.,Non-OADS,/arxiv_data1/oa_pdf/ed/a9/epi-8-231.PMC3669115.pdf
Cell Metab 2012; 16:9-17; PMID:22768835;  http://dx.doi.org/10.1016/j.cmet.2012.06.001.,OADS,/arxiv_data1/oa_pdf/ed/a9/epi-8-231.PMC3669115.pdf
Mol Cell  2011; 42:426-37; PMID:21596309; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ed/a9/epi-8-231.PMC3669115.pdf
Science 2000; 289:2126-8; PMID:11000115; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ed/a9/epi-8-231.PMC3669115.pdf
Cancer Cell 2008; 13:472- 82; PMID:18538731; http://dx.doi.org/10.1016/j.ccr.2008.05.005.,Non-OADS,/arxiv_data1/oa_pdf/ed/a9/epi-8-231.PMC3669115.pdf
Science 1956; 123:309-14; PMID:13298683; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ed/a9/epi-8-231.PMC3669115.pdf
Int  J Cell Biol 2012; 2012:161837; PMID:22888353;  http://dx.doi.org/10.1155/2012/161837.,OADS,/arxiv_data1/oa_pdf/ed/a9/epi-8-231.PMC3669115.pdf
Nat Rev Cancer 2009; 9:691-700; PMID:19759539;  http://dx.doi.org/10.1038/nrc2715.,Non-OADS,/arxiv_data1/oa_pdf/ed/a9/epi-8-231.PMC3669115.pdf
Cell Cycle 2009; 8:3243- 5; PMID:19806017; http://dx.doi.org/10.4161/ cc.8.20.9522.in MEFs showed the life span extension  with defective insulin/IGF1 (daf-2 in   C. elegans ) signaling was dependent on the  catabolism of proline.,OADS,/arxiv_data1/oa_pdf/ed/a9/epi-8-231.PMC3669115.pdf
Proc Natl Acad Sci U S A 1971; 68:1516-9; PMID:5283941; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ed/a9/epi-8-231.PMC3669115.pdf
Cancer Res  2012; 72:5130-40; PMID:22850421; http://dx.doi.org/10.1158/0008-5472.CAN-12-1949.,Non-OADS,/arxiv_data1/oa_pdf/ed/a9/epi-8-231.PMC3669115.pdf
Life Sci 1981; 28:53-8; PMID:6894321; http://dx.doi.org/10.1016/0024-3205(81)90365-9.,OADS,/arxiv_data1/oa_pdf/ed/a9/epi-8-231.PMC3669115.pdf
J Cell Physiol 1982; 110:255-61; PMID:6896335; http://dx.doi.org/10.1002/ jcp.1041100306.,Non-OADS,/arxiv_data1/oa_pdf/ed/a9/epi-8-231.PMC3669115.pdf
Antioxid Redox Signal 2011; 15:551- 89; PMID:20919933; http://dx.doi.org/10.1089/ ars.2010.3492.,Non-OADS,/arxiv_data1/oa_pdf/ed/a9/epi-8-231.PMC3669115.pdf
"Gastroenterology 2008; 135:2128-40, 2140, e1-8; PMID:18801366;  http://dx.doi.org/10.1053/j.gastro.2008.07.027.",Non-OADS,/arxiv_data1/oa_pdf/ed/a9/epi-8-231.PMC3669115.pdf
Am J Physiol Cell Physiol 2010; 298:C982-92; PMID:20164384; http://dx.doi.org/10.1152/ajp - cell.00498.2009.,OADS,/arxiv_data1/oa_pdf/ed/a9/epi-8-231.PMC3669115.pdf
Cell Metab 2012; 15:451-65; PMID:22482728; http://dx.doi.org/10.1016/j.cmet.2012.02.013.,OADS,/arxiv_data1/oa_pdf/ed/a9/epi-8-231.PMC3669115.pdf
Cell Metab 2012; 15:417- 8; PMID:22482723; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ed/a9/epi-8-231.PMC3669115.pdf
Respir Physiol Neurobiol 2010; 174:175-81; PMID:20708106; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ed/a9/epi-8-231.PMC3669115.pdf
Amino Acids  2008; 35:673-9; PMID:18528746; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ed/a9/epi-8-231.PMC3669115.pdf
J Biol Chem 2008; 283:10485-92; PMID:18287100;  http://dx.doi.org/10.1074/jbc.M702181200.,OADS,/arxiv_data1/oa_pdf/ed/a9/epi-8-231.PMC3669115.pdf
Immunity 2011; 35:871- 82; PMID:22195744; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ed/a9/epi-8-231.PMC3669115.pdf
Nat Genet  2009; 41:1016-21; PMID:19648921; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ed/a9/epi-8-231.PMC3669115.pdf
J Mol Biol 2006; 359:1364- 77; PMID:16730026; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ed/a9/epi-8-231.PMC3669115.pdf
PLoS One 2012; 7:e45190; PMID:23024808; http://dx.doi.org/10.1371/journal.pone.0045190.,Non-OADS,/arxiv_data1/oa_pdf/ed/a9/epi-8-231.PMC3669115.pdf
Hum Mol Genet 2000; 9:2853-8; PMID:11092761;  http://dx.doi.org/10.1093/hmg/9.19.2853.,OADS,/arxiv_data1/oa_pdf/ed/a9/epi-8-231.PMC3669115.pdf
Oncogene 2009; 28:4326-43; PMID:19826415; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ed/a9/epi-8-231.PMC3669115.pdf
J Biol Chem  2003; 278:9784-9; PMID:12514185; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ed/a9/epi-8-231.PMC3669115.pdf
J Biol Chem 2006; 281:2044-52;  PMID:16303758; http://dx.doi.org/10.1074/jbc.M507867200.,OADS,/arxiv_data1/oa_pdf/ed/a9/epi-8-231.PMC3669115.pdf
Oncogene 2006; 25:5640-7; PMID:16619034;  http://dx.doi.org/10.1038/sj.onc.1209564.,OADS,/arxiv_data1/oa_pdf/ed/a9/epi-8-231.PMC3669115.pdf
Carcinogenesis 2005; 26:1335-42; PMID:15817612;  http://dx.doi.org/10.1093/carcin/bgi083.,Non-OADS,/arxiv_data1/oa_pdf/ed/a9/epi-8-231.PMC3669115.pdf
Cancer Res 2009; 69:6414-22; PMID:19654292; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ed/a9/epi-8-231.PMC3669115.pdf
Mol Cell Biochem 2007; 295:85-92;  PMID:16874462; http://dx.doi.org/10.1007/s11010- 006-9276-6.,Non-OADS,/arxiv_data1/oa_pdf/ed/a9/epi-8-231.PMC3669115.pdf
Cancer Res 2012; 72:3677-86; PMID:22609800; http://dx.doi.org/10.1158/0008-5472.CAN-12- 0080.,Non-OADS,/arxiv_data1/oa_pdf/ed/a9/epi-8-231.PMC3669115.pdf
J Cell Biochem 2009; 107:759- 68; PMID:19415679; http://dx.doi.org/10.1002/ jcb.22174.,Non-OADS,/arxiv_data1/oa_pdf/ed/a9/epi-8-231.PMC3669115.pdf
Oncogene 2010; 29:4914-24; PMID:20562915;  http://dx.doi.org/10.1038/onc.2010.237.,OADS,/arxiv_data1/oa_pdf/ed/a9/epi-8-231.PMC3669115.pdf
Proc Natl Acad Sci U S A 2012; 109:8983-8; PMID:22615405; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ed/a9/epi-8-231.PMC3669115.pdf
Arch Biochem Biophys  2010; 498:136-42; PMID:20450881; http://dx.doi.org/10.1016/j.abb.2010.04.020.,OADS,/arxiv_data1/oa_pdf/ed/a9/epi-8-231.PMC3669115.pdf
ERs exist as two isoforms   (ERα and ER β) that belong to the family of transcriptional  *Correspondence to: Eric Hervouet; Email: eric.hervouet@univ-fcomte.fr Submitted: 11/15/12; Revised: 01/15/13; Accepted: 01/25/13http://dx.doi.org/10.4161/epi.23790Estrogen signaling is mediated by E rα and Er β in hormone  dependent breast cancer (BC).,Non-OADS,/arxiv_data1/oa_pdf/0e/3e/epi-8-237.PMC3669116.pdf
Histopathology 2010; 57:171-92; PMID:20500230;  http://dx.doi.org/10.1111/j.1365-2559.2010.03568.x.,Non-OADS,/arxiv_data1/oa_pdf/0e/3e/epi-8-237.PMC3669116.pdf
Endocrinology  1997; 138:863-70; PMID:9048584; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0e/3e/epi-8-237.PMC3669116.pdf
Ann N Y Acad Sci  2005; 1041:233-47; PMID:15956714; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0e/3e/epi-8-237.PMC3669116.pdf
Breast Cancer Res 2008; 10:R29; PMID:18377656;  http://dx.doi.org/10.1186/bcr1987.,Non-OADS,/arxiv_data1/oa_pdf/0e/3e/epi-8-237.PMC3669116.pdf
Lancet Oncol 2011; 12:477-88;  PMID:21514219; http://dx.doi.org/10.1016/S1470-2045(11)70076-6.,Non-OADS,/arxiv_data1/oa_pdf/0e/3e/epi-8-237.PMC3669116.pdf
Structure  2008; 16:341-50; PMID:18334209; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0e/3e/epi-8-237.PMC3669116.pdf
BMC Biotechnol  2011; 11:31; PMID:21470401; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0e/3e/epi-8-237.PMC3669116.pdf
Cancer 1999; 85:112- 8; PMID:9921982; http://dx.doi.org/10.1002/ (SICI)1097-0142(19990101)85:1<112::AID- CNCR16>3.0.CO;2-T. 9.,Non-OADS,/arxiv_data1/oa_pdf/0e/3e/epi-8-237.PMC3669116.pdf
J Pathol 2007; 211:269- 77; PMID:17139617; http://dx.doi.org/10.1002/ path.2106.,Non-OADS,/arxiv_data1/oa_pdf/0e/3e/epi-8-237.PMC3669116.pdf
PLoS One 2010; 5:e11333; PMID:20613874; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/0e/3e/epi-8-237.PMC3669116.pdf
Science 2003; 300:489- 92; PMID:12702876; http://dx.doi.org/10.1126/sci- ence.1083558.,OADS,/arxiv_data1/oa_pdf/0e/3e/epi-8-237.PMC3669116.pdf
Int J Biochem Cell  Biol 2009; 41:87-95; PMID:18834952; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0e/3e/epi-8-237.PMC3669116.pdf
Biosci Rep 2010; 30:217- 22; PMID:19555348; http://dx.doi.org/10.1042/ BSR20090044.,Non-OADS,/arxiv_data1/oa_pdf/0e/3e/epi-8-237.PMC3669116.pdf
T umour Biol 2012; 33:413-20; PMID:21922275; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0e/3e/epi-8-237.PMC3669116.pdf
BMC  Cancer 2010; 10:23; PMID:20109227; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0e/3e/epi-8-237.PMC3669116.pdf
Cancer Biol Ther 2004; 3:1304-12; PMID:15662126; http://dx.doi.org/10.4161/ cbt.3.12.1458.,Non-OADS,/arxiv_data1/oa_pdf/0e/3e/epi-8-237.PMC3669116.pdf
T umour Biol  2012; 33:315-23; PMID:22362381; http://dx.doi.org/10.1007/s13277-012-0343-1.,Non-OADS,/arxiv_data1/oa_pdf/0e/3e/epi-8-237.PMC3669116.pdf
Genes Dev 2011; 25:1132-46; PMID:21632823;  http://dx.doi.org/10.1101/gad.619211.,Non-OADS,/arxiv_data1/oa_pdf/0e/3e/epi-8-237.PMC3669116.pdf
FEBS J  2009; 276:7400-11; PMID:19922474; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0e/3e/epi-8-237.PMC3669116.pdf
Mol  Endocrinol 2011; 25:2003-16; PMID:22052999;  http://dx.doi.org/10.1210/me.2011-1024.,Non-OADS,/arxiv_data1/oa_pdf/0e/3e/epi-8-237.PMC3669116.pdf
Endocrinology 2003; 144:4562-74;  PMID:12959972; http://dx.doi.org/10.1210/en.2003- 0567.,Non-OADS,/arxiv_data1/oa_pdf/0e/3e/epi-8-237.PMC3669116.pdf
Genome Biol 2004; 5:R66; PMID:15345050;  http://dx.doi.org/10.1186/gb-2004-5-9-r66.,OADS,/arxiv_data1/oa_pdf/0e/3e/epi-8-237.PMC3669116.pdf
Horm Cancer  2010; 1:146-55; PMID:21761357; http://dx.doi.org/10.1007/s12672-010-0015-9.,Non-OADS,/arxiv_data1/oa_pdf/0e/3e/epi-8-237.PMC3669116.pdf
Breast Cancer Res T reat 2008; 107:235-42;  PMID:17453341; http://dx.doi.org/10.1007/s10549- 007-9542-7.,Non-OADS,/arxiv_data1/oa_pdf/0e/3e/epi-8-237.PMC3669116.pdf
Mol Endocrinol  2010; 24:993-1006; PMID:20351197; http://dx.doi.org/10.1210/me.2009-0438.,Non-OADS,/arxiv_data1/oa_pdf/0e/3e/epi-8-237.PMC3669116.pdf
Mol Cell 2008; 31:212- 21; PMID:18657504; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/0e/3e/epi-8-237.PMC3669116.pdf
Cancer Res 2004; 64:8184-92; PMID:15548683;  http://dx.doi.org/10.1158/0008-5472.CAN-04-2045.,Non-OADS,/arxiv_data1/oa_pdf/0e/3e/epi-8-237.PMC3669116.pdf
Mol Biol  Rep 2009; 36:2201-7; PMID:19107573; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0e/3e/epi-8-237.PMC3669116.pdf
Mol Endocrinol 1998; 12:1605-18; PMID:9773983;  http://dx.doi.org/10.1210/me.12.10.1605.,Non-OADS,/arxiv_data1/oa_pdf/0e/3e/epi-8-237.PMC3669116.pdf
EMBO J 2011; 30:4764-76; PMID:22002538;  http://dx.doi.org/10.1038/emboj.2011.368.,OADS,/arxiv_data1/oa_pdf/0e/3e/epi-8-237.PMC3669116.pdf
Cancer  Res 2006; 66:4929-35; PMID:16651450; http://dx.doi.org/10.1158/0008-5472.CAN-05-4461.,Non-OADS,/arxiv_data1/oa_pdf/0e/3e/epi-8-237.PMC3669116.pdf
Proc Natl Acad Sci U S A  2011; 108:7541-6; PMID:21502505; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0e/3e/epi-8-237.PMC3669116.pdf
J Biol Chem  2009; 284:19867-77; PMID:19509295; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0e/3e/epi-8-237.PMC3669116.pdf
J Biol Chem  2011; 286:13925-36; PMID:21378170; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0e/3e/epi-8-237.PMC3669116.pdf
Cell  2007; 128:505-18; PMID:17289570; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0e/3e/epi-8-237.PMC3669116.pdf
Cancer Res 2011; 71:7238-49; PMID:21975933; http://dx.doi.org/10.1158/0008-5472.CAN-11-0896.,Non-OADS,/arxiv_data1/oa_pdf/0e/3e/epi-8-237.PMC3669116.pdf
EMBO Rep 2010; 11:438-44;  PMID:20448663; http://dx.doi.org/10.1038/ embor.2010.62.,OADS,/arxiv_data1/oa_pdf/0e/3e/epi-8-237.PMC3669116.pdf
PLoS Genet 2011; 7:e1002368; PMID:22125492; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0e/3e/epi-8-237.PMC3669116.pdf
Cancer Res  2011; 71:2118-28; PMID:21282336; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0e/3e/epi-8-237.PMC3669116.pdf
Proc Natl Acad Sci U S A 2005; 102:3611-6; PMID:15731352; http://dx.doi.org/10.1073/ pnas.0407159102.,OADS,/arxiv_data1/oa_pdf/0e/3e/epi-8-237.PMC3669116.pdf
Genes Dev 2010; 24:708-19; PMID:20360387;  http://dx.doi.org/10.1101/gad.568410.19.,OADS,/arxiv_data1/oa_pdf/0e/3e/epi-8-237.PMC3669116.pdf
Int J Cancer 2003; 107:353- 8; PMID:14506733; http://dx.doi.org/10.1002/ijc.11403.,Non-OADS,/arxiv_data1/oa_pdf/0e/3e/epi-8-237.PMC3669116.pdf
Oncogene  2003; 22:3511-7; PMID:12789259; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0e/3e/epi-8-237.PMC3669116.pdf
Cancer Res  2007; 67:7731-7; PMID:17699777; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0e/3e/epi-8-237.PMC3669116.pdf
Endocrinology 2010; 151:731-40; PMID:19966177;  http://dx.doi.org/10.1210/en.2009-0955.,Non-OADS,/arxiv_data1/oa_pdf/0e/3e/epi-8-237.PMC3669116.pdf
Clin Cancer Res 2009; 15:3672-9; PMID:19458056; http://dx.doi.org/10.1158/1078- 0432.CCR-08-2343.,Non-OADS,/arxiv_data1/oa_pdf/0e/3e/epi-8-237.PMC3669116.pdf
Mol Cell Biol  2009; 29:4949-58; PMID:19620290; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0e/3e/epi-8-237.PMC3669116.pdf
Med Oncol  2012; 29:1569-75; PMID:22105146; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0e/3e/epi-8-237.PMC3669116.pdf
Am J Pathol  2004; 164:2003-12; PMID:15161636; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0e/3e/epi-8-237.PMC3669116.pdf
Cancer Res 2011; 71:1893-903;  PMID:21245100; http://dx.doi.org/10.1158/0008- 5472.CAN-10-2458.,Non-OADS,/arxiv_data1/oa_pdf/0e/3e/epi-8-237.PMC3669116.pdf
Mol Cell Endocrinol  2010; 314:17-22; PMID:19772891; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0e/3e/epi-8-237.PMC3669116.pdf
EMBO J  2009; 28:1418-28; PMID:19339991; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0e/3e/epi-8-237.PMC3669116.pdf
Mol Cell Biol  2009; 29:4982-93; PMID:19581286; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0e/3e/epi-8-237.PMC3669116.pdf
Cell 2003; 115:751-63;  PMID:14675539; http://dx.doi.org/10.1016/S0092-8674(03)00934-6.,OADS,/arxiv_data1/oa_pdf/0e/3e/epi-8-237.PMC3669116.pdf
J Biol Chem 2003; 278:38586- 92; PMID:12874288; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/0e/3e/epi-8-237.PMC3669116.pdf
Genes Cancer  2010; 1:434-43; PMID:21779454; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0e/3e/epi-8-237.PMC3669116.pdf
Epigenetics 2009; 4:487- 99; PMID:19786833; http://dx.doi.org/10.4161/ epi.4.7.9883.,Non-OADS,/arxiv_data1/oa_pdf/0e/3e/epi-8-237.PMC3669116.pdf
Genome Res 2010; 20:733-44; PMID:20442245; http://dx.doi.org/10.1101/gr.101923.109.68.,OADS,/arxiv_data1/oa_pdf/0e/3e/epi-8-237.PMC3669116.pdf
Carcinogenesis 2011; 32:812- 21; PMID:21304052; http://dx.doi.org/10.1093/car- cin/bgr017.,Non-OADS,/arxiv_data1/oa_pdf/0e/3e/epi-8-237.PMC3669116.pdf
J Biol Chem 2009; 284:30275- 87; PMID:19744932; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/0e/3e/epi-8-237.PMC3669116.pdf
J Biol  Chem 2009; 284:30264-74; PMID:19744931; http://dx.doi.org/10.1074/jbc.M109.045526.,OADS,/arxiv_data1/oa_pdf/0e/3e/epi-8-237.PMC3669116.pdf
Mol Cell Biol 2010; 30:399-412; PMID:19917725; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0e/3e/epi-8-237.PMC3669116.pdf
Cell  2004; 118:545-53; PMID:15339660; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0e/3e/epi-8-237.PMC3669116.pdf
Oncogene 2008; 27:1971- 80; PMID:17922032; http://dx.doi.org/10.1038/ sj.onc.1210839.,OADS,/arxiv_data1/oa_pdf/0e/3e/epi-8-237.PMC3669116.pdf
Cancer Res 2005; 65:6557-67;  PMID:16061635; http://dx.doi.org/10.1158/0008- 5472.CAN-05-0486.,Non-OADS,/arxiv_data1/oa_pdf/0e/3e/epi-8-237.PMC3669116.pdf
Mol Endocrinol 2010; 24:76- 90; PMID:19887647; http://dx.doi.org/10.1210/ me.2009-0218.,Non-OADS,/arxiv_data1/oa_pdf/0e/3e/epi-8-237.PMC3669116.pdf
Cell 2005; 122:33- 43; PMID:16009131; http://dx.doi.org/10.1016/j.cell.2005.05.008.59.,OADS,/arxiv_data1/oa_pdf/0e/3e/epi-8-237.PMC3669116.pdf
Endocr  J 2009; 56:131-9; PMID:18997445; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0e/3e/epi-8-237.PMC3669116.pdf
Hum Reprod 2009; 24:1126- 32; PMID:19202141; http://dx.doi.org/10.1093/ humrep/dep015.,OADS,/arxiv_data1/oa_pdf/0e/3e/epi-8-237.PMC3669116.pdf
Clin Cancer Res  2009; 15:3519-29; PMID:19451595; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0e/3e/epi-8-237.PMC3669116.pdf
Cancer  Lett 2012; 316:62-9; PMID:22082530; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0e/3e/epi-8-237.PMC3669116.pdf
FASEB J 2010; 24:2273-80;  PMID:20181937; http://dx.doi.org/10.1096/fj.09- 140533.,Non-OADS,/arxiv_data1/oa_pdf/0e/3e/epi-8-237.PMC3669116.pdf
Cancer Res 2008; 68:1786-96; PMID:18339859; http://dx.doi.org/10.1158/0008- 5472.CAN-07-5547.,Non-OADS,/arxiv_data1/oa_pdf/0e/3e/epi-8-237.PMC3669116.pdf
Epigenetic regulation of glucose transporter 4 by estrogen receptor β. Mol Endocrinol  2011; 25:2017-28; PMID:22016564; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0e/3e/epi-8-237.PMC3669116.pdf
Cell Cycle 2007; 6:2010- 8; PMID:17700064; http://dx.doi.org/10.4161/ cc.6.16.4549.,OADS,/arxiv_data1/oa_pdf/0e/3e/epi-8-237.PMC3669116.pdf
Carcinogenesis 2010; 31:376-81; PMID:20008439; http://dx.doi.org/10.1093/carcin/bgp304.,Non-OADS,/arxiv_data1/oa_pdf/0e/3e/epi-8-237.PMC3669116.pdf
"Epigenetics 8:3, 246–251; March 2013; © 2013 Landes Bioscience REsEaR ch papER 246 Epigenetics Volume 8 Issue 3 REsEaR ch papER *Correspondence to: Tobias Lilja; Email: tobias.lilja@ki.se Submitted: 11/07/12; Revised: 01/15/13; Accepted: 01/23/13http://dx.doi.org/10.4161/epi.23752Introduction Rett syndrome (RTT) is a developmental disorder manifested  by primarily neurological symptoms, such as motor disabili - ties, mental retardation, communication problems, epilepsy and breathing disturbances.",Non-OADS,/arxiv_data1/oa_pdf/e1/44/epi-8-246.PMC3669117.pdf
Brain  Dev 2005; 27:331-9; PMID:16023547; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e1/44/epi-8-246.PMC3669117.pdf
Science  2008; 320:1224-9; PMID:18511691; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e1/44/epi-8-246.PMC3669117.pdf
Curr Biol 2011; 21:406- 12; PMID:21353562; http://dx.doi.org/10.1016/j.cub.2011.01.054.,OADS,/arxiv_data1/oa_pdf/e1/44/epi-8-246.PMC3669117.pdf
Ann Neurol 2010; 68:944-50; PMID:21154482; http://dx.doi.org/10.1002/ ana.22124.10.,OADS,/arxiv_data1/oa_pdf/e1/44/epi-8-246.PMC3669117.pdf
Science 2003; 302:885-9; PMID:14593183;  http://dx.doi.org/10.1126/science.1086446.,OADS,/arxiv_data1/oa_pdf/e1/44/epi-8-246.PMC3669117.pdf
Neuron  2006; 49:341-8; PMID:16446138; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e1/44/epi-8-246.PMC3669117.pdf
Curr Opin Genet Dev 2007; 17:121-5;  PMID:17317146; http://dx.doi.org/10.1016/j.gde.2007.02.003.,OADS,/arxiv_data1/oa_pdf/e1/44/epi-8-246.PMC3669117.pdf
Mol Cell Biol  2010; 30:4656-70; PMID:20679481; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e1/44/epi-8-246.PMC3669117.pdf
Epigenetics  2007; 2:214-22; PMID:18075316; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e1/44/epi-8-246.PMC3669117.pdf
Hum Genet  2002; 110:545-52; PMID:12107440; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e1/44/epi-8-246.PMC3669117.pdf
Nat Genet 1999; 23:185-8;  PMID:10508514; http://dx.doi.org/10.1038/13810.,OADS,/arxiv_data1/oa_pdf/e1/44/epi-8-246.PMC3669117.pdf
J Child Neurol 2008; 23:543-9; PMID:18056689;  http://dx.doi.org/10.1177/0883073807309786.,Non-OADS,/arxiv_data1/oa_pdf/e1/44/epi-8-246.PMC3669117.pdf
Mol Cell 2010; 37:457-68; PMID:20188665;  http://dx.doi.org/10.1016/j.molcel.2010.01.030.,OADS,/arxiv_data1/oa_pdf/e1/44/epi-8-246.PMC3669117.pdf
Nat Neurosci  2009; 12:311-7; PMID:19234456; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e1/44/epi-8-246.PMC3669117.pdf
Nature 2011; 475:497- 500; PMID:21716289; http://dx.doi.org/10.1038/ nature10214.,Non-OADS,/arxiv_data1/oa_pdf/e1/44/epi-8-246.PMC3669117.pdf
J Neurosci 2010; 30:5346-56;  PMID:20392956; http://dx.doi.org/10.1523/ JNEUROSCI.5966-09.2010.,Non-OADS,/arxiv_data1/oa_pdf/e1/44/epi-8-246.PMC3669117.pdf
J Neurosci 2009; 29:5051-61; PMID:19386901; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e1/44/epi-8-246.PMC3669117.pdf
Nature  2012; 484:105-9; PMID:22425995; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e1/44/epi-8-246.PMC3669117.pdf
Epigenetics 2010; 5:61-7; PMID:20093853;  http://dx.doi.org/10.4161/epi.5.1.10630.,Non-OADS,/arxiv_data1/oa_pdf/e1/44/epi-8-246.PMC3669117.pdf
"Epigenetics 8:3, 290–302; March 2013; © 2013 Landes Bioscience REsEaR ch papER 290 Epigenetics Volume 8 Issue 3*Correspondence to: Zachary A. Kaminsky; Email: zkamins1@jhmi.edu Submitted: 01/07/13; Revised: 02/05/13; Accepted: 02/07/13http://dx.doi.org/10.4161/epi.23924Introduction Until recently, the combination of genetic risk factors in conjunc - tion with environmental influence was believed to cause complex  non-Mendelian diseases.",Non-OADS,/arxiv_data1/oa_pdf/56/96/epi-8-290.PMC3669121.pdf
"Using the top cell epigenotype specific ( cETs) marks,  we generated a publically available R package, “ cETs,” located at http://psychiatry.igm.jhmi.edu/kaminsky/software.htm  that is capable of quantifying neuronal proportions and generating in silico neuronal profiles capable of removing cell  type heterogeneity bias from DN a methylation data.",OADS,/arxiv_data1/oa_pdf/56/96/epi-8-290.PMC3669121.pdf
We have generated a publically available R package called  “CETS” capable of performing the above analyses in DNA meth - ylation data sets (http://psychiatry.igm.jhmi.edu/kaminsky/soft - ware.htm).,OADS,/arxiv_data1/oa_pdf/56/96/epi-8-290.PMC3669121.pdf
Brain Res  Bull 2010; 83:103-7; PMID:19729053; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/56/96/epi-8-290.PMC3669121.pdf
Am J Hum Genet 2008; 82:696-711;  PMID:18319075; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/56/96/epi-8-290.PMC3669121.pdf
PLoS One 2007; 2:e895;  PMID:17878930; http://dx.doi.org/10.1371/journal.pone.0000895.,Non-OADS,/arxiv_data1/oa_pdf/56/96/epi-8-290.PMC3669121.pdf
PLoS One 2012; 7:e34451;  PMID:22511943; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/56/96/epi-8-290.PMC3669121.pdf
Placenta 2008;  29(Suppl A):S29-35; PMID:18031808; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/56/96/epi-8-290.PMC3669121.pdf
FEBS J  2008; 275:1617-23; PMID:18331347; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/56/96/epi-8-290.PMC3669121.pdf
Biochem Biophys Res Commun 2008; 366:360- 6; PMID:18062916; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/56/96/epi-8-290.PMC3669121.pdf
Genes Cells 2007; 12:1305-14; PMID:18076568;  http://dx.doi.org/10.1111/j.1365-2443.2007.01136.x.,OADS,/arxiv_data1/oa_pdf/56/96/epi-8-290.PMC3669121.pdf
Genome Res 2008; 18:780-90; PMID:18316654; http://dx.doi.org/10.1101/ gr.7301508.,OADS,/arxiv_data1/oa_pdf/56/96/epi-8-290.PMC3669121.pdf
Nat Genet  2009; 41:178-86; PMID:19151715; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/56/96/epi-8-290.PMC3669121.pdf
Nat Genet 2009; 41:1350-3;  PMID:19881528; http://dx.doi.org/10.1038/ng.471.,Non-OADS,/arxiv_data1/oa_pdf/56/96/epi-8-290.PMC3669121.pdf
Psychiatry Res 2010; 184:23- 8; PMID:20817488; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/56/96/epi-8-290.PMC3669121.pdf
Bipolar Disord  2005; 7:358-69; PMID:16026489; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/56/96/epi-8-290.PMC3669121.pdf
Schizophr Res 2004; 67:269-75; PMID:14984887;  http://dx.doi.org/10.1016/S0920-9964(03)00181-6.,OADS,/arxiv_data1/oa_pdf/56/96/epi-8-290.PMC3669121.pdf
J Comp Neurol  2009; 513:532-41; PMID:19226510; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/56/96/epi-8-290.PMC3669121.pdf
Neurosci Biobehav Rev 2010; 34:285-94;  PMID:19651155; http://dx.doi.org/10.1016/j.neubio-rev.2009.07.010.,OADS,/arxiv_data1/oa_pdf/56/96/epi-8-290.PMC3669121.pdf
Harv Rev Psychiatry  2009; 17:214-25; PMID:19499420; http://dx.doi.org/10.1080/10673220902979896.,Non-OADS,/arxiv_data1/oa_pdf/56/96/epi-8-290.PMC3669121.pdf
Genome Res  2011; 21:688-96; PMID:21467265; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/56/96/epi-8-290.PMC3669121.pdf
Nucleic  Acids Res 2007; 35(Web Server issue):W193-200;  PMID:17478515; http://dx.doi.org/10.1093/nar/ gkm226.,OADS,/arxiv_data1/oa_pdf/56/96/epi-8-290.PMC3669121.pdf
Am J Hum Genet 2012; 90:260-72; PMID:22305529;  http://dx.doi.org/10.1016/j.ajhg.2011.12.020.,OADS,/arxiv_data1/oa_pdf/56/96/epi-8-290.PMC3669121.pdf
BMC Bioinformatics 2012; 13:86; PMID:22568884; http://dx.doi.org/10.1186/1471- 2105-13-86.,OADS,/arxiv_data1/oa_pdf/56/96/epi-8-290.PMC3669121.pdf
PLoS Genet 2010; 6:e1000952;  PMID:20485568; http://dx.doi.org/10.1371/journal.,OADS,/arxiv_data1/oa_pdf/56/96/epi-8-290.PMC3669121.pdf
Genome  Biol 2010; 11:R70; PMID:20602769; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/56/96/epi-8-290.PMC3669121.pdf
Am J Med  Genet B Neuropsychiatr Genet 2011; 156B:382- 92; PMID:21438146; http://dx.doi.org/10.1002/ ajmg.b.31181.,Non-OADS,/arxiv_data1/oa_pdf/56/96/epi-8-290.PMC3669121.pdf
Cell 2003; 114:75-86; PMID:12859899; http://dx.doi.org/10.1016/S0092-8674(03)00477-X.,OADS,/arxiv_data1/oa_pdf/56/96/epi-8-290.PMC3669121.pdf
Neuron 2005; 47:567-79;  PMID:16102539; http://dx.doi.org/10.1016/j.neu- ron.2005.07.007.,OADS,/arxiv_data1/oa_pdf/56/96/epi-8-290.PMC3669121.pdf
Proc Natl Acad Sci U S A 1995; 92:1510- 4; PMID:7878010; http://dx.doi.org/10.1073/ pnas.92.5.1510.,OADS,/arxiv_data1/oa_pdf/56/96/epi-8-290.PMC3669121.pdf
Genome Res 2004; 14:1462-73; PMID:15289471; http://dx.doi.org/10.1101/gr.2538704.,OADS,/arxiv_data1/oa_pdf/56/96/epi-8-290.PMC3669121.pdf
Am J Hum Genet 2007; 81:1304-15; PMID:17999367; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/56/96/epi-8-290.PMC3669121.pdf
J Vis Exp 2008; PMID:19078943; http://dx.doi.org/10.3791/914.37.,Non-OADS,/arxiv_data1/oa_pdf/56/96/epi-8-290.PMC3669121.pdf
Genome  Biol 2012; 13:R97; PMID:23034122; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/56/96/epi-8-290.PMC3669121.pdf
J Neurosci Res 2003; 73:400- 9; PMID:12868073; http://dx.doi.org/10.1002/ jnr.10655.33.,Non-OADS,/arxiv_data1/oa_pdf/56/96/epi-8-290.PMC3669121.pdf
Cell Tissue Bank  2011; 12:311-8; PMID:20703815; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/56/96/epi-8-290.PMC3669121.pdf
Neurobiol Learn Mem 2012; 97:69- 80; PMID:21982980; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/56/96/epi-8-290.PMC3669121.pdf
"www.landesbioscience.com Epigenetics 303Epigenetics 8:3, 303–316; March 2013; © 2013 Landes Bioscience REsEaR ch papER REsEaR ch papER REsEaR ch papER *Correspondence to: Sanja A. Farkas; Email: sanja.farkas@orebroll.se Submitted: 01/10/13; Revised: 02/08/13; Accepted: 02/12/13http://dx.doi.org/10.4161/epi.23988Introduction Cellular intake of folate is crucial for nucleotide synthesis,  methylation reactions and production of glycine and ser - ine.1-3 Methylation reactions of DNA, protein and RNA by  S-adenosylmethionine (SAM) are normally followed further downstream by the re-methylation of homocysteine (Hcy) to methionine.",Non-OADS,/arxiv_data1/oa_pdf/c3/fb/epi-8-303.PMC3669122.pdf
"These expression data are  in accordance with annotations in the BioGPS database, 20 see  http://biogps.org.",OADS,/arxiv_data1/oa_pdf/c3/fb/epi-8-303.PMC3669122.pdf
"Prior to primer design, we used the online web tool CpG island searcher (http://cpgislands.usc.edu/) to locate the CpG sites and putative CpG islands (CGI).",OADS,/arxiv_data1/oa_pdf/c3/fb/epi-8-303.PMC3669122.pdf
J Inherit Metab  Dis 2011; 34:75-81; PMID:20814827; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c3/fb/epi-8-303.PMC3669122.pdf
Annu Rev Nutr 2010; 30:57-81;  PMID:20645850; http://dx.doi.org/10.1146/annurev.,OADS,/arxiv_data1/oa_pdf/c3/fb/epi-8-303.PMC3669122.pdf
Birth Defects Res A Clin Mol Teratol  2009; 85:295-302; PMID:19301298; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c3/fb/epi-8-303.PMC3669122.pdf
Dev Dyn 2003; 226:112-7; PMID:12508232;  http://dx.doi.org/10.1002/dvdy.10203.,OADS,/arxiv_data1/oa_pdf/c3/fb/epi-8-303.PMC3669122.pdf
Biosci Biotechnol Biochem 2008; 72:2277-84; PMID:18776693; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c3/fb/epi-8-303.PMC3669122.pdf
Dev Dyn  2004; 231:221-31; PMID:15305303; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c3/fb/epi-8-303.PMC3669122.pdf
Nat Genet 1999; 23:228-32;  PMID:10508523; http://dx.doi.org/10.1038/13861.,OADS,/arxiv_data1/oa_pdf/c3/fb/epi-8-303.PMC3669122.pdf
Hum Reprod 2011; 26:2232-8;  PMID:21576080; http://dx.doi.org/10.1093/humrep/der144.,OADS,/arxiv_data1/oa_pdf/c3/fb/epi-8-303.PMC3669122.pdf
European  Journal of Cancer 2011; 47:S25-S; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c3/fb/epi-8-303.PMC3669122.pdf
Epigenetics 2011; 6:828-37; PMID:21636973; http://dx.doi.org/10.4161/epi.6.7.16500.,Non-OADS,/arxiv_data1/oa_pdf/c3/fb/epi-8-303.PMC3669122.pdf
PLoS  One 2012; 7:e33213; PMID:22479372; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c3/fb/epi-8-303.PMC3669122.pdf
Nat Genet  2009; 41:178-86; PMID:19151715; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c3/fb/epi-8-303.PMC3669122.pdf
Nat Genet 2009; 41:1350-3;  PMID:19881528; http://dx.doi.org/10.1038/ng.471.,Non-OADS,/arxiv_data1/oa_pdf/c3/fb/epi-8-303.PMC3669122.pdf
Genome Biol 2009; 10:R130;  PMID:19919682; http://dx.doi.org/10.1186/gb-2009- 10-11-r130.,OADS,/arxiv_data1/oa_pdf/c3/fb/epi-8-303.PMC3669122.pdf
Nat Genet  2006; 38:1378-85; PMID:17072317; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c3/fb/epi-8-303.PMC3669122.pdf
Placenta 2010; 31:134-43; PMID:20036773;  http://dx.doi.org/10.1016/j.placenta.2009.11.017.24.,OADS,/arxiv_data1/oa_pdf/c3/fb/epi-8-303.PMC3669122.pdf
PLoS One  2011; 6:e28599; PMID:22163044; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c3/fb/epi-8-303.PMC3669122.pdf
Biochem J 2004; 383:249- 57; PMID:15214842; http://dx.doi.org/10.1042/ BJ20040414.,OADS,/arxiv_data1/oa_pdf/c3/fb/epi-8-303.PMC3669122.pdf
Biochem J 2002; 367:629- 40; PMID:12144527; http://dx.doi.org/10.1042/ BJ20020512.,Non-OADS,/arxiv_data1/oa_pdf/c3/fb/epi-8-303.PMC3669122.pdf
Biochim Biophys Acta 2005; 1731:115-24;  PMID:16225938; http://dx.doi.org/10.1016/j.bba- exp.2005.08.010.,OADS,/arxiv_data1/oa_pdf/c3/fb/epi-8-303.PMC3669122.pdf
Clin Cancer Res  2006; 12:608-16; PMID:16428507; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c3/fb/epi-8-303.PMC3669122.pdf
J Biol Chem  2004; 279:374-84; PMID:14551190; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c3/fb/epi-8-303.PMC3669122.pdf
Mol Genet Metab 2000; 70:310-5; PMID:10993718;  http://dx.doi.org/10.1006/mgme.2000.3034.,OADS,/arxiv_data1/oa_pdf/c3/fb/epi-8-303.PMC3669122.pdf
Hum Mol Genet 2009;  18(R2):R113-29; PMID:19808787; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c3/fb/epi-8-303.PMC3669122.pdf
J Nutr Biochem  2009; 20:172-6; PMID:18547797; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c3/fb/epi-8-303.PMC3669122.pdf
Methods  2001; 25:402-8; PMID:11846609; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c3/fb/epi-8-303.PMC3669122.pdf
J Biol Chem 2008; 283:20687- 95; PMID:18499665; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/c3/fb/epi-8-303.PMC3669122.pdf
Ann Hum Genet 2009; 73:484-91;  PMID:19650776; http://dx.doi.org/10.1111/j.1469- 1809.2009.00529.x.,Non-OADS,/arxiv_data1/oa_pdf/c3/fb/epi-8-303.PMC3669122.pdf
"www.landesbioscience.com Epigenetics 317Epigenetics 8:3, 317–332; March 2013; © 2013 Landes Bioscience REsEaR ch papER REsEaR ch papER REsEaR ch papER *Correspondence to: Melanie Ehrlich; Email: ehrlich@tulane.edu Submitted: 01/25/13; Revised: 02/08/13; Accepted: 02/12/13http://dx.doi.org/10.4161/epi.23989Introduction The importance of tissue-specific differences in human DNA  methylation1 is emerging with much greater clarity because of  the recent availability of human methylome profiles2 and the  recognition of 5-hydroxymethylcytosine (5-hmC) as the sixth genetically programmed base in mammalian DNA.",Non-OADS,/arxiv_data1/oa_pdf/bf/93/epi-8-317.PMC3669123.pdf
"DN a and chromatin epigenetic marks for OBSCN (chr1: 228,378,622–228,575,138; includ - ing C1orf145 ) are indicated as in the previous figures with the addition of Mt and Mb data for  histone h 3 methylation and acetylation (Broad, http://genome.ucsc.edu) shown in bar format.",OADS,/arxiv_data1/oa_pdf/bf/93/epi-8-317.PMC3669123.pdf
"www.landesbioscience.com Epigenetics 329The program closestBed80 was employed to determine the  nearest gene for each DM site using a subset of the contents  of the UCSC refFlat table (http://genome.ucsc.edu/cgi-bin/ hgTables, 5/01/12) including only one isoform per gene.",OADS,/arxiv_data1/oa_pdf/bf/93/epi-8-317.PMC3669123.pdf
"Data sets and sample information for histone modifi - cations and CTCF binding; non-strand-specific RNA-seq; and strand-specific RNA-seq [Long RNA-seq, > 200 nt poly(A) +  RNA] were from the ENCODE project (http://genomes.ucsc.edu) via the laboratories of Bradley Bernstein (Broad Institute), Barbara Wold (California Institute of Technology), and Tom Gingeras (Cold Spring Harbor), respectively.",OADS,/arxiv_data1/oa_pdf/bf/93/epi-8-317.PMC3669123.pdf
"12,76 RRBS data are avail - able from the UCSC genome browser (http://genome.ucsc.edu/cgi-bin/hgTrackUi?hgsid=292099017&c=chr1&g=wgEncodeHaibMethylRrbs).",OADS,/arxiv_data1/oa_pdf/bf/93/epi-8-317.PMC3669123.pdf
"In addition, for a few genes, DNA methyla - tion profiles from the Infinium Human Methylation 450 plat - form (http://genome.ucsc.edu/cgi-bin/hgTrackUi?hgsid=292099619&c=chr20&g=wgEncodeHaibMethyl450), which also uses bisulfite-treated DNA, were used to supplement the RRBS pro - files to qualitatively evaluate correlations between DNA methyla - tion and gene expression.",OADS,/arxiv_data1/oa_pdf/bf/93/epi-8-317.PMC3669123.pdf
"77 BED files containing  DNA methylation data for each sample from the UCSC genome browser (http://genome.ucsc.edu) were aggregated into matrices with rows included for each site detected in any sample, with one matrix for tissues and another for cell lines.",OADS,/arxiv_data1/oa_pdf/bf/93/epi-8-317.PMC3669123.pdf
"330 Epigenetics Volume 8 Issue 3Acknowledgments We thank the ENCODE Chromatin Group at the Broad Institute  for the chromatin data, and the ENCODE Transcription Group at California Institute of Technology (Barbara Wold’s group at CalTech for the RNA-seq data and Tom Gingeras’ group at Cold Spring Harbor Laboratory; http://genome.ucsc.edu) for mak - ing their data available prepublication.",Non-OADS,/arxiv_data1/oa_pdf/bf/93/epi-8-317.PMC3669123.pdf
Nucleic Acids Res  1982; 10:2709-21; PMID:7079182; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bf/93/epi-8-317.PMC3669123.pdf
Science 2009; 324:929-30;  PMID:19372393; http://dx.doi.org/10.1126/sci-ence.1169786.,OADS,/arxiv_data1/oa_pdf/bf/93/epi-8-317.PMC3669123.pdf
Nature 2011; 473:398-402; PMID:21460836;  http://dx.doi.org/10.1038/nature10008.,Non-OADS,/arxiv_data1/oa_pdf/bf/93/epi-8-317.PMC3669123.pdf
Cell  2011; 145:423-34; PMID:21496894; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bf/93/epi-8-317.PMC3669123.pdf
Epigenomics 2010; 2:657-69; PMID:21339843;  http://dx.doi.org/10.2217/epi.10.44.,OADS,/arxiv_data1/oa_pdf/bf/93/epi-8-317.PMC3669123.pdf
Hum Genet 2011; 130:187-201; PMID:21597963; http://dx.doi.org/10.1007/ s00439-011-1007-8.9.,Non-OADS,/arxiv_data1/oa_pdf/bf/93/epi-8-317.PMC3669123.pdf
Epigenetics Chromatin 2011; 4:7;  PMID:21545704; http://dx.doi.org/10.1186/1756- 8935-4-7.,Non-OADS,/arxiv_data1/oa_pdf/bf/93/epi-8-317.PMC3669123.pdf
Am J Pathol 2012; 181:2079- 93; PMID:23031258; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/bf/93/epi-8-317.PMC3669123.pdf
BMC Med Genomics 2011; 4:67;  PMID:21951698; http://dx.doi.org/10.1186/1755- 8794-4-67.,OADS,/arxiv_data1/oa_pdf/bf/93/epi-8-317.PMC3669123.pdf
PLoS One 2010; 5:e15367;  PMID:21203455; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/bf/93/epi-8-317.PMC3669123.pdf
Cancer Res 2011; 71:7360-5;  PMID:22052461; http://dx.doi.org/10.1158/0008- 5472.CAN-11-2023.16.,Non-OADS,/arxiv_data1/oa_pdf/bf/93/epi-8-317.PMC3669123.pdf
Biochemistry 2012; 51:1009- 19; PMID:22229759; http://dx.doi.org/10.1021/ bi2014739.,Non-OADS,/arxiv_data1/oa_pdf/bf/93/epi-8-317.PMC3669123.pdf
PLoS One 2009; 4:e4475;  PMID:19221588; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/bf/93/epi-8-317.PMC3669123.pdf
Biochem Biophys Res Commun 2011; 411:832- 7; PMID:21802410; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/bf/93/epi-8-317.PMC3669123.pdf
Hum Mol Genet 2012; 21:2485-96; PMID:22367967;  http://dx.doi.org/10.1093/hmg/dds063.,OADS,/arxiv_data1/oa_pdf/bf/93/epi-8-317.PMC3669123.pdf
BMC Med  Genet 2011; 12:169; PMID:22185286; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bf/93/epi-8-317.PMC3669123.pdf
Mol Cell Biol  2010; 30:1937-45; PMID:20154144; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bf/93/epi-8-317.PMC3669123.pdf
PLoS  One 2011; 6:e19481; PMID:21573063; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/bf/93/epi-8-317.PMC3669123.pdf
Physiol Rev  2009; 89:1217-67; PMID:19789381; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/bf/93/epi-8-317.PMC3669123.pdf
Cell 2011; 146:67- 79; PMID:21722948; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/bf/93/epi-8-317.PMC3669123.pdf
PLoS One  2012; 7:e43279; PMID:22916236; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bf/93/epi-8-317.PMC3669123.pdf
T ransgenic Res 2008; 17:599-608; PMID:18288583; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/bf/93/epi-8-317.PMC3669123.pdf
Nucleic Acids Res  2012; 40:4841-9; PMID:22362737; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bf/93/epi-8-317.PMC3669123.pdf
Genomics 1997; 43:267- 77; PMID:9268629; http://dx.doi.org/10.1006/ geno.1997.4829.,OADS,/arxiv_data1/oa_pdf/bf/93/epi-8-317.PMC3669123.pdf
Nat Commun 2012; 3:818;  PMID:22569366; http://dx.doi.org/10.1038/ncom-ms1826.,OADS,/arxiv_data1/oa_pdf/bf/93/epi-8-317.PMC3669123.pdf
Nucleic Acids Res  2012; 40:8255-65; PMID:22730288; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bf/93/epi-8-317.PMC3669123.pdf
Nat Struct Mol Biol 2012; 19:1037- 43; PMID:22961382; http://dx.doi.org/10.1038/ nsmb.2372.,OADS,/arxiv_data1/oa_pdf/bf/93/epi-8-317.PMC3669123.pdf
EMBO J 2011; 30:4198-210; PMID:21847099; http://dx.doi.org/10.1038/emboj.2011.295.,Non-OADS,/arxiv_data1/oa_pdf/bf/93/epi-8-317.PMC3669123.pdf
Mamm Genome 2010; 21:556-64; PMID:21107579; http://dx.doi.org/10.1007/s00335- 010-9304-4.,OADS,/arxiv_data1/oa_pdf/bf/93/epi-8-317.PMC3669123.pdf
Dev Dyn  2012; 241:1310-24; PMID:22674535; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bf/93/epi-8-317.PMC3669123.pdf
Genome Biol 2009; 10:R130;  PMID:19919682; http://dx.doi.org/10.1186/gb-2009- 10-11-r130.,OADS,/arxiv_data1/oa_pdf/bf/93/epi-8-317.PMC3669123.pdf
Genomics  2008; 91:492-502; PMID:18450418; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bf/93/epi-8-317.PMC3669123.pdf
Cell  2008; 132:311-22; PMID:18243105; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bf/93/epi-8-317.PMC3669123.pdf
Proc Natl Acad Sci U S A 2006; 103:7729-34; PMID:16684884; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bf/93/epi-8-317.PMC3669123.pdf
Cell Mol Life Sci 2009; 66:1647-60; PMID:19137260; http://dx.doi.org/10.1007/s00018- 009-8647-z.,OADS,/arxiv_data1/oa_pdf/bf/93/epi-8-317.PMC3669123.pdf
J Neurosci  2011; 31:1448-60; PMID:21273429; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/bf/93/epi-8-317.PMC3669123.pdf
Dev Cell 2009; 17:662-73; PMID:19922871; http://dx.doi.org/10.1016/j.dev- cel.2009.10.013.,OADS,/arxiv_data1/oa_pdf/bf/93/epi-8-317.PMC3669123.pdf
J Cell Biol  2001; 154:123-36; PMID:11448995; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bf/93/epi-8-317.PMC3669123.pdf
Nat Chem  Biol 2012; 8:328-30; PMID:22327402; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bf/93/epi-8-317.PMC3669123.pdf
Science  2011; 333:1303-7; PMID:21817016; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bf/93/epi-8-317.PMC3669123.pdf
Proc Natl Acad Sci U S A 2010; 107:15485- 90; PMID:20716685; http://dx.doi.org/10.1073/ pnas.1010506107.,OADS,/arxiv_data1/oa_pdf/bf/93/epi-8-317.PMC3669123.pdf
Nat Biotechnol  2010; 28:495-501; PMID:20436461; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bf/93/epi-8-317.PMC3669123.pdf
Dev Dyn 2007; 236:353-63; PMID:17117436;  http://dx.doi.org/10.1002/dvdy.21010.,OADS,/arxiv_data1/oa_pdf/bf/93/epi-8-317.PMC3669123.pdf
Development 2012; 139:1910-20; PMID:22513369; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bf/93/epi-8-317.PMC3669123.pdf
J Hum Genet 2012; 57:477-84; PMID:22718021; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bf/93/epi-8-317.PMC3669123.pdf
Cell Cycle  2011; 10:2662-8; PMID:21811096; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bf/93/epi-8-317.PMC3669123.pdf
Development 2004; 131:829-37; PMID:14736747;  http://dx.doi.org/10.1242/dev.00975.,OADS,/arxiv_data1/oa_pdf/bf/93/epi-8-317.PMC3669123.pdf
Genesis 2005; 41:202-9; PMID:15789408;  http://dx.doi.org/10.1002/gene.20116.,OADS,/arxiv_data1/oa_pdf/bf/93/epi-8-317.PMC3669123.pdf
Dev Biol 2010; 339:519-27; PMID:20045680; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bf/93/epi-8-317.PMC3669123.pdf
Nat Methods 2008;  5:621-8; PMID:18516045; http://dx.doi.org/10.1038/ nmeth.1226.,OADS,/arxiv_data1/oa_pdf/bf/93/epi-8-317.PMC3669123.pdf
Hum Genet 1994; 93:270-4; PMID:7545913;  http://dx.doi.org/10.1007/BF00212021.,Non-OADS,/arxiv_data1/oa_pdf/bf/93/epi-8-317.PMC3669123.pdf
Neurogenetics 2006; 7:67-80; PMID:16572319;  http://dx.doi.org/10.1007/s10048-006-0032-6.,Non-OADS,/arxiv_data1/oa_pdf/bf/93/epi-8-317.PMC3669123.pdf
Bioinformatics  2010; 26:841-2; PMID:20110278; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bf/93/epi-8-317.PMC3669123.pdf
Genome Res 2011; 21:1757- 67; PMID:21750106; http://dx.doi.org/10.1101/ gr.121541.111.,OADS,/arxiv_data1/oa_pdf/bf/93/epi-8-317.PMC3669123.pdf
PLoS Genet 2012; 8:e1002789;  PMID:22761590; http://dx.doi.org/10.1371/journal.pgen.1002789.,Non-OADS,/arxiv_data1/oa_pdf/bf/93/epi-8-317.PMC3669123.pdf
Nat Protoc 2012; 7:562- 78; PMID:22383036; http://dx.doi.org/10.1038/ nprot.2012.016.74.,OADS,/arxiv_data1/oa_pdf/bf/93/epi-8-317.PMC3669123.pdf
FASEB J 2011; 25:3861-72; PMID:21795504;  http://dx.doi.org/10.1096/fj.11-186122.,Non-OADS,/arxiv_data1/oa_pdf/bf/93/epi-8-317.PMC3669123.pdf
Cell Metab  2012; 15:405-11; PMID:22405075; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bf/93/epi-8-317.PMC3669123.pdf
PLoS Genet  2011; 7:e1002228; PMID:21852959; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bf/93/epi-8-317.PMC3669123.pdf
2011; http://CRAN.R-project.org/ package=bigmemory.,Non-OADS,/arxiv_data1/oa_pdf/bf/93/epi-8-317.PMC3669123.pdf
2011; http://CRAN.R-project.org/ package=lme4.67.,Non-OADS,/arxiv_data1/oa_pdf/bf/93/epi-8-317.PMC3669123.pdf
Dev Cell  2010; 19:903-12; PMID:21145505; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bf/93/epi-8-317.PMC3669123.pdf
Science 2012; 336:934-7; PMID:22539555;  http://dx.doi.org/10.1126/science.1220671.,Non-OADS,/arxiv_data1/oa_pdf/bf/93/epi-8-317.PMC3669123.pdf
Hum Mol Genet  2012; 21(R1):R90-6; PMID:22936691; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bf/93/epi-8-317.PMC3669123.pdf
BMC  Genomics 2010; 11:176; PMID:20230627; http://dx.doi.org/10.1186/1471-2164-11-176.,OADS,/arxiv_data1/oa_pdf/bf/93/epi-8-317.PMC3669123.pdf
Cardiovasc  Res 2011; 91:212-22; PMID:21498422; http://dx.doi.org/10.1093/cvr/cvr112.,Non-OADS,/arxiv_data1/oa_pdf/bf/93/epi-8-317.PMC3669123.pdf
Nucleic Acids Res 1994; 22:2234-41; PMID:8036150; http://dx.doi.org/10.1093/nar/22.12.2234.,OADS,/arxiv_data1/oa_pdf/bf/93/epi-8-317.PMC3669123.pdf
Cell Cycle 2010; 9:3965-76; PMID:20935518;  http://dx.doi.org/10.4161/cc.9.19.13193.,OADS,/arxiv_data1/oa_pdf/bf/93/epi-8-317.PMC3669123.pdf
"www.landesbioscience.com Epigenetics 333Epigenetics 8:3, 333–346; March 2013; © 2013 Landes Bioscience REsEaR ch papER REsEaR ch papER REsEaR ch papER *Correspondence to: David Gomez-Cabrero; Email: david.gomezcabrero@ki.se Submitted: 12/26/12; Revised: 02/05/13; Accepted: 02/13/13http://dx.doi.org/10.4161/epi.24008Introduction Epigenome-wide association studies represent an opportunity to  investigate disease-associated epigenetic variation in common human diseases.",Non-OADS,/arxiv_data1/oa_pdf/f4/87/epi-8-333.PMC3669124.pdf
Nat Rev Genet 2011; 12:529-41;  PMID:21747404; http://dx.doi.org/10.1038/nrg3000.,OADS,/arxiv_data1/oa_pdf/f4/87/epi-8-333.PMC3669124.pdf
Nat Biotechnol 2010; 28:1049-52; PMID:20944596;  http://dx.doi.org/10.1038/nbt1010-1049.,OADS,/arxiv_data1/oa_pdf/f4/87/epi-8-333.PMC3669124.pdf
Nature  2010; 465:721-7; PMID:20535201; http://dx.doi.org/10.1038/nature09230.4.,Non-OADS,/arxiv_data1/oa_pdf/f4/87/epi-8-333.PMC3669124.pdf
PLoS One 2011; 6:e22226;  PMID:21779396; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/f4/87/epi-8-333.PMC3669124.pdf
Nucleic Acids Res 2010; 38:391- 9; PMID:19906696; http://dx.doi.org/10.1093/nar/ gkp992.,OADS,/arxiv_data1/oa_pdf/f4/87/epi-8-333.PMC3669124.pdf
Methods Mol Biol 2012; 925:149-58;  PMID:22907495; http://dx.doi.org/10.1007/978-1- 62703-011-3_9.7.,Non-OADS,/arxiv_data1/oa_pdf/f4/87/epi-8-333.PMC3669124.pdf
Methods Mol  Biol 2009; 507:55-64; PMID:18987806; http://dx.doi.org/10.1007/978-1-59745-522-0_5.,Non-OADS,/arxiv_data1/oa_pdf/f4/87/epi-8-333.PMC3669124.pdf
Nature 2009; 462:315-22; PMID:19829295;  http://dx.doi.org/10.1038/nature08514.,Non-OADS,/arxiv_data1/oa_pdf/f4/87/epi-8-333.PMC3669124.pdf
Nat Genet 2011; 43:768-75; PMID:21706001;  http://dx.doi.org/10.1038/ng.865.,OADS,/arxiv_data1/oa_pdf/f4/87/epi-8-333.PMC3669124.pdf
Science  1990; 249:1288-90; PMID:1697983; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f4/87/epi-8-333.PMC3669124.pdf
N Engl J Med 2010; 363:2424- 33; PMID:21067377; http://dx.doi.org/10.1056/ NEJMoa1005143.,OADS,/arxiv_data1/oa_pdf/f4/87/epi-8-333.PMC3669124.pdf
Nature  2012; 483:479-83; PMID:22343889; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f4/87/epi-8-333.PMC3669124.pdf
Cell 2012; 150:12- 27; PMID:22770212; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f4/87/epi-8-333.PMC3669124.pdf
Clin Chem Lab Med 2012; 50:1707-21;  PMID:23089699; http://dx.doi.org/10.1515/cclm- 2011-0935.,Non-OADS,/arxiv_data1/oa_pdf/f4/87/epi-8-333.PMC3669124.pdf
Nat Rev Genet  2012; 13:679-92; PMID:22945394; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f4/87/epi-8-333.PMC3669124.pdf
Nat Rev Genet  2010; 11:191-203; PMID:20125086; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f4/87/epi-8-333.PMC3669124.pdf
Bioinformatics  2008; 24:1547-8; PMID:18467348; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f4/87/epi-8-333.PMC3669124.pdf
2011. http://CRAN.R-project.org/ package=randomLCA20.,Non-OADS,/arxiv_data1/oa_pdf/f4/87/epi-8-333.PMC3669124.pdf
PLoS  One 2012; 7:e41361; PMID:22848472; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f4/87/epi-8-333.PMC3669124.pdf
BMC Med Genomics 2011; 4:84; PMID:22171553;  http://dx.doi.org/10.1186/1755-8794-4-84.,Non-OADS,/arxiv_data1/oa_pdf/f4/87/epi-8-333.PMC3669124.pdf
Biometrics 1996; 52:797-810;  PMID:8805757; http://dx.doi.org/10.2307/2533043.,Non-OADS,/arxiv_data1/oa_pdf/f4/87/epi-8-333.PMC3669124.pdf
Stat Methods Med Res  1998; 7:354-70; PMID:9871952; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f4/87/epi-8-333.PMC3669124.pdf
BMC Bioinformatics 2010; 11:587;  PMID:21118553; http://dx.doi.org/10.1186/1471- 2105-11-587.,OADS,/arxiv_data1/oa_pdf/f4/87/epi-8-333.PMC3669124.pdf
Genome Res 2009; 19:1165-74; PMID:19494038; http://dx.doi.org/10.1101/ gr.091470.109.,OADS,/arxiv_data1/oa_pdf/f4/87/epi-8-333.PMC3669124.pdf
FEBS Lett 2009; 583:1713-20; PMID:19376112;  http://dx.doi.org/10.1016/j.febslet.2009.04.012.,OADS,/arxiv_data1/oa_pdf/f4/87/epi-8-333.PMC3669124.pdf
Nat Rev Genet 2012; 13:484-92; PMID:22641018; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f4/87/epi-8-333.PMC3669124.pdf
Nat Genet  2009; 41:178-86; PMID:19151715; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f4/87/epi-8-333.PMC3669124.pdf
Nat Genet 2009; 41:1350-3;  PMID:19881528; http://dx.doi.org/10.1038/ng.471.10.,OADS,/arxiv_data1/oa_pdf/f4/87/epi-8-333.PMC3669124.pdf
Genome Res 2008; 18:780-90;  PMID:18316654; http://dx.doi.org/10.1101/ gr.7301508.,OADS,/arxiv_data1/oa_pdf/f4/87/epi-8-333.PMC3669124.pdf
Nat  Biotechnol 2010; 28:1097-105; PMID:20852635;  http://dx.doi.org/10.1038/nbt.1682.,OADS,/arxiv_data1/oa_pdf/f4/87/epi-8-333.PMC3669124.pdf
Genomics 2011; 98:288- 95; PMID:21839163; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f4/87/epi-8-333.PMC3669124.pdf
Epigenomics 2009; 1:177- 200; PMID:22122642; http://dx.doi.org/10.2217/epi.09.14.,OADS,/arxiv_data1/oa_pdf/f4/87/epi-8-333.PMC3669124.pdf
Epigenetics 2011; 6:692-702;  PMID:21593595; http://dx.doi.org/10.4161/ epi.6.6.16196.,Non-OADS,/arxiv_data1/oa_pdf/f4/87/epi-8-333.PMC3669124.pdf
Epigenomics  2011; 3:771-84; PMID:22126295; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f4/87/epi-8-333.PMC3669124.pdf
Genome  Biol 2012; 13:R44; PMID:22703947; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f4/87/epi-8-333.PMC3669124.pdf
Epigenomics  2012; 4:325-41; PMID:22690668; http://dx.doi.org/10.2217/epi.12.21.,OADS,/arxiv_data1/oa_pdf/f4/87/epi-8-333.PMC3669124.pdf
Bioinformatics 2013; 29:189-96; PMID:  23175756; http://dx.doi.org/10.1093/bioinformatics/ bts680 19.,OADS,/arxiv_data1/oa_pdf/f4/87/epi-8-333.PMC3669124.pdf
Int J Epidemiol 2012; 41:200- 9; PMID:22422453; http://dx.doi.org/10.1093/ije/ dyr238.,OADS,/arxiv_data1/oa_pdf/f4/87/epi-8-333.PMC3669124.pdf
Bacteriophage  2013; 3:e24323; http://dx.doi.org/10.4161/bact.243232.,Non-OADS,/arxiv_data1/oa_pdf/de/ab/bbug-4-119.PMC3669148.pdf
2013 Feb 25; Available from: http:// www.the-scientist.com//?articles.view/articleNo/34501/ title/Antibody-Drug-Combo-Approved/http://www.the-scientist.com//?articles.view/articleNo/34501/title/Antibody-Drug-Combo-Approved/ http://www.nytimes.com/2013/02/23/business/fda-approves-breast-cancer-drug.html?_r=02.,Non-OADS,/arxiv_data1/oa_pdf/c2/2d/bbug-4-121.PMC3669149.pdf
Pollack A.  http://www.nytimes.com/2013/02/23/ business/fda-approves-breast-cancer-drug.html?_r=0FDA approves a New Drug for Advanced Breast Cancer.,Non-OADS,/arxiv_data1/oa_pdf/c2/2d/bbug-4-121.PMC3669149.pdf
"2013 Feb 22;  Available from: http://www.nytimes.com/2013/02/23/business/fda-approves-breast-cancer-drug.html?_r=0 GSK absorbs Sirtris Pharma giant GlaxoSmithKline (GSK) will close  Sirtris Pharmaceuticals, a firm intent on devel-oping compounds that stave off age-related disease GSK acquired Sirtris, based in Cambridge,  Massachusetts, in 2008 for US$720 million, and had allowed it to function as a distinct unit.",Non-OADS,/arxiv_data1/oa_pdf/c2/2d/bbug-4-121.PMC3669149.pdf
2013 March 13; Available  from: http://blogs.nature.com/news/2013/03/gsk-absorbs-controversial-longevity-company.html2.,Non-OADS,/arxiv_data1/oa_pdf/c2/2d/bbug-4-121.PMC3669149.pdf
"Nature 2013;  494:406-7; http://dx.doi.org/10.1038/494406a BIOFAB: New tools for synthetic biologists Launched in 2009 with a US$1.4-million grant  from the US National Science Foundation, B ioFAB aims t o advance synthetic biology by  creating standard biological “parts” in the form of DNA sequences that control gene expres-sion.",Non-OADS,/arxiv_data1/oa_pdf/c2/2d/bbug-4-121.PMC3669149.pdf
Researchers can obtain the sequences for free online (see http://www.biofab.org/data).,Non-OADS,/arxiv_data1/oa_pdf/c2/2d/bbug-4-121.PMC3669149.pdf
Available from: http://www.biofab.org/2.,Non-OADS,/arxiv_data1/oa_pdf/c2/2d/bbug-4-121.PMC3669149.pdf
Nature  2013; 495:150-1; http://dx.doi.org/10.1038/495150a; PM iD:23486033 3.,OADS,/arxiv_data1/oa_pdf/c2/2d/bbug-4-121.PMC3669149.pdf
Nat Methods 2013; 10:347-53; PM iD:23474467; http://dx.doi.or g/10.1038/nmeth.2403 4.,OADS,/arxiv_data1/oa_pdf/c2/2d/bbug-4-121.PMC3669149.pdf
Nat Methods 2013;  10:354-60; PM iD:23474465; http://dx.doi.or g/10.1038/nmeth.2404,OADS,/arxiv_data1/oa_pdf/c2/2d/bbug-4-121.PMC3669149.pdf
Nature 2013;  495:286-7; http://dx.doi.org/10.1038/495286a2.,OADS,/arxiv_data1/oa_pdf/c2/2d/bbug-4-121.PMC3669149.pdf
Available from: http://www.reuters.com/ article/2013/04/01/us-india-novartis-patent-idUS - BRE93002 i20130401,Non-OADS,/arxiv_data1/oa_pdf/c2/2d/bbug-4-121.PMC3669149.pdf
*Correspondence to: Roy D. Sleator; Email: roy.sleator@cit.ie Submitted: 03/13/13; Accepted: 03/13/13http://dx.doi.org/10.4161/bioe.24296,Non-OADS,/arxiv_data1/oa_pdf/e4/ab/bbug-4-123.PMC3669150.pdf
Anal Chem 2011; 83:4327-41; PMID:21612267; http://dx.doi.org/10.1021/ac2010857.,OADS,/arxiv_data1/oa_pdf/e4/ab/bbug-4-123.PMC3669150.pdf
Nature 1953; 171:737-8; PMID:13054692; http://dx.doi.org/10.1038/171737a0.,Non-OADS,/arxiv_data1/oa_pdf/e4/ab/bbug-4-123.PMC3669150.pdf
J Biotechnol 2012; 160:72-9; PMID:22406111; http://dx.doi.org/10.1016/j.jbiotec.2012.02.012.,OADS,/arxiv_data1/oa_pdf/e4/ab/bbug-4-123.PMC3669150.pdf
Nat  Biotechnol 2009; 27:1151-62; PMID:20010598; http://dx.doi.org/10.1038/nbt.1590.,OADS,/arxiv_data1/oa_pdf/e4/ab/bbug-4-123.PMC3669150.pdf
Science 2012; 337:1628; PMID:22903519; http://dx.doi.org/10.1126/sci-ence.1226355.,OADS,/arxiv_data1/oa_pdf/e4/ab/bbug-4-123.PMC3669150.pdf
Nature 2013; 494:77-80; PMID:23354052; http://dx.doi.org/10.1038/nature11875.,OADS,/arxiv_data1/oa_pdf/e4/ab/bbug-4-123.PMC3669150.pdf
J Mol Biol 1970; 51:393-409; PMID:5312501; http://dx.doi.org/10.1016/0022-2836(70)90150-6.,OADS,/arxiv_data1/oa_pdf/e4/ab/bbug-4-123.PMC3669150.pdf
J Mol Biol 1970; 51:379-91; PMID:5312500; http://dx.doi.org/10.1016/0022-2836(70)90149-X.,OADS,/arxiv_data1/oa_pdf/e4/ab/bbug-4-123.PMC3669150.pdf
Methods Enzymol 1987; 155:335-50; PMID:3431465; http://dx.doi.org/10.1016/0076-6879(87)55023-6.,OADS,/arxiv_data1/oa_pdf/e4/ab/bbug-4-123.PMC3669150.pdf
Science 2007; 317:111-4; PMID:17615355; http://dx.doi.org/10.1126/science.1141758.,OADS,/arxiv_data1/oa_pdf/e4/ab/bbug-4-123.PMC3669150.pdf
Nature 2008; 456:387-90; PMID:19020620; http://dx.doi.org/10.1038/nature07446.,Non-OADS,/arxiv_data1/oa_pdf/e4/ab/bbug-4-123.PMC3669150.pdf
M ol Ecol 2012; 21:3379-81; PMID:22953331;  http://dx.doi.org/10.1111/j.1365-294X.2012.05594.x.,OADS,/arxiv_data1/oa_pdf/e4/ab/bbug-4-123.PMC3669150.pdf
Art J 1996; 55:70-4; http://dx.doi.org/10.2307/777811.,Non-OADS,/arxiv_data1/oa_pdf/e4/ab/bbug-4-123.PMC3669150.pdf
Bioeng Bugs 2010; 1:229-30; PMID:21327053; http://dx.doi.org/10.4161/bbug.1.4.12465.,OADS,/arxiv_data1/oa_pdf/e4/ab/bbug-4-123.PMC3669150.pdf
Science 2010; 329:52-6; PMID:20488990; http://dx.doi.org/10.1126/science.1190719.,Non-OADS,/arxiv_data1/oa_pdf/e4/ab/bbug-4-123.PMC3669150.pdf
"Bioengineered 4:3, 130–135; May/June 2013; © 2013 Landes Bioscience CoMM entary 130 Bioengineered  Volume 4 Issue 3Keywords:  age-related macular  degeneration, TSG-6, Ccl2, Cx3cr1, rd8,  animal model Submitted: 08/14/2012Revised: 11/15/2012Accepted: 11/17/2012http://dx.doi.org/10.4161/bioe.22949 *Correspondence to: Chi-Chao Chan;  Email: chanc@nei.nih.govTuo et al.",Non-OADS,/arxiv_data1/oa_pdf/74/3c/bbug-4-130.PMC3669152.pdf
PLoS One 2012; 7:e35551; PMID:22545116; http://dx.doi.org/10.1371/journal.pone.0035551.,Non-OADS,/arxiv_data1/oa_pdf/74/3c/bbug-4-130.PMC3669152.pdf
Am J Hum Genet 2001; 69:198-203; PMID:11389483; http://dx.doi.org/10.1086/321263.,OADS,/arxiv_data1/oa_pdf/74/3c/bbug-4-130.PMC3669152.pdf
Hum Mol Genet 2003; 12:2179-89; PMID:12915475; http://dx.doi.org/10.1093/hmg/ddg232.,OADS,/arxiv_data1/oa_pdf/74/3c/bbug-4-130.PMC3669152.pdf
"Glia 2007; 55:1486-97; PMID:17705196; http://dx.doi.org/10.1002/glia.20561.material that were transported along with  the “knocked out” gene onto C57BL/6N background, having created potential sites of genetic variability.",Non-OADS,/arxiv_data1/oa_pdf/74/3c/bbug-4-130.PMC3669152.pdf
J Neuroinflammation 2012; 9:59; PMID:22452753; http://dx.doi.org/10.1186/1742-2094-9-59.,Non-OADS,/arxiv_data1/oa_pdf/74/3c/bbug-4-130.PMC3669152.pdf
Nat Med 2003; 9:1390-7; PMID:14566334; http://dx.doi.org/10.1038/nm950.,OADS,/arxiv_data1/oa_pdf/74/3c/bbug-4-130.PMC3669152.pdf
J Clin Invest 2007; 117:2920-8; PMID:17909628; http://dx.doi.org/10.1172/JCI31692.,Non-OADS,/arxiv_data1/oa_pdf/74/3c/bbug-4-130.PMC3669152.pdf
PLoS One 2011; 6:e22818; PMID:21850237; http://dx.doi.org/10.1371/journal.pone.0022818.5.,Non-OADS,/arxiv_data1/oa_pdf/74/3c/bbug-4-130.PMC3669152.pdf
Ophthalmic Res 2008; 40:115-9; PMID:18421223; http://dx.doi.org/10.1159/000119860.,Non-OADS,/arxiv_data1/oa_pdf/74/3c/bbug-4-130.PMC3669152.pdf
Invest Ophthalmol Vis Sci 2007; 48:3827-36; PMID:17652758; http://dx.doi.org/10.1167/iovs.07-0051.,Non-OADS,/arxiv_data1/oa_pdf/74/3c/bbug-4-130.PMC3669152.pdf
Prog Retin Eye Res 2010; 29:169-90; PMID:20206286; http://dx.doi.org/10.1016/j.preteyeres.2010.02.002.,Non-OADS,/arxiv_data1/oa_pdf/74/3c/bbug-4-130.PMC3669152.pdf
Invest Ophthalmol Vis Sci 2012; 53:2921-7; PMID:22447858; http://dx.doi.org/10.1167/iovs.12-9662.,Non-OADS,/arxiv_data1/oa_pdf/74/3c/bbug-4-130.PMC3669152.pdf
Invest Ophthalmol Vis Sci 2010; 51:6009-17; PMID:20538989; http://dx.doi.org/10.1167/iovs.09-4956.,Non-OADS,/arxiv_data1/oa_pdf/74/3c/bbug-4-130.PMC3669152.pdf
Am J Pathol 1998; 153:1641-6; PMID:9811357; http://dx.doi.org/10.1016/S0002-9440(10)65753-7.,OADS,/arxiv_data1/oa_pdf/74/3c/bbug-4-130.PMC3669152.pdf
Am J Pathol 2000; 157:135-44; PMID:10880384; http://dx.doi.org/10.1016/S0002-9440(10)64525-7.,OADS,/arxiv_data1/oa_pdf/74/3c/bbug-4-130.PMC3669152.pdf
Nat Med 2008; 14:194-8; PMID:18223656; http://dx.doi.org/10.1038/nm1709.,OADS,/arxiv_data1/oa_pdf/74/3c/bbug-4-130.PMC3669152.pdf
Mol Neurobiol 2010; 41:290-8; PMID:20221855; http://dx.doi.org/10.1007/s12035-010-8110-z.,Non-OADS,/arxiv_data1/oa_pdf/74/3c/bbug-4-130.PMC3669152.pdf
Prog Retin Eye Res 2009; 28:348-68; PMID:19560552; http://dx.doi.org/10.1016/j.preteyeres.2009.06.001.,Non-OADS,/arxiv_data1/oa_pdf/74/3c/bbug-4-130.PMC3669152.pdf
Semin Immunopathol 2008; 30:97-110; PMID:18299834; http://dx.doi.org/10.1007/s00281-008-0112-9.21.,Non-OADS,/arxiv_data1/oa_pdf/74/3c/bbug-4-130.PMC3669152.pdf
Exp Eye Res 2008; 86:675-83; PMID:18308304; http://dx.doi.org/10.1016/j.exer.2008.01.014.,OADS,/arxiv_data1/oa_pdf/74/3c/bbug-4-130.PMC3669152.pdf
Am J Pathol 2009; 175:799-807; PMID:19608872; http://dx.doi.org/10.2353/ajpath.2009.090089.,Non-OADS,/arxiv_data1/oa_pdf/74/3c/bbug-4-130.PMC3669152.pdf
"Neurobiol Aging 2012; 33:433, e1-10; PMID:21397984; http://dx.doi.org/10.1016/j.neurobiolaging.2011.01.009.",OADS,/arxiv_data1/oa_pdf/74/3c/bbug-4-130.PMC3669152.pdf
Brain Behav Immun 2009; 23:318-24; PMID:18822367; http://dx.doi.org/10.1016/j.bbi.2008.09.001.,Non-OADS,/arxiv_data1/oa_pdf/74/3c/bbug-4-130.PMC3669152.pdf
Exp Eye Res 2002; 75:543-53; PMID:12457866; http://dx.doi.org/10.1006/exer.2002.2047.,Non-OADS,/arxiv_data1/oa_pdf/74/3c/bbug-4-130.PMC3669152.pdf
Arch Ophthalmol 2001; 119:1643-9; PMID:11709015; http://dx.doi.org/10.1001/archopht.119.11.1643.,Non-OADS,/arxiv_data1/oa_pdf/74/3c/bbug-4-130.PMC3669152.pdf
Ophthalmic Res 2006; 38:71-3; PMID:16352919; http://dx.doi.org/10.1159/000090266.13.,Non-OADS,/arxiv_data1/oa_pdf/74/3c/bbug-4-130.PMC3669152.pdf
Invest Ophthalmol Vis Sci 2011; 52:2897-904; PMID:21245403; http://dx.doi.org/10.1167/iovs.10-6114.,Non-OADS,/arxiv_data1/oa_pdf/74/3c/bbug-4-130.PMC3669152.pdf
Ophthalmic Res 2008; 40:124-8; PMID:18421225; http://dx.doi.org/10.1159/000119862.,Non-OADS,/arxiv_data1/oa_pdf/74/3c/bbug-4-130.PMC3669152.pdf
Eye (Lond) 1988; 2:552-77; PMID:2476333; http://dx.doi.org/10.1038/eye.1988.106.,OADS,/arxiv_data1/oa_pdf/74/3c/bbug-4-130.PMC3669152.pdf
Mol Aspects Med 2012; 33:376-98; PMID:22575354; http://dx.doi.org/10.1016/j.mam.2012.04.006.,OADS,/arxiv_data1/oa_pdf/74/3c/bbug-4-130.PMC3669152.pdf
Invest Ophthalmol Vis Sci 2009; 50:1392-9; PMID:19029031; http://dx.doi.org/10.1167/iovs.08-2868.,Non-OADS,/arxiv_data1/oa_pdf/74/3c/bbug-4-130.PMC3669152.pdf
Acta Ophthalmol Scand 2006; 84:4-15; PMID:16445433; http://dx.doi.org/10.1111/j.1600-0420.2005.00627.x.,Non-OADS,/arxiv_data1/oa_pdf/74/3c/bbug-4-130.PMC3669152.pdf
"www.landesbioscience.com  Bioengineered  147Bioengineered 4:3, 147–152; M ay/June 2013; © 2013 Landes Bioscience Resea Rch pape R Resea Rch pape R *Correspondence to: Thu-Ha Nguyen; Email: thu-ha.nguyen@boku.ac.at Submitted: 11/13/2012; Revised: 11/21/2012; Accepted: 11/21/2012http://dx.doi.org/10.4161/bioe.22988Introduction Lactic acid bacteria (LAB) are used in many industrial processes  and their application in winemaking was already reported by Pasteur in 1858.",Non-OADS,/arxiv_data1/oa_pdf/c0/23/bbug-4-147.PMC3669155.pdf
Appl Microbiol Biotechnol 2011; 92:441-7; PMID:21870044; http://dx.doi.org/10.1007/s00253-011-3546-2.,Non-OADS,/arxiv_data1/oa_pdf/c0/23/bbug-4-147.PMC3669155.pdf
Crit Rev Food Sci Nutr 2005; 45:265-86; PMID:16047495; http://dx.doi.org/10.1080/10408690490478118.,Non-OADS,/arxiv_data1/oa_pdf/c0/23/bbug-4-147.PMC3669155.pdf
Food Bioprocess Tech 2011; 4:876-906; http://dx.doi.org/10.1007/s11947-010-0448-8.,Non-OADS,/arxiv_data1/oa_pdf/c0/23/bbug-4-147.PMC3669155.pdf
Antonie Van  Leeuwenhoek 1999; 76:317-31; PMID:10532386; http://dx.doi.org/10.1023/A:1002088931106.,Non-OADS,/arxiv_data1/oa_pdf/c0/23/bbug-4-147.PMC3669155.pdf
nov. Int J Syst Bacteriol 1995; 45:395-7; PMID:7537074; http://dx.doi.org/10.1099/00207713-45-2-395.,Non-OADS,/arxiv_data1/oa_pdf/c0/23/bbug-4-147.PMC3669155.pdf
J Appl Microbiol 2005; 99:565-72; PMID:16108798; http://dx.doi.org/10.1111/j.1365-2672.2005.02628.x.,OADS,/arxiv_data1/oa_pdf/c0/23/bbug-4-147.PMC3669155.pdf
Lett Appl Microbiol 2009; 48:149-56; PMID:19141041; http://dx.doi.org/10.1111/j.1472-765X.2008.02505.x.10.,Non-OADS,/arxiv_data1/oa_pdf/c0/23/bbug-4-147.PMC3669155.pdf
Arch Mikrobiol 1969; 68:259-77; PMID:5383856; http://dx.doi.org/10.1007/BF00409918.,Non-OADS,/arxiv_data1/oa_pdf/c0/23/bbug-4-147.PMC3669155.pdf
Hoppe Seylers Z Physiol Chem 1973; 354:163-8; PMID:4803252; http://dx.doi.org/10.1515/bchm2.1973.354.1.163.,OADS,/arxiv_data1/oa_pdf/c0/23/bbug-4-147.PMC3669155.pdf
Hoppe Seylers Z Physiol  Chem 1976; 357:1209-14; PMID:992575; http://dx.doi.org/10.1515/bchm2.1976.357.2.1209.,OADS,/arxiv_data1/oa_pdf/c0/23/bbug-4-147.PMC3669155.pdf
Int J Syst Bacteriol 1999; 49:1417-28; PMID:10555321; http://dx.doi.org/10.1099/00207713-49-4-1417.,Non-OADS,/arxiv_data1/oa_pdf/c0/23/bbug-4-147.PMC3669155.pdf
AMB Express 2012; 2:1-9; PMID:22214346; http://dx.doi.org/10.1186/2191-0855-2-19.19.,Non-OADS,/arxiv_data1/oa_pdf/c0/23/bbug-4-147.PMC3669155.pdf
J Appl Bact 1960; 23:130-5; http://dx.doi.org/10.1111/j.1365-2672.1960.tb00188.x.,Non-OADS,/arxiv_data1/oa_pdf/c0/23/bbug-4-147.PMC3669155.pdf
Anal Biochem 1976; 72:248-54; PMID:942051; http://dx.doi.org/10.1016/0003-2697(76)90527-3.,Non-OADS,/arxiv_data1/oa_pdf/c0/23/bbug-4-147.PMC3669155.pdf
Nature 1970; 227:680-5; PMID:5432063; http://dx.doi.org/10.1038/227680a0.,OADS,/arxiv_data1/oa_pdf/c0/23/bbug-4-147.PMC3669155.pdf
"Protein J 2012; 31:353-8; PMID:22528138; http://dx.doi.org/10.1007/s10930-012-9409-6Keywords:  prothrombin activator,  recombinant trocarin, recombinant oscu - tarin, recombinant ecarin, coagulation  factor X, FX, thrombin Submitted: 09/12/12Revised: 10/25/12Accepted: 10/26/12http://dx.doi.org/10.4161/bioe.22676 Correspondence to: Ann Lövgren;   Email: ann.lovgren@astrazeneca.comThree prothrombin activators; eca - rin, which was originally isolated  from the venom of the saw-scaled viper  Echis carinatus , trocarin from the rough- scaled snake Tropidechis carinatus ,  and oscutarin from the Taipan snake Oxyuranus scutellatus , were expressed  in mammalian cells with the purpose to obtain recombinant prothrombin activators that could be used to convert prothrombin to thrombin.",OADS,/arxiv_data1/oa_pdf/63/6d/bbug-4-153.PMC3669156.pdf
J Biol Chem 2005;  280:27393-401; PMID:15897196; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/63/6d/bbug-4-153.PMC3669156.pdf
Trends Mol  Med 2004; 10:299-302; PMID:15242675; http://dx.doi.org/10.1016/j.molmed.2004.05.003.,OADS,/arxiv_data1/oa_pdf/63/6d/bbug-4-153.PMC3669156.pdf
World  J Gastroenterol 2008; 14:1370-7; PMID:18322950;  http://dx.doi.org/10.3748/wjg.14.1370.,Non-OADS,/arxiv_data1/oa_pdf/63/6d/bbug-4-153.PMC3669156.pdf
Protein J 2012; 31:353- 8; PMID:22528138; http://dx.doi.org/10.1007/s10930-012-9409-6.,OADS,/arxiv_data1/oa_pdf/63/6d/bbug-4-153.PMC3669156.pdf
J Biochem 2004; 135:577- 82; PMID:15173195; http://dx.doi.org/10.1093/jb/ mvh070.,OADS,/arxiv_data1/oa_pdf/63/6d/bbug-4-153.PMC3669156.pdf
Biochemistry 1982; 21:3437- 43; PMID:7052123; http://dx.doi.org/10.1021/ bi00257a029.,Non-OADS,/arxiv_data1/oa_pdf/63/6d/bbug-4-153.PMC3669156.pdf
Thromb  Res 1978; 13:219-32; PMID:694841; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/63/6d/bbug-4-153.PMC3669156.pdf
Available from:  http://www.rossix.com/Rox_Prothrombin.html7.,Non-OADS,/arxiv_data1/oa_pdf/63/6d/bbug-4-153.PMC3669156.pdf
Hepatology 1993; 18:990-7; PMID:8406374;  http://dx.doi.org/10.1002/hep.1840180434.,Non-OADS,/arxiv_data1/oa_pdf/63/6d/bbug-4-153.PMC3669156.pdf
Toxicon 2005; 45:1133- 45; PMID:15922779; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/63/6d/bbug-4-153.PMC3669156.pdf
Toxin Reviews 1993; 12:155-73;  http://dx.doi.org/10.3109/15569549309033110.,Non-OADS,/arxiv_data1/oa_pdf/63/6d/bbug-4-153.PMC3669156.pdf
Pathophysiol Haemost Thromb  2005; 34:234-40; PMID:16707934; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/63/6d/bbug-4-153.PMC3669156.pdf
J Thromb Haemost 2007; 5:117-26;  PMID:17239167; http://dx.doi.org/10.1111/j.1538-7836.2006.02266.x.acids sequences of the translated exons are  shown in Figure 3 .,Non-OADS,/arxiv_data1/oa_pdf/63/6d/bbug-4-153.PMC3669156.pdf
"Proc Natl Acad Sci U S A 2012; 109:2678-83; PMID: 22308420; http://dx.doi.org/10.1073/pnas.1117907109Keywords:  Synechocystis  sp PCC6803,  genome-scale modeling, COBRA meth - ods, biosustainability, metabolic engi - neering, photosynthetic robustness Submitted: 09/30/12Accepted: 11/06/12http://dx.doi.org/10.4161/bioe.22792 *Correspondence to: Ines Thiele; Email: ithiele@hi.isWe recently assessed the metabo - lism of Synechocystis  sp PCC6803  through a constraints-based reconstruc - tion and analysis approach and identi - fied its main metabolic properties.",OADS,/arxiv_data1/oa_pdf/12/88/bbug-4-158.PMC3669157.pdf
Nat Biotechnol 2009; 27:1128- 9; PMID:20010592; http://dx.doi.org/10.1038/nbt1209-1128.,Non-OADS,/arxiv_data1/oa_pdf/12/88/bbug-4-158.PMC3669157.pdf
Nat Biotechnol 2009; 27:1177-80; PMID:19915552; http://dx.doi.org/10.1038/nbt.1586.,Non-OADS,/arxiv_data1/oa_pdf/12/88/bbug-4-158.PMC3669157.pdf
Appl Environ Microbiol 2012; 78:2660-8; PMID:22307292; http://dx.doi.org/10.1128/AEM.07901-11.,OADS,/arxiv_data1/oa_pdf/12/88/bbug-4-158.PMC3669157.pdf
Metab Eng 2010; 12:173-86; PMID:19840862; http://dx.doi.org/10.1016/j.ymben.2009.10.003.,OADS,/arxiv_data1/oa_pdf/12/88/bbug-4-158.PMC3669157.pdf
J Theor Biol 1992; 154:455-73; PMID:1593897; http://dx.doi.org/10.1016/S0022-5193(05)80162-6.,OADS,/arxiv_data1/oa_pdf/12/88/bbug-4-158.PMC3669157.pdf
Int J Hydrogen Energy 2012; 37:12205-18; http://dx.doi.org/10.1016/j.ijhydene.2012.06.032.,OADS,/arxiv_data1/oa_pdf/12/88/bbug-4-158.PMC3669157.pdf
"J Bacteriol 2004; 186:1737-46; PMID:14996805; http://dx.doi.org/10.1128/JB.186.6.1737-1746.2003.may hamper the possibilities for re-rout - ing the carbon flux, thus, limiting the bio - technological capabilities of Synechocystis .",Non-OADS,/arxiv_data1/oa_pdf/12/88/bbug-4-158.PMC3669157.pdf
Ann N Y Acad Sci  2010; 1195:28-45; PMID:20536815; http://dx.doi.org/10.1111/j.1749-6632.2010.05457.x.,OADS,/arxiv_data1/oa_pdf/12/88/bbug-4-158.PMC3669157.pdf
Science 2009; 326:1397-9; PMID:19933101; http://dx.doi.org/10.1126/sci - ence.1180251.,OADS,/arxiv_data1/oa_pdf/12/88/bbug-4-158.PMC3669157.pdf
Appl Microbiol Biotechnol 2011; 91:471-90; PMID:21691792; http://dx.doi.org/10.1007/s00253-011-3394-0.,Non-OADS,/arxiv_data1/oa_pdf/12/88/bbug-4-158.PMC3669157.pdf
Nature 1979; 277:293-4; http://dx.doi.org/10.1038/277293a0.,Non-OADS,/arxiv_data1/oa_pdf/12/88/bbug-4-158.PMC3669157.pdf
Curr Opin Biotechnol 2008; 19:235-40; PMID:18539450; http://dx.doi.org/10.1016/j.copbio.2008.05.007.,OADS,/arxiv_data1/oa_pdf/12/88/bbug-4-158.PMC3669157.pdf
J Appl Microbiol 2009; 106:1-12; PMID:19191979; http://dx.doi.org/10.1111/j.1365-2672.2008.03918.x.,Non-OADS,/arxiv_data1/oa_pdf/12/88/bbug-4-158.PMC3669157.pdf
Appl Microbiol Biotechnol 2002; 58:123-37; PMID:11876404; http://dx.doi.org/10.1007/s00253-001-0864-9.,OADS,/arxiv_data1/oa_pdf/12/88/bbug-4-158.PMC3669157.pdf
Metab Eng 2011; 13:610-6; PMID:21827869; http://dx.doi.org/10.1016/j.ymben.2011.07.004.,OADS,/arxiv_data1/oa_pdf/12/88/bbug-4-158.PMC3669157.pdf
Appl Environ Microbiol 2010; 76:3462-6; PMID:20363793; http://dx.doi.org/10.1128/AEM.00202-10.,OADS,/arxiv_data1/oa_pdf/12/88/bbug-4-158.PMC3669157.pdf
Energy & Environmental Science 2009; 2:857-64; http://dx.doi.org/10.1039/b811937f.,OADS,/arxiv_data1/oa_pdf/12/88/bbug-4-158.PMC3669157.pdf
Metab Eng 2011; 13:353-63; PMID:21569861; http://dx.doi.org/10.1016/j.ymben.2011.04.004.,OADS,/arxiv_data1/oa_pdf/12/88/bbug-4-158.PMC3669157.pdf
Metab Eng 2011; 13:169-76; PMID:21220042; http://dx.doi.org/10.1016/j.ymben.2011.01.001.,OADS,/arxiv_data1/oa_pdf/12/88/bbug-4-158.PMC3669157.pdf
Metab Eng 2010; 12:70-9; PMID:19833224; http://dx.doi.org/10.1016/j.ymben.2009.10.001.,OADS,/arxiv_data1/oa_pdf/12/88/bbug-4-158.PMC3669157.pdf
"Bioengineered 4:3, 172–179; May/June 2013; © 2013 Landes Bioscience artic Le addendu M 172 Bioengineered  Volume 4 issue 3Keywords:  Escherichia coli , Saccharomyces  boulardii , interleukin-10, probiotics,  hemolysin A, transport system, bacterial  cell lysis, biological containment Abbreviations:  A, absorbance; BRP,  bacteriocin-release protein; EBV, Epstein- Barr virus; EcN, E. coli  Nissle 1917;  hIL-10, human interleukin-10; HlyA, hemolysin A; HCMV, human cyto - megalovirus; IBD, inflammatory bowel disease; IL-10, interleukin-10; mAB, monoclonal antibody; mIL-10, murine interleukin-10; M r, molar mass; OmpT,  outer membrane protease T; SD, Shine-Dalgarno; STAT3, signal transducer and activator of transcription 3; Tyr, tyrosine Submitted: 07/24/12Revised: 10/21/12Accepted: 10/23/12http://dx.doi.org/10.4161/bioe.22646 *Correspondence to: Christoph Pöhlmann and  Florian Gunzer; Email: Christoph.Poehlmann@ rbk.de and florian.gunzer@tu-dresden.deThe anti-inflammatory cytokine  interleukin-10 and its viral homo - logs were chosen as model proteins for the development of drug delivery sys - tems based on probiotic carriers like E. coli Nissle 1917, E. coli G3/10, and Saccharomyces boulardii .",Non-OADS,/arxiv_data1/oa_pdf/df/ef/bbug-4-172.PMC3669160.pdf
J Mol Microbiol Biotechnol 2012; 22:1-9; PMID:22353729; http://dx.doi.org/10.1159/000336043,Non-OADS,/arxiv_data1/oa_pdf/df/ef/bbug-4-172.PMC3669160.pdf
Supplemental Materials Supplemental materials may be found here: http://www.landesbioscience.com/journals/bioe/article/22646/(234 aa) for the mature EBV IL-10 includ - ing the N-terminal α -mating factor signal  sequence].,Non-OADS,/arxiv_data1/oa_pdf/df/ef/bbug-4-172.PMC3669160.pdf
Structure 1995; 3:591-601; PMID:8590020; http://dx.doi.org/10.1016/S0969-2126(01)00193-9.,OADS,/arxiv_data1/oa_pdf/df/ef/bbug-4-172.PMC3669160.pdf
Mol  Gen Genet 1992; 233:42-8; PMID:1603076; http://dx.doi.org/10.1007/BF00587559.,OADS,/arxiv_data1/oa_pdf/df/ef/bbug-4-172.PMC3669160.pdf
Appl Microbiol Biotechnol 1995; 44:118-25; PMID:8579825; http://dx.doi.org/10.1007/BF00164490.,Non-OADS,/arxiv_data1/oa_pdf/df/ef/bbug-4-172.PMC3669160.pdf
J Mol Microbiol Biotechnol 2012; 22:1-9; PMID:22353729; http://dx.doi.org/10.1159/000336043.,Non-OADS,/arxiv_data1/oa_pdf/df/ef/bbug-4-172.PMC3669160.pdf
Nature 1981;  294:665-7; PMID:7031483; http://dx.doi.org/10.1038/294665a0.,Non-OADS,/arxiv_data1/oa_pdf/df/ef/bbug-4-172.PMC3669160.pdf
Mol Membr Biol 2005; 22:29-39; PMID:16092522; http://dx.doi.org/10.1080/09687860500042013.,OADS,/arxiv_data1/oa_pdf/df/ef/bbug-4-172.PMC3669160.pdf
Gene 1996; 179:133-40; PMID:8955639; http://dx.doi.org/10.1016/S0378-1119(96)00424-6.,OADS,/arxiv_data1/oa_pdf/df/ef/bbug-4-172.PMC3669160.pdf
Methods Enzymol 1990; 182:132-43;  PMID:2179663; http://dx.doi.org/10.1016/0076-6879(90)82013-R. 17.,OADS,/arxiv_data1/oa_pdf/df/ef/bbug-4-172.PMC3669160.pdf
FEMS Immunol Med Microbiol 1998; 20:111-9; PMID:9544778; http://dx.doi.org/10.1111/j.1574-695X.1998.tb01117.x.,Non-OADS,/arxiv_data1/oa_pdf/df/ef/bbug-4-172.PMC3669160.pdf
Dtsch Med Wochenschr 1916; 42:1181-4; http://dx.doi.org/10.1055/s-0028-1135392.References 1.,Non-OADS,/arxiv_data1/oa_pdf/df/ef/bbug-4-172.PMC3669160.pdf
Immunopharmacol Immunotoxicol 2010; 32:1-4; PMID:19778176; http://dx.doi.org/10.3109/08923970902817890.,Non-OADS,/arxiv_data1/oa_pdf/df/ef/bbug-4-172.PMC3669160.pdf
Vaccine 2001; 19:1573-80; PMID:11166877; http://dx.doi.org/10.1016/S0264-410X(00)00354-6.,Non-OADS,/arxiv_data1/oa_pdf/df/ef/bbug-4-172.PMC3669160.pdf
Immunol Rev 2008; 226:205-18; PMID:19161426; http://dx.doi.org/10.1111/j.1600-065X.2008.00706.x.,Non-OADS,/arxiv_data1/oa_pdf/df/ef/bbug-4-172.PMC3669160.pdf
Enzyme Microb Technol  2000; 27:761-5; PMID:11118583; http://dx.doi.org/10.1016/S0141-0229(00)00297-0.,OADS,/arxiv_data1/oa_pdf/df/ef/bbug-4-172.PMC3669160.pdf
Science 2000; 289:1352-5; PMID:10958782; http://dx.doi.org/10.1126/science.289.5483.1352.,OADS,/arxiv_data1/oa_pdf/df/ef/bbug-4-172.PMC3669160.pdf
Clin Gastroenterol Hepatol 2006; 4:754-9; PMID:16716759; http://dx.doi.org/10.1016/j.cgh.2006.03.028.,Non-OADS,/arxiv_data1/oa_pdf/df/ef/bbug-4-172.PMC3669160.pdf
Infect Disord Drug Targets 2009; 9:518-47; PMID:19594425; http://dx.doi.org/10.2174/187152609789105722.,Non-OADS,/arxiv_data1/oa_pdf/df/ef/bbug-4-172.PMC3669160.pdf
Biochemistry 1993; 32:8807-15; PMID:8364028; http://dx.doi.org/10.1021/bi00085a011.,Non-OADS,/arxiv_data1/oa_pdf/df/ef/bbug-4-172.PMC3669160.pdf
Biochemistry 1998; 37:16943-51; PMID:9836587; http://dx.doi.org/10.1021/bi981555y.Figure 5.  activ ation of S tat3 phos phorylation by S. boulardii  secreted recombinant viral iL-10 .,Non-OADS,/arxiv_data1/oa_pdf/df/ef/bbug-4-172.PMC3669160.pdf
J Exp Med 2000; 191:213-24; PMID:10637267; http://dx.doi.org/10.1084/jem.191.2.213.,OADS,/arxiv_data1/oa_pdf/df/ef/bbug-4-172.PMC3669160.pdf
PLoS One  2012; 7:e33351; PMID:22479389; http://dx.doi.org/10.1371/journal.pone.0033351.34.,Non-OADS,/arxiv_data1/oa_pdf/df/ef/bbug-4-172.PMC3669160.pdf
Biotechnol Prog 2001; 17:573-6; PMID:11386882; http://dx.doi.org/10.1021/bp010018t.,OADS,/arxiv_data1/oa_pdf/df/ef/bbug-4-172.PMC3669160.pdf
Therap Adv Gastroenterol 2012; 5:111-25; PMID:22423260; http://dx.doi.org/10.1177/1756283X11428502.,Non-OADS,/arxiv_data1/oa_pdf/df/ef/bbug-4-172.PMC3669160.pdf
Inflamm Bowel Dis 2012; PMID:22570250; http://dx.doi.org/10.1002/ibd.23006.30.,Non-OADS,/arxiv_data1/oa_pdf/df/ef/bbug-4-172.PMC3669160.pdf
Science 2006; 312:1044-6;  PMID:16645050; http://dx.doi.org/10.1126/sci - ence.1126439.,OADS,/arxiv_data1/oa_pdf/df/ef/bbug-4-172.PMC3669160.pdf
Protein Expr Purif 1995; 6:481-6; PMID:8527934; http://dx.doi.org/10.1006/prep.1995.1064.,OADS,/arxiv_data1/oa_pdf/df/ef/bbug-4-172.PMC3669160.pdf
Protein Expr Purif 2003; 28:63-8; PMID:12651108; http://dx.doi.org/10.1016/S1046-5928(02)00637-X.,OADS,/arxiv_data1/oa_pdf/df/ef/bbug-4-172.PMC3669160.pdf
hum V accin immunother 2013;  9:801-3; PM id:23322214; http://dx.doi.or g/10.4161/ hv.23302,Non-OADS,/arxiv_data1/oa_pdf/3f/79/gmic-4-177.PMC3669161.pdf
Virulence 2013; 4:230-40; PM id:23 406779; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3f/79/gmic-4-177.PMC3669161.pdf
"www.landesbioscience.com  Gut Microbes  179Gut Microbes 4:3, 179–180; M ay/June 2013; © 2013 Landes Bioscience The inside passa Ge The inside passa Ge Keywords:  neutrophil extracellular traps,  NETs, perox duox, human defensin 6,  septin Submitted: 03/11/13Accepted: 03/11/13http://dx.doi.org/10.4161/gmic.24388 Correspondence to: V.K.",Non-OADS,/arxiv_data1/oa_pdf/ef/ba/gmic-4-179.PMC3669162.pdf
J Cell Biol 2012; 198:773-83; PMID:22945932;  http://dx.doi.org/10.1083/jcb.201203170.,OADS,/arxiv_data1/oa_pdf/ef/ba/gmic-4-179.PMC3669162.pdf
J Immunol 2012; 189:2689-95; PMID:22956760; http://dx.doi.org/10.4049/jimmunol.1201719.,Non-OADS,/arxiv_data1/oa_pdf/ef/ba/gmic-4-179.PMC3669162.pdf
Cell Host Microbe 2010; 8:445-54; PMID:21075355; http://dx.doi.org/10.1016/j.chom.2010.10.005.of proteins that appear to play a role in  autophagy.,OADS,/arxiv_data1/oa_pdf/ef/ba/gmic-4-179.PMC3669162.pdf
Blood 2009; 114:2619-22; PMID:19541821; http://dx.doi.org/10.1182/blood-2009-05-221606.,Non-OADS,/arxiv_data1/oa_pdf/ef/ba/gmic-4-179.PMC3669162.pdf
Science 2012; 337:477-81; PMID:22722251; http://dx.doi.org/10.1126/sci - ence.1218831.6.,OADS,/arxiv_data1/oa_pdf/ef/ba/gmic-4-179.PMC3669162.pdf
Science 2010; 327:1644-8; PMID:20223948; http://dx.doi.org/10.1126/sci - ence.1184008.,OADS,/arxiv_data1/oa_pdf/ef/ba/gmic-4-179.PMC3669162.pdf
Cell Host Microbe 2010; 8:433-44; PMID:21075354; http://dx.doi.org/10.1016/j.chom.2010.10.009.mutations that affect NADPH oxidase  function and have heightened susceptibil - ity to infections since their neutrophils are defective for phagocytosis and NET for - mation.,OADS,/arxiv_data1/oa_pdf/ef/ba/gmic-4-179.PMC3669162.pdf
"www.landesbioscience.com  Gut Microbes  193Gut Microbes 4:3, 193–200; Ma y/June 2013; © 2013 Landes Bioscience Resea Rch pape R Resea Rch pape R *Correspondence to: Saul Tzipori; Email: saul.tzipori@tufts.edu Submitted: 11/16/12; Revised: 01/23/13; Accepted: 02/02/13http://dx.doi.org/10.4161/gmic.23867Introduction Intestinal microbiomes play an important role in human health.",Non-OADS,/arxiv_data1/oa_pdf/76/47/gmic-4-193.PMC3669164.pdf
Nature 2009; 457:480-4; PMID:19043404; http://dx.doi.org/10.1038/nature07540.,Non-OADS,/arxiv_data1/oa_pdf/76/47/gmic-4-193.PMC3669164.pdf
Nutrients 2011; 3:637-82; PMID:22254115; http://dx.doi.org/10.3390/nu3060637.,Non-OADS,/arxiv_data1/oa_pdf/76/47/gmic-4-193.PMC3669164.pdf
Clin Dev Immunol 2012; 2012:932072; PMID:22110540; http://dx.doi.org/10.1155/2012/932072.,Non-OADS,/arxiv_data1/oa_pdf/76/47/gmic-4-193.PMC3669164.pdf
Nature 2012; 490:55-60; PMID:23023125; http://dx.doi.org/10.1038/nature11450.,OADS,/arxiv_data1/oa_pdf/76/47/gmic-4-193.PMC3669164.pdf
Nature 2008; 455:1109-13; PMID:18806780; http://dx.doi.org/10.1038/nature07336.,Non-OADS,/arxiv_data1/oa_pdf/76/47/gmic-4-193.PMC3669164.pdf
Nutrients 2012; 4:1095-119; PMID:23016134; http://dx.doi.org/10.3390/nu4081095.,Non-OADS,/arxiv_data1/oa_pdf/76/47/gmic-4-193.PMC3669164.pdf
PLoS One 2012; 7:e36095; PMID:22553482; http://dx.doi.org/10.1371/journal.pone.0036095.,Non-OADS,/arxiv_data1/oa_pdf/76/47/gmic-4-193.PMC3669164.pdf
Cell 2012; 150:470-80; PMID:22863002; http://dx.doi.org/10.1016/j.cell.2012.07.008.,OADS,/arxiv_data1/oa_pdf/76/47/gmic-4-193.PMC3669164.pdf
Mol Syst Biol 2008; 4:157; PMID:18197175; http://dx.doi.org/10.1038/msb4100190.,OADS,/arxiv_data1/oa_pdf/76/47/gmic-4-193.PMC3669164.pdf
Sci T ransl Med 2009; 1:ra14; PMID:20368178; http://dx.doi.org/10.1126/scitrans-lmed.3000322.,OADS,/arxiv_data1/oa_pdf/76/47/gmic-4-193.PMC3669164.pdf
ISME J 2010; 4:1094-8; PMID:20664551; http://dx.doi.org/10.1038/ismej.2010.110.,OADS,/arxiv_data1/oa_pdf/76/47/gmic-4-193.PMC3669164.pdf
Sci T ransl Med 2011; 3:10ra106; PMID:22030749; http://dx.doi.org/10.1126/scitranslmed.3002701.,Non-OADS,/arxiv_data1/oa_pdf/76/47/gmic-4-193.PMC3669164.pdf
Cell Host Microbe 2012; 12:139-52; PMID:22863420; http://dx.doi.org/10.1016/j.chom.2012.07.004.,OADS,/arxiv_data1/oa_pdf/76/47/gmic-4-193.PMC3669164.pdf
Lancet 2012; 379:672-83; PMID:22019026; http://dx.doi.org/10.1016/S0140-6736(11)61091-X.,OADS,/arxiv_data1/oa_pdf/76/47/gmic-4-193.PMC3669164.pdf
Science 2003; 299:411-4; PMID:12493821; http://dx.doi.org/10.1126/sci-ence.1078942.18.,OADS,/arxiv_data1/oa_pdf/76/47/gmic-4-193.PMC3669164.pdf
Vet Immunol Immunopathol 2007; 119:243-53; PMID:17643495; http://dx.doi.org/10.1016/j.vetimm.2007.05.022.,Non-OADS,/arxiv_data1/oa_pdf/76/47/gmic-4-193.PMC3669164.pdf
Vet Immunol Immunopathol 2005; 105:151-61; PMID:15797484; http://dx.doi.org/10.1016/j.vetimm.2004.12.022.,Non-OADS,/arxiv_data1/oa_pdf/76/47/gmic-4-193.PMC3669164.pdf
Dev Comp Immunol 2005; 29:977-87; PMID:15936819; http://dx.doi.org/10.1016/j.dci.2005.03.008.,OADS,/arxiv_data1/oa_pdf/76/47/gmic-4-193.PMC3669164.pdf
Infect Immun 2003; 71:2182-91; PMID:12654840; http://dx.doi.org/10.1128/IAI.71.4.2182-2191.2003.,Non-OADS,/arxiv_data1/oa_pdf/76/47/gmic-4-193.PMC3669164.pdf
Gut Microbes 2011; 2:145-58; PMID:21804357; http://dx.doi.org/10.4161/gmic.2.3.16333.,Non-OADS,/arxiv_data1/oa_pdf/76/47/gmic-4-193.PMC3669164.pdf
Appl Environ Microbiol 2012; 78:2359-66; PMID:22286988; http://dx.doi.org/10.1128/AEM.05239-11.,OADS,/arxiv_data1/oa_pdf/76/47/gmic-4-193.PMC3669164.pdf
Gut Microbes 2012; 3:383-93; PMID:22688727; http://dx.doi.org/10.4161/gmic.21008.,Non-OADS,/arxiv_data1/oa_pdf/76/47/gmic-4-193.PMC3669164.pdf
"Gastroenterology 2009; 137:1716-24, e1-2; PMID:19706296; http://dx.doi.org/10.1053/j.gastro.2009.08.042.",Non-OADS,/arxiv_data1/oa_pdf/76/47/gmic-4-193.PMC3669164.pdf
Adv Parasitol 1998; 40:187-221; PMID:9554074; http://dx.doi.org/10.1016/S0065-308X(08)60121-9.,OADS,/arxiv_data1/oa_pdf/76/47/gmic-4-193.PMC3669164.pdf
J Microbiol Methods 2003; 55:541-55; PMID:14607398; http://dx.doi.org/10.1016/j.mimet.2003.08.009.,OADS,/arxiv_data1/oa_pdf/76/47/gmic-4-193.PMC3669164.pdf
Appl Environ Microbiol 2009; 75:7537-41; PMID:19801464; http://dx.doi.org/10.1128/AEM.01541-09.,Non-OADS,/arxiv_data1/oa_pdf/76/47/gmic-4-193.PMC3669164.pdf
Appl Environ Microbiol 2007; 73:5261-7; PMID:17586664; http://dx.doi.org/10.1128/AEM.00062-07.,OADS,/arxiv_data1/oa_pdf/76/47/gmic-4-193.PMC3669164.pdf
BMC Bioinformatics 2006; 7:371; PMID:16893466; http://dx.doi.org/10.1186/1471-2105-7-371.,OADS,/arxiv_data1/oa_pdf/76/47/gmic-4-193.PMC3669164.pdf
Mol Ecol Notes 2006; 6:288-95; http://dx.doi.org/10.1111/j.1471-8286.2005.01155.x.,Non-OADS,/arxiv_data1/oa_pdf/76/47/gmic-4-193.PMC3669164.pdf
Science 1965; 147:250-60; PMID:17788203; http://dx.doi.org/10.1126/sci-ence.147.3655.250.36.,OADS,/arxiv_data1/oa_pdf/76/47/gmic-4-193.PMC3669164.pdf
ISME J 2012; 6:94-103; PMID:21716311; http://dx.doi.org/10.1038/ismej.2011.82.,OADS,/arxiv_data1/oa_pdf/76/47/gmic-4-193.PMC3669164.pdf
Nucleic Acids Res 2009; 37(Database issue):D141-5; PMID:19004872; http://dx.doi.org/10.1093/nar/gkn879.,OADS,/arxiv_data1/oa_pdf/76/47/gmic-4-193.PMC3669164.pdf
PLoS One 2012; 7:e40425; PMID:22792313; http://dx.doi.org/10.1371/journal.pone.0040425.,Non-OADS,/arxiv_data1/oa_pdf/76/47/gmic-4-193.PMC3669164.pdf
BMC Genomics 2007; 8:215; PMID:17615075; http://dx.doi.org/10.1186/1471-2164-8-215.,OADS,/arxiv_data1/oa_pdf/76/47/gmic-4-193.PMC3669164.pdf
ISME J 2012; 6:57-70; PMID:21753800; http://dx.doi.org/10.1038/ismej.2011.90.,OADS,/arxiv_data1/oa_pdf/76/47/gmic-4-193.PMC3669164.pdf
Nature 2012; 489:231-41; PMID:22972296; http://dx.doi.org/10.1038/nature11551.,Non-OADS,/arxiv_data1/oa_pdf/76/47/gmic-4-193.PMC3669164.pdf
J Pediatr Gastroenterol Nutr 2010; 51:77-84; PMID:20479681; http://dx.doi.org/10.1097/MPG.0b013e3181d1b11e.,Non-OADS,/arxiv_data1/oa_pdf/76/47/gmic-4-193.PMC3669164.pdf
Science 2011; 334:105-8; PMID:21885731; http://dx.doi.org/10.1126/sci-ence.1208344.,OADS,/arxiv_data1/oa_pdf/76/47/gmic-4-193.PMC3669164.pdf
Cell Host Microbe 2008; 3:213-23; PMID:18407065; http://dx.doi.org/10.1016/j.chom.2008.02.015.26.,OADS,/arxiv_data1/oa_pdf/76/47/gmic-4-193.PMC3669164.pdf
Mol Biochem Parasitol 2000; 108:187-97; PMID:10838221; http://dx.doi.org/10.1016/S0166-6851(00)00211-5.,OADS,/arxiv_data1/oa_pdf/76/47/gmic-4-193.PMC3669164.pdf
J Infect Dis 2010; 201:428-34; PMID:20039803; http://dx.doi.org/10.1086/649799.,OADS,/arxiv_data1/oa_pdf/76/47/gmic-4-193.PMC3669164.pdf
J Infect Dis 2012; 205:1019-23; PMID:22279124; http://dx.doi.org/10.1093/infdis/jir874.,OADS,/arxiv_data1/oa_pdf/76/47/gmic-4-193.PMC3669164.pdf
Front Microbiol 2011; 2:226; PMID:22102844; http://dx.doi.org/10.3389/fmicb.2011.00226.,OADS,/arxiv_data1/oa_pdf/76/47/gmic-4-193.PMC3669164.pdf
J Infect Dis 2010; 201:903-11; PMID:20136414; http://dx.doi.org/10.1086/650995.,OADS,/arxiv_data1/oa_pdf/76/47/gmic-4-193.PMC3669164.pdf
T rends Microbiol 2012; 20:50-7; PMID:22153753; http://dx.doi.org/10.1016/j.tim.2011.11.002.,OADS,/arxiv_data1/oa_pdf/76/47/gmic-4-193.PMC3669164.pdf
PLoS One 2008; 3:e2836; PMID:18665274; http://dx.doi.org/10.1371/journal.pone.0002836.,Non-OADS,/arxiv_data1/oa_pdf/76/47/gmic-4-193.PMC3669164.pdf
"Gut Microbes 4:3, 236–240; May/June 2013; © 2013 Landes Bioscience artic Le addendu M 236 Gut Microbes  Volume 4 issue 3Keywords:  keystone species, microbiota,  resistant starch, anaerobic bacteria,  microbial consortia, human colon, cross-feeding Submitted: 01/15/13Revised: 02/11/13Accepted: 02/13/13http://dx.doi.org/10.4161/gmic.23998 *Correspondence to: Harry J.",Non-OADS,/arxiv_data1/oa_pdf/88/f4/gmic-4-236.PMC3669169.pdf
ISME J 2012; 6:1535-43; PMID:22343308; http://dx.doi.org/10.1038/ismej.2012.4,OADS,/arxiv_data1/oa_pdf/88/f4/gmic-4-236.PMC3669169.pdf
ISME J 2012; 6:1535-43; PMID:22343308; http://dx.doi.org/10.1038/ismej.2012.4.,OADS,/arxiv_data1/oa_pdf/88/f4/gmic-4-236.PMC3669169.pdf
Anaerobe 2012; 18:523-9;  PMID:22982042; http://dx.doi.org/10.1016/j.anaer - obe.2012.09.002.,OADS,/arxiv_data1/oa_pdf/88/f4/gmic-4-236.PMC3669169.pdf
Environ Microbiol 2010; 12:304-14; PMID:19807780; http://dx.doi.org/10.1111/j.1462-2920.2009.02066.x.,OADS,/arxiv_data1/oa_pdf/88/f4/gmic-4-236.PMC3669169.pdf
Br J Nutr  2009; 101:541-50; PMID:18590586; http://dx.doi.org/10.1017/S0007114508019880.,Non-OADS,/arxiv_data1/oa_pdf/88/f4/gmic-4-236.PMC3669169.pdf
FEMS Microbiol Lett 2009; 294:1-8; PMID:19222573; http://dx.doi.org/10.1111/j.1574-6968.2009.01514.x.,OADS,/arxiv_data1/oa_pdf/88/f4/gmic-4-236.PMC3669169.pdf
Microbiology 2006; 152:3281-90; PMID:17074899; http://dx.doi.org/10.1099/mic.0.29233-0.,Non-OADS,/arxiv_data1/oa_pdf/88/f4/gmic-4-236.PMC3669169.pdf
Appl Environ  Microbiol 2008; 74:6271-9; PMID:18689518; http://dx.doi.org/10.1128/AEM.01169-08.,OADS,/arxiv_data1/oa_pdf/88/f4/gmic-4-236.PMC3669169.pdf
Gut Microbes 2012; 3:289-306; PMID:22572875; http://dx.doi.org/10.4161/gmic.19897.,Non-OADS,/arxiv_data1/oa_pdf/88/f4/gmic-4-236.PMC3669169.pdf
Nat Rev Microbiol 2008; 6:121-31; PMID:18180751; http://dx.doi.org/10.1038/nrmicro1817.,OADS,/arxiv_data1/oa_pdf/88/f4/gmic-4-236.PMC3669169.pdf
FEMS Microbiol Ecol 2008; 66:505-15; PMID:18616586; http://dx.doi.org/10.1111/j.1574-6941.2008.00527.x.,OADS,/arxiv_data1/oa_pdf/88/f4/gmic-4-236.PMC3669169.pdf
ISME J 2011; 5:220-30; PMID:20686513; http://dx.doi.org/10.1038/ismej.2010.118.,OADS,/arxiv_data1/oa_pdf/88/f4/gmic-4-236.PMC3669169.pdf
PLoS One 2010; 5:e15046; PMID:21151493; http://dx.doi.org/10.1371/journal.pone.0015046.,OADS,/arxiv_data1/oa_pdf/88/f4/gmic-4-236.PMC3669169.pdf
Nature 2009; 457:480-4; PMID:19043404; http://dx.doi.org/10.1038/nature07540.,Non-OADS,/arxiv_data1/oa_pdf/88/f4/gmic-4-236.PMC3669169.pdf
Nature 2010; 464:59-65; PMID:20203603; http://dx.doi.org/10.1038/nature08821.17.,Non-OADS,/arxiv_data1/oa_pdf/88/f4/gmic-4-236.PMC3669169.pdf
Int J Syst Evol Microbiol 2006; 56:2437-41; PMID:17012576; http://dx.doi.org/10.1099/ijs.0.64098-0.,OADS,/arxiv_data1/oa_pdf/88/f4/gmic-4-236.PMC3669169.pdf
Proc Nutr Soc 1991; 50:149-59; PMID:1661009; http://dx.doi.org/10.1079/PNS19910026.,OADS,/arxiv_data1/oa_pdf/88/f4/gmic-4-236.PMC3669169.pdf
FEMS Microbiol Ecol 2003; 46:81-9; PMID:19719585; http://dx.doi.org/10.1016/S0168-6496(03)00207-1.,OADS,/arxiv_data1/oa_pdf/88/f4/gmic-4-236.PMC3669169.pdf
FEMS Microbiol Ecol 2010; 74:205-13; PMID:20662929; http://dx.doi.org/10.1111/j.1574-6941.2010.00941.x.,OADS,/arxiv_data1/oa_pdf/88/f4/gmic-4-236.PMC3669169.pdf
Environ Microbiol 2008; 10:3275-83; PMID:18713272; http://dx.doi.org/10.1111/j.1462-2920.2008.01717.x.,OADS,/arxiv_data1/oa_pdf/88/f4/gmic-4-236.PMC3669169.pdf
J Bacteriol 2005; 187:7569-78; PMID:16267281; http://dx.doi.org/10.1128/JB.187.22.7569-7578.2005.,Non-OADS,/arxiv_data1/oa_pdf/88/f4/gmic-4-236.PMC3669169.pdf
PLoS One 2010; 5:e12476; PMID:20814577; http://dx.doi.org/10.1371/journal.pone.0012476.,OADS,/arxiv_data1/oa_pdf/88/f4/gmic-4-236.PMC3669169.pdf
Appl Environ  Microbiol 2004; 70:5810-7; PMID:15466518; http://dx.doi.org/10.1128/AEM.70.10.5810-5817.2004.,OADS,/arxiv_data1/oa_pdf/88/f4/gmic-4-236.PMC3669169.pdf
J Appl Bacteriol 1989; 66:407-17; PMID:2666379; http://dx.doi.org/10.1111/j.1365-2672.1989.tb05110.x.25.,Non-OADS,/arxiv_data1/oa_pdf/88/f4/gmic-4-236.PMC3669169.pdf
Appl Environ Microbiol 2008; 74:1646-8; PMID:18083887; http://dx.doi.org/10.1128/AEM.01226-07.,OADS,/arxiv_data1/oa_pdf/88/f4/gmic-4-236.PMC3669169.pdf
Appl Environ Microbiol 2007; 73:6526-33; PMID:17766450; http://dx.doi.org/10.1128/AEM.00508-07.,OADS,/arxiv_data1/oa_pdf/88/f4/gmic-4-236.PMC3669169.pdf
"www.landesbioscience.com Autophagy 653Autophagy 9:5, 653–666; May 2013; © 2013 Landes BioscienceBAsic ReseAR ch P APeR  BAsic ReseAR ch P APeR *Correspondence to: Omar Benzakour; Email: Omar.Benzakour@univ-poitiers.fr Submitted: 09/06/12; Revised: 01/28/13; Accepted: 01/31/13http://dx.doi.org/10.4161/auto.23839Introduction In tissues separated by blood barriers such as the testis and the  retina, where professional circulating phagocytes cannot infil - trate, phagocytosis is performed by resident cells of epithelial ori - gin.1 Because of their non-hematopoietic lineage, resident cells of  epithelial origin that enable the clearance of apoptotic substrates A chimerical phagocytosis model reveals   the recruitment by Sertoli cells   of autophagy for the degradation   of ingested illegitimate substrates Marina G. Yefimova,1,2 Nadia Messaddeq,3 Thomas h arnois,1,4 Annie- claire Meunier,1 Jonathan c larhaut,4 Anaïs Noblanc,1  Jean-Luc Weickert,3 Anne c antereau,1 Michel Philippe,1 Nicolas Bourmeyster1,4 and Omar Benzakour1,* 1institut de Physiologie et Biologie c ellulaires; c NRs-FRe 3511; Université de Poitiers; Poitiers, France; 2sechenov i nstitute of e volutionary Physiology and Biochemistry Russian  Academy of s ciences; s t.Petersburg, Russia; 3Department of Neurobiology and Genetics; i nstitute of Genetics and Molecular and c ellular Biology ( iGBM c); illkirch, France;  4iNseRM cic 0802; c entre h ospitalier Universitaire ( chU) de Poitiers; Université de Poitiers; Poitiers, France Keywords:  autophagy, homeostatic phagocytosis, Sertoli cells, MERTK tyrosine kinase, apoptotic substrates, protein S,  vitamin  K-dependent factor Abbreviations:  ANXA5, annexin A5; ATG, autophagy-related; BECN1, Beclin 1, autophagy related; CDC42, cell division cycle 42  (GTP binding protein, 25 kDa); EM, electron microscopy; GAS6, growth arrest-specific protein 6; GTP, guanosine triphosphate;  MAP1LC3A/LC3, microtubule-associated protein 1 light chain 3 alpha; MAP1LC3A-I/LC3-I, cytoplasmic form of MAP1LC3A/ LC3; MAP1LC3A-II/LC3-II, lipid modified form of MAP1LC3A; MERTK, c-mer proto-oncogene tyrosine kinase;   myosin II, non-muscle myosin II; PS, phosphatidylserine; PROS1, protein S (alpha); POS, photoreceptor outer segments;   RAC1, RAS-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1); RHOA, RAS homolog gene  family, member A; RB, residual bodies; SQSTM1/p62, sequestosome 1 are referred to as nonprofessional phagocytes.1 The clearance  of apoptotic substrates by nonprofessional phagocytes plays an important role in tissue homeostasis and is referred to as homeo - static phagocytosis.",Non-OADS,/arxiv_data1/oa_pdf/e1/71/auto-9-653.PMC3669177.pdf
T rends Cell Biol 1995;  5:85-7; PMID:14732160; http://dx.doi.org/10.1016/ S0962-8924(00)88955-2 2.,OADS,/arxiv_data1/oa_pdf/e1/71/auto-9-653.PMC3669177.pdf
J Cell Biol  2010; 189:1059-70; PMID:20584912; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e1/71/auto-9-653.PMC3669177.pdf
Endocrinology 1986; 119:1673-81;  PMID:3757907; http://dx.doi.org/10.1210/endo-119- 4-1673 4.,Non-OADS,/arxiv_data1/oa_pdf/e1/71/auto-9-653.PMC3669177.pdf
Prog Retin Eye Res 2007; 26:263-301;  PMID:17258931; http://dx.doi.org/10.1016/j.pretey- eres.2006.12.002 5.,Non-OADS,/arxiv_data1/oa_pdf/e1/71/auto-9-653.PMC3669177.pdf
Biol Reprod  1999; 61:1541-7; PMID:10570001; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e1/71/auto-9-653.PMC3669177.pdf
J Biol Chem 2002; 277:17016- 22; PMID:11861639; http://dx.doi.org/10.1074/jbc.M107876200 7.,OADS,/arxiv_data1/oa_pdf/e1/71/auto-9-653.PMC3669177.pdf
Rev Infect Dis 1981;  3:282-8; PMID:7020045; http://dx.doi.org/10.1093/clinids/3.2.282 8.,Non-OADS,/arxiv_data1/oa_pdf/e1/71/auto-9-653.PMC3669177.pdf
T rends  Cell Biol 2006; 16:189-97; PMID:16529932; http://dx.doi.org/10.1016/j.tcb.2006.02.003 9.,OADS,/arxiv_data1/oa_pdf/e1/71/auto-9-653.PMC3669177.pdf
J Biol Chem 2002; 277:27559- 66; PMID:12016218; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/e1/71/auto-9-653.PMC3669177.pdf
Nat Rev Immunol 2008; 8:327-36; PMID:18421305; http://dx.doi.org/10.1038/nri230313.,Non-OADS,/arxiv_data1/oa_pdf/e1/71/auto-9-653.PMC3669177.pdf
Invest Ophthalmol Vis Sci 2003; 44:826-38;  PMID:12556419; http://dx.doi.org/10.1167/iovs.02- 0438 14.,Non-OADS,/arxiv_data1/oa_pdf/e1/71/auto-9-653.PMC3669177.pdf
Reproduction 2008; 135:77-87; PMID:18159085;  http://dx.doi.org/10.1530/REP-07-0287 15.,Non-OADS,/arxiv_data1/oa_pdf/e1/71/auto-9-653.PMC3669177.pdf
Nature  1999; 398:723-8; PMID:10227296; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e1/71/auto-9-653.PMC3669177.pdf
Exp Eye Res 2005; 81:581-91; PMID:15949798;  http://dx.doi.org/10.1016/j.exer.2005.03.017 17.,OADS,/arxiv_data1/oa_pdf/e1/71/auto-9-653.PMC3669177.pdf
Mol Cell Neurosci  2006; 33:96-108; PMID:16901715; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e1/71/auto-9-653.PMC3669177.pdf
Nat Immunol 2003; 4:87-91; PMID:12447359; http://dx.doi.org/10.1038/ni871 19.,Non-OADS,/arxiv_data1/oa_pdf/e1/71/auto-9-653.PMC3669177.pdf
J Neuroimmune Pharmacol  2008; 3:130-40; PMID:18247125; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e1/71/auto-9-653.PMC3669177.pdf
Science 1998; 282:1717-21; PMID:9831565;  http://dx.doi.org/10.1126/science.282.5394.1717 21.,Non-OADS,/arxiv_data1/oa_pdf/e1/71/auto-9-653.PMC3669177.pdf
Nat Cell Biol 2000; 2:191-6; PMID:11025683;  http://dx.doi.org/10.1038/35036454 22.,OADS,/arxiv_data1/oa_pdf/e1/71/auto-9-653.PMC3669177.pdf
Invest Ophthalmol Vis Sci 2009; 50:2427-35;  PMID:19117932; http://dx.doi.org/10.1167/iovs.08- 3058 23.,Non-OADS,/arxiv_data1/oa_pdf/e1/71/auto-9-653.PMC3669177.pdf
EMBO J 2011; 30:636- 51; PMID:21169990; http://dx.doi.org/10.1038/ emboj.2010.338 24.,Non-OADS,/arxiv_data1/oa_pdf/e1/71/auto-9-653.PMC3669177.pdf
Nat Cell Biol 2010; 12:814-22;  PMID:20811353; http://dx.doi.org/10.1038/ ncb0910-814 25.,OADS,/arxiv_data1/oa_pdf/e1/71/auto-9-653.PMC3669177.pdf
PLoS Biol 2006; 4:e36;  PMID:16464128; http://dx.doi.org/10.1371/journal.,OADS,/arxiv_data1/oa_pdf/e1/71/auto-9-653.PMC3669177.pdf
Science 2004; 306:1037-40; PMID:15528445; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e1/71/auto-9-653.PMC3669177.pdf
Nature 2007; 450:1253-7; PMID:18097414;  http://dx.doi.org/10.1038/nature06421 28.,Non-OADS,/arxiv_data1/oa_pdf/e1/71/auto-9-653.PMC3669177.pdf
J Biol Chem 2007; 282:2695-706; PMID:17135247;  http://dx.doi.org/10.1074/jbc.M609784200 29.,OADS,/arxiv_data1/oa_pdf/e1/71/auto-9-653.PMC3669177.pdf
Proc Natl Acad Sci U S A  2008; 105:16952-7; PMID:18971338; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e1/71/auto-9-653.PMC3669177.pdf
Methods Enzymol 2009; 452:181-97;  PMID:19200883; http://dx.doi.org/10.1016/S0076- 6879(08)03612-4 31.,OADS,/arxiv_data1/oa_pdf/e1/71/auto-9-653.PMC3669177.pdf
FEBS Lett 2010; 584:1319-26;  PMID:20083107; http://dx.doi.org/10.1016/j.febs- let.2010.01.020 32.,OADS,/arxiv_data1/oa_pdf/e1/71/auto-9-653.PMC3669177.pdf
Cell 2007; 128:931-46; PMID:17350577; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e1/71/auto-9-653.PMC3669177.pdf
Biol Reprod 2008; 78:697-704;  PMID:18094362; http://dx.doi.org/10.1095/biolre- prod.107.063107 35.,Non-OADS,/arxiv_data1/oa_pdf/e1/71/auto-9-653.PMC3669177.pdf
J Biol Chem 2003; 278:45720- 9; PMID:12941957; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/e1/71/auto-9-653.PMC3669177.pdf
J Cell Biol 1973; 58:650- 61; PMID:4747920; http://dx.doi.org/10.1083/ jcb.58.3.650,OADS,/arxiv_data1/oa_pdf/e1/71/auto-9-653.PMC3669177.pdf
Dev Ophthalmol 2003; 37:141-54; PMID:12876835;  http://dx.doi.org/10.1159/000072044 59.,Non-OADS,/arxiv_data1/oa_pdf/e1/71/auto-9-653.PMC3669177.pdf
Biol Reprod 2007; 77:190-201;  PMID:17442851; http://dx.doi.org/10.1095/biolre- prod.107.060558 60.,OADS,/arxiv_data1/oa_pdf/e1/71/auto-9-653.PMC3669177.pdf
EMBO J 2008; 27:2281-92; PMID:19172737;  http://dx.doi.org/10.1038/emboj.2008.156 61.,Non-OADS,/arxiv_data1/oa_pdf/e1/71/auto-9-653.PMC3669177.pdf
Prog Lipid  Res 1983; 22:79-131; PMID:6348799; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e1/71/auto-9-653.PMC3669177.pdf
Mol Cell Endocrinol 1998; 142:75-86;  PMID:9783905; http://dx.doi.org/10.1016/S0303- 7207(98)00115-4 63.,OADS,/arxiv_data1/oa_pdf/e1/71/auto-9-653.PMC3669177.pdf
Amino Acids 2000; 19:561-70; PMID:11140359;  http://dx.doi.org/10.1007/s007260070006 64.,OADS,/arxiv_data1/oa_pdf/e1/71/auto-9-653.PMC3669177.pdf
Anal Biochem 1992; 204:220-6; PMID:1514691;  http://dx.doi.org/10.1016/0003-2697(92)90165-4 65.,OADS,/arxiv_data1/oa_pdf/e1/71/auto-9-653.PMC3669177.pdf
Cell 2010; 140:313-26; PMID:20144757; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e1/71/auto-9-653.PMC3669177.pdf
Hum Exp Toxicol  1996; 15:406-10; PMID:8735465; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e1/71/auto-9-653.PMC3669177.pdf
Cell Biol Toxicol 2003; 19:107-19; PMID:12776928;  http://dx.doi.org/10.1023/A:1023359222963 51.,Non-OADS,/arxiv_data1/oa_pdf/e1/71/auto-9-653.PMC3669177.pdf
Cancer Res 2006; 66:6861-70; PMID:16818664; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e1/71/auto-9-653.PMC3669177.pdf
Cell Death Differ  2009; 16:966-75; PMID:19325568; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e1/71/auto-9-653.PMC3669177.pdf
Ann N Y Acad  Sci 1989; 564:154-72; PMID:2672955; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e1/71/auto-9-653.PMC3669177.pdf
Int J Biochem Cell Biol  1998; 30:1001-10; PMID:9785463; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e1/71/auto-9-653.PMC3669177.pdf
"Livera G, Rouiller-Fabre V, Pairault C, Levacher C, Habert R. Regulation and perturbation of testicular  functions by vitamin A. Reproduction 2002; 124:173- 80; PMID:12141930; http://dx.doi.org/10.1530/ rep.0.124017338.",Non-OADS,/arxiv_data1/oa_pdf/e1/71/auto-9-653.PMC3669177.pdf
Autophagy 2010; 6:36-45; PMID:19901555;  http://dx.doi.org/10.4161/auto.6.1.10324 40.,Non-OADS,/arxiv_data1/oa_pdf/e1/71/auto-9-653.PMC3669177.pdf
Physiology (Bethesda) 2010; 25:8-15; PMID:20134024; http://dx.doi.org/10.1152/ physiol.00038.2009 42.,Non-OADS,/arxiv_data1/oa_pdf/e1/71/auto-9-653.PMC3669177.pdf
J Histochem Cytochem  1995; 43:85-96; PMID:7822769; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e1/71/auto-9-653.PMC3669177.pdf
T rends Cell Biol 1998;  8:365-72; PMID:9728398; http://dx.doi.org/10.1016/ S0962-8924(98)01329-4 45.,OADS,/arxiv_data1/oa_pdf/e1/71/auto-9-653.PMC3669177.pdf
Cell Tissue Res 1991; 264:589- 98; PMID:1907888; http://dx.doi.org/10.1007/ BF00319048 46.,Non-OADS,/arxiv_data1/oa_pdf/e1/71/auto-9-653.PMC3669177.pdf
Mol Biol Cell  2007; 18:4669-80; PMID:17855509; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e1/71/auto-9-653.PMC3669177.pdf
Nat Cell Biol  2011; 13:1076-83; PMID:21804544; http://dx.doi.org/10.1038/ncb2299 48.,OADS,/arxiv_data1/oa_pdf/e1/71/auto-9-653.PMC3669177.pdf
Curr Biol 2002; 12:1413-8;  PMID:12194823; http://dx.doi.org/10.1016/S0960- 9822(02)01069-2,OADS,/arxiv_data1/oa_pdf/e1/71/auto-9-653.PMC3669177.pdf
"www.landesbioscience.com Autophagy 667Autophagy 9:5, 667–682; May 2013; © 2013 Landes Bioscience BAsic ReseAR ch P APeR BAsic ReseAR ch P APeR *Correspondence to: Penny P. Powell, Kostas Kostarelos and Thomas Wileman; Email: p.powell@uea.ac.uk, k.kostarelos@ucl.ac.uk and T.Wileman@uea.ac.uk Submitted: 05/14/12; Revised: 01/30/13; Accepted: 02/04/13http://dx.doi.org/10.4161/auto.23877Introduction Successful gene therapy requires efficient delivery of nucleic  acids into cells.",Non-OADS,/arxiv_data1/oa_pdf/5c/c3/auto-9-667.PMC3669178.pdf
J Biol Chem  2007; 282:24131-45; PMID:17580304; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5c/c3/auto-9-667.PMC3669178.pdf
Dev Cell 2006; 10:839-50;  PMID:16740485; http://dx.doi.org/10.1016/j.dev- cel.2006.04.002 17.,OADS,/arxiv_data1/oa_pdf/5c/c3/auto-9-667.PMC3669178.pdf
J Cell Sci 2004; 117:4837-48; PMID:15340014; http://dx.doi.org/10.1242/ jcs.01370 18.,OADS,/arxiv_data1/oa_pdf/5c/c3/auto-9-667.PMC3669178.pdf
"Arf6 promotes autophagosome formation via  effects on phosphatidylinositol 4,5-bisphosphate  and phospholipase D. J Cell Biol 2012; 196:483- 96; PMID:22351926; http://dx.doi.org/10.1083/ jcb.201110114 21.",Non-OADS,/arxiv_data1/oa_pdf/5c/c3/auto-9-667.PMC3669178.pdf
Nat Cell Biol  2007; 9:1102-9; PMID:17909521; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5c/c3/auto-9-667.PMC3669178.pdf
ACS Nano 2011; 5:7874- 84; PMID:21923168; http://dx.doi.org/10.1021/ nn2020858 11.,OADS,/arxiv_data1/oa_pdf/5c/c3/auto-9-667.PMC3669178.pdf
Autophagy 2010; 6:449-54; PMID:20383065; http://dx.doi.org/10.4161/auto.6.4.11612 12.,Non-OADS,/arxiv_data1/oa_pdf/5c/c3/auto-9-667.PMC3669178.pdf
J Biol Chem 2010; 285:1371- 83; PMID:19910472; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/5c/c3/auto-9-667.PMC3669178.pdf
Autophagy 2009; 5:307- 13; PMID:19182529; http://dx.doi.org/10.4161/ auto.5.3.7664 14.,Non-OADS,/arxiv_data1/oa_pdf/5c/c3/auto-9-667.PMC3669178.pdf
J Biol Chem 1995; 270:18997-9007; PMID:7642560; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5c/c3/auto-9-667.PMC3669178.pdf
Curr  Opin Biotechnol 2010; 21:640-5; PMID:20674331;  http://dx.doi.org/10.1016/j.copbio.2010.07.003 2.,OADS,/arxiv_data1/oa_pdf/5c/c3/auto-9-667.PMC3669178.pdf
J Biol Chem 2002; 277:18021- 8; PMID:11875062; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/5c/c3/auto-9-667.PMC3669178.pdf
Biomaterials  2010; 31:5894-902; PMID:20452664; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5c/c3/auto-9-667.PMC3669178.pdf
Mol Ther 2005; 11:336-47; PMID:15727930; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5c/c3/auto-9-667.PMC3669178.pdf
Curr Gene  Ther 2008; 8:335-52; PMID:18855631; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5c/c3/auto-9-667.PMC3669178.pdf
Nat Cell Biol 2010; 12:831- 5; PMID:20811355; http://dx.doi.org/10.1038/ ncb0910-831 7.,OADS,/arxiv_data1/oa_pdf/5c/c3/auto-9-667.PMC3669178.pdf
Cell 2011; 147:728-41;  PMID:22078875; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/5c/c3/auto-9-667.PMC3669178.pdf
Autophagy 2010; 6:36-45; PMID:19901555;  http://dx.doi.org/10.4161/auto.6.1.10324 23.,Non-OADS,/arxiv_data1/oa_pdf/5c/c3/auto-9-667.PMC3669178.pdf
EMBO J 2010; 29:1792- 802; PMID:20418806; http://dx.doi.org/10.1038/ emboj.2010.74,OADS,/arxiv_data1/oa_pdf/5c/c3/auto-9-667.PMC3669178.pdf
"Do not distribute.www.landesbioscience.com  Autophagy  683A utophagy 9:5, 683–696; May 2013; © 2013 Landes Bioscience BAsic Rese ARch  PAP e R BAsic Rese ARch  PAP e R *Correspondence to: Kathryn C. Zoon; Email: kzoon@niaid.nih.gov Submitted: 10/27/11; Revised: 02/03/13; Accepted: 02/07/13http://dx.doi.org/10.4161/auto.23921Introduction Type I interferons (IFNs) are a pleiotropic family of   cytokines with known antiviral, antiproliferative and Autophagy is an evolutionarily conserved cellular recycling mechanism that occurs at a basal level in all cells.",Non-OADS,/arxiv_data1/oa_pdf/e5/c8/auto-9-683.PMC3669179.pdf
Pharmaceuticals (Basel) 2010; 3:994-1015; PMID:20664817; http://dx.doi.org/10.3390/ph3040994 2.,Non-OADS,/arxiv_data1/oa_pdf/e5/c8/auto-9-683.PMC3669179.pdf
Growth Factors 2004; 22:243-51; PMID:15621727; http://dx.doi.org/10.1080/08977190400000833 3.,Non-OADS,/arxiv_data1/oa_pdf/e5/c8/auto-9-683.PMC3669179.pdf
Nature 1985; 313:597-600; PMID:3881681; http://dx.doi.org/10.1038/313597a0 5.,Non-OADS,/arxiv_data1/oa_pdf/e5/c8/auto-9-683.PMC3669179.pdf
J Virol 2010; 84:10671-80; PMID:20686046; http://dx.doi.org/10.1128/JVI.00818-10 6.,Non-OADS,/arxiv_data1/oa_pdf/e5/c8/auto-9-683.PMC3669179.pdf
Cancer Lett 1999; 142:23-30; PMID:10424777; http://dx.doi.org/10.1016/S0304-3835(99)00109-3 7.,Non-OADS,/arxiv_data1/oa_pdf/e5/c8/auto-9-683.PMC3669179.pdf
J Biol Chem 1997; 272:21872-7; PMID:9268319; http://dx.doi.org/10.1074/jbc.272.35.21872 8.,OADS,/arxiv_data1/oa_pdf/e5/c8/auto-9-683.PMC3669179.pdf
Pharmacol Ther 2003; 98:129-42; PMID:12725866; http://dx.doi.org/10.1016/S0163-7258(03)00016-0 10.,Non-OADS,/arxiv_data1/oa_pdf/e5/c8/auto-9-683.PMC3669179.pdf
Cell Cycle 2008; 7:2112-6; PMID:18635959; http://dx.doi.org/10.4161/cc.7.14.6258 11.,OADS,/arxiv_data1/oa_pdf/e5/c8/auto-9-683.PMC3669179.pdf
J Cell Sci 2011; 124:161-70; PMID:21187343; http://dx.doi.org/10.1242/jcs.064576 13.,OADS,/arxiv_data1/oa_pdf/e5/c8/auto-9-683.PMC3669179.pdf
Curr Opin Immunol 2006; 18:375-82; PMID:16782319; http://dx.doi.org/10.1016/j.coi.2006.05.019 14.,OADS,/arxiv_data1/oa_pdf/e5/c8/auto-9-683.PMC3669179.pdf
Immunity 2007; 27:11-21; PMID:17663981; http://dx.doi.org/10.1016/j.immu-ni.2007.07.00415.,OADS,/arxiv_data1/oa_pdf/e5/c8/auto-9-683.PMC3669179.pdf
Nat Rev Mol Cell Biol 2008; 9:1004-10; PMID:18971948; http://dx.doi.org/10.1038/nrm2529 16.,Non-OADS,/arxiv_data1/oa_pdf/e5/c8/auto-9-683.PMC3669179.pdf
J Cell Sci 2004; 117:2805-12; PMID:15169837; http://dx.doi.org/10.1242/jcs.01131 17.,OADS,/arxiv_data1/oa_pdf/e5/c8/auto-9-683.PMC3669179.pdf
J Biol Chem 1998; 273:33889-92; PMID:9852036; http://dx.doi.org/10.1074/jbc.273.51.33889 18.,OADS,/arxiv_data1/oa_pdf/e5/c8/auto-9-683.PMC3669179.pdf
J Cell Biol 2005; 171:603-14; PMID:16286508; http://dx.doi.org/10.1083/jcb.200507002 19.,OADS,/arxiv_data1/oa_pdf/e5/c8/auto-9-683.PMC3669179.pdf
Nat Rev Mol Cell Biol 2011; 12:21-35; PMID:21157483; http://dx.doi.org/10.1038/nrm3025 20.,OADS,/arxiv_data1/oa_pdf/e5/c8/auto-9-683.PMC3669179.pdf
Sci Signal 2012; 5:pe13; PMID:22457329; http://dx.doi.org/10.1126/scisignal.2003019 21.,OADS,/arxiv_data1/oa_pdf/e5/c8/auto-9-683.PMC3669179.pdf
Cell 2004; 119:753-66; PMID:15607973; http://dx.doi.org/10.1016/j.cell.2004.11.038 22.,OADS,/arxiv_data1/oa_pdf/e5/c8/auto-9-683.PMC3669179.pdf
J Cell Biol 2002; 157:455-68; PMID:11980920; http://dx.doi.org/10.1083/jcb.200109094 23.,OADS,/arxiv_data1/oa_pdf/e5/c8/auto-9-683.PMC3669179.pdf
J Biol Chem 2005; 280:20722-9; PMID:15778222; http://dx.doi.org/10.1074/jbc.M413934200 24.,OADS,/arxiv_data1/oa_pdf/e5/c8/auto-9-683.PMC3669179.pdf
Annu Rev Pathol 2008; 3:427-55; PMID:18039129; http://dx.doi.org/10.1146/annurev.pathmechdis.2.010506.091842 25.,Non-OADS,/arxiv_data1/oa_pdf/e5/c8/auto-9-683.PMC3669179.pdf
J Biol Chem 2009; 284:27808-15; PMID:19687011; http://dx.doi.org/10.1074/jbc.M109.028324 26.,OADS,/arxiv_data1/oa_pdf/e5/c8/auto-9-683.PMC3669179.pdf
Cancer Cell 2008; 13:343-54; PMID:18394557; http://dx.doi.org/10.1016/j.ccr.2008.02.001 27.,Non-OADS,/arxiv_data1/oa_pdf/e5/c8/auto-9-683.PMC3669179.pdf
Hepatology 2008; 47:1773-85; PMID:18393362; http://dx.doi.org/10.1002/hep.2214628.,Non-OADS,/arxiv_data1/oa_pdf/e5/c8/auto-9-683.PMC3669179.pdf
T raffic 2006; 7:1590-5; PMID:17040485; http://dx.doi.org/10.1111/j.1600-0854.2006.00495.x 29.,Non-OADS,/arxiv_data1/oa_pdf/e5/c8/auto-9-683.PMC3669179.pdf
Nat Rev Mol Cell Biol 2007; 8:931-7; PMID:17712358; http://dx.doi.org/10.1038/nrm2245 31.,OADS,/arxiv_data1/oa_pdf/e5/c8/auto-9-683.PMC3669179.pdf
Cell Struct Funct 1998; 23:33-42; PMID:9639028; http://dx.doi.org/10.1247/csf.23.33 32.,OADS,/arxiv_data1/oa_pdf/e5/c8/auto-9-683.PMC3669179.pdf
J Cell Biol 1968; 36:617-24; PMID:5645550; http://dx.doi.org/10.1083/jcb.36.3.617 35.,OADS,/arxiv_data1/oa_pdf/e5/c8/auto-9-683.PMC3669179.pdf
J Biol Chem 2006; 281:8518-27; PMID:16415355; http://dx.doi.org/10.1074/jbc.M506182200 36.,OADS,/arxiv_data1/oa_pdf/e5/c8/auto-9-683.PMC3669179.pdf
Clin Cancer Res 2011; 17:654-66; PMID:21325294; http://dx.doi.org/10.1158/1078-0432.CCR-10-2634 37.,Non-OADS,/arxiv_data1/oa_pdf/e5/c8/auto-9-683.PMC3669179.pdf
J Biol Chem 2010; 285:28715-22; PMID:20592027; http://dx.doi.org/10.1074/jbc.M110.133355 38.,OADS,/arxiv_data1/oa_pdf/e5/c8/auto-9-683.PMC3669179.pdf
Cell Host Microbe 2010; 8:422-32; PMID:21075353; http://dx.doi.org/10.1016/j.chom.2010.10.006 39.,OADS,/arxiv_data1/oa_pdf/e5/c8/auto-9-683.PMC3669179.pdf
PLoS One 2009; 4:e4588; PMID:19242543; http://dx.doi.org/10.1371/journal.pone.0004588 40.,Non-OADS,/arxiv_data1/oa_pdf/e5/c8/auto-9-683.PMC3669179.pdf
Nat Rev Immunol 2008; 8:559-68; PMID:18575461; http://dx.doi.org/10.1038/nri2314 41.,Non-OADS,/arxiv_data1/oa_pdf/e5/c8/auto-9-683.PMC3669179.pdf
Mol Psychiatry 2005; 10:538-44; PMID:15494706; http://dx.doi.org/10.1038/sj.mp.4001600,Non-OADS,/arxiv_data1/oa_pdf/e5/c8/auto-9-683.PMC3669179.pdf
J Cell Sci 2009; 122:1707-11; PMID:19461070; http://dx.doi.org/10.1242/jcs.031773 60.,OADS,/arxiv_data1/oa_pdf/e5/c8/auto-9-683.PMC3669179.pdf
Cell 2002; 110:163-75; PMID:12150925; http://dx.doi.org/10.1016/S0092-8674(02)00808-5 62.,OADS,/arxiv_data1/oa_pdf/e5/c8/auto-9-683.PMC3669179.pdf
Genes Cells 2004; 9:359-66; PMID:15066126; http://dx.doi.org/10.1111/j.1356-9597.2004.00727.x 63.,OADS,/arxiv_data1/oa_pdf/e5/c8/auto-9-683.PMC3669179.pdf
J Interferon Cytokine Res 2006; 26:866-76; PMID:17238829; http://dx.doi.org/10.1089/jir.2006.26.866 64.,OADS,/arxiv_data1/oa_pdf/e5/c8/auto-9-683.PMC3669179.pdf
Cytometry A 2011; 79:507-17; PMID:21538841; http://dx.doi.org/10.1002/cyto.a.21071 66.,Non-OADS,/arxiv_data1/oa_pdf/e5/c8/auto-9-683.PMC3669179.pdf
Autophagy 2012; 8:1371-82; PMID:22895056; http://dx.doi.org/10.4161/auto.2102851.,Non-OADS,/arxiv_data1/oa_pdf/e5/c8/auto-9-683.PMC3669179.pdf
J Biol Chem 1995; 270:15938-41; PMID:7608146; http://dx.doi.org/10.1074/jbc.270.27.15938 52.,OADS,/arxiv_data1/oa_pdf/e5/c8/auto-9-683.PMC3669179.pdf
J Exp Med 2008; 205:315-22; PMID:18227218; http://dx.doi.org/10.1084/jem.20070763 53.,Non-OADS,/arxiv_data1/oa_pdf/e5/c8/auto-9-683.PMC3669179.pdf
Nat Rev Cancer 2002; 2:489-501; PMID:12094235; http://dx.doi.org/10.1038/nrc839 54.,Non-OADS,/arxiv_data1/oa_pdf/e5/c8/auto-9-683.PMC3669179.pdf
J Neuroimmunol 2003; 139:155-9; PMID:12799034; http://dx.doi.org/10.1016/S0165-5728(03)00160-7 55.,Non-OADS,/arxiv_data1/oa_pdf/e5/c8/auto-9-683.PMC3669179.pdf
Biochem Biophys Res Commun 2001; 284:583-6; PMID:11396940; http://dx.doi.org/10.1006/bbrc.2001.5025 56.,OADS,/arxiv_data1/oa_pdf/e5/c8/auto-9-683.PMC3669179.pdf
J Biol Chem 2003; 278:27772-80; PMID:12759354; http://dx.doi.org/10.1074/jbc.M301364200 58.,OADS,/arxiv_data1/oa_pdf/e5/c8/auto-9-683.PMC3669179.pdf
Exp Cell Res 2004; 295:173-82; PMID:15051500; http://dx.doi.org/10.1016/j.yexcr.2003.12.02142.,OADS,/arxiv_data1/oa_pdf/e5/c8/auto-9-683.PMC3669179.pdf
Science 2007; 315:1398-401; PMID:17272685; http://dx.doi.org/10.1126/sci-ence.1136880 44.,OADS,/arxiv_data1/oa_pdf/e5/c8/auto-9-683.PMC3669179.pdf
J Infect Dis 2012; 205:1258-67; PMID:22396599; http://dx.doi.org/10.1093/infdis/jis187 45.,OADS,/arxiv_data1/oa_pdf/e5/c8/auto-9-683.PMC3669179.pdf
PLoS One 2011; 6:e20849; PMID:21695150; http://dx.doi.org/10.1371/journal.pone.0020849 46.,Non-OADS,/arxiv_data1/oa_pdf/e5/c8/auto-9-683.PMC3669179.pdf
Genes Dev 2009; 23:784-7; PMID:19279323; http://dx.doi.org/10.1101/gad.519709 47.,Non-OADS,/arxiv_data1/oa_pdf/e5/c8/auto-9-683.PMC3669179.pdf
Science 1992; 257:809-13; PMID:1496401; http://dx.doi.org/10.1126/science.1496401 48.,OADS,/arxiv_data1/oa_pdf/e5/c8/auto-9-683.PMC3669179.pdf
Genes Dev 1990; 4:1753-65; PMID:2249773; http://dx.doi.org/10.1101/gad.4.10.1753 49.,Non-OADS,/arxiv_data1/oa_pdf/e5/c8/auto-9-683.PMC3669179.pdf
"Cancer Res 2013; 73:160–71; PMID:23149913; http://dx.doi.org/10.1158/0008-5472.CAN-11-3635Keywords:  VEGF-C, NRP-2, WDFY1,  LAMP-2, autophagy, chemotherapy Abbreviations:  BAFA1, bafilomycin A1;  LAMP2, lysosomal-associated membrane  protein 2; MTORC, mechanistic target of rapamycin complex; NRP2, neuro - pilin 2; VEGFC, vascular endothelial growth factor C Submitted: 12/06/12Revised: 01/23/13Accepted: 01/25/13http://dx.doi.org/10.4161/auto.23783 *Correspondence to: Kaustubh Datta;   Email: kaustubh.datta@unmc.eduUnderstanding the molecular mecha - nisms promoting therapy resistance  is important.",Non-OADS,/arxiv_data1/oa_pdf/9d/30/auto-9-789.PMC3669190.pdf
"1Journal of Craniovertebral  Junction and SpineJ JC VS Editor-in-Chief :  Atul Goel  (INDIA)Open Access HTML Format For entire Editorial Board visit :  http://www.jcvjs.com/editorialboard.asp Editorial Instability and basilar invagination Atul Goel Department of Neurosurgery, K.E.M.",Non-OADS,/arxiv_data1/oa_pdf/50/64/JCVJS-3-1.PMC3669466.pdf
"11Journal of Craniovertebral  Junction and SpineJ JC VS Editor-in-Chief :  Atul Goel  (INDIA)Open Access HTML Format For entire Editorial Board visit :  http://www.jcvjs.com/editorialboard.asp Original Article Mechanism and patterns of cervical spine fractures-dislocations in vertebral artery injury Pankaj Gupta, Atin Kumar, Shivanand Gamangatti Department of Radiodiagnosis, All India Institute of Medical Sciences, New Delhi, India Corresponding author: Dr. Atin Kumar, Department of Radiodiagnosis, AIIMS, New Delhi, India.",Non-OADS,/arxiv_data1/oa_pdf/86/55/JCVJS-3-11.PMC3669467.pdf
"16Journal of Craniovertebral  Junction and SpineJ JC VS Editor-in-Chief :  Atul Goel  (INDIA)Open Access HTML Format For entire Editorial Board visit :  http://www.jcvjs.com/editorialboard.asp Case Report Large intradural craniospinal arachnoid cyst: A case  report and review of literature Souvagya Panigrahi, Sudhansu Sekhar Mishra, Srikant Das, Sunil Kumar Patra,  Pratap Chandra Satpathy Department of Neurosurgery, S.C.B.",Non-OADS,/arxiv_data1/oa_pdf/d5/ff/JCVJS-3-16.PMC3669468.pdf
"19Journal of Craniovertebral  Junction and SpineJ JC VS Editor-in-Chief :  Atul Goel  (INDIA)Open Access HTML Format For entire Editorial Board visit :  http://www.jcvjs.com/editorialboard.asp Case Report  Delayed anterior cervical plate dislodgement with  pharyngeal wall perforation and oral extrusion of cervical plate screw after 8 years: A very rare complication Ravindranath Kapu, Manish Singh, Anil Pande, Matabushi Chakravarthy Vasudevan, Ravi  Ramamurthi Post Graduate Institute of Neurological Surgery, Dr. A. Lakshmipathi Neurosurgical Centre, VHS Hospital, Chennai, Tamil Nadu, I ndia Corresponding author: Dr. Ravindranath Kapu, Post Graduate Institute of Neurological Surgery, Dr. A. Lakshmipathi Neurosurgical  Centre, VHS Hospital, IT Corridor,  Taramani Main Road, Chennai - 600 113, Tamil Nadu, India.",Non-OADS,/arxiv_data1/oa_pdf/59/a8/JCVJS-3-19.PMC3669469.pdf
"23Journal of Craniovertebral  Junction and SpineJ JC VS Editor-in-Chief :  Atul Goel  (INDIA)Open Access HTML Format For entire Editorial Board visit :  http://www.jcvjs.com/editorialboard.asp Case Report Pediatric intervertebral disc calcification: A no touch  lesion Monika Garg, Sanyal Kumar, Bhawna Satija, Rajat Gupta1 Departments of Radiodiagnosis and 1Orthopaedics, Employee’s State Insurance Hospital and Post Graduate Institute of Medical Science and  Research, Basaidarapur, New Delhi, India Corresponding author: Dr. Bhawna Satija, B-1/57, First Floor, Paschim Vihar, New Delhi - 110 063, India.",Non-OADS,/arxiv_data1/oa_pdf/7f/41/JCVJS-3-23.PMC3669470.pdf
"26 Journal of Craniovertebral  Junction and SpineEditor-in-Chief :  Atul Goel  (INDIA )Open Access   HTML Format For entire Editorial Board visit :  http://www.jcvjs.com/editorialboard.aspJ JC VS Case Report Syringomyelia as a presenting feature of shunt  dysfunction: Implications for the pathogenesis  of syringomyelia Natarajan Muthukumar Department of Neurosurgery, Madurai Medical College, Madurai, Tamil Nadu, India Corresponding author: Dr. Natarajan Muthukumar, Muruganagam, 138, Anna Nagar, Madurai – 625 020, Tamil Nadu, India.",Non-OADS,/arxiv_data1/oa_pdf/eb/67/JCVJS-3-26.PMC3669471.pdf
3Journal of Craniovertebral  Junction and SpineJ JC VS Editor-in-Chief :  Atul Goel  (INDIA)Open Access HTML Format For entire Editorial Board visit :  http://www.jcvjs.com/editorialboard.asp Review Article Keraunoparalysis: What a neurosurgeon should know  about it?,Non-OADS,/arxiv_data1/oa_pdf/90/81/JCVJS-3-3.PMC3669472.pdf
The application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/90/81/JCVJS-3-3.PMC3669472.pdf
"32Journal of Craniovertebral  Junction and SpineEditor-in-Chief :  Atul Goel  (INDIA)Open Access HTML Format For entire Editorial Board visit :  http://www.jcvjs.com/editorialboard.aspJ JC VS Case Report Primary calcified rhabdoid meningioma of the cranio-cervical junction: A case report and review of literature Mohammad Abolfotoh1,2, Daryoush Tavanaiepour1, Changki Hong1,3, Ian F .",Non-OADS,/arxiv_data1/oa_pdf/c0/cc/JCVJS-3-32.PMC3669473.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/c0/cc/JCVJS-3-32.PMC3669473.pdf
"7Journal of Craniovertebral  Junction and SpineJ JC VS Editor-in-Chief :  Atul Goel  (INDIA)Open Access HTML Format For entire Editorial Board visit :  http://www.jcvjs.com/editorialboard.asp Original Article Management of low back pain in computer users:  A multidisciplinary approach Kiran M. Shete, Prachi Suryawanshi, Neha Gandhi Spinalogy Clinic, Vidya building, Next to Hotel Sarja, ITI Road, Aundh, Pune, Maharashtra, India Corresponding author: Dr. Kiran M. Shete, Spinalogy Clinic, Vidya building, Next to Hotel Sarja, ITI Road, Aundh, Pune - 411 00 7, Maharashtra, India.",Non-OADS,/arxiv_data1/oa_pdf/ea/87/JCVJS-3-7.PMC3669474.pdf
As Available from: http://www.sf-36.org/ announcements/Updated_SF36_bookChapter_Sept04.pdf [Last accessed on 2012 Oct 13].,Non-OADS,/arxiv_data1/oa_pdf/ea/87/JCVJS-3-7.PMC3669474.pdf
Start a QR-code reading  software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the  journal.,Non-OADS,/arxiv_data1/oa_pdf/56/90/JFDS-4-58.PMC3669477.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.Announcement,Non-OADS,/arxiv_data1/oa_pdf/56/90/JFDS-4-58.PMC3669477.pdf
The application can be downloaded  from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/0a/1d/JFDS-4-63.PMC3669478.pdf
"2, Available from: http://lifeloom.com// II2Aggrawal.htm.",Non-OADS,/arxiv_data1/oa_pdf/7d/b1/JFDS-4-70.PMC3669480.pdf
"Source of Support:  Nil, Conflict of Interest:  None declared Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.",Non-OADS,/arxiv_data1/oa_pdf/7d/b1/JFDS-4-70.PMC3669480.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/ id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/0e/ea/JFDS-4-93.PMC3669485.pdf
Available from http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/PediatricAdvisoryCommittee/ UCM204723.pdf .,Non-OADS,/arxiv_data1/oa_pdf/48/8b/40257_2013_Article_20.PMC3669499.pdf
Available from http://www.fda.,Non-OADS,/arxiv_data1/oa_pdf/48/8b/40257_2013_Article_20.PMC3669499.pdf
Accessed 2 April 2012; Novartis 2004–2008 corporate annual reports.Available from http://www.novartis.com/newsroom/corporate-publi cations/archive.shtml .,Non-OADS,/arxiv_data1/oa_pdf/48/8b/40257_2013_Article_20.PMC3669499.pdf
Available from http://www.evaluatepharma.com/ Universal/View.aspx?type=Search&query=elidel .,OADS,/arxiv_data1/oa_pdf/48/8b/40257_2013_Article_20.PMC3669499.pdf
(Using yearly conversion rates available from http://www.mac.,Non-OADS,/arxiv_data1/oa_pdf/48/8b/40257_2013_Article_20.PMC3669499.pdf
"December 8, 2000. http://www.accessdata.fda.gov/drugsatfda_docs/nda/2000/ 50777_Protopic_Approv.pdf .",Non-OADS,/arxiv_data1/oa_pdf/48/8b/40257_2013_Article_20.PMC3669499.pdf
"December 13, 2001. http://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/ 21-302_ELIDEL_Approv.pdf .",OADS,/arxiv_data1/oa_pdf/48/8b/40257_2013_Article_20.PMC3669499.pdf
http://www.fda.gov/Drugs/DrugSafety/Postmarket DrugSafetyInformationforPatientsandProviders/ucm153941.htm .,Non-OADS,/arxiv_data1/oa_pdf/48/8b/40257_2013_Article_20.PMC3669499.pdf
"March 22, 2010. http://www.fda.gov/downloads/AdvisoryCommittees/ CommitteesMeetingMaterials/PediatricAdvisoryCommittee/UCM208036.pdf .",Non-OADS,/arxiv_data1/oa_pdf/48/8b/40257_2013_Article_20.PMC3669499.pdf
"May 16, 2011. http://www.fda.gov/downloads/AdvisoryCommittees/ CommitteesMeetingMaterials/PediatricAdvisoryCommittee/UCM261384.pdf .",Non-OADS,/arxiv_data1/oa_pdf/48/8b/40257_2013_Article_20.PMC3669499.pdf
http://injury-law.freeadvice.com/ injury-law/drug-toxic_chemicals/elidel-lawsuit.htm .,Non-OADS,/arxiv_data1/oa_pdf/48/8b/40257_2013_Article_20.PMC3669499.pdf
http://www.lawyersandsettlements.com/case/elidel.html .,Non-OADS,/arxiv_data1/oa_pdf/48/8b/40257_2013_Article_20.PMC3669499.pdf
http://www.awkolaw.com/elidel/ .,Non-OADS,/arxiv_data1/oa_pdf/48/8b/40257_2013_Article_20.PMC3669499.pdf
http://www.weitz lux.com/eczema-elidel-protopic-cancer_218024.html .,Non-OADS,/arxiv_data1/oa_pdf/48/8b/40257_2013_Article_20.PMC3669499.pdf
2005 April [online].http://www.dermatology.ca/media/position_statement/position_ topical_calcineurin_inhibitors.html .,Non-OADS,/arxiv_data1/oa_pdf/48/8b/40257_2013_Article_20.PMC3669499.pdf
"June 19, 2000. http://www.accessdata.fda.gov/drugsatfda_docs/nda/ 2000/50777_protopic.cfm .",OADS,/arxiv_data1/oa_pdf/48/8b/40257_2013_Article_20.PMC3669499.pdf
"November6, 2001. http://www.accessdata.fda.gov/drugsatfda_docs/nda/ 2001/21-302_Elidel.cfm .",OADS,/arxiv_data1/oa_pdf/48/8b/40257_2013_Article_20.PMC3669499.pdf
"Feb- ruary 15, 2005. http://www.fda.gov/ohrms/dockets/ac/05/slides/ 2005-4089s2_01_06_Hill.ppt .",Non-OADS,/arxiv_data1/oa_pdf/48/8b/40257_2013_Article_20.PMC3669499.pdf
2005. http://www.fda.gov/ohrms/dockets/ac/05/brieﬁng/ 2005-4089b2_01_07_Tox%20Review%20Redacted.pdf .,OADS,/arxiv_data1/oa_pdf/48/8b/40257_2013_Article_20.PMC3669499.pdf
"February 15, 2005. http://www.fda.gov/ohrms/dockets/ac/05/minutes/ 2005-4089m1_Minutes.pdf .",OADS,/arxiv_data1/oa_pdf/48/8b/40257_2013_Article_20.PMC3669499.pdf
"Brieﬁng document from Angelika Manthripragada, Epidemiol- ogist, Division of Epidemiology, Ofﬁce of Surveillance andEpidemiology, FDA Center for Drug Evaluation and Research.Calcineurin inhibitor pediatric literature review, September 23, 2010. http://www.fda.gov/downloads/AdvisoryCommittees/ CommitteesMeetingMaterials/PediatricAdvisoryCommittee/UCM255139.pdf .",Non-OADS,/arxiv_data1/oa_pdf/48/8b/40257_2013_Article_20.PMC3669499.pdf
"Brieﬁng document from Angelika Manthripragada, Epidemiol- ogist, Division of Epidemiology, Ofﬁce of Surveillance andEpidemiology, FDA Center for Drug Evaluation and Research.Addendum: Update on calcineurin inhibitor pediatric literature review, May 10, 2011. http://www.fda.gov/downloads/Advisory Committees/CommitteesMeetingMaterials/PediatricAdvisoryCommittee/UCM255140.pdf .",Non-OADS,/arxiv_data1/oa_pdf/48/8b/40257_2013_Article_20.PMC3669499.pdf
http://seer.cancer.gov/faststats .,Non-OADS,/arxiv_data1/oa_pdf/48/8b/40257_2013_Article_20.PMC3669499.pdf
"Melanocytic lesions in children and adolescents, March 22, 2010. http://www.fda.gov/ downloads/AdvisoryCommittees/CommitteesMeetingMaterials/PediatricAdvisoryCommittee/UCM207878.pdf .",Non-OADS,/arxiv_data1/oa_pdf/48/8b/40257_2013_Article_20.PMC3669499.pdf
"Protopic /C210(tacrolimus) Ointment, February 15, 2005. http://www.fda.gov/ohrms/dockets/ac/05/slides/2005-4089s2_ 03_01_Fujsawa%20FDA%20Feb%2015.ppt .",OADS,/arxiv_data1/oa_pdf/48/8b/40257_2013_Article_20.PMC3669499.pdf
"Discussion topic: risk evaluation, labeling, risk communication, and disseminationof information on potential cancer risk among pediatric patients treated for atopic dermatitis with topical dermatological immunosuppressants, January 27, 2005. http://www.fda.gov/ ohrms/dockets/ac/05/brieﬁng/2005-4089b2_02_02_Protopic%20Fujisawa%20brieﬁng.pdf .",Non-OADS,/arxiv_data1/oa_pdf/48/8b/40257_2013_Article_20.PMC3669499.pdf
"BPCA drug use review: comparison of Elidel /C210cream and Protopic/C210 ointment utilization trends following 2006 labeling changes, July 17, 2009. http://www.fda.gov/downloads/AdvisoryCom mittees/CommitteesMeetingMaterials/PediatricAdvisoryComm ittee/UCM204723.pdf .",Non-OADS,/arxiv_data1/oa_pdf/48/8b/40257_2013_Article_20.PMC3669499.pdf
http://www.nationaleczema.org/ eczema-treatments/topical-corticosteroids Accessed 2 Apr 2012.,Non-OADS,/arxiv_data1/oa_pdf/48/8b/40257_2013_Article_20.PMC3669499.pdf
October 2011. http://www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulatoryInformation/Guidances/ucm07 5096.pdf .,Non-OADS,/arxiv_data1/oa_pdf/48/8b/40257_2013_Article_20.PMC3669499.pdf
http://www.fda.gov/ NewsEvents/Newsroom/PressAnnouncements/2011/ucm245848.,Non-OADS,/arxiv_data1/oa_pdf/48/8b/40257_2013_Article_20.PMC3669499.pdf
"June 19, 2000. http://www.accessdata.fda.gov/drugsatfda_docs/nda/2000/50777_protopic.cfm .",OADS,/arxiv_data1/oa_pdf/48/8b/40257_2013_Article_20.PMC3669499.pdf
"Topical tacrolimus ointment (Protopic /C210), May 16, 2011. http://www.fda.gov/downloads/AdvisoryCommittees/ CommitteesMeetingMaterials/PediatricAdvisoryCommittee/ UCM261387.pdf .",Non-OADS,/arxiv_data1/oa_pdf/48/8b/40257_2013_Article_20.PMC3669499.pdf
"November 6, 2001. http://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/ 21-302_Elidel.cfm .",OADS,/arxiv_data1/oa_pdf/48/8b/40257_2013_Article_20.PMC3669499.pdf
H-120.988 2012. https://ssl3.ama-assn.org/apps/ecomm/PolicyFinderForm.,Non-OADS,/arxiv_data1/oa_pdf/48/8b/40257_2013_Article_20.PMC3669499.pdf
http://www.cancernetwork.com/co nference-reports/sabcs2010/ content/article/10165/1754922 .,Non-OADS,/arxiv_data1/oa_pdf/db/1a/10549_2013_Article_2573.PMC3669502.pdf
Version 2.2001. http://www.nccn.org/professionals /physician_gls/pdf/breast.pdf .,Non-OADS,/arxiv_data1/oa_pdf/db/1a/10549_2013_Article_2573.PMC3669502.pdf
http://clinicaltrials.gov/ ct2/show/NCT00541086 .,Non-OADS,/arxiv_data1/oa_pdf/db/1a/10549_2013_Article_2573.PMC3669502.pdf
http://ctep.cancer.gov/protocolD evelopment/electronic_applica- tions/docs/ctcaev3.pdf .,Non-OADS,/arxiv_data1/oa_pdf/db/1a/10549_2013_Article_2573.PMC3669502.pdf
"For the analysis of the width of nanofibers, the software ImageJ 1.42q (copyright by Wayne Rasband, National Institutesof Health, USA; http://rsb.info.nih.gov/ij ) was used.",OADS,/arxiv_data1/oa_pdf/6f/b7/396_2012_Article_2866.PMC3669512.pdf
Available at: http://www.fda.gov/ohrms/dockets/ac/cber05.html#Blood Products .,Non-OADS,/arxiv_data1/oa_pdf/72/dc/cit156.PMC3669524.pdf
Available at: http://www.who.int/hiv/pub/vct/ en/hivtestingpolicy04.pdf .,Non-OADS,/arxiv_data1/oa_pdf/72/dc/cit156.PMC3669524.pdf
Available at: http://www.who.int/hiv/pub/vct/htc_ framework/en/index.html .,Non-OADS,/arxiv_data1/oa_pdf/72/dc/cit156.PMC3669524.pdf
Available at: http://www.fda.gov/biologicsbloodvac cines/safetyavailability/hivhometestkits/ucm126460.htm .,Non-OADS,/arxiv_data1/oa_pdf/72/dc/cit156.PMC3669524.pdf
Available at: http://www.nytimes.com/2012/07/04/ health/oraquick-at-home-hiv-test-wins-fda-approval.html .,Non-OADS,/arxiv_data1/oa_pdf/72/dc/cit156.PMC3669524.pdf
Available at: http://www.aidsactioneurope.org/clearinghouse/ search/hiv-home-testing .,Non-OADS,/arxiv_data1/oa_pdf/72/dc/cit156.PMC3669524.pdf
Available at:http://www.nat.org.uk/Information-and-Resources/NAT-publications.,Non-OADS,/arxiv_data1/oa_pdf/72/dc/cit156.PMC3669524.pdf
Available at: http://www.sahivsoc.org/newsroom/ society-news .,Non-OADS,/arxiv_data1/oa_pdf/72/dc/cit156.PMC3669524.pdf
Available at: http://www.gatesfoundation.org/annual-letter/2012/Pages/ home-en.aspx .,Non-OADS,/arxiv_data1/oa_pdf/72/dc/cit156.PMC3669524.pdf
Available at: http://hivnet.org/downloads/pdf/annual_report_checkpoint_20071.pdf .,OADS,/arxiv_data1/oa_pdf/72/dc/cit156.PMC3669524.pdf
Available at: http://poptech.org/system/uploaded_ ﬁles/27/origi nal/Project_Masiluleke_Brief.pdf .,Non-OADS,/arxiv_data1/oa_pdf/72/dc/cit156.PMC3669524.pdf
Avail- able at: http://www.who.int/hiv/pub/vct/9789241501033/en/index.html .,Non-OADS,/arxiv_data1/oa_pdf/72/dc/cit156.PMC3669524.pdf
Available at: http://www.cdc.gov/ nchhstp/newsroom/docs/2012/CDC-MSM-0612-508.pdf .,Non-OADS,/arxiv_data1/oa_pdf/72/dc/cit156.PMC3669524.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/ licenses/by/3.0/), which permits unrestricted reuse, distribution, and reproduction inany medium, provided the original work is properly cited.DOI: 10.1093/cid/cit192 Outbreaks in the Intensive Care Unit CID 2013:57 (1 July) 65",Non-OADS,/arxiv_data1/oa_pdf/da/2e/cit192.PMC3669527.pdf
Cluster Detection SaTScan was used for detection of outbreaks of bacterialspecies ( http://www.satscan.org ).,OADS,/arxiv_data1/oa_pdf/da/2e/cit192.PMC3669527.pdf
Available at: http://www.R-project.org/ .,Non-OADS,/arxiv_data1/oa_pdf/da/2e/cit192.PMC3669527.pdf
Available from: http://www.icmr.nic.in/final/BGDRC- TEchnical%20Report.pdf [Last cited on 2012 Nov 12].,Non-OADS,/arxiv_data1/oa_pdf/3e/ae/LI-30-103.PMC3669548.pdf
Start a QR-code reading  software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the  journal.,Non-OADS,/arxiv_data1/oa_pdf/3e/ae/LI-30-103.PMC3669548.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.Announcement,Non-OADS,/arxiv_data1/oa_pdf/3e/ae/LI-30-103.PMC3669548.pdf
Available from: http://www.who.int/mediacentre/factsheets/fs312/ en/index.html.,Non-OADS,/arxiv_data1/oa_pdf/57/63/LI-30-108.PMC3669549.pdf
Available from: URL: http://mospi.nic.in/Mospi_ New/upload/State_wise_SDP_2004‑05_14mar12.pdf.,OADS,/arxiv_data1/oa_pdf/b0/d0/LI-30-139.PMC3669554.pdf
Available from: http://www.eha‑health.,Non-OADS,/arxiv_data1/oa_pdf/b0/d0/LI-30-139.PMC3669554.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/ id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/b0/d0/LI-30-139.PMC3669554.pdf
Email: raghupathy.a@iiphh.org and nandu.k@iiphh.org   Website: http://ceu.phpc.cam.ac.uk/staff/raghupathy ‑anchala/ Announcement,Non-OADS,/arxiv_data1/oa_pdf/2f/ac/LI-30-148.PMC3669556.pdf
The  application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/0b/96/LI-30-166.PMC3669562.pdf
"A search over PUBMED, URL>  http://www.ncbi.nlm.nih.gov/pubmed< with key word  ‘cognitive decline’ and a filter ‘human studies’ provides  around 10,596 articles related to cognitive decline.",Non-OADS,/arxiv_data1/oa_pdf/5e/41/LI-30-170.PMC3669564.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/7f/1c/LI-30-97.PMC3669567.pdf
W oosley RL: Drugs that prolong the QT interval and/or induce T orsades  de pointes  (Arizon CER T web site) Available from: http://www.azcert.,Non-OADS,/arxiv_data1/oa_pdf/b3/7a/JPP-4-116.PMC3669570.pdf
Available from: http://www.en.wikipedia.org/wiki/impact_factor.,OADS,/arxiv_data1/oa_pdf/6c/bc/JPP-4-125.PMC3669571.pdf
Available from: http://www.harzing.com.,Non-OADS,/arxiv_data1/oa_pdf/6c/bc/JPP-4-125.PMC3669571.pdf
Available from http://www.ease.org.uk/sites/default/files/ease_ statement_ifs_final.pdf.,Non-OADS,/arxiv_data1/oa_pdf/6c/bc/JPP-4-125.PMC3669571.pdf
Available from: http://www.harzing.com/pop_hindex.htm.,Non-OADS,/arxiv_data1/oa_pdf/6c/bc/JPP-4-125.PMC3669571.pdf
Available from: http://www.welfens.,Non-OADS,/arxiv_data1/oa_pdf/6c/bc/JPP-4-125.PMC3669571.pdf
The application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/ee/d1/JPP-4-145.PMC3669577.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/34/70/JPP-4-155.PMC3669580.pdf
The application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/32/f8/JPP-4-162.PMC3669583.pdf
Available from: http://web.tnmgrmu.ac.in/CME/ accreditationcentre.pdf.,Non-OADS,/arxiv_data1/oa_pdf/97/16/JPP-4-164.PMC3669584.pdf
Available from:  http://www.dnaindia.com/ mumbai/report_mumbai‑doctors‑desperate‑to‑get‑credit‑points_1651641.,Non-OADS,/arxiv_data1/oa_pdf/97/16/JPP-4-164.PMC3669584.pdf
"The backbone of the portal is the  database  (http://www.orphadata.org), which houses the  majority of the products that are accessible from the main webpages.",OADS,/arxiv_data1/oa_pdf/0b/ce/JPP-4-168.PMC3669585.pdf
Available from: http://nccam.nih.gov/health/whatiscam/(Last accessed on 2012  May 21).,OADS,/arxiv_data1/oa_pdf/6f/6e/JPP-4-83.PMC3669586.pdf
Start a QR-code reading  software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the  journal.,Non-OADS,/arxiv_data1/oa_pdf/6f/6e/JPP-4-83.PMC3669586.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.Announcement,Non-OADS,/arxiv_data1/oa_pdf/6f/6e/JPP-4-83.PMC3669586.pdf
Available from: http://www.who.int/features/factfiles/ageing/en/index.,OADS,/arxiv_data1/oa_pdf/33/be/JPP-4-91.PMC3669588.pdf
Available form: http://www.who.int/ healthinfo/global_burden_disease/GBD_report_2004update_full.pdf.,Non-OADS,/arxiv_data1/oa_pdf/33/be/JPP-4-91.PMC3669588.pdf
Available  from: http://www.jpgmonline.com/text.asp?2011/57/3/189/85201 [Last cited  on 2012 Mar  18].,Non-OADS,/arxiv_data1/oa_pdf/33/be/JPP-4-91.PMC3669588.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/33/be/JPP-4-91.PMC3669588.pdf
Available from: http://www.thomsonhc.com.,Non-OADS,/arxiv_data1/oa_pdf/b8/6a/JPP-4-95.PMC3669589.pdf
"104 Asian Spine J 2013;7(2):104-110 Copyright Ⓒ 2013 by Korean Society of Spine Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c1/8f/asj-7-104.PMC3669694.pdf
"Keywords: Lumbar vertebrae; Hip; Bone density; Absorptiometry, PhotonClinical Study Asian Spine J 2013;7(2):104-110  •  http://dx.doi.org/10.4184/asj.2013.7.2.104 ASJ Asian Spine Journal Introduction Musculoskeletal disorders are a major leading cause of  long term disability, days of restricted activity and health  care utilization [1].",Non-OADS,/arxiv_data1/oa_pdf/c1/8f/asj-7-104.PMC3669694.pdf
"BMD and chronic low back pain Asian S pine J ournal 105 Copyright Ⓒ 2013 by Korean Society of Spine Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c1/8f/asj-7-104.PMC3669694.pdf
"Prefixed PEEK cage plate system Asian S pine J ournal 111 Copyright Ⓒ 2013 by Korean Society of Spine Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a6/b7/asj-7-111.PMC3669695.pdf
Keywords: Fracture dislocation; Cage; Anterior reductionTechnical Note Asian Spine J 2013;7(2):111-114  •  http://dx.doi.org/10.4184/asj.2013.7.2.111 ASJ Asian Spine Journal Introduction Distractive flexion injury is the most common injury of  the lower cervical spine [1].,Non-OADS,/arxiv_data1/oa_pdf/a6/b7/asj-7-111.PMC3669695.pdf
"V-Rod technique Asian S pine J ournal 115 Copyright Ⓒ 2013 by Korean Society of Spine Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/99/b2/asj-7-115.PMC3669696.pdf
"Keywords: Spondylolysis; V-rod technique; Apophyseal ring fractureTechnical Note Asian Spine J 2013;7(2):115-118  •  http://dx.doi.org/10.4184/asj.2013.7.2.115 ASJ Asian Spine Journal Introduction Lumbar spondylolysis and apophyseal ring fractures [1,2]  are not uncommon in children and adolescents.",Non-OADS,/arxiv_data1/oa_pdf/99/b2/asj-7-115.PMC3669696.pdf
"Anterior cervical arachnoid cyst Asian S pine J ournal 119 Copyright Ⓒ 2013 by Korean Society of Spine Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b1/9d/asj-7-119.PMC3669697.pdf
"Keywords: Cervical; Arachnoid cyst; Intradural; Review of the literature; Spinal Case Report Asian Spine J 2013;7(2):119-125  •  http://dx.doi.org/10.4184/asj.2013.7.2.119 ASJ Asian Spine Journal Introduction Intradural arachnoid cysts are uncommon and arise  in thoracic, lumbar and cervical region in decreasing  frequency.",Non-OADS,/arxiv_data1/oa_pdf/b1/9d/asj-7-119.PMC3669697.pdf
"126 Asian Spine J 2013;7(2):126-130 Copyright Ⓒ 2013 by Korean Society of Spine Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/33/09/asj-7-126.PMC3669698.pdf
Keywords: Thoracic vertebrae; Paraplegia; Disc herniationCase Report Asian Spine J 2013;7(2):126-130  •  http://dx.doi.org/10.4184/asj.2013.7.2.126 ASJ Asian Spine Journal Introduction Hyperextension injury in the thoracic spine is uncom - mon and can be caused by direct or indirect trauma [1- 4].,Non-OADS,/arxiv_data1/oa_pdf/33/09/asj-7-126.PMC3669698.pdf
"Hyperextension injury in thoracic spine Asian S pine J ournal 127 Copyright Ⓒ 2013 by Korean Society of Spine Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/33/09/asj-7-126.PMC3669698.pdf
"Acute Schmorl node in dorsal spine Asian S pine J ournal 131 Copyright Ⓒ 2013 by Korean Society of Spine Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/db/21/asj-7-131.PMC3669699.pdf
"Keywords: Magnetic resonance imaging; Acute painful Schmorl node; Intravertebral disc herniationCase Report Asian Spine J 2013;7(2):131-135  •  http://dx.doi.org/10.4184/asj.2013.7.2.131 ASJ Asian Spine Journal Introduction Schmorl nodes, classically known as intravertebral disc  herniations, were first described by Schmorl in 1927 [1].",Non-OADS,/arxiv_data1/oa_pdf/db/21/asj-7-131.PMC3669699.pdf
"136 Asian Spine J 2013;7(2):136-138 Copyright Ⓒ 2013 by Korean Society of Spine Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/50/61/asj-7-136.PMC3669700.pdf
Keywords:  Epidural; Varix; Perineural cyst; SurgeryCase Report Asian Spine J 2013;7(2):136-138  •  http://dx.doi.org/10.4184/asj.2013.7.2.136 ASJ Asian Spine Journal Introduction Lumbar epidural varices are enlarged venous structures  located around the dura mater of the spinal cord.,Non-OADS,/arxiv_data1/oa_pdf/50/61/asj-7-136.PMC3669700.pdf
"Lumbar epidural varix Asian S pine J ournal 137 Copyright Ⓒ 2013 by Korean Society of Spine Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/50/61/asj-7-136.PMC3669700.pdf
"Intradural extramedullary spinal anaplastic ependymoma Asian S pine J ournal 139 Copyright Ⓒ 2013 by Korean Society of Spine Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bf/1f/asj-7-139.PMC3669701.pdf
Keywords:  Ependymoma; Intradural extramedullary spinal cord neoplasms; Spinal cord tumorCase Report Asian Spine J 2013;7(2):139-142  •  http://dx.doi.org/10.4184/asj.2013.7.2.139 ASJ Asian Spine Journal Introduction Spinal ependymomas are the most common intramedul - lary tumors and occur predominantly in adults.,Non-OADS,/arxiv_data1/oa_pdf/bf/1f/asj-7-139.PMC3669701.pdf
"Endoscopic surgery for spine tumor Asian S pine J ournal 143 Copyright Ⓒ 2013 by Korean Society of Spine Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/24/d4/asj-7-143.PMC3669702.pdf
Keywords:  Endoscopic surgery; Osteoid osteoma; Cervical spineCase Report Asian Spine J 2013;7(2):143-147  •  http://dx.doi.org/10.4184/asj.2013.7.2.143 ASJ Asian Spine Journal Introduction Spinal endoscopic surgery is mainly performed for lum - bar spine disorders.,Non-OADS,/arxiv_data1/oa_pdf/24/d4/asj-7-143.PMC3669702.pdf
"148 Asian Spine J 2013;7(2):148-155 Copyright Ⓒ 2013 by Korean Society of Spine Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c9/96/asj-7-148.PMC3669703.pdf
"Keywords:  Intravertebral vacuum cleft; Pathogenesis; Vertebroplasty; Kyphoplasty; Kümmell’s disease Review Article Asian Spine J 2013;7(2):148-155  •  http://dx.doi.org/10.4184/asj.2013.7.2.148 ASJ Asian Spine Journal Introduction With the aging population, the incidence of osteoporotic  vertebral compression fractures (OVCFs) is increasing  and becoming a major health-care issue [1,2].",Non-OADS,/arxiv_data1/oa_pdf/c9/96/asj-7-148.PMC3669703.pdf
"The intravertebral vacuum cleft in vertebral fracture Asian S pine J ournal 149 Copyright Ⓒ 2013 by Korean Society of Spine Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c9/96/asj-7-148.PMC3669703.pdf
"156 Asian Spine J 2013;7(2):156-157 Copyright Ⓒ 2013 by Korean Society of Spine Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9f/8f/asj-7-156.PMC3669704.pdf
"Asian Spine Journal • pISSN 1976-1902 eISSN 1976-7846 • www.asianspinejournal.orgReceived Jan 31, 2013; Revised Mar 7, 2013; Accepted Mar 7, 2013 Corresponding author: Amit Agrawal Department of Neurosurgery, Narayana Medical College Hospital,  Chinthareddypalem, Nellore-524003, Andhra Pradesh, India Tel: +91-8096410032, E-mail: dramitagrawal@gmail.comNeglected Fracture-Dislocation of the Cervical  Spine without Neurological Deficits Amit Agrawal1, Saginela Satish Kumar2, Harneet Singh Ghotra1, Surya Pratap Singh1 1Department of Neurosurgery, Narayana Medical College Hospital, Nellore, India 2Department of Emergency Medicine, Narayana Medical College Hospital, Nellore, IndiaLetter to the Editor Asian Spine J 2013;7(2):156-157  •  http://dx.doi.org/10.4184/asj.2013.7.2.156 ASJ Asian Spine Journal Dear Sir,  Neglected spinal injuries, either secondary to over - looked diagnosis [1] or due to circumstantial and socio- economic factors [2], are not uncommon but discussed  infrequently in the literature [1,2].",Non-OADS,/arxiv_data1/oa_pdf/9f/8f/asj-7-156.PMC3669704.pdf
"Neglected fracture-dislocation of cervical spine Asian S pine J ournal 157 Copyright Ⓒ 2013 by Korean Society of Spine Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9f/8f/asj-7-156.PMC3669704.pdf
"158 Asian Spine J 2013;7(2):158-158 Copyright Ⓒ 2013 by Korean Society of Spine Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/51/77/asj-7-158.PMC3669705.pdf
"Group of Hospitals, Grant Medical College, Mumbai, India Asian Spine Journal 2013;7(1):50-54 http://dx.doi.org/10.4184/asj.2013.7.1.50  This article on Asian Spine Journal was initially published without the word ‘Canal’ in the title.",Non-OADS,/arxiv_data1/oa_pdf/51/77/asj-7-158.PMC3669705.pdf
